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The antibacterial activities of oils and extracts from walnut, cashew and pumpkin were 
investigated on methicillin resistant and susceptible strain MRSA 252 and S. aureus ATCC 
6538 using the disc agar diffusion technique. Results revealed that the tested bacteria were 
sensitive to the three oils. Walnut and pumpkin oil showed better activity with clear zones of 
inhibitions. A combinational study of oils with conventional antibiotics shows that MRSA 252 
and ATCC 6538 exhibited different reactions such as synergy, resistant, potentiation and 
indifference effects when combined with the oils. Minimum inhibitory concentration (MIC) 
and minimum biofilm inhibition concentration (MBIC) tests show that inhibitory effect of 
walnut oil against MRSA 252 and S. aureus ATCC 6538 biofilm formation was stronger 
compared to cashew and pumpkin oils. In addition, minimum biofilm eradication concentration 
(MBEC) test revealed that walnut and pumpkin oils were able to eradicate preformed biofilms 
of MRSA 252 and ATCC 6538 within 48 h of growth with eradication from 12 h with reduced 
viable counts. Preliminary investigation of the pathogenicity of the S. aureus strains showed 
that MRSA 252 biofilms were more virulent against Galleria mellonella than S. aureus ATCC 
6538 biofilms. A test to determine whether walnut oil could treat infections caused by both 
strains shows that G. mellonella previously infected with MRSA 252 and S. aureus ATCC 
6538 biofilms were able to survive in a 5-day study even though they developed brownish 
pellicles. Scanning electron microscopy (SEM) of S. aureus biofilms shows that MRSA 252 
and ATCC 6538 biofilms produced different morphological structures and slime confirming 
the complexity of the biofilms. Using molecular methods, polymerase chain reaction (PCR) 
confirms the presence of numerous virulence genes such as adhesion, biofilm and antibiotic 
resistance genes in MRSA 252 and ATCC 6538, gene expression analysis results indicates that 
intercellular adhesion (icaADBC) genes were down-regulated between 6-12 h and only up-
regulated at 24 h, the biofilm formation genes were up-regulated at 12, 24 and 48 h while the 
accessory regulatory gene (agrA) and methicillin resistant (mecA) gene were up-regulated at 
12 and 24 h but down-regulated at 48 h in the strains. Preliminary chemical investigation of 
walnut oil indicates the presence of different compounds that could be responsible for its 
antimicrobial activity. Using gas chromatography–mass spectrometry (GC-MS), major and 
minor fatty acids were identified in walnut oil. Structural elucidation of the fractionated walnut 
oil sample conducted using hydrogen proton NMR (1H NMR), 13C NMR, attached proton test 
(APT), confirmed linolenic acid and glyceric acid as the probable compounds responsible for 
its activity against MRSA 252 and S. aureus ATCC 6538 biofilms.
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Chapter 1. Introduction to Staphylococcus aureus 
1.1 Brief historical perspective of staphylococci 
The staphylococci are members of the family of Gram-positive cocci, Staphylococcaceae, 
which is in the order Bacillaceace (Kuroda et al., 2001). The term Staphylococcus means bunch 
of grapes, for their ability to form clusters which are grape – like (Figure 1). Since many 
decades ago, S. aureus was the first bacterial human pathogen identified (Davies and Davies, 
2010). In 1878, Koch was the first scientist to differentiate gram positive cocci from gram 
negative cocci strains and recognized that human infection such as abscesses is connected with 
the presence of clusters of gram-positive cocci. The author noted that different human diseases 
were caused by staphylococci depending on whether they formed cocci in pairs or clusters. In 
1880, Sir Alexander Ogston, a Scottish surgeon conclusively established the causative role of 
the coccus in abscesses and other suppurative lesions. During Alexander Ogston research 
study, he discovered a cluster forming coccus was the cause of certain pyogenic abscesses in 
human beings when he injected the pus from the knee of a man containing staphylococci into 
mice, and it produced abscesses; however, when the pus was heated and treated with phenol 
no abscesses was produced. Therefore in 1882, Ogston named the bacteria staphylococcus. 
Similarly, Lious pasteur who worked on coagulase testing was able to classify staphylococci 
rather than pigment production, wherein a positive coagulase test was able to identify S. aureus. 
Thereafter, in 1884, Rosenbach succeeded in differentiating staphylococci species based on 
their colonial pigmentation, whereby the most pathogenic staphylococcal strain formed a 
golden pigment and less pathogenic strains produced white colonies. Based on this, Rosenbach 
called the pathogenic strain with golden pigments S. aureus and the less pathogenic strain with 
white colonies S. albus now known as S. epidermidis. 
                        
                 Figure 1. Morphology of S. aureus in cluster, chains and single arrangements  
S. aureus stained by crystal violet and observed under the microscope using 10 x magnification lens  
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1.2 Classification and status of staphylococcal species 
Historically the genera Staphylococcus and Micrococcus were placed together with the genera 
Stomatococcus and Planococcus in the same family, classified Micrococcaceae, but molecular 
test and chemotaxonomic analysis showed that the various catalase positive and gram-positive 
cocci differ (Plata et al., 2009). Based on this, the family Staphylococcaceae and other families 
including Listeriaceae, Planococcaceae, Bacillaceae and Paenibacillaceae are all placed in the 
order Bacillales which belong to the class Bacilli (Vasconcelos and de Souza, 2010). 
As of the year 2014, there are 41 known species and 24 subspecies in the Staphylococcus genus. 
About half of these staphylococcal species are endogenous to humans, including coagulase-
negative species: S. epidermidis, S. saprophyticus, S. cohnii, S. haemolyticus, S. xylosus, S. 
warneri, S. hominis, S. capitis, S. simulans, S. saccharolyticus, S. caprae, S. auricularis, S. 
lugdunensis, and S. schleiferi and coagulase positive species: S. aureus (Vasconcelos and de 
Souza, 2010). 
1.3 Staphylocccus aureus 
1.3.1 Morphology and biochemical characteristics of S. aureus  
S. aureus is a spherical and cluster forming coccus approximately 1µm in diameter (Plata et 
al., 2009) (Figure 2). S. aureus is a non-motile, non-spore former and facultative anaerobe that 
grow by aerobic respiration or by fermentation of glucose that yields mainly lactic acid. S. 
aureus is oxidase negative (Okafor, 2011). The bacterium is catalase, coagulase and mannitol 
positive, a major distinguishing factor of S. aureus from S. epidermidis. S. aureus can grow 
between 15oC - 45oC and at sodium chloride (NaCl) concentrations as high as 15% (Bruins et 
al., 2007). On solid medium, S. aureus form characteristic smooth and translucent golden 
yellow colonies on general purpose medium due to the secretion of carotenoids situated in their 
cell membrane (Trüper and Schleifer, 2006). This carotenoid pigment gives S. aureus its 
characteristic colour and protects the bacteria from the action of toxic oxidants from 







                              
Figure 2. Golden yellow colonies of S. aureus bacterium on agar plate 
Photograph of S. aureus on trypticase soy agar showing a growing pattern of spherical cocci.  
1.3.2 Epidemiology of S. aureus infections 
1.3.2.1 Global epidemiology of S. aureus and MRSA  
Healthcare-associated methicillin resistant S. aureus (HA-MRSA) otherwise referred to as 
hospital associated MRSA are clonal lineages that typically cause hospital-acquired infections, 
whereas community-associated methicillin resistant S. aureus (CA-MRSA) infections are 
composed of different lineages and occur in people with no previous history of hospitalisation 
(Chambers, 2001).  
1.3.2.2 HA-MRSA   
In majority of the hospitals across the world, hospital acquired (HA) types of MRSA are highly 
prevalent. Based on the LEADER Program, data obtained from 2004 and 2005 shows a 
prevalence of 54.3% and 58.2% in the USA (Tenover et al., 2006; Chambers, 2001; Faria et 
al., 2005). Although invasive MRSA infections in healthcare settings seem to be decreasing in 
the USA it is still a threat to patients. Between the year 2005 and 2011, the rates of invasive 
MRSA dropped by 31%; and the largest decrease (55%) was observed among hospital 
infections (CDC, Threat Report 2013). In 2008 and 2011 precisely, MRSA proportions 
observed in Canada and Australia were 27.1% and 30.4% (Potashman et al., 2016; Hassoun, 
Linden & Friedman 2017). In Europe and Northern Europe, MRSA proportions are generally 
lower and higher in both South and South-Eastern countries. In 2012, the average proportion 
of MRSA isolated from invasive infection was 17.9% (EARSS Annual Report, 2012). Only 
two countries, Portugal and Romania reported proportions above 50%, which were 53.8% and 
53.9 (Goossens et al., 2005). Many countries, particularly African countries report a 10%-50% 
average proportion of MRSA isolated from invasive infection in healthcare settings while 
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lower proportions (3%) have been reported in 6 countries, including Denmark (1.3%), Iceland 
(1.7%), Finland (2.1%), the Netherlands (1.3%), Sweden (0.7%) and Norway (1.3%) (Larsen 
et al., 2009; Tavares, 2014). Statistically significant decreasing trends which have been 
observed in some European courtiers, in recent years. Arguably, this has been caused by 
improved infection control as well as the restriction of some antibiotic classes in the hospitals 
globally (Harbarth et al., 2015).  
Currently, many S. aureus isolates (50%) now show resistance to methicillin in most countries 
in East Asian countries including Taiwan (65.1%), Hong Kong (56.9%), Korea (78.6%), 
Vietnam (75.1%), Sri Lanka (87.5%) and Thailand (57.0%) (Nickerson et al., 2012; Chuang 
and Huang, 2013). Countries such as Iran, reported 44.5% S. aureus isolates as MRSA strains 
(Askari et al., 2012). In contrast, lower prevalence was recorded in India and the Philippines 
(22.6%) and (38.1%) S. aureus isolates being MRSA (Mahmood et al., 2010).  
In African countries, the prevalence of MRSA has never been lower than 50% in most of the 
African countries, except for South Africa (19%) (Falagas et al., 2013). Sporadic increase in 
resistant MRSA isolates have been reported in Tunisia, the prevalence of MRSA increased 
from 17% to 41% between 2003 and 2007 (Borg et al., 2007), in Libya it was 32% in 2007. In 
Botswana, the prevalence was between 24–42% between 2001 and 2008. In Algeria and Egypt, 
the prevalence was 45% and 52% between 2003 and 2005, respectively. Ethiopia and Ivory 
Coast recorded a prevalence of 49% and 40%, respectively. In South Africa, the prevalence 
decreased from 37% in 2006 to 25% during 2007–2010 (Borg et al., 2007).  
1.3.2.3 Prevalence of MRSA in Nigeria and other African countries 
In a review conducted in Nigeria, the prevalence was higher in the Northern part than the 
Southern part. The prevalence was 30% and 28% between 2005 and 2010, respectively. 
Majority of the healthcare MRSA were found to be transmitted mostly from personnel infected 
with MRSA to patients. In a review study, conducted in 2013 by the Nnamdi Azikiwe 
University Teaching Hospital, Nnewi, health-care workers including medical doctors, nurses 
and laboratory scientists, accounted for 24%, 35% and 29% of personnel to patient transmission 
of MRSA (Akujobi et al., 2013). Similarly, in 2018, Abdullahi and Iregbu, (2018) conducted 
a study at the National hospital Abuja, Nigeria, and suggested that the carriage rate of MRSA 
among health-care workers was 13.6% and higher prevalence was observed among the clinical 
healthcare workers than the non-clinical staff (10% vs. 3.6%). In 2013, Udobi, and co-workers 
conducted a study in intensive care unit at Ahmadu Bello hospital, Zaria and reported a 
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prevalence of MRSA colonization among healthcare and patients to be 11.83% and 2.1% and 
all MRSA isolates were highly resistant to antibiotics such as penicillin, erythromycin, and 17 
(85.7%) were highly sensitive to vancomycin. Borg and colleagues (2007) reported a high 
prevalence of more than 50% of MRSA strains in countries including Jordan, Malta, Cyprus 
and Egypt. This high prevalence in Nigeria and the neighbouring countries was attributed to 
overcrowding, poor infection control facilities, lack of control of antibiotic usage and poor 
hand-hygiene facilities in the hospitals (Borg et al., 2007). 
Most of MRSA infections are caused by S. aureus strains belonging to a few clonal complexes 
(CC) in hospitals between 1962 and 2007 (Abdulgader et al., 2015).The most prevalent are 
CC5 (USA100 a Japan clone, USA800 a pediatric clone, UK-EMRSA-3, Italian or Southern 
German clone, CC8 a Iberian clone or UK-EMRSA-5 a Rome clone, USA500 or UK-EMRSA-
2 or 6 a Brazilian clone, CC22 or UK-EMRSA-15, CC30 or USA200, UK-EMRSA-16, 
USA1100, the Pacific Oceania clone), and CC45 or USA600, a Berlin clone (In summary, the 
two most abundant clones worldwide are the CC5 and CC8. Two pandemic HA-MRSA clones, 
namely multilocus sequence type (ST) 239 (CC8) and ST5 (CC5), have been spreading in many 
countries. In Nigeria, and her neighbouring countries, isolates of CC5, CC30, CC80 and CC152 
(Figure 3) were non-cytotoxic, whereas isolates of CC22, CC8, CC15, CC45 and CC88 were 
very cytotoxic (Abdulgader et al., 2015).  
 
               
        Figure 3. MRSA clonal complexes identified in Nigeria. Source: Abdulgader et al., (2015). 
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1.3.3 Carriage of S aureus 
S. aureus colonizes the human body without any clinical signs and symptoms and lives as a 
commensal in the human nose. its main habitat is the anterior of the nares (Krismer and Peschel, 
2011). It infects the nasal vestibule, which is the anterior part of the nasal cavity, it resides on 
the small tiny hairs called vibrissae (Wertheim et al., 2005). This organism can also be found 
transiently on the skin, respiratory tract, and intestines. Three main states of human nasal 
carriage patterns exist among healthy individuals in a population (Verhoeven et al., 2014). 
About 20% of healthy individuals never carry S. aureus at all and are thus referred to as non-
carriage individuals (Lamers et al., 2011). Approx. 60% harbour S. aureus but not all the time 
and finally 20% of healthy individuals harbour S. aureus persistently without any clinical signs 
(Wertheim et al., 2005). S. aureus isolates of major concern to the medical society are 
methicillin-sensitive and resistant strains, which are also persistent colonizers. The persistent 
and the intermittent carriers are regarded as being responsible for disseminating S. aureus into 
the hospital and community settings (Kuehnert, et al., 2006). This is because they are carriers 
of S. aureus. The anterior of the nares are lined by epidermis that are fully keratinised with 
sebaceous glands, hairs and sweat glands. The nasal vestibule is enclosed by cartilages present 
in the nose and lined by the epithelium that lines the skin which becomes continuous with the 
nasal mucous membrane (Derycke et al., 2010). Apparently S aureus flourishes here in absence 
of host defenses. For S aureus to adhere in the vestibule, it establishes interaction with host cell 
surfaces to prevent their rapid elimination by both physical and chemical means. To effectively 
colonize the host, it is thought that surface components of S. aureus cells interact with surface 
components such as glycoproteins and proteoglycans which are on the human cell membranes. 
Glycoproteins and proteoglycans are known to contribute to the adhesion of bacteria. Other 
vital surfaces to which S. aureus adheres include surfactant protein A which acts are surface 
receptors, mucin coated epithelial cells, secretory immunoglobulin A and glycolipids (Derycke 
et al., 2010).  
1.3.4 Transmission and risk factors of colonization of human nose with S. aureus  
1.3.4.1 Transmission of S. aureus 
Since S. aureus is a normal human flora and is found in various body sites, infection can occur 
when the colonising strain gain access to a normally sterile site as a result of skin trauma or 
injury to mucosal surfaces (Ricciardi-Castagnoli & Granucci, 2002). Usually trauma incidents 
cause minor injuries to the skin or multiple layers of epithelial tissues. Skin traumas are caused 
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by cuts, abrasion, burns and other forms of injury (Ricciardi-Castagnoli & Granucci, 2002). 
Skin trauma incidents are acute wounds, which have a probability of becoming chronic wounds 
if not manged properly (Stone, 2013). In addition, S. aureus can also be transmitted from person 
to person via contaminated hands and objects or, less often, by inhalation of infected droplets 
dispersed by sneezing or coughing. Once the bacterium is transmitted, it may likely become 
established as the recipient flora and later gain access to a sterile body site (Ricciardi-
Castagnoli and Granucci, 2002; Percival et al., 2015). The spread of S. aureus through direct 
contact with an infected person possess a serious challenge in the hospital settings and 
community.  
1.3.4.2 Risk factors of colonization with S. aureus 
S. aureus can infect anyone at any certain age, but certain people are more prone or are at 
increased risk of developing very serious staphylococcal infections. These include people who 
have a weak immune system or suffered chronic illnesses (Ricciardi-Castagnoli & Granucci, 
2002). Generally, S. aureus infections occur when the immune system of the host is weakened 
and as such it cannot respond to external stimuli (Ricciardi-Castagnoli and Granucci, 2002). 
This means infections occur more in immunocompromised persons with weak immune systems 
(Ricciardi-Castagnoli and Granucci, 2002).  Health conditions such as cancer, autoimmune 
deficiency diseases or have human immunodeficiency virus (AIDS/HIV) and diabetes reduces 
human immunity and increases the danger of hospital associated MRSA (Albertson et al., 
2015).  
Current invasive medical tests such as catheterization, dialysis and surgery increase risk of 
infection because the processes require frequent use of catheters or insertion of needles to 
access the bloodstream (Percival et al., 2015). Also, patients with serious health related 
problems admitted in hospital for long period of time in the intensive care unit are exposed to 
longer use of invasive devices and increased contact with healthcare workers. Therefore, length 
of stay and use of invasive procedures are possible risk factors of acquiring health care 
associated infections (HAI) such as urinary infections associated with catheter, surgical site 
infection and blood infections (Stone, 2013). Patients who undergone surgery continually or 
have implanted medical device such as an artificial joint are at higher risk of infection. This is 
because implants are foreign materials in the human body associated with risk of microbial 
infection (bacterial or fungal infections) overtime. Implant infections occur by inoculation of a 
few pathogen from the patient’s skin or mucous membranes during implantation. At times, the 
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bacterium may be acquired from the hands of the surgical doctors, nurses or other clinical staff 
(Percival et al., 2015). 
Workers in health care centres (assistant physicians, nurses, cleaners, doctors) and people who 
come in contact with these set of workers are also at high risk of MRSA infections (Cohen et 
al., 2012). Children especially new-born are also at high risk of infection because of their low 
immunity (PrabhuDas et al., 2011). Major risk factors for new born includes premature birth 
and low weight A child is premature when born before 38 weeks and this means the infant have 
underdeveloped immune system, making them prone to increase infections (PrabhuDas et al., 
2011; Schaumburg et al., 2014). 
Involvement in matches (for example football, wrestling) (Grosset-Janin et al., 2012) use of 
contaminated materials by many people (razors, towels) (Batabyal et al., 2012; Miller and 
Diep, 2008), inadequate personal hygiene and poor sanitary conditions (Samuel et al., 2010) 
are all community acquired MRSA infections risk factors. 
Interestingly, another MRSA risk factor is companion animals (Cuny et al., 2010). Studies have 
showed that it is very likely that people get infected from rabbits, dogs, pigs, horses, and cats, 
because they have been found to harbor S. aureus (Cohn and Middleton, 2010; Petinaki and 
Spiliopoulou, 2012; Labro and Bryskier, 2014). 
1.3.4.3 Colonization of S. aureus in human nasal carriage and increased risk of 
subsequent infections 
Colonization increases the risk for subsequent human infection. Previous reports have 
associated nasal carriage with increased infection danger in hospital victims after surgical 
operations. Colonization of the anterior nares provides a reservoir through which this 
pathogenic bacterium is disseminated to other body sites when host defenses are breached, 
whether by aspiration, shaving, insertion of catheter or surgery (Gordon and Lowy, 2008). 
Once an individual is colonized, there is an increased risked for S. aureus infection and 
development of subsequent of human infections.  Majority of the studies carried out between 
1990s to 2014 has clearly showed that nasal carriage of S. aureus increases the risk for the 
development of nosocomial infections in patients in hospital settings. These includes patients 
undergoing surgery (includes thoracic and orthopaedic surgery) (Jensen et al., 1999; Kalmeijer 
et al., 2000; Wertheim et al., 2005), those on continuous ambulatory peritoneal dialysis 
(CAPD) or haemodialysis (Luzar et al., 1990; Wanten et al., 1996; Zimakoff et al., 1996); 
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Nouwen et al., 2005), those with AIDs and HIV (Nguyen  et al., 1999; Winke et al., 1992), 
those with intravascular devices-related S. aureus bacteraemia (SAB) (Snydman et al, (1990), 
those with liver cirrhosis and after liver transplantation (Lefranc et al., 2005), patients admitted 
to intensive care units (ICU) (Corbella et al., 1997; Pujol et al., 1996; Keene et al., 2005; Honda 
et al., 2010), those with Wegener’s granulomatosis (Stegeman et al., 1994; Zycinska et al., 
2008), those colonized with MRSA and patients with diabetes mellitus (insulin-dependent) 
(Kluytmans et al., 1997; Wertheim et al., 2005; Datta et al., 2014).  
In surgical patients, the risk of developing S. aureus bacteraemia has been observed. Wertheim 
et al., (2004) identified S. aureus as the most frequent cause of bacteraemia in hospital patients. 
They screened 14008 patients comprising of non-bacteraemia and non-surgical patients for S. 
aureus carriage and possiblilty of developing nosocomial bacteraemia. In this study, they 
observed that there was a 3-fold higher risk for non-surgical patients who were S. aureus nasal 
carriers 1·2% (40/3420), to acquire a nosocomial blood infection versus non-carriers 0·4% 
(41/10 588). A relative risk of 3.0 was also noted for the development of nosocomial 
bacteraemia. Furthermore, Jensen and his co-workers looked at nasal carriage in relation to 
surgery. Nasal cultures were performed in 61 (72%) of 85 hospital-acquired S. aureus 
bacteraemia (SAB) patients. They observed that nasal carriers among patients in surgery had 
significantly increased risk (OR 4·0) for nosocomial bacteraemia compared to patients without 
SAB (Jensen et al., 1999).  
In orthopaedic surgery, S. aureus has been identified as the main causative pathogen for 
surgical site infections. Kalmeijer et al., (2000) observed a cohort of 272 patients in orthopaedic 
surgery with prosthetic implants for the risk of developing surgical site infections (SSI). Of 
these patients, 6.6% (18) of 272 patients had infections at the site, 11 had superficial infection 
and 7 patients had deep surgical site infections. S. aureus was seen as the main pathogen 
responsible for these three cases of surgical site infections. Kalmeijer et al., (2000), suggested 
that high-level nasal carriage of S aureus was the most crucial factor for developing surgical 
site infections with S aureus. 
In patients undergoing haemodialysis, S. aureus is the most frequently found bacterium in 
infections at the vascular access site causing bacteraemia. In a prospective study on 43 
haemodialysis patients by Nielsen et al., (1998), they found that the relative risk for S aureus 
bacteraemia was 26·2 (6·1–113) when S. aureus was colonising the vascular insertion site, and 
3·3 (0·74–15·1), in the case of S. aureus nasal carriage. They reasoned that haemodialysis 
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catheter-related S. aureus bacteraemia was highly unlikely if the patient had not been nasally 
colonized or at the insertion site during the time the catheter was inserted.  
In patients on continuous ambulatory peritoneal dialysis (CAPD, S aureus is the main cause of 
CAPD –related infections, often leading to catheter loss. Nasal carriage is a major risk factor 
for infections in patients on CAPD, mainly associated with exit site and tunnel infections. Luzar 
et al., (1990) studied 140 patients just starting (CAPD) in an hospital in England to assess the 
relation of the nasal carriage of S. aureus to subsequent catheter-exit-site infection or 
peritonitis. In this study, 63 patients were nasally colonized with S. aureus and nasal carriage 
frequently reoccur among the patients having diabetes than among the 110 patients who were 
not undergoing CAPD. The nasal carriers of S. aureus had a significantly increased risk of exit-
site infection than the non-carriers. Also risk of peritonitis was higher in nasally colonized 
patients. Luzar et al., (1990), concluded that in patients starting CAPD, nasal carriage of S. 
aureus is associated with catheter-exit-site infection. Similarly, Wanten et al., (1996) has 
established that nasal carriage of S. aureus increases the risk for subsequent infection in patients 
on CAPD. In a prospective study by Wanten et al., (1996), 54 patients on CAPD were assessed 
and 31 (57%) patients were found to be nasal carriers of S. aureus, 6 of these 31 patients 
developed peritonitis as opposed to patients who were non-carriers. In a recent study, Nouwen 
et al., (2005) investigated the risk of S. aureus nasal carriage among 52 patients on CAPD. The 
52 patients tested comprised of persistent (20), intermittent (10) and non-carriers (22). In this 
study they found that only persistent and not intermittent S. aureus carriers were significantly 
at higher risk for all CPD-related infections. 
In human immunodeficiency virus patients, nosocomial S. aureus bacteraemia, skin and soft 
tissue infections have been observed, which often reoccur. Even increased infection rates are 
found in patients with autoimmune diseases compared with HIV patients. Nguyen et al., (1999) 
found that nasal carriage is a determinant for the development of S. aureus infection in this 
patient population. Other risk factors for infection such as low CD4 cell count, vascular 
catheter, and neutropenia were identified. The risk for developing an S. aureus infection was 
approximately ten percent for every six months in patients who were nasal carriers of S. aureus 
and had CD4 cell counts of less than 100 cells/L. Similarly, in HIV infected patients, S. aureus 
septicaemia have been identified. Winke et al., (1992) investigated 136 HIV-infected patients 
for the S. aureus nasal carriage and development of subsequent S. aureus infection. They 
observed that 60 of 136 HIV-infected patients harboured S. aureus in their nose on culturing 
compared to 12 of 39 patients with chronic infections and 11 of 47 hospital staff that are 
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healthy. Another 12 HIV-infected patients were also identified to be S. aureus carriers on 
follow-up cultures. They also observed that AIDs patients had a higher carriage rate compared 
to HIV-positive patients indicating that S. aureus nasally colonized patients were more 
critically ill. Additionally, 8 patients with S. aureus septicaemia were observed, all of whom 
were nasal carriers; and no S. aureus septicaemia was observed in the non-colonized patients.  
In liver transplant patients S. aureus is the prominent cause of bacterial infection. Nasal 
carriage of MRSA is associated with a high risk of infection in patients undergoing surgery. 
Lefranc et al., (2005) carried out a prospective cohort study to identify the risk factors for S. 
aureus infection immediately after liver transplantation. Three hundred and twenty-three 
patients (323) were assessed. Of the 323 patients 19.5% (63) patients developed staphylococcal 
infection (36 MRSA) and (27 MSSA) within one month of surgical operation. Lefranc et al., 
(2005) concluded that, preoperative nasal carriage of MSSA and MRSA is an independent risk 
factor for S. aureus infection in liver transplant patients.  
Pujol et al., (1996) looked at the development of bacteraemia in patients in an intensive care 
unit (ICU).  Majority of S. aureus bacteraemia is caused by intravascular devices. In this cohort 
study, Pujol et al., (1996) reported that 38 (7.7%) of 488 patients admitted to the ICU had S. 
aureus bacteraemia. Rates of bacteraemia determined in patients were 24 (38%) of the MRSA 
carriers, 8 (9.5%) of the MSSA carriers, and 6 (1.7%) of non-carriers. Carriers of S. aureus had 
a relative risk of 12.4 for the development of bacteraemia. The relative risk for S. aureus 
bacteraemia was 3.9 for MRSA carriers. They suggested that among ICU patients, nasal 
carriers of S. aureus are at increased risk for S. aureus bacteraemia. In a more recent study, 
colonization with S. aureus seem to pose serious risk for subsequent S. aureus infection. S. 
aureus is a significant cause of infection in ICU patients. Also, a prospective cohort study on 
5,161 patients admitted in the ICU by Honda et al., (2010) showed that approximately 1433 
patients (27.8%) of 5,161 were nasally colonized by S. aureus at admission. Six hundred and 
seventy-four patients (47%) and 759 (53%) patients were colonized with MRSA and MSSA. 
They established that ICU patients colonized with S. aureus were at increased risk of 
developing a S. aureus infection in the care unit. Keene et al., (2005) evaluated S. aureus nasal 
colonization and the risk of subsequent S. aureus infection in (ICU) patients. A cohort study of 
208 patients admitted in ICU showed that 47 (23%) were nasally colonized with S. aureus and 
24% of these patients developed S. aureus infections versus 2% of non-colonized patients. 
Keene et al., (2005) believed S. aureus infection was significantly elevated in nasally colonized 
ICU patients. Furthermore, S.  aureus nasal carriage has been linked with subsequent 
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staphylococcal infections in ICU patients. In 1994, 752 patients admitted to an ICU for more 
than 2 days were studied prospectively for S. aureus colonization and infection. At the ICU 
admission 166 (22.1%) patients carried S. aureus in their nose, while 586 patients were non-
carriers. Of the 166 patients harbouring S. aureus in their nose,163 harbored MSSA and 3 
MRSA. During their stay in the ICU 24 of the 586 patients who were non-carriers became nasal 
carriers (eleven harboured MSSA and thirteen MRSA), and 1 patient initially colonized by 
MSSA was recolonized by methicillin resistant S. aureus. However, after 14 days, patients 
harbouring S. aureus in their nose was at greater risk of developing Staphylococcal infections 
at ICU admission than for patients found to be initially negative (Corbella et al., 1997). 
Also, regarding intravascular device-related bacteraemia, Snydman et al., (1990) reported on a 
cohort of 107 interleukin-2 treated patients. In their study they monitored patients undergoing 
the interleukin-2 +/- LAK cancer immunotherapy and control groups of patients in the surgical 
intensive care unit, patients receiving parenteral nutrition, and patients with tumors for the 
subsequent development of nosocomial bacteraemia. They identified S. aureus bacteraemia 
among the patients receiving parenteral nutrition (2.8%), in the surgical intensive care unit 
(4.1%) or having tumours (1.9%). S. aureus seems to be causative agent of the bacteraemia. 
Snydman et al, (1990) reasoned that colonization with S. aureus increased the risk of S. aureus 
bacteraemia 6.3- fold, they suggested that S. aureus colonization of both the nose and skin 
desquamation increased the risk of S. aureus bacteraemia 14.5-fold in patients receiving 
interleukin-2 treatment. 
In MRSA carriers, increased risk of S. aureus infection has been suggested. Lye et al., (1993) 
observed that among patients undergoing CAPD, nasal carriers were at increased risk for 
MRSA infection compared with non-carriers. In this study, they found an increased rate of exit 
site infection and peritonitis in MRSA nasal carriers. Moreover, in the MRSA carriers, there 
was a higher number of catheter losses and CAPD patient dropouts. In addition, MRSA nasal 
carriage is considered a main risk factor for subsequent endogenous infections. A prospective 
cohort study of 306 outpatients under maintenance haemodialysis from a dialysis centre in 
Taiwan conducted between March 2007 to December 2008 by Lai et al., (2011) revealed that 
29 MRSA carriers (9.48%) were identified at study start. After a period of 613 days of 
maintenance, significant survival differences between MRSA carriers and those who do not 
carry MRSA were observed. Compared with non-carriers, MRSA carriers had a 2.46-fold 
increased risk of subsequent infections. Recently, in a retrospective cohort study conducted by 
Datta et al., (2013) on 1,140 patients who are MRSA-positive under between March 2008 and 
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June 2011 at a tertiary care teaching hospital in USA observed that there was a significant trend 
in infection risk with increasing nasal burden.  
Lastly, chronic nasal carriage has been associated with high relapse of Wegener granulomatosis 
in hospital out patients. In this study, 57 out patients were observed. Among these patients, 36 
were chronic nasal carriers of S. aureus, 22 of thirty-six patients who were either persistently 
or intermittently positive for antineutrophil cytoplasmic antibody (ANCA) had a relapse as 
opposed to 1 of twenty-one persistently negative patients This subgroup of patients was more 
prone to relapse of Wegener granulomatosis (Stegeman et al., 1994). Wegener’s 
granulomatosis is a necrotizing granulomatous inflammation of both the upper and lower 
respiratory tract and glomerulonephritis. Zycinska et al., (2008) examined possible risk factors 
for relapse including refractory nasal carriage of S. aureus in patients with Wegener’s 
granulomatosis. Swab cultures from the nose of 28 patients suffering from Wegener’s 
granulomatosis were taken. In the study, Zycinska et al., (2008) observed that the 28 patients 
were chronic nasal carriers of S. aureus and this was identified as an independent risk factor 
for relapse in patients with Wegener’s granulomatosis.  
1.4. S. aureus virulence and diseases 
1.4.1 S. aureus virulence factors and pathogenesis of infections  
The ability of S. aureus to cause infections depends on the numerous virulence factors 
expressed by the pathogen to aid its pathogenicity in human body (Foster, 2014; Deleo et al., 
2011). One of the virulence factors are cell surface proteins and extracellular proteins that 
promote colonization of the host tissues.  Other types of virulence factors such as capsule and 
protein A helps the bacterium to inhibit phagocytosis and evasion of the immune system 
resulting in the persistence of bacteria in the host blood.  Furthermore, other potential virulence 
factors such as toxins damage host tissues causing varying clinical symptoms (O’Riordian and 
Lee, 2004; Curtis, 2005). For most infections caused by S. aureus, pathogenesis is caused by 
many factors. Therefore, it is difficult to determine the role of any factor. Before an infection 
can be initiated by S. aureus it must first gain access into the body. It can enter in several ways; 
via the nose or mucosal surfaces, open wounds or sores, surgery sites or intravenous drug use 
(Foster, 2014; Curtis, 2005). Once it gains access, it establishes itself by attaching to the host 
tissues or cells. This it does by expressing cell surface proteins that promote their attachment 
to host proteins such as laminin and fibronectin that are part of the extracellular matrix (ECM) 
of the epithelial and endothelial cells. Fibronectin is found on both epithelial and endothelial 
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cell surfaces and a vital component of blood clots (Deleo et al., 2011). Furthermore, majority 
of S. aureus strains are also known to express a fibrin or fibrinogen binding protein (fib) 
responsible for attachment of S. aureus to traumatized tissues and blood clots. 
After attachment to host tissue, S. aureus further expresses many virulence factors that has the 
capability to subvert host defense mechanisms (Deleo et al., 2011). To do this, S. aureus again 
expresses a capsular polysaccharide of either capsular polysaccharide 5 or capsular 
polysaccharide 8 that prevent the bacterium from being phagocytosed by the host neutrophils. 
Protein A is surface protein produced by S. aureus, which binds immunoglobulin G molecules 
by the Fc region. In blood, S. aureus bind to IgG molecules in a wrong orientation thus 
disrupting opsonophagocytic (Foster, 2014; Deleo et al., 2011). S. aureus may also secrete 
chemotaxis inhibitory protein (CHIP) of staphylococci or the extracellular adherence protein 
(EAP), which interfere with neutrophil extravasation and chemotaxis to the site of infection 
(Foster, 2004). S. aureus produces many enzymes, that enable it to invade and destroy host 
tissues and spread to other sites. These includes proteases, lipases, and elastases (Foster, 2014). 
Also, S. aureus is known to express several toxins that are potentially responsible for the 
development of symptoms during occurrence of an infection (Dinges et al., 2000). Most of 
these are produced in the stationary phase of growth. For example, leucocidin toxin causes 
membrane damage to leukocytes; alpha-toxin (α-toxin) is responsible for septic shock; 
enterotoxins and toxic shock syndrome toxin (TSST-1) is responsible for toxic shock, some 
toxins cause erythrocytes damage, causing hemolysis (Dinges et al., 2000; Plata et al., 2009). 
However, of all these toxins, α-toxin is the most potent membrane-damaging toxin produced 
by S. aureus. Alpha-toxin is expressed as a monomer that binds to the membrane of susceptible 
host cells. After binding, the different subunits then oligomerize together forming hexameric 
rings with a central pore via which most cellular contents leak (Dinges et al., 2000). Usually 
for successful binding, susceptible host cells have a receptor mainly for α-toxin, which permits 
low concentrations of α-toxin to bind, causing small pores through which monovalent cations 
can pass. But at high concentrations, non-specific reactions occur between the toxin with 
membrane lipids, causing larger pores through which small molecules and divalent ions can 
pass. Receptors such as platelets and monocytes present in susceptible hosts are sensitive to 
alpha-toxin. Both receptors have affinity sites that allow successful binding of toxin. After 
binding, many secondary reactions take place causing cytokines and eicosanoids release which 
inturn triggers the expression of some inflammatory mediators (DuMont et al., 2013; Spaulding 
et al., 2013).  This reaction can cause the commonly known septic shock syndrome that occur 
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during chronic infections caused by S. aureus. Other toxins such as leucocidin and Gamma-
toxin (γ-toxin) are two-component protein toxins that damage membranes of susceptible host 
cells. The two proteins are produced separately but act together to damage membranes. 
Gamma-toxin locus expresses three main protein components. Components A and B of γ-toxin 
are hemolytic and weakly leukotoxic. The classical Panton and Valentine (PV) leukocidin is 
different from leukotoxin which is expressed by the γ-toxin locus. It has potent leukotoxicity 
and, in contrast to γ-toxin, is nonhemolytic. Panton and valentine leukocidin cause 
dermonecrosis infection when injected subcutaneously in rabbits. In addition, at a low 
concentration the toxin releases inflammatory mediators from human neutrophils, leading to 
degranulation (Dinges et al., 2000; DuMont et al., 2013; Spaulding et al., 2013). 
Other toxins expressed by S. aureus are exotoxins. Exotoxins are toxins secreted by bacteria 
that can cause damage to the host by destroying cells or disrupting normal cellular metabolism. 
Exotoxins are referred to as superantigens or pyogenic toxin superantigens because they 
provoke non-specific activation of the human immune system. Superantigens interact with 
antigen-presenting cells and T cells, by direct binding of the major histocompatibility complex 
(MHC) class II proteins and T-cell receptors, to induce T cells proliferation resulting in 
polyclonal T cell activation and massive cytokine release, thereby bypassing the normal antigen 
processing and presenting mechanism (Miljković-Selimović et al., 2015). Examples of such 
exotoxins are toxic shock syndrome toxin (TSST-1) and enterotoxins toxins. These two toxins 
are secreted by S. aureus with several biological attributes like pyrogenicity and 
superantigenicity (Orwin et al., 2002). Enterotoxin has six serotypes namely serotype A, B, C, 
D, E, and G. Enterotoxins are the common cause diarrhoea and vomiting when ingested in food 
and are responsible for staphylococcal food poisoning. When enterotoxin is produced 
systemically, it can cause TSS by stimulating T cells expressing Vβ element in their T-cell 
receptor, leading to proliferation of T-cell and continuous release of proinflammatory cytokines 
for example TNF-α, interferon-γ, interleukin (IL)-1β and IL-6 (Krakauer and Stiles, 2013). 
Toxic shock syndrome B and C cause 50% of non-menstrual TSS in women. TSST-1 is also 
responsible for 80% of TSS, including all women menstrual cases. TSS can occur as a 
consequence to any staphylococcal infection if an enterotoxin or TSST-1 is systemically 
expressed and the host does not have appropriate neutralizing antibodies. What it does is that 
it stimulates the production of increased number of interleukins (interleukin 1 and 2) and tumor 
necrosis factor (Masignani et al., 2013).  
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1.4.2 Strategy of host colonization and diseases   
The pathogenicity of S. aureus is because of the production of a large variety of protein 
virulence factors including membrane cell wall interface protein, membrane proteins, cell wall-
proteins and proteins actively secreted through different pathways into the extracellular milieu. 
All these virulence factors enable and determine the pathogenicity of S. aureus playing vital 
role in the colonization and invasion of host tissues, facilitate persistence help to evade the 
immune system of the host and mediate cytotoxicity. As such all these proteins constitute a 
reservoir of virulence factors (Ajayi, 2018).  
S. aureus employ many strategies to be able to colonize and infect the host latter. These 
strategies are mediated by secretion of virulence factors (Gordon and Lowy, 2008). A primary 
event in S. aureus colonization is the adherence to host components mediated by binding of 
fibronectin, fibrinogen and cytokeratins usually within nasal epithelium. This binding is 
mediated by more than one adhesin proteins that mediate the initial attachment of bacteria to 
host tissue, providing a critical step to establish infection. These adhesins can be categorized 
into two: cell surface proteins of S. aureus called microbial surface components recognizing 
adhesive matrix molecules” (MSCRAMMs) and “secreted expanded repertoire adhesive 
molecules” (SERAMS) (Gordon and Lowy, 2008).  
1.4.2.1 Microbial surface component recognising adhesive matrix molecule 
(MSCRAMMS)  
MSCRAMMs are cell surface proteins encoded on the bacterial chromosome and have single 
or multiple binding ligands (Foster et al., 2016). In S. aureus, numerous MSCRAMMs are 
anchored to the cell peptidoglycan by a covalent bond through conserved mechanism. This 
mechanism involves a conserved protein structure with a N-terminal secretory signal peptide 
needed for the transport or translocation of protein from across the interior of S. aureus cell to 
its outer membrane (Sec-dependent secretion), and a positively charge tail –C-domain, which 
ensures that the protein is not produced. Close to the C-terminal is a transmembrane spanning 
terminal, which is itself preceded by a LPXTG motif that is essential for anchoring the cell 
proteins into the cell wall peptidoglycan. This process of anchoring involves a transpeptidation 
mechanism, which is brought about by sortase enzyme. Sortase enzyme is encoded by the gene 
srtA and it is a membrane enzyme that cleaves the MSCRAMMs between the threonine and 
the glycine of its LPXTG motif, and catalyzes the formation of an amide bond between 
carboxyl-group of threonine and the amino-group of peptidoglycans. Examples of 
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MSCRAMMs include protein A, clumping factors A and B (ClfA and ClfB) (Siboo et al., 
2001; O´ Brien et al., 2002; Hair et al., 2010), fibronectin binding proteins A and B (FnbA and 
FnbB ) (Fowler et al., 2000; Wann, Gurusiddappa & Höök, 2000; Massey et al., 2001), and 
collagen-binding protein (Cna) (Hienz et al., 1996; Deivanayagam et al., 2000; Que and 
Glauser 2005), fibronogen binding proteins  (Fib) (Cho et al., 2001; Ajayi, 2018) and elastin 
binding protein (Ebp) (Downer et al., 2002) (Figure 4).  
MSCRAMMs play important role in initiation of acute and severe human infections (Archer et 
al., 2011). S. aureus strains possess different groups of MSCRAMMs and so may be inclined 
to causing different kinds of human infections (Gordon and Lowy, 2008). Once S. aureus can 
adhere to human tissues or medical prosthetic materials, it is able to grow and persist in various 
ways. It can form slime called biofilms on host tissues and surfaces of prosthetic materials 
enabling it to persevere by evading host defenses and antimicrobial agents (Gordon and Lowy, 
2008). The ability of S. aureus to form biofilm and reside in it, is probably one major reason 
why medical device infections and other human diseases, are difficult to treat. For example, 
the infected prosthetic device can be so difficult to eradicate without removal of the device 
from the host body (Gordon and Lowy, 2008).  
Acute or mild infections caused by the bacterium include skin and soft tissue infections (for 
example boils, impetigo, cellulitis and skin abscess) (Archer et al., 2011). However, S. aureus 
infections becomes worse because of its ability to form biofilms which are slimy protective 
coverings. Chronic infections associated with biofilm includes (a) osteomyelitis (bone 
infection) (b) indwelling medical device infection (caused by the formation of S. aureus biofilm 
on orthopaedic implants including wires, external fixators, pins, mini-large fragment implants 
and nails). Other indwelling medical devices that are liable to staphylococcal biofilm infection 
include intravenous catheters, mechanical heart valves, invasive blood pressure units, stitch 
materials, cosmetic surgical implants, penile implants, infusion pumps, pacemakers and central 
nervous system shunts, (c) Chronic wound infections such as pressure sores, venous stasis 
ulcers and diabetic foot ulcers), (d) endocarditis (infection of the heart valve), (e) ocular 
infections which include conjunctivitis, keratitis and endophthalmitis, (f) periodontitis 
(inflammation and infection of the ligaments and bones that support the teeth and peri-
implantitis), (g) chronic rhinosinusitis (inflammation of the nasal passages and sinus cavities) 
(Archer et al., 2011) and (h) bacteraemia (blood stream infection) (Agarwal et al., 2010). 
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Figure 4. Virulence factors of S. aureus with both cell wall associated proteins and secreted proteins playing 
roles as pathogenic determinants (Gordon and Lowy, 2008). 
From the image represented above, A, shows surface and secreted proteins, B and C, are cross-sections of the cell 
wall envelope.  
 
Fibronectin binding proteins (Fnbps)  
Fibronectin binding protein (FnbA and FnbB) are S. aureus MSCRAMMs, encoded by 
fibronectin A and B (fnbA and fnbB) genes (Foster et al., 2014; Foster, 2016). These two 
proteins are closely related but individually transcribed. Protein fibronectins of S. aureus are 
multifunctional adhesin which recognizes fibrinogen, fibronectin as well elastin. Both proteins 
have considerable organization and similar sequence and are comprised of a few well-defined 
domains. Binding proteins of FnbA and FnbB contain a secretory signal sequence at the N-
terminal of the A domain and a C-terminal domain LPXTG motif necessary for sortase 
mediated anchoring of the fibronectins to the peptidoglycan. The N-terminal of the A domains 
of FnBPs are found on the cell surface and facilitates elastin and fibrinogen binding (Foster et 
al., 2014; Foster, 2016).  
The binding of FnbA and FnbB to host fibronectin enhances the adherence and invasion of S. 
aureus into the osteoblasts, epithelial, endothelial, fibroblastic cells which are not phagocytic. 
The invasion mediated by fibronectins take place via the formation of a fibronectin bridge 
between the bacterium and the alpha 5 beta 1 integrin (Henderson et al., 2011). This in-turn 
enhances the dissemination of S. aureus from the host blood stream to vital internal organs and 
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escape of immune responses and antimicrobials (Foster et al., 2014). This was demonstrated 
in the study of the role of FnbA in endocarditis where binding to fibronectin and fibrinogen is 
considered vital in establishment of Staphylococcal endocarditis. Binding to fibronection was 
required for the disease to spread and while binding of fibrinogen was essential for initial 
attachment on damaged valves (Burke et al., 2010).  
Clumping factors (Clfs)  
ClfA is S. aureus binding protein with two main domains designated as N2 and N3 that binds 
to the C-domain of the fg (fibrinogen) gamma chain resulting in platelet aggregation or 
bacterial clumping in human blood (Talay, 2004). The contribution of ClfA to S. aureus 
pathogenesis has been demonstrated in different animal models of infections. In an arthritis 
model, an S. aureus mutant lacking functional clfA couldn’t cause arthritis when compared to 
the Newman wild type strain. In this study, mice were immunized with recombinantly produced 
ClfA domain which conferred some protection from subsequent infections by the induction of 
ClfA-specific antibodies (Lacey, et al., 2016). ClfB also bind fibrinogen (Fg), a glycopeptide 
present in human blood responsible for blood clotting. Fg is the major human blood protein 
deposited on implanted medical devices (Deivanayagam et al., 2002). ClfB is a bifunctional 
adhesin. In addition to Fg, clfB can bind to type I cytokeratin I0 present on the squamous of 
human nasal cells. Cytokeratin I0 is the main component of squamous cells and is a major 
factor determining the ability of the bacterium to adhere to squamous epithelial cells and to 
colonize the anterior nares of humans (Ganesh et al., 2011).  
Collagen adhesin protein (Cna)  
Cna is the collagen binding MSCRAMM of S. aureus (Zong et al., 2005). Cna shares a common 
structural organization with other surface proteins, that includes (a) an N-terminal signal 
sequence, (b) a repetitive region (c) a non-repetitive region and (d) C-terminus anchoring 
domain that includes a hydrophobic membrane-spanning domain, an LPXTG anchoring motif, 
and an amino acid carboxy-terminal tail (Nallapareddy et al., 2003). The repetitive region 
exhibits strain-dependent variability with respect to length while the non-repetitive region is 
often responsible for binding of the ECM protein. Though the S. aureus cna shares these 
structural attributes, it is unique by comparison to other surface proteins. For example, the gene 
encoding Cna is not available in all S. aureus isolates. In addition, although it has the LPXTG 
anchoring motif, Cna seems to be anchored to the S. aureus cell through its hydrophobic 
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membrane-spanning domain rather than a covalent linkage to the cell wall peptidoglycan 
(Snodgrass et al., 1999).  
Staphylococcal protein A (spa)  
Protein A is a crucial MSCRAMM of S. aureus. Protein A is coded by the spa gene and it has 
multifunctional roles (Kerrigan et al., 2002). Firstly, spa can bind to the Fc portion of 
immunoglobulin G (IgG) antibody, resulting in the pathogen becoming coated with IgG in an 
inappropriate conformation not recognized by the Fc receptor on neutrophils resulting in 
evasion of phagocytosis. Secondly, spa can bind to the fab region of IgM (immunoglobulin M) 
antibody, on the surface of B lymphocyte cell receptors, leading to increased number of B cells 
(activation) and cell death (apotosis) (Goodyear and Silverman, 2003). Thirdly, spa binds to 
TNFR1 (tumor-necrosis factor) on the air way epithelium and stimulate a 22-inflammatory 
response dominated by polymorphonuclear leukocytes in airway epithelial cells. This sort of 
interaction plays a key role in the pathogenesis of S. aureus pneumonia (Bien et al., 2011).  
Elastin binding protein (EbpS)    
Elastin binding protein Elastin, together with microfibrillar constituents, make up the elastic 
fiber extracellular matrix (Kielty et al., 2002). Microfibrillars are fiber-like strands, consisting 
of glycoproteins and cellulose. The role of elastin is to maintain the structural integrity and 
function of tissues in which extensibility or deformability is necessary. Thus, elastic fibers and 
elastin are available in human tissues that require elasticity for example major blood vessels, 
skin and lungs (Downer et al., 2002).  
1.4.2.2 Secreted expanded repertoire adhesive molecules (SERAMS)   
SERAMs are the second group of adhesins. SERAMs are secreted but partially bound to cell 
surface. SERAMs are not related in structure but share a common function. SERAMs include 
the extracellular fibrinogen binding protein (Efb), extracellular matrix protein (Emp) and 
extracellular adhesive protein (Eap) (Chavakis et al., 2007). Eap appears to be the well-studied 
S. aureus adhesin. Eap enhances adherence of S. aureus to human components. Harraghy et 
al., (2003) purified Eap from the supernatant of S. aureus and found that it was capable of 
binding to the surface of S. aureus and to at least seven human blood proteins for example fg, 
fn, vitronectin and prothrombin. 
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1.4.2.3 S. aureus intercellular adhesion genes   
The icaA, icaB, icaC and icaD operons have also been identified in S. aureus. They are the 
icaADBC operons which encodes the structural genes necessary for synthesis of PIA. The ica 
operon is composed of four open reading frames, (icaA, icaD, icaB and icaC) and a regulatory 
gene known as icaR. IcaA is responsible for N-acetylglucosaminyl transferase activity during 
PIA synthesis; IcaD is required for optimal transferase activity. IcaB, a deacetylase, is 
responsible for the deacetylation of the poly-N-acetylglucosamine molecule. IcaC is a 
transmembrane protein that plays a putative role in externalisation, elongation and 
translocation of the growing polysaccharide to the cell surface and is responsible for the 
production of the length of PIA molecule (McCann et al., 2008). 
1.5 Biofilms 
1.5.1 S. aureus biofilm 
Naturally, bacteria have two growth life styles termed planktonic or sessile. Planktonic growth 
means the growth of bacterial cells in liquid while the sessile growth refers to bacterial cells 
that are attached to a surface (Davey and O'Toole, 2000). Interestingly in biofilm formation, 
planktonic cells are the ones that form biofilms (Mancl et al., 2013). In simple terms a biofilm 
is a collection of bacterial cells that is encased in an exopolymeric substance produced by them 
(Carr et al., 2009).   
The structure of S. aureus biofilm is complex and heterogeneous (Flemming and Wingender, 
2010). Visualization of biofilm structures by some researchers under the microscope has 
described the structure of biofilm as mushroom-shaped and often formed by microcolonies 
(Flemming and Wingender, 2010). Biofilm structure contains interstitial voids through which 
essential nutrients flow into different microbial communities of the biofilm (Stewart and 
Franklin, 2008). 
S. aureus has an extracellular matrix known as EPS that acts as slime or glue (Flemming and 
Wingender, 2010). The EPS encloses all microbial cells and allows the assemblage of S. aureus 
cells into biofilms (Vertes et al., 2012). Major constituents of the extracellular matrix of most 
biofilm forming organisms that have frequently been reported include protein, DNA and 
polysaccharide intercellular adhesin (PIA). Although the constituents of the extracellular 
matrix of S. aureus are still not clear, varying reports have been given about the main 
constituent of the extracellular matrix of S. aureus (Flemming and Wingender, 2010). PIA is 
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comprised of 80-85% beta-1-6 linked –N-acetyl glucosamine and a small amount of residues 
that consists of 15-20% of ester linked succinate and phosphate (Rohde et al., 2010). The 
icaADBC operon identified in majority of S. aureus species is responsible for PIA production 
(Beenken et al., 2004). S. aureus biofilm matrix comprises extracellular DNA (eDNA), human 
factors and proteins that are secreted and obtained from lysis and PIA (Foulston et al., 2014). 
eDNA is a product of autolysis of subpopulations (Bayles et al., 2007). 
S. aureus may form biofilms on biotic and abiotic or inert surfaces (Aparna and Yadav, 2008). 
Factors that have great influence on biofilm formation mechanism of S. aureus are: the bacterial 
species (strain characteristics), the substratum (physical and chemical properties) and 
environmental factors (Renner and Weibel, 2011). Other important vital factors affecting the 
adherence of microbes to different surfaces include: bacteria, suitable substrate and cellular 
recognition of attachment sites on a surface, composition of cell outer layer, exposure of 
planktonic cells to sub-inhibitory concentrations of antibiotics, nutrient availability, structure 
of cell surface, quorum sensing and regulatory network within the entire population (Paraje, 
2011).  
1.5.2 The phases of S. aureus biofilm formation  
A few studies in human pathogenic organisms forming biofilm have provided concise details 
of biofilm formation in S. aureus. The formation of biofilm in S. aureus is in three important 
phases attachment phase, fully matured phase and dispersal phase (Yarwood et al., 2004).  
Biofilms form by initial attachment to a surface, which can occur on tissues or after covering 
of an abiotic surface by host matrix proteins in the human body. The attachment of S. aureus 
to human extracellular matrix proteins is the first step of biofilm formation. S. aureus expresses 
numerous MSCRAMMs that can adhere to human matrix proteins (such as fibrinogen or 
fibronectin) deposited on implants (Otto, 2008). MSCRAMMs have three main regions or 
domains, a ligand binding region (that is exposed), a cell wall spanning domain which contain 
a repeat sequence and a sorting signal region containing a LPXTG motif (Foster et al., 2014). 
The anchorage of MSCRAMMs to S. aureus cell wall is covalently initiated by the enzymes 
known as sortases that cleaves the C-terminal of LPXTG of the MSCRAMMs to cell wall. An 
important member of this family is Sortase A that has the capacity to recognize the C-terminal 
of the LPXTG motif of the MSCRAMMs (Tsompanidou et al., 2012).  
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The attachment of S. aureus to abiotic surfaces (biomaterials) largely depends on the nature of 
the polymer material and on the cell surface characteristics of the bacteria. The initial 
interaction is believed to occur via nonspecific physicochemical forces such as charge, van der 
Waals forces, and hydrophobic interactions (Gross et al., 2001). S. aureus colonization of 
abiotic surfaces depends on the charge of its teichoic acids. The role of teichoic acids in the 
first step of biofilm formation, however, has remained elusive. S. aureus teichoic acids are 
highly charged cell wall anionic polymers that are uniformly distributed over the entire S. 
aureus peptidoglycan wall, contributing a large amount of negative charge to the bacterial 
surface. There are two types of teichoic acids, wall teichoic acid (WTA) and lipoteichoic acid 
a lipid anchor (LTA). S. aureus teichoic acids are composed of alternating phosphate and ribitol 
(wall teichoic acids) or glycerol (lipoteichoic acids) groups, which are replaced with d-alanine 
and N-acetylglucosamine. Research studies have shown that an S. aureus dltA mutant bearing 
a stronger negative charge due to the lack of D-alanine esters in its teichoic acid can no longer 
attach to to polystyrene or glass. The much stronger net negative charge of the dltA mutant, 
however, probably leads to a pronounced increase in the repulsive forces, thereby disabling 
any adherence of the bacteria to polystyrene or glass (Gross et al., 2001).  
Maturation phase is the second phase of biofilm formation in S. aureus (Molin and Tolker-
Nielsen, 2003). This phase is distinguished by intercellular aggregation resulting from gradual 
accumulation and structuring forces. Once S. aureus attaches to a surface, it proliferates 
facilitating the synthesis of (PIA) responsible for cell-cell adhesion (Heilmann, 2011). At the 
end of maturation phase, biofilm has a 3 dimensional structure (Garrett et al., 2008). 
The third phase is the detachment (or dispersal) phase. Biofilm detachment is crucial for the 
dissemination of S. aureus to other colonization sites. Dispersal may occur by the detachment 
of pair or cluster cells. Several factors may contribute to detachment (a) cessation of the 
production of biofilm building material, such as exopolysaccharide, and (b) detachment factors, 
such as secreted enzymes (proteases nuclease and dispersin B) and surfactants phenol-soluble 
modulins (PSMs) that degrade the matrix (Otto, 2008). The enzymatic dispersal mechanism 
that has been described in S. aureus is the protease dispersal mechanism (Lister and Horswill, 





1.5.3 Enzymatic dispersal mechanism in S. aureus  
(i) Extracellular proteases of S. aureus  
There are over 10 proteases secreted by most S. aureus strains. The proteases encoded in the 
S. aureus genome are organized into four distinct operons mediating synthesis of a 
metalloprotease (Aur), seven serine proteases (SspA and SplA-F) (organized in two distinct 
operons), and two cysteine proteases (Staphopains ScpA and SspB). The six Spl enzymes 
coded by splA-F do not require proteolytic activation. The Aur, ScpA, SspA, and SspB 
proteases are produced as zymogens or pro-enzymes). The Aur and ScpA zymogens undergo 
auto-proteolytic cleavage outside the cell and SspA and SspB are activated in a subsequent 
proteolytic cascade which is initiated with cleavage of SspA by Aur which then activates SspB. 
The secreted extracellular proteases have a broad substrate specificity hence can degrade both 
surface proteins and secreted proteins (Mootz et al., 2013).  
1.5.3.1 Serine proteases   
Serine proteases are enzymes that contain a histidine, serine, and/or an aspartate residue at their 
active site. The seven serine proteases secreted by S. aureus are all members of the trypsin 
family of enzymes. The SspA and SspB protease are encoded by a single polycistronic operon 
wherein SspA is a serine protease and SspB is a cysteine protease. The six Spl proteases 
(SplABCDEF) are encoded by a separate polycistronic operon and are active upon secretion. 
SspA, also known as V8 protease, is a glutamyl endopeptidase that has the distinction of being 
the first purified and characterized proteolytic enzyme of S. aureus (Mukherji et al., 2015).  
1.5.3.2 Cysteine proteases 
Cysteine proteases are characterized by two nucleophilic cysteine residues joined together by 
a thiol bond. S. aureus secretes two cysteine proteases, ScpA and SspB, which have been 
termed Staphopain A and Staphopain B (Mukherji et al., 2015).  
1.5.3.3 Metalloprotease 
Metalloprotease (Aur) is the only metalloprotease secreted by S. aureus. Aur is required to 
activate SspA by proteolytic cleavage and this initiates a proteolytic cascade of activation 




(ii) Protease dispersal mechanism 
The ability of S. aureus proteases to disrupt proteinaceous matrix materials has been 
demonstrated in previous studies. It has been shown that V8 serine protease can degrade FnBPs 
and aureolysin can degrade ClfB to mediate biofilm disruption. While the staphopains can 
disrupt the biofilm matrix, no target proteins have yet been found. The underlying mechanism 
through which S. aureus proteases disassemble a fully matured biofilm is complicated not only 
by the number of proteases involved but also by the myriad of protein targets. However, recent 
studies have shown that the production of proteases is positively regulated through the S. 
aureus quorum sensing system, agr. The agr system is activated upon detection of an 
autoinducing peptide (AIP) that is encoded and produced by the agr operon. The agr system 
induces the expression of both proteases and PSMs, which act as surfactants to disperse 
biofilms (Lister and Horswill, 2014). Thus, activation of the agr system can result in a shift 
from a biofilm state to a planktonic state of growth. This has been demonstrated through the 
addition of AIP to existing biofilms, which results in complete dispersal (Boles and Horswill, 
2008), and through the use of fluorescent reporters, which demonstrated that cells detach from 
the biofilm after agr activation (Yarwood et al., 2004). 
1.6 Biofilm formation and quorum sensing in S. aureus  
Qs often referred to as intercellular signaling play vital role in S. aureus virulence. In the past 
bacteria have been regarded as entities whose main role is to source for nutrient and proliferate 
(Fraune and Bosch, 2010). However, the recent findings of cell-to-cell communication often 
called quorum sensing has revealed that bacteria are capable of coordinated activity (Fuqua et 
al., 2001).  
1.6.1 The accessory gene regulator quorum sensing in S. aureus 
The agr quorum-sensing system plays central role in the pathogenesis of S. aureus (Yarwood 
and Schlievert, 2003). Agr is a global regulator of the staphylococcal virulon also called 
accessory genes. These accessory genes encode cell wall proteins and secreted proteins of S. 
aureus. Agr controls the expression of majority of the extracellular protein genes present in S. 
aureus. The most important of these genes and their products are (a) superantigens (sea, seb, 
sec, sed, eta, etb and tst encoding enterotoxin A, enterotoxin B, enterotoxin C, enterotoxin D, 
exfoliatin A, exfoliatin B and toxic shock toxin-1) (b) cytotoxins (hla, hlb, hld, hlg and lukS/F 
encoding α,-hemolysin, β-hemolysin, δ-hemolysin γ-Hemolysin and P-V leucocidin), (c) 
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enzymes (SplA–F, ssp, aur, sspB, scp, geh, lip, fme, plc, nuc, hys, coa and sak encoding serine 
protease-like, V8 protease, metalloprotease (aureolysin), cysteine protease, staphopain 
(protease II), glycerol ester (hydrolase), lipase (butyryl esterase), FAME (Fatty acid 
esterification), PI-phospholipase C, nuclease, hyaluronidase, coagulase and staphylokinase), 
(d) surface proteins (spa, cna, fnbA, fnbB, clfA, clfB encoding protein A, collagen binding 
protein, fnbA and fnbB, clumping factor A and clumping factor B) (e) capsular polysaccharides 
(cap5 and cap8 encoding polysaccharide capsular type 5 and polysaccharide capsular type 8) 
(Novick et al., 2003).  
Agr is a central transcriptional regulator that controls the expression of virulence-associated 
protein genes in S. aureus (Traber et al., 2008). Agr suppresses the post-exponential-phase 
expression of cell surface binding proteins (responsible for the primary stages of colonization) 
and enhances the expression of secreted proteins (involved in the long-term survival of the 
organism at the site of infection). Agr has been linked to virulence in animal model associated 
infections and have been found to play a major role in human infection such as osteomyelitis, 
endocarditis and septic arthritis. Although the exact role of the agr locus differ with the type 
of infection model used (Yarwood et al., 2004).  
The production of virulence factors by S. aureus is controlled in response to cell density, 
availability of energy, superantigens and signals from the environment so that these factors are 
only secreted when needed. In vitro, the production of different extracellular proteins follows 
a specific order that is temporal in which surface proteins are produced before proteases or 
haemolysins and other degrading enzymes. Transcript profiling has shown that genes encoding 
adhesins decrease early in growth, whereas genes encoding proteins secreted by the bacteria 
increase during post exponential growth (Novick et al., 2003). This expression pattern appears 
to correlate with the population cell density sensing agr which is generally activated in mid 
exponential phase thus increasing several secreted proteins and decreasing a number of surface 
proteins (Novick et al., 2003). However, when energy or metabolites are not sufficient like in 
respiratory chain or citric acid cycle mutant’s majority of the exoproteins are not synthesized 
allowing the bacteria to carry on its housekeeping roles. Also, some environmental signals 
affect the production of extracellular proteins, in some cases relating to the need to conserve 
resources under harmful conditions. Subinhibitory concentrations of ethanol and antibiotics 
that hinder the functions of ribosome have a general inhibitory effect on the synthesis of 
accessory gene proteins. The genetic variability of SAg gene is another response factor 
27 
 
controlling the production of virulence since these genes are known to cause toxinoses, and an 
organism expressing a toxin does not need other exoproteins (Novick et al., 2003). 
1.6.2 Regulatory factors identified in S. aureus 
Apart from agr, other additional regulatory factors comprising several loci such as sarA, rot, 
arlRS, svrA, sigB and saeRS has been reported in S. aureus (Steinhuber et al., 2003). These 
regulatory systems are two-component signal transduction systems that co-ordinately control 
the expression of S. aureus virulence factors that enable the organism to adapt to varied 
environments in vitro and in vivo (Liang et al., 2005; Steinhuber et al., 2003). These regulators 
play important role in the control of the expression of virulence factors such as hemolysins, 
protein A (Spa), fibronectin-binding proteins (FnbpA and FnbpB coded by fnbA and fnbB), 
capsular polysaccharide (CP, coded by the cap operon (Steinhuber et al., 2003). These 
additional regulators allow the S. aureus to respond to environmental signals in addition to 
bacterial cell density, and sometimes counter agr activity (Yarwood and Schlievert, 2003). For 
example, the S. aureus accessory regulatory (SarA) protein influences expression of 
extracellular proteins and adhesins. This locus contains transcripts that are overlapping, sarA, 
sarC, and sarB. SarA binds to conserved regions termed Sar boxes within promoter regions of 
genes encoding cell surface proteins (spa, encoding protein A), genes encoding exoproteins 
(hla, encoding alpha-hemolysin) and agr. SarA binding to agr promoter elements augments 
both RNAII and RNAIII transcription and therefore contributes to virulence factor regulation 
indirectly. In several studies, SarA has been shown to control the expression of virulence genes 
hla and spa sometimes acting independently of agr showing that SarA regulates certain 
virulence factors on its own in an agr-independent manner (Dunman et al., 2001). ArlRS 
comprises a two-component system that appears to counter agr autoinduction by repressing 
production of hemolysins and exoenzymes.  Expression of arlRS was itself reduced in an agr 
mutant. An arlS mutant was enhanced for biofilm formation, despite the increased expression 
of agr and the presumed downregulation of surface-associated adhesion factors. ArlRS also 
appears to regulate autolytic activity. SrrAB, inhibit RNAIII expression and may itself be 
repressed by agr. The repressor of toxins (Rot) and the sigma factor B (sigB) affect the 
expression of many virulence associated genes. Rot counters agr activity by upregulating some 
of the genes that are downregulated by RNAIII, making it an antagonist of agr regulation and 
a mutation in rot was shown to partially restore the wild-type phenotype of an agr mutant. 
Sigma factor B, which responds to environmental stress also appears to at times counter agr 
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activity in that it increases the expression of some exoproteins early in growth (Yarwood and 
Schlievert, 2003).  
1.6.3 The agr system in S. aureus  
The agr operates a two-component signalling system. It is induced by a peptide, encoded within 
the locus that is the ligand for the histidine kinase component of the signalling module. Thus, 
agr is a sensor of population density or a quorum sensor (Wright et al., 2005). 
The agr system in S. aureus consist of an approx.3 kb locus containing divergent operons called 
RNAII and RNAIII transcribed from P2 and P3 which are non-overlapping promoters, (Manna 
and Cheung, 2001) (Figure 5). The P2 operon encodes proteins, agrB, agrD, agrC and agrA 
that generate the agr-sensing mechanism and encodes the RNAII transcript. AgrB is a 
transmembrane protein involved in (a) processing of the agrD product into an octapeptide; (b) 
processing and synthesis of the autoinducing peptide (AIP) that is the activating ligand for the 
signal receptor, AgrC whose role is to activate transcription of RNAIII (Geisinger et al., 2006), 
(c) AgrA and AgrC form a two-component regulatory system in which the transmembrane 
component, AgrC (histidine kinase) binds the extracellular AIP activating autophosphorylation 
(dephosphorylation), followed by phosphorylation or dephosphorylation of the AgrA a 
response regulator which jointly with SarA increases the transcription of P2 and P3 (in the late-
log phase of growth, when the concentration of the signal in the medium is high) leading to the 
secretion of RNAIII, which regulates transcription of the target genes through a few 
intercellular regulatory mediators including saeRS (Yarwood and Schlievert, 2003; Wright et 
al., 2005). 
Increased transcription of the P3 operon results in increased production of intracellular RNAIII. 
RNAIII encodes the toxin δ-hemolysin (via hld) but, particularly, increases the transcription 
(and in certain instances, translation) of some secreted virulence factors, which include TSS 
toxin-1 and hemolysins. However, some toxins, such as enterotoxins A and K, produced in low 
levels and during exponential phase, are regulated by RNAIII. Other secreted toxins, for 
example enterotoxins B, C, and D, are only partly increased by RNAIII and can be produced 
in high concentrations independently of agr (Figure 5). RNAIII regulates the synthesis of rot a 
major pleiotropic transcription factor by blocking its translation. This interference of RNAIII 
with Rot translation is direct, involving RNAIII acting as a trans antisense pairing with 
complementary sequences in the 5′ region of rot, and causing cleavage of the rot transcript 
(Geisinger et al., 2006).  
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Figure 5. Schematic diagram of S. aureus accessory gene regulatory system (agr) (Salam and Quave, 2018). 
1.7 Antibiotic resistance and resistance mechanisms in S. aureus  
1.7.1 Antibiotics commonly used in the treatment of S. aureus infections and their mode 
of action  
An antibiotic is a type of antimicrobial substance active against bacteria. Antibiotics are 
medications widely used in the treatment and prevention of bacterial infections (Liu and 
Breukink, 2016). The activity of antibiotics is to either kill or inhibit the growth of bacteria. 
There are ten main classes of antibiotics; they include penicillin, tetracyclines, cephalosporins, 
quinolones, lincomycin, macrolides, sulfonmaides, glycopeptides, aminoglycosides and 
carbapenems. The antibiotics perform their functions in different ways exhibiting different 
mechanism of action. The most important antibiotic mechanisms include inhibition of cell wall 
synthesis, inhibition of protein synthesis and inhibition of DNA synthesis (del Giudice, 
Hubiche and ér ôme Etienne 2012; Faron, Ledeboer & Buchan, 2016). 
To an extent, antibiotic activity and resistance appears to be influenced by differences in the 
bacterial structure. All bacterial cell walls contain a peptidoglycan layer also called murein and 
location of which varies between Gram-positive and Gram-negative bacteria (Liu and 
Breukink, 2016). Peptidoglycan layer acts as the bacterial cell wall’s backbone, offering 
strength to the cell wall. In addition, the peptidoglycan layer helps maintain the rigidity of the 
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bacterial cell wall to prevent the cell from rupturing. Peptidoglycan layer is made up of amino 
acids that forms a mesh-like layer outside the plasma membrane of bacteria forming the cell 
wall. It is the sugar component of the peptidoglycan that contains alternating units of N-
acetylmuramic acid and N-acetylglucosamine with the former having short peptide stems 
attached to it. Bacterial transpeptidases (detected as penicillin-binding proteins PBPs) are 
essential enzymes that catalyse this crosslinking step. Peptidoglycan production involves initial 
synthesis of precursors in the cytoplasm, transport of lipid-bound precursors across the 
cytoplasmic membrane, insertion of the glycan units into the cell wall, and lastly 
transpeptidation linking and maturation (Liu and Breukink, 2016).  
1.7.1.1 Inhibition of peptidoglycan synthesis 
Some antibiotics inhibit the synthesis of bacterial cell wall. These antibiotics include β-lactam 
compounds such as penicillins (e.g. ampicillin, penicillin G and methicillin), carbapenems and 
cephalosporins as well as β-lactamase inhibitors and monolactams (Kohanski, Dwyer & 
Collins, 2010). They are called beta-lactams because of the unusual 4-member ring that is 
common to all their members. Structurally, bacteria resemble primitive plants in that the 
cellular contents are surrounded by an inner peptidoglycan cell wall in addition to an inner 
plasma membrane. Specific antibacterial such as drugs in the β-lactams interfere with the 
synthesis of the peptidoglycan cell wall, weakening the peptidoglycan scaffold within the 
bacterial wall so that the structural integrity eventually fails (Kohanski et al., 2010; Liu and 
Breukink, 2016). Penicillin irreversibly blocks bacterial cell wall synthesis by inhibiting the 
formation of peptidoglycan cross-links. Penicillin covalently binds to the enzyme 
transpeptidase that links the peptidoglycan molecules in bacteria, it inhibits the molecule so 
that it cannot react any further and cell wall cannot be further synthesized. The cell wall of the 
bacterium is weakened even further because the build-up of peptidoglycan precursors triggers 
bacterial cell wall hydrolysis and autolysins and destroys pre-existing peptidoglycan. Penicillin 
makes a great inhibitor because of its four membered beta lactam rings, which makes it 
especially reactive (Liu and Breukink, 2016). Penicillin acts as a suicide inhibitor by binding 
with the transpeptidase enzyme it inactivates itself. 
1.7.1.2 Creation of an alternate pathway   
A similar class of antibiotics that prevent a different step in cell wall synthesis are the 
vancomycin, teicoplanin and glycopeptides (Gardete and Tomasz, 2014). Vancomycin, a 
glycopeptide antibiotic with a significantly larger structure, also prevents cell wall construction 
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by interfering with transglycosylases. Vancomycin inhibits bacterial cell wall synthesis, which 
stops the bacteria growing and dividing properly. The cell walls are made of strings of sugars, 
crosslinked by short peptide chains. By binding to D -alanyl- D -alanine groups on the end of 
the peptide chains, it stops the crosslinks forming. This prevents the bacteria from building its 
strong peptidoglycan network (Gardete and Tomasz, 2014). 
1.7.1.3 Inhibitors of protein synthesis  
Other antibiotic agents that display antibacterial effect by inhibiting synthesis of protein are 
the tetracyclines, macrolides, aminoglycosides and chloramphenicol which interfere with 
ribosome function (Trzcinski et al., 2000). Protein synthesis is a complex, multi-step process 
involving many enzymes as well as conformational alignment. However, the majority of 
antibiotics that block bacterial protein synthesis interfere with the processes at the 30S subunit 
or 50S subunit of the 70S bacterial ribosome. The aminoacyltRNA synthetases that activate 
each amino acid required for peptide synthesis are not antibiotic targets. Instead, the primary 
steps in the process that are attacked are (1) the formation of the 30S initiation complex (made 
up of mRNA, the 30S ribosomal subunit, and formyl-methionyl-transfer RNA), (2) the 
formation of the 70S ribosome by the 30S initiation complex and the 50S ribosome, and (3) 
the elongation process of assembling amino acids into a polypeptide (Trzcinski et al., 2000; 
del Giudice, Hubiche & ér ôme Etienne 2012; Piątkowska et al., 2012). 
Tetracyclines, including doxycycline, prevent the binding of aminoacyl-tRNA by blocking the 
A (aminoacyl) site of the 30S ribosome (Trzcinski et al., 2000). They are capable of inhibiting 
protein synthesis in both 70S and 80S (eukaryotic) ribosomes, but they preferentially bind to 
bacterial ribosomes due to structural differences in RNA subunits. Additionally, tetracyclines 
are effective against bacteria by exploiting the bacterial transport system and increasing the 
concentration of the antibiotic within the cell to be significantly higher than the environmental 
concentration (Trzcinski et al., 2000; del Giudice et al., 2012). 
Aminoglycoside antibiotics have an affinity for the 30S ribosome subunit. Streptomycin, one 
of the most commonly used aminoglycosides, interferes with the creation of the 30S initiation 
complex. Kanamycin and tobramycin also bind to the 30S ribosome and block the formation 
of the larger 70S initiation complex (Rahimi, 2016). 
Erythromycin, a macrolide, binds to the 23S rRNA component of the 50S ribosome and 
interferes with the assembly of 50S subunits. Erythromycin, roxithromycin, and clarithromycin 
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all prevent elongation at the transpeptidation step of synthesis by blocking the 50S polypeptide 
export tunnel. Elongation is prematurely terminated after a small peptide has been formed but 
cannot move past the macrolide roadblock (Piątkowska et al., 2012). 
1.7.1.4 Inhibitors of topoisomerase synthesis 
Furthermore, antibiotics such as fluoroquinolones, quinolones, and sulphonamides are known 
to inhibit DNA and RNA synthesis (Correia et al., 2017). Quinolones are a main group of 
antibiotics that interfere with DNA synthesis by inhibiting topoisomerase, most frequently 
topoisomerase II (DNA gyrase), an enzyme involved in DNA replication. DNA gyrase relaxes 
supercoiled DNA molecules and initiates transient breakages and re-joins phosphodiester 
bonds in super helical turns of closed-circular DNA. This allows the DNA strand to be 
replicated by DNA or RNA polymerases. The fluoroquinolones, second-generation quinolones 
that include levofloxacin, norfloxacin, and ciprofloxacin, are active against staphylococci 
(Correia et al., 2017). 
1.7.2 Development of antibiotic resistance in S. aureus. 
1.7.2.1 Time line and brief history of antibiotic resistance in staphylococci  
In 1941, Penicillin was used to treat soldiers who suffered from staphylococcal infections 
during the Second World War (Quinn, 2013). After few years, resistance emerged and spread 
fast worldwide. Penicillin resistant S. aureus in hospitals increased in number between 1946 to 
1948 from 6.5 % to 50% (Quinn, 2013). Since this number was still rising greatly in 1949, 
other natural antimicrobials agents were developed for medical care. These included 
macrolides, tetracyclines, chloramphenicol and macrolides. All these antimicrobials agents 
proved effective when they were first used to treat S. aureus. However, very quickly S. aureus 
developed resistance against these antimicrobials. Resistance of S. aureus was not to an 
antimicrobial agent only, but a combination of antimicrobials and multi-resistance S. aureus 
became a global problem in hospital settings in the year 1950 (Levy and Marshall, 2004; 
Marston et al., 2016). After a period of 10 years, 1960s to be precise, other drugs such as 
cephalosporins and synthetic penicillinase stable β-lactams such as nafcillin, methicillin and 
oxacillin were introduced to help stabilize staphylococcal penicillinase (Chambers and DeLeo, 
2009). Then in 1961, resistance to the newly discovered methicillin drug appeared and this 
spread fast all through the 1970s and reached 20 % of S. aureus at a major general hospital in 
Lagos, Nigeria, 10% of S. aureus in a general hospital setting in Birmingham, United Kingdom 
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and 15% of S. aureus from different infective sources in Denmark (Livermore et al., 2000; 
Shittu et al., 2011). In 1980s, gentamicin was introduced, and this led to a decrease of 
prevalence of MRSA though gentamicin resistant strain of S. aureus and MRSA began to 
emerge quickly during the same time (Yılmaz and Aslantaş, 2017). Then 1990s antimicrobials 
agents of the fluoroquinolone class were introduced. Later, MRSA clinical strains appeared 
resistant to ciprofloxacin (Didier et al., 2011). This resistance was low because the spread of 
resistance was minimal compared to those of other antimicrobials. Till today, antimicrobial 
agents such as glycopeptides remain fairly active against MRSA. Similarly, and fusidic acid 
and Rifampicin are also considered as possible alternatives to treat S. aureus infections 
although fusidic acid resistance MRSA has been widely encountered in coagulase negative 
staphylococci of the S. sciuri species group (Dobie and Gray, 2004; Foster, 2017). 
1.7.3. Resistant mechanisms exhibited by MRSA to selected clinically important drugs  
Various mechanisms by which S. aureus inactivates the activity of antimicrobials can be 
summarized into two main groups namely: (A) biochemical mechanisms and (B) genetic 
mechanisms.  
1.7.3.1 Biochemical mechanism of resistance  
Acquisition of blaZ genes (Penicillin resistance) 
In the 20th century, penicillin was the first drug of choice used to treat S. aureus infections. 
But since the introduction of penicillin, S. aureus have been evolving and developing resistance 
to penicillin. Before this time, S. aureus infections such as skin rash and wounds were only 
treated with plants believed to possess healing properties but patients that develop bacteraemia 
infection due to S. aureus infections were more likely to die of their infection. The mode of 
action of penicillin is that it inhibits the penicillin binding protein (PBP) within the bacterial 
cell therefore preventing the PBP from diffusing across the peptidoglycan layer also known as 
murein resulting to a weakened cell wall. Inhibiting PBP simply means the bacteria dies 
because of osmosis (Deleo et al., 2011; Deurenberg et al., 2007). Then in 20th century, the 
discovery of penicillin and its curative action against infections was widely seen as the miracle 
cure for infections. However, soon after its implementation as a routine antibiotic across the 
world, penicillin resistant strains emerged in the hospital as well as in the community 
(Deurenberg et al., 2007). Penicillin resistance is due to the acquisition of blaZ gene encoding 
β-lactam antibiotics. Generally, in staphylococci, beta lactam is an enzyme synthesized 
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extracellularly when they are exposed to lactam drugs for example Amoxicillin. The work of 
blaZ gene is that it hydrolyses the β-lactam thereby rendering the β-lactam very inactive. It is 
this inactivation that in-turn renders Penicillin based antibiotics such as Carbapenems and 
Cephalosporin in active in treatment of S. aureus infections (Alekshun and Levy, 2007).  
Inactivation of beta lactam groups by penicillin binding proteins of S. aureus 
S. aureus cell wall is surrounded by peptidoglycan which is 20-40 mm thick (Pinho et al., 
2001). The peptidoglycan is comprised of glycan chains which are short and are targeted by 
antibiotics such methicillin and penicillin in the beta-lactamase class (Pinho et al., 2001). Cross 
linking takes place outside of the cytoplasmic membrane in a reaction catalysed by penicillin 
binding protein. Four different binding proteins are present in S. aureus; PBPs, PBPs, PBPs 
and PBPs. All PBP have two main domains involved in transpeptidation and 
transglycosylation. The beta-lactam antibiotic, which look like the bond of the stem of peptide 
for cross linking, hinder the transpepetidation of the PBP domain which interfere with the 
cross-linking reaction causing the cell wall of the bacteria to become weak and cell ruptures 
due to osmosis (Fuda et al., 2004; Villegas-Estrada et al., 2008). 
S. aureus resistance due to acquisition of plasmids  
Plasmids are extrachromosomal DNA molecules that can replicate independently of the 
chromosome and can integrate into the host cell (Chamber and Deleo 2009). Plasmids are 
acquired by community acquired MRSA (CA-MRSA) and are not necessary for cell survival. 
Plasmids acquired by CA-MRSA carry along with them high antibiotic resistance. For instance, 
Erythromycin drug resistance was accompanied by a 2kb plasmid. In previous research study, 
the β-lactamse resistance was found to have 41 kb plasmid which only codes for the β-
lactamase resistance but also Mupirocin, Tetracycline, Cadmium resistance. Tetracycline and 
Trimethoprim resistance is due to the integration of a type-pT181 and acquisition of Tn4003-
type plasmid (Lomovskaya and Watkins 2001; Chamber and Deleo 2009). 
Acquisition of mecA gene and presence of phenol groups (Methicillin Resistance)  
The sudden evolution of antibiotic resistance by S. aureus to various antibiotics penicillinase 
resistance β-lactam prompted the implementation of the semi-synthetic penicillinase-resistant 
penicillin termed methicillin. Methicillin is quite different from Penicillin because of the 
presence of a phenol groups having a methoxy group in its structure. Methicillin works by 
inhibiting peptidoglycan synthesis in S. aureus. Inhibition is by the inhibition of PBP involved 
35 
 
in peptidoglycan synthesis. This mode of action appears quite like that Penicillin, except for 
the addition of methoxy group that also secretes an enzyme which decreases the affinity for β-
lactamase (Fishovitz et al., 2014; Llarrull et al., 2009). 
Shortly after the introduction of penicillin for medical use in the 1960’s, resistant strains began 
to develop. Methicillin resistance in S. aureus occurs due to the expression of PBP2a which is 
76KDa and methicillin-hydrolysing β-lactamase. PBP2a is a foreign PBP that is resistant to 
Methicillin and takes over the transpeptidation reaction. This PBP2a is coded for by a mecA 
gene which is a large stretch of foreign DNA with 40 to 60Kb). S. aureus acquired the mecA 
gene which is known to express PBP2 allegedly from S. aureus. Staphylococcal Cassette 
Chromosome (SCC) is a novel genetic element that carries mecA gene which facilitate 
resistance of β-lactamase and carrier of mecA gene across Staphylococcal species (Stryjewski 
and Corey, 2014). 
Vancomycin resistance   
Vancomycin is a glycopeptide used to treat MRSA infections, and this led to vancomycin 
resistance. Vancomycin was first reported in 1988 among the enterococci, but suddenly in 
2002, the first S. aureus isolate that was vancomycin resistance (VRSA) was reported. 
Vancomycin resistance in Staphylococcus species was found to develop as a result of the 
genetic exchange of some antimicrobial resistant genes between staphylococci and enterococci. 
The resistant genes were found on plasmids and transposons. VRSA was then characterized in 
2002 and result revealed the presence of a composite plasmid that needed two main activities 
to occur. The first activity is the transfer of the plasmid of enterococci into a recipient strain of 
S. aureus and secondly a transposition that leads to composite plasmid which is composed of 
a staphylococcal plasmid and that of enterococci transposon (Chamber and Deleo 2009). 
1.7.3.2 Genetic mechanism of antibiotic resistance in S. aureus  
The gene encoding virulence and antibiotic resistance are both located in S. aureus bacterial 
chromosome and plasmids. The genes are associated in clusters to form resistance or 
pathogenicity island which are transferred by integrons, phage or transposons called mobile 





S. aureus genome    
S. aureus genome size varies from 2.5-3.1 Mb (Kuroda et al., 2001). The genome contains 
approximately 2,500 open reading frames. Since the first two S. aureus genome sequences; 
N315 and Mu50, were analyzed and published in the year 2001, other genome sequences have 
also been studied. These include: MRSA252 and MSSA476, USA300-FPR3737, MW2, COL, 
USA300-HOU-MR, NCTC8325, ET3-1, JH-1 and JH-9, Newman and TW20 (Cocchiaro et 
al., 2006). The genome is comprised of genes which are most likely acquired by lateral gene 
transfer. S. aureus genome displays an overall conservation of sequence and structure, although 
this unique consistency is sometimes disrupted with tiny pockets of heterogeneity (Cocchiaro 
et al., 2006). The genome consists of two important parts (i) core genome that is conserved 
between the S. aureus lineages and (ii) the accessory genome (Lindsay, 2014). The core 
genome consists of genes that are used for daily events while the accessory genome contains 
the non-essential sequences mobile genetic elements. It is this difference and inclusions in the 
genome that accounts for both phenotypic and genotypic variations in S. aureus (Kuroda et al., 
2001; Lindsay, 2014). 
(i) The core genome 
Approximately 80% of the S. aureus genes are contained in the core genome. These include 
cell surface genes, as well as genes encoding both regulatory and metabolic features. As a part 
of the core genome, the CV genes make up about 12% of the S. aureus genome, and often 
encode regulators of virulence genes or surface MSCRAMMs involved in human interactions 
during colonisation of the anterior nares, such as the surface protein (SpA) (Holden and 
Lindsay, 2008). 
(ii) The accessory genome 
The remaining 20% of the S. aureus genome is the accessory genome, comprising of mobile 
genetic elements containing well over 50% of virulence factors in S. aureus. Mobile genetic 
elements (MGEs) include pathogenicity islands, chromosome cassettes, plasmids and 
transposons and bacteriophages. Many of these MGEs carry genes with both virulence and 
antibiotic resistance roles (Lindsay, 2014). MGEs are elements of dissemination of virulence 




Staphylococcal cassette chromosome (SCC) 
The SCC is a DNA genetic element situated on the chromosome of MRSA. Five different 
members of the SCC family exist. They vary in length, structure and composition however 
each SCC member shares genomic insertion sites, inverted and direct repeat which allows the 
SCC to act as a carrier for the mecA gene (Lindsay, 2014). SCC types I-IV are associated with 
hospital acquired infections (HA-MRSA) for instance ST239-MRSA-III associated with 
hospital infections in East Coast of Australia in the 90’s and ST250-MRSA -I which is the 
MRSA strain reported in Australia in the year 1960 (Plata, 2009). 
Staphylococcal cassette chromosome (SCCmec) 
SCC is a major mobile genetic element that serves as the important vehicle responsible for gene 
exchange among S. aureus strains; SCCmec belong to the SCC family, the members of which 
serve as carriers of methicillin resistance (Plata et al., 2009). SCCmec is a genomic island that 
is inserted at the 3‘end of orf X and that is located near the replication origin of S. aureus. 
SCCmec is comprised of the mec gene complex, which codes both methicillin resistance and 
the ccr gene complex, which codes the recombinases responsible for its mobility and contains 
two site specific recombines genes, ccrA and ccrB (Plata et al., 2009). There are five different 
mec gene complexes which comprises of (mecA, mecI, and mecR1) and the insertion sequences 
comprising IS431 and IS1272. 
– Class A IS431-mecA- mecR1-mec I, 
-- Class B IS431-mecA-∆mecR1-IS1272, 
-- Class C1 IS431-mecA-∆mecR1-IS431 
-- Class D IS431-mecA-∆mecR1 
-- Class E blaZ-mecA-∆mecR1-mec1 
To date, eight SCCmec types (I-VIII) have been identified based on the allotype of recombinase 
gene (ccr) and the class of mec gene complex. These SCCmec types are distributed in different 
S. aureus strains. For example, SCCmec type I-III are harboured mostly by HA-MRSA strains 
(Diederen and Kluytmans, 2006; Turlej et al., 2011). SCCmec types IV-VII of elements have 
been widely distributed among CA-MRSA strains. The type IV, V, VI and VII elements are 
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characterised by their small sizes and lack of resistance genes, other than mecA (Gill et al., 
2011). It is believed that SCCmec types IV harboured by the S. aureus community strains are 
acquired from the MRSA strains rather than an evolution of a hospital isolate that has found its 
way into the community (Gill et al., 2011). 
Pathogenicity islands 
S. aureus pathogenicity islands (SaPIs) are a family that generally carry few superantigen 
genes, encoding a range of TSST-1 and or enterotoxins. SaPIs are specifically integrated at 
certain chromosomal sites but can be mobilized following infection by certain staphylococcal 
bacteriophages or by induction of endogenous prophages (Novick, 2003). SaPIs is formed by 
integration of plasmids or by incorporation of bacteriophages carrying toxin genes (Penadés et 
al., 2015).  
Plasmids 
Plasmids are important genetic vehicle in S. aureus genome that carries antibiotic resistant 
genes. Several plasmids found in staphylococci, such as plasmid pUB110, belonging to a group 
of a small multicopy plasmids, is found incorporated in the type II SCCmec of some S. aureus 
strains. This plasmid encodes resistance to antimicrobials such as kanamycin, tobramycin, 
aminoglycosides and bleomycin. Resistance to tetracycline resistance is encoded by pT181 
while penicillins and heavy metals, such as mercury, is encoded by pI258 (Shintani et al., 
2015). 
Transposons (Tn) 
Transposons are small transferable pieces of DNA situated in S. aureus chromosome, which 
seem to be involved in modification or inactivation of certain cellular functions. Tn 554 is a 
site-specific transposon that encodes resistance to macrolide-lincosamide-streptogramin B 
antibiotics and spectinomycin. Tn 58001 carries a gene (tet M) which encodes tetracycline and 
aminocycline resistance (Hiramatsu et al., 2004). 
1.7.4 MRSA 252 and antibiotic resistance   
Over many decades now, S. aureus has undergone genetic changes that have resulted in the 
emergence of antibiotic resistant strains that appears to be very successful at transmission and 
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causing human infections in the hospitals (Holden et al., 2004). Due to the genetic changes, 
many genetic lineages have emerged and only a few of them have acquired SCCmec and this 
makes them become successful MRSA clones. Many of this hospital clones have developed 
multiple resistance to drugs, reduced susceptibility to vancomycin although very rare. MRSA 
252 is an example of S. aureus strain found in the hospitals. MRSA 252 is an important clinical 
strain also known as EMRSA-16 clone (Holden et al., 2004; Lim et al., 2015).  It is an antibiotic 
resistant strain with acquired SCCmec III and a major causative agent of human infections 
particularly wound infection in Europe, but recently, many of its isolates has been reported in 
countries like Nigeria and several other countries (Lim et al., 2015). Based on genetic diversity, 
antibiotic resistance of MRSA 252 has been associated to horizontal acquisition of mobile 
DNA and genomic islands. Thus, most of the genes encoding vital metabolic functions in the 
enhance the survival and growth of MRSA 252 in the hospital settings, contributing immensely 
to the success of EMRSA-16 clone (Holden et al., 2004; Lim et al., 2015).   
1.7.5 Some identified factors for the emergence and spread of resistance in S. aureus 
The emergence of resistance is a natural response of microbes to the presence of antimicrobial 
agents (Li and Webster, 2018). Factors responsible for the emergence and resistance of S. 
aureus includes (i) behavioural factors, (ii) inappropriate prescribing and dispensing of 
antibiotics (iii) patients and (iv) government.  
Behavioural factors contribute to the increase in multidrug resistance by S. aureus species 
(Levy, 2002). These are the external factors and it includes the use of antibiotics in livestock’s, 
misuse of antibiotics, inappropriate prescription and dispensing practices as well as improper 
hygienic practices. These involve the behavioural conduct of the doctors, patients, dispensers, 
agriculturists, government to prescription, usage and regulation of antibiotics. These factors 
are elucidated below.  
Lack of access of prescribers to recent information about drug makes them prescribe drugs less 
rationally (Richardson, 2017; Li and Webster, 2018). Incentives and enticement from 
pharmaceutical companies makes the prescribers to prescribe drugs unnecessarily and 
inappropriately (Richardson, 2017). Moreover, it is a usual practice in many developing 
countries for antibiotics to be dispensed without appropriate prescription method. Worse of it 
is that in countries like Nigeria and her neighbouring countries, antibiotics are dispensed at any 
time over the counter with any prior prescription by a doctor. This form of practices had been 
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attributed to weak laws in the countries with resultant increase in multidrug resistant S. aureus 
species and high mortality and morbidity of S. aureus associated infections (Onanuga and 
Awhowho, 2012; Onanuga and Temedie, 2011).  
Patients attitude has contributed immensely to the emergence of drug resistance through poor 
compliance to the usage of antibiotics (French, 2010; Ventola, 2015), especially if their 
symptoms are mild and could be resolved as soon as possible (Ventola, 2015). The attitudes of 
self-medication that is well practiced among patients has contributed to the emergence of 
multidrug S. aureus species to most of the first-generation drugs such as penicillin, 
streptomycin, ampicillin, cephalosporins (Rossolini, et al., 2014).  
Lastly, government contribute to emergence of resistance in S. aureus species because of 
weakness in legislation and enforcement allowing the circulation of substandard and 
counterfeit antimicrobial in the market. Poor regulation of advertisement and drug promotions 
increases sales and encourages use of antimicrobials unnecessarily. Lack of adequate training 
and certification of both prescribers and dispensers may be due to poor provision and regulation 
by government (Okeke, Lamikanra & Edelman, 1999; Shittu et al., 2011; Tadesse et al., 2017). 
Currently, there are a few antibiotics available for treating S. aureus infections. However, 
increased resistance to many drugs has led to the severity of infections caused by the bacteria. 
In addition, weak immunity in human cells due to health problems such as diabetes, cancer and 
other immune-deficiency diseases and the unique ability of the bacteria to form biofilms as 
well as develop drug resistance have greatly increased the number of life threating infections 
in human. As at today, bacterial infections still remain a major causative agent of human 
mortality. In this regard, plant oils (which are usually referred to as essential or vegetable oils) 
and their biologically active compounds are potential candidates as antibacterial agents. 
Several types of plant oils and their major active compounds from different medicinal plants 
have been reported by numerous authors to possess a wide range of inhibitory potentials for 
example antifungal, antibacterial, analgestic, antioxidant, antiviral and anti-inflammatory 
(Saxenaa, Joshib & Singhc, 2009; Orhan, Özçelik & Şener, 2011; Zakavi et al., 2013; Bardaa 
et al., 2016). The effect of antibacterial activity of plant oils may be to inhibit or destroy 
bacterial cells. Therefore, the potentials exhibited by plant oils have made them an interesting 
research area to search for alternatives to antibiotics that could help curb the menace of S. 




1.8 Plant seed and nuts  
1.8.1 Nuts and seed types and their ethnobotanical uses 
1.8.1.1 African walnut (Tetracarpidium conophorum- Mull. Arg) 
African walnut (Tetracarpidium conophorum- Mull. Arg) is a perennial creeping shrub (shown 
in Figure 6) that grows in temperate areas in Africa such as Cameroon, Gabon and Liberia 
including Nigeria (Ayoola, Onawumi, & Faboya, 2011). African walnuts are dry nuts which 
are encased in green pods. As African walnut matures, the outer covering dries and falls off 
leaving the segment tough black shell and the white seed (Figure 11). The white seed nut is the 
edible nut (Ekwe and Ihemeje, 2013). T. conophorum is often called by different names such 
as awusa (Yoruba), Ukpa in Igbo, kaso or ngak in Cameroon (Ayoola et al., 2011). A bitter 
after taste is observed upon drinking water immediately after consumption of walnut and this 
has been attributed to the presence of alkaloids in the nut although phenols can confer such 
characteristic. African walnut tree is about 40m in length and are usually harvested between 
July to December (Ayoola et al., 2011).  
1.8.1.2 Cashew nut (Anacardium occidentale L.) 
Cashew, (Anacardium occidentale), is an evergreen tropical shrub (Aliyu and Awopetu, 2007). 
Cashew is now propagated widely because of its nuts in areas of Africa particularly Nigeria, 
India, Tanzania, Vietnam, Madagascar, Asia and Philippines and Sri-Lanka (Azam-Ali and 
Judge, 2001). At maturity cashew fruit can appear as red or yellow (Akinhanmi, Atasie & 
Akintokun, 2008) (Figure 7).  At the tip end of each cashew nut is a bean kidney shaped ovary 
called nuts with tough multiple layers of shell. Cashew nut tree is about 46ft tall (Aliyu and 
Awopetu, 2007). 
1.8.1.3 Fluted pumpkin (Telfairia occidentalis)  
Pumpkin (T. occidentalis) is a dioecious perennial crop cultivated in many nations of West 
Africa but is mainly cultivated in Nigeria (Aregheore, 2012). Common English names for the 
plant are fluted gourd, fluted pumpkin and Yoruba name is ugu (Aniekwe and Mbah, 2015). 
The plant is large ranging in size from 16 to 105 cm in length with an average diameter of 9cm. 
The seed count in the fluted gourd can be up to 196 per gourd, typically 3.4 to 4.9 cm in length 
for both pistillate and staminate varieties (Figure 8). Fluted pumpkin flowers grow in sets of 
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five showing a creamy-white and dark red petal unlike the light green colour of the young fruit 
and yellow colour when ripe (Odiaka, Akoroda & Odiaka, 2008). 
 
      
Figure 6: African walnuts in Nigeria. (A) ripe-walnut still in its pod on the tree and (B) ripe walnuts in 
segmented black shells after removal from pod (C) display of walnut in open market in Lagos Nigeria. 
 
 
            
Figure 7. Cashew nut in Nigeria. (A) Cashew tree showing nuts with different degree of ripening. (B) 
Ripe-cashew nut fruits and (C) processed sun-dried nuts. 
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Figure 8. Pumpkin seeds in Nigeria. (A) Ripe-fluted pumpkin on the tree (B) harvested and processing of 
pumpkin seed (C) sun-dried pumpkin seeds 
 
1.8.2 Ethno-botanical uses of nuts and seed 
African walnut is basically boiled and consumed as snacks. In the western and northern part of 
Nigeria, the nuts are either boiled or roasted and served as snacks to welcome visitors (Ekwe 
& Ihemeje, 2013). In Cameroon, only adults are known consume walnuts until recent times. 
African walnut is also consumed raw for the of food as well as medicinal purposes (Akpuaka 
and Nwankwor, 2000), however, the leaves, bark and roots has been employed by herbal 
doctors in treatment of certain health issues (Ajaiyeoba and Fadare, 2006) (See Table 1). 
Cashew nuts are consumed as snacks. In different parts of Nigeria, cashew nuts are usually 
roasted and eaten (Olife, Jolaoso & Onwualu 2013). The leaves, bark and roots of cashew has 
also been used for treatment of health conditions (Alexander et al., 2004). Fluted pumpkin seed 
is basically used in the southern part of Nigeria as food condiments. The seeds are also used in 






    Table 1. Ethnobotanical uses of African walnut, cashew and pumpkin seeds in 
Nigeria. 
Sources: Okpashi et al., (2013); Dada, (2015); Oboh, Nwanna & Elusiyan (2010); Olife, 
Jolaoso & Onwualu, (2013); Akpuaka and Nwankwor, (2000); Ndie, Nnamani & Oselebe 
(2010); Ajaiyeoba and Fadare, (2006); Ekwe and Ihemeje, (2013). 
The scientific basis for the uses of walnut, cashew and pumpkin seed presented in Table 1 are 
yet to be fully researched and properly documented. It will be quite necessary to identify the 
key bioactive compounds. 
1.9 Phytochemicals compound in nuts and antimicrobial activity of plant oils. 
1.9.1 Plant oils 
Edible oils obtained from plants are called vegetable oils. Edible oils are comprised of 
triglycerides (Rosillo-Calle et al., 2009). Triglycerides are three molecules of fatty acids and 
ester of one molecule of glycerol. Fatty acids are main nutritional constituents present in edible 
seed and nut oils (Siyanbola et al., 2013). Edible oils are usually classified as Oleic-Linoleic 
acid oils because they have a high amount of polyunsaturated linoleic acid and unsaturated 
fatty acids, such as the monounsaturated oleic acid. They are characterised by a higher ratio of 
polyunsaturated fatty acids to saturated fatty acids (Siyanbola et al., 2013).  
             Uses                                 Part of plant 
 African walnut                  Cashew nut                    Pumpkin seed 
Treatment of chronic skin 
infections such as heat rash, 
eczema, boils Folliculitis. 
 
Treatment of fungal infections 
such as ringworm, nail 
infections 
 
As pain relieve for abdominal 
pains and tooth ache when 
used as a tonic and beverage. 
 
Treatment of diabetes, cramps 
and constipation 
 
Control of asthma, cough, 
diarrhoea 
 
Cancer treatment and high 
blood pressure. 
 
Minor cuts and Wound 
infections 
 














Nut, root and bark 
 
 
Root and bark 
 
 
Nut, root and bark 
 
 
Nut, bark and leaves 
 













Leaves and bark 
 
 
Root and bark 
 
 
root and bark 
 
 
Nut, bark and leaves 
 














Root and bark 
 
 
Root and bark 
 
 
Leaves and root 
 
 





Edible oils also contain phytochemicals such as flavonoids, terpenoids and alkaloids. They are 
beneficial to human health. Most of the phytochemicals have been proven to have therapeutic 
activities such as antibacterial, antioxidant and antifungal roles (O’Brien et al., 2005).  
Edible oils can be extracted from plants seed and nuts by exerting pressure on the plant parts 
to squeeze out oil by mechanical process or by chemical method (O’Brien et al., 2005). There 
are several types of vegetable oils derived from plant sources which include the most 
commonly consumed edible oils from cotton seed, sunflower, soybean, groundnut; and others 
such as castor, rapeseed, palm and coconut (Rosillo-Calle et al., 2009). Edible oils also include 
the less known oils such as tiger nut, walnut, pumpkin and rice bran.  
1.9.2 Bioactive phytochemicals compounds in nuts and their classifications  
The term phytochemical compounds are synonymously used with bioactive compounds and 
are sometimes used interchangeably. In the study of Chen and Blumberg (2008) on 
phytochemical composition of nuts, they classified the bioactive components in nuts into 4 
main classes namely Phenols and Phytosterols, Alkaloids, Carotenoids and Organosulfurs (see 
Figure 9). Phytochemical refers to chemicals derived from plants that is not regarded as 
important dietary nutrients but are believed to be beneficial to human health (Scalbert et al., 
2011). 
 





1.9.2.1 Alkaloids  
Alkaloids are a class of naturally occurring organic compounds that mostly contain basic 
nitrogen atoms (Bolling et al., 2011). Alkaloids belong to the category of secondary 
metabolites. The isolation of alkaloids dates back to nineteenth century (Jain et al., 2017. The 
current use of modern methods and instrumentation has enabled the elucidation of alkaloid 
structures. Alkaloids are well-defined crystalline substances which react with acids to form 
salts. They may exist as N –oxides or in the free-state in plants (Jain et al., 2017). Alkaloids 
contain carbon, hydrogen and nitrogen elements and oxygen. The functions of alkaloids in 
plants is still not unclear although study show that they may serve as defence of the plant 
against singlet oxygen which is responsible for damage to living tissues. The toxicity of 
alkaloids has also been suggestive that it acts as defence chemical against attacks by plant 
herbivores and microorganisms. In nuts, alkaloids occur in small amounts, usually < 0.08% 
(Scalbert et al., 2011; Bolling et al., 2011). Some of the alkaloids in nuts, found in Areca nut 
are arecolin, areacaine and guvacine, but only arecoline has antibacterial activity (Nwokota, 
2015) (Figure 10). 
                
Alkaloids found in nuts (Nwokota, 2015) 
 
 
           Figure 10. Alkaloids, phenol and carotenoids present in nuts (Chen and Blumberg, 2008) 
 
















1.9.2.2 Carotenoids  
Carotenoids are polyisoprenoids that naturally occurring in plants. Carotenoids are readily 
available in plant foods that are coloured (Alasalvar and Shahidi, 2009; Chen et al., 2010). Nuts 
are not main sources of carotenoids (Halvorsen et al., 2006). Carotenoids play two major roles 
in plants; firstly, they absorb light energy for photosynthesis, secondly and they protect 
chlorophyll from photo damage. There are well over 600 carotenoids that have been isolated 
from plants and characterised. In nuts, three major carotenoids are present in lower quantity; 
β-carotene, lutein, zeaxanthin and β-cryptoxanthin (Figure 10). Pistachos is an example of nut 
with low concentrations in µg/100g β-carotene and lutein. Carotenoids are classified into two, 
xanthophylls and carotenes. Xanthophylls contain oxygen in their structure while carotenes are 
purely hydrocarbons and contain no oxygen in their structure (Chen et al., 2010).  
1.9.2.1 Phenolics  
Phenols are aromatic organic compounds which consists of one or more hydroxyl groups 
attached to an aromatic hydrocarbon group (Chen and Blumberg, 2008; Salcedo, de Mishima, 
& Nazareno, 2010). Phenol is a benzene derivative and is the simplest member of the phenolic 
group (Figure 10). its structure is a hydroxyl group (-OH) bonded to a phenyl ring and its 
formula is C6H5OH (Bullo et al., 2011). Plant phenols are grouped into three classes; they 
include flavonoids, stilbenes and phenolic acids. The three classes all have a hydroxyl groups 
conjugated to an aromatic hydrocarbon. Phenolic compounds are ubiquitous in plant foods with 
total daily intakes estimated at 500-1000 mg (Chen & Blumberg, 2008). The total phenolic 
content among nuts varies widely based on varieties.  For example, pistachios, pecans and 
walnuts are rich sources of phenolics (Chen and Blumberg, 2008).  
1.9.2.2 Proanthocyanins 
Proanthocyanins, are polyphenol groups found in plant foods. They are flavanol oligomers and 
are composed primarily of epicatechin linked catechin. The size of proanthocyanins differs in 
plant foods and is ascertained by the level of polymerization. Polyphenol is found in walnut 
and other nuts (Coates & Howe, 2007). 
1.9.2.3 Phytosterol and stilbenes 
Phytosterols are plant produced steroids which are lipophilic (Lagarda et al., 2006). Sterols 
comprise of three six-carbon rings, one five-carbon ring conjugated to an aliphatic chain, and 
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a C3 hydroxyl group on the A ring. Phytosterols in nuts are mainly composed of b-sitosterol 
(Segura et al., 2006). Stilbenes are chalcones because their arrangement comprise of phenyl 
groups. So far, resveratrol and piceid are types of stilbenes found in nuts (Fernández-Mar et 
al., 2012). 
1.9.3 Antibacterial activity of plant oils 
Antibacterial activity of plant oils seed and nuts oils have been known to possess biological 
activity, particularly antifungal, antibacterial and antioxidant activities. Orhan et al., (2011) 
found that oils of hazel nut and walnut had antibacterial effects against several bacterial strains 
such as S. aureus, P. aeruginosa, Proteus mirabilis, Klebsiella pneumonia and E. coli. S. 
aureus, and E. coli. Hammer et al., (1999) analysed the antimicrobial activity of oils from 52 
plant species on human pathogens such as P. aeruginosa, Salmonella enteric subsp. enterica 
serotype typhimurium, Serratia marcescens and S. aureus, Acinetobacter baumanii, 
Aeromonas veronii C. albicans, E. coli and K. pneumonia and stated that out of all the oils, 
only oregano, lemongrass, and bay inhibited all organisms while oils from pumpkin, sage and 
sweet almond, apricot kernel, evening primrose, macadamia, did not have any effect on the 
organisms. However, Oyewole and Abalaka, (2012) found that pumpkin oil can inhibit the 
growth of organisms like Pseudomonas aeruginosa, Salmonella typhi and E coli and S. aureus. 
Kubo et al., (2006) investigated the antimicrobial activity of cashew nut shell liquid oil against 
methicillin resistant S. aureus (MRSA). He found that the oil exhibited inhibitory activity 
against the bacteria due to the presence of anacardic acid and other metabolites in the oil. 
Saxena et al., (2009) found that walnut oil inhibited both sets of bacteria particularly, Bacillus 
subtilis, B. licheniformis, S. aureus and K. pneumonia. Similarly, Rhati et al., (2014) found that 
walnut oil had antibacterial activity against S. aureus, Proteus vulgaris, P. aeruginosa, K. 
pneumonia, and B. subtilis. They reported that the activity could be due to the presence of 
alkaloids. Adeel et al., (2014) showed that pumpkin oil had good antimicrobial action against 
S. aureus with very high zones of inhibition due to the presence of carotenoids. Based on the 
previous studies, walnut, cashew and pumpkin seeds were choosen for this study for further 






2.0 Hypothesis, aims and objectives of the research  
Hypothesis: African walnut, cashew and pumpkin are nuts and seeds from Euphorbiaceae, 
Anacardiaceae and Cucurbitaceae from which oils are extracted and have antibacterial activity 
on staphylococcal species.  
Aims: The main aim of this project, however, is to determine the biochemical characteristics 
and antimicrobial potential of seed and nut oils against S. aureus. 
The objectives of this study are:  
To grow biofilms of S. aureus ATCC 6538 and MRSA 252 inorder to identify and study the 
expression of the virulence genes 
To determine antibacterial activity of oils from African walnut, cashew and pumpkin oils and 
extracts. 
To identify phytochemical constituents of African walnut, cashew and pumpkin oils and 
extracts. 
To characterise the most effective oil and identify active components. 
Problem statement  
After decades of antibiotic use, S. aureus have evolved in Nigeria and across the globe that 
have become resistant to most commonly used antibiotics (Akujobi et al., 2013). These are the 
methicillin-resistant Staphylococcus aureus (MRSA). MRSA has increasingly become very 
important human pathogen in many countries in the world since its inception in 1961 and the 
first outbreak of infection in 1968 (Abdulgader et al., 2015). Reports from the National 
Nosocomial Infections Surveillance System of the Centers for Disease Control and Prevention 
showed in August 2005 and October 2010 that MRSA on average accounts for 28-30% of S. 
aureus isolates causing nosocomial infection in hospitals and intensive care units (Akujobi et 
al., 2013). There is evidence that hospital-acquired MRSA infection increases morbidity, risk 
of mortality, medical care costs and loss of productivity (Abdulgader et al., 2015). Thus, a 
methicillin resistant and susceptible strain were used for this analysis to find active natural 





Extraction of African walnut, cashew and pumpkin oils are followed by other analysis. 
Different methodologies were used in this study including:  
1. The extraction of oil from the nuts and seed of African walnut, cashew and 
pumpkin. 
Complex molecules contained in the oils were extracted using mechanical press and 
solvent extraction methods.  
2. Antimicrobial assays 
The crude oils and solvent extracted oils as well as an active ingredient were tested in 
Methicillin resistant and susceptible S. aureus strains. Tests performed includes disc 
diffusion tests, minimum inhibition concentration (MIC), minimum biofilm inhibitory 
concentrations (MBIC), minimum biofilm eradication concentration (MBEC), 
scanning electron microscopy to observe biofilm growth, synergy test, fractional 
inhibitory concentration (FICI) to investigate their potential therapeutic activities. 
3. Phytochemical analysis 
To identify active metabolites, standard methods were used to determine alkaloids, 
carotenoids, phenols etc of the oils and infra-red was performed. 
4. Isolation of active compounds. 
Fractional distillation method was used to separate the cold pressed oil into fractions to 
obtain active component (s) that possessed biological activity. 
5. Identification of active compound  
This was achieved by performing infra-red spectroscopic method, NMR; proton NMR 
and carbon NMR.  








Chapter 2.  Materials and Methods 
2.1 Materials  
2.1.1   Collection of plant materials and identification 
Fresh African walnut (Tetracarpidium conophorum- Mull. Arg), cashew (Anacardium 
occidentale L.) and pumpkin seed (Telfairia occidentalis), of selected Nigerian plants that are 
used for the treatment of skin infections, burns and wounds were purchased in September 
through October 2016 from village farmers. For this study, an ethical approval from the 
University of Salford was obtained to stand in place for the Nagoya ethics that is yet to be 
implemented in Nigeria. Figure 11 and Table 2 shows the pictures and list of plant materials 
used in this study. The seeds and nuts were identified by a plant scientist in the Department of 
Biological Sciences, Olabisi Onabanjo University, Ogun State, Nigeria.  


















Table 2. Plant materials used in this study 
Plant seed and 
nut used 




African walnut Tetracapidium 
conophorum-Mull Arg 
Euphorbiaceae Skin swellings and 
wound treatment, 
Reduction of 








Anacardiaceae Eczema, syphilis 
related skin 
disorder and 







Pumpkin Telfaira occidentatlis  Cucurbitaceae 
commonly 
known as gourds 








2.1.2 Solvents, chemicals and media used in this study 
Solvents 
Solvents used for extraction and chemical studies were n-hexane (boiling point 61.2oC), 
chloroform (boiling point 61.2oC), petroleum ether (boiling point 42 - 62oC), obtained from 
Sigma Aldrich, Dorset, UK and Fisher Scientific, Loughborough, UK.  
Chemical reagents  
Extraction and phytochemical reagents including boron trifluoride (BF3-MeOH), ethyl alcohol, 
hydrochloric acid (HCl), potassium iodide, ferric chloride, wagner reagent, magnesium ribbon 
and lysostaphin were obtained from Sigma Aldrich, Dorset, UK, while saturated sodium 
chloride solution and anhydrous sodium sulphate reagent were obtained from Fisher Scientific, 
Loughborough, UK and Scientific Laboratory Supplies, UK. Scanning Electron Microscopy 
(SEM) materials including glutaraldehyde, sodium cacodylate buffer, sodium hydroxide, 
sodium phosphate dibasic, sodium phosphate monobasic and osmium tetroxide was purchased 
from Sigma Aldrich, Dorset, UK.  
Media 
Microbial culture media including Trypticase soy broth (TSB) and Trypticase soy agar (TSA) 
and Brain heart infusion (BHI) were purchased from Appleton Woods, Norton, UK. Mueller 
Hinton Broth (MHB) and Mueller Hinton Agar (MHA) was obtained from Sigma Aldrich, 
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Dorset, UK. Columbia blood agar base (CBAB) was obtained from ThermoScientific, 
Hampshire, UK.  
Consumables 
Congo red, horse blood and glucose were purchased from ThermoScientific, Hampshire, UK. 
Materials for biofilm growth including Nunc 96-well plates with lids, polystyrene tissue culture 
plates and MBEC TM biofilm inoculator were obtained from Innovotech, Hertfordshine, UK. 
Glucose, parafilm, sterile loops and sterile petri-dishes 60 mm in size were obtained from 
Scientific Laboratory Supplies, UK. Mineral oil and safranin for staining biofilms was also 
obtained from Sigma Aldrich, Dorset, UK. Cotton buds, filter papers, universal tube (10 mL), 
pipettes (10 – 25 mL) and bacterial spreaders were obtained from Scientific Laboratory 
Supplies, UK.  
2.1.3 Bacterial strains used for antimicrobial susceptibility testing 
The bacterial strains used in this study were methicillin-susceptible (MSSA) laboratory strain 
S. aureus ATCC 6538, Staphylococcus aureus ATCC 12228 and methicillin-resistant (MRSA), 
a clinical wound isolate MRSA 252. Both ATCC 6538 and ATCC 12228 were obtained in the 
form of stock from the American Type Culture Collection (ATCC Manassas, VA, USA). 
MRSA 252 was collected from University of Salford, Manchester, UK. ATCC 6538 strain was 
selected because it is a standard strain for testing antimicrobial agents and drug discovery. In 
addition, it is known for its ability to form biofilms. ATCC 12228 was selected because it is a 
standard strain known to be a negative biofilm former. MRSA 252 was selected because it is 
among the pathogens often implicated with staphylococcal disease outbreaks in Europe and 
across the world and a biofilm former as well. All strains were preserved as stock in the freezer 
at −80°C. 
2.1.4 Antibiotics discs  
A group of 12 antibiotics belonging to different mechanistic classes and potencies was initially 
explored for the disc diffusion test. These includes: vancomycin, chloramphenicol, gentamicin, 
erythromycin, penicillin G, streptomycin, rifampicin, oxacillin, linezolid and carbenicillin. 
(Table 3) shows the antibiotics concentrations. Antibiotic-impregnated discs (Thermo Fisher 
Scientific, UK) were stored in sealed cartridges along with desiccant at -20°C in freezer. Only 
the working supply of discs was kept in the refrigerator at 4°C for one week. Before using the 
discs for assay, the discs are usually removed from refrigerator and left at room temperature 
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for 30 minutes. This was to ensure that the discs equilibrated at room temperature thus 
minimizing the amount of condensation that occurred when warm air comes in contact with 
cold discs. 
Table 3. Antibiotics used in the study 












2.2.1 Extraction process of African walnut, cashew and pumpkin oils and their 
respective extracts 
2.2.1.1 Preparation of plant materials for extraction  
After identification, the seeds and nuts were sorted, and damaged ones discarded. The seed and 
nuts were washed in cold water to remove dirt adhering to the surface. After washing, manual 
separation of the pulps from the seed and husk from the nuts was done. The seed and nuts were 
then sundried in shade for 14 days. The nuts and seeds were pulverised using MarlexExcella 
mixer/grinding machine (Amazon, UK), packed in air tight containers and kept in the 
refrigerator at 4°C for further processing.  
Antibiotics Antibiotics potency 
(µg) 
Vancomycin 10  
Erythromycin 10  
Chloramphenicol 10  
Oxacillin 10  
Streptomycin 10  
Rifampicin 15  
Gentamicin 10  
Linezolid 10  
Penicillin G 10  
Carbenicillin 10  
Trimethoprim 1.25  
Ciprofloxacin 5  
Cefoxitin 30  
Oxacillin 5  
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2.2.1.2 Extraction of oils from African walnut, cashew and pumpkin using mechanical 
press method 
The method of choice for the extraction of the plant oils was screw press method. The 
advantage of using this method is to yield more oil and ensure that the vital components present 
in oil are preserved. The step wise method described by Jokic et al., (2014) was used to extract 
oils from African walnut, cashew and pumpkin seeds. The extraction of oils from walnut, 
cashew and pumpkin were performed using a screw expeller (Model SPU 20, Senta, Serbia). 
African walnut, cashew and pumpkin oils were obtained by pressing 200 g of individual seed 
and nuts. The minimum and maximum nozzle size used was 7 and 12 mm, respectively. The 
frequency had a minimum of 10 Hz and a maximum of 20 Hz. The temperature of oil presses 
was between 70 and 100 °C. After pressing, the volume of each screw pressed oils was 
measured and after that the oil was centrifuged. The percentage yields of individual oil after 
three extractions were calculated by weight difference. Also, the average yield of each oil 
sample was obtained. In addition, the oil sample was recovered, and physical characteristics of 
the oil samples were observed. The extracted oils were stored in white bottles at 4 °C until 
analysed. After extraction, the physical properties of each extract were recorded, and the 
amount of extract obtained was measured using an analytical balance and result obtained was 
used to calculate the percentage yield of each oil sample.   
2.2.1.3 Extraction of African walnut, cashew and pumpkin extracts using solvent 
extraction method 
To effectively extract the sample extracts needed for analysis, a standard procedure was 
developed this involved using the same amount of seeds/nuts and equal amount of solvents as 
well as the extraction time. By doing so, the final yield obtained from different solvents used 
were compared one to another. The extraction method was sequential extraction with solvents 
of increasing polarity. Petroleum ether, n-Hexane and chloroform were the solvents used for 
the extractions. Extractions of extract from African walnut, cashew and pumpkin were done 
separately at different times. Prior to extraction, the pulverized seed and nut samples were kept 
in an oven at 105 oC for 1 h to remove any moisture that may still be present. Thirty (30 g) of 
each dried sample seed was wrapped in a white muslin cloth and put into a porous thimble of 
the Soxhlet extractor, using 200 ml of different solvents such as chloroform, petroleum ether 
and n-hexane of HPLC grade with boiling range of 40-60 oC. The Soxhlet was coupled with 
condenser and flask already filled with the set up was heated heating mantle at 65 °C to allow 
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solvent boiling. In the process the solvent vapour travels up a distillation arm and flowed into 
the chamber housing the sample material. The extract seeps through the pores of the thimble 
and fills the siphon tube where it flows back down into the round bottom flask. The process 
was allowed to continue for 8 h until a clear solvent was obtained in the thimble chamber. At 
the end of the extraction, the resulting mixture of the extracts was filtered with a 10 mm 
Syringe-driven with a filter 0.45 micron to remove any impurities. The solvents were further 
removed completely with a rotary-evaporator (Model N-1, Eyela, Tokyo Rikakikal Co., Ltd., 
Japan). The extracts were stored in white bottles and tubes under nitrogen at 4 °C until 
analysed. After extraction, the physical properties of each extract were recorded, and the 
amount of extract obtained was measured using an analytical balance and result obtained was 
used to calculate the percentage yield of each oil sample.  
2.2.1.4 Oil and Extract Yield Determination (%)  
The method of Efeovbokhan et al., (2015) was used to determine both the oil and extract yield 
of each sample. After evaporation of n-hexane, chloroform and petroleum ether solvents from 
the extracts, the weight of seeds, weight of each extract and the amount of solvent used for 
extraction were considered for the calculation of percentage yield of extracts which was 
recorded. To calculate the percentage yield of oil from African walnut, cashew and pumpkin 
the same was used. The weight of seeds, weight of oil obtained from African walnut, cashew 
and pumpkin were considered for the calculation. Percent yield of both the extracts and oils 
were calculated to know the amount of stock to prepare for further analysis. Percent yield was 
calculated to know the amount of stock to prepare for further analysis.  
Percentage yield of extracts = Weight of extracted extract (g) x 100 (Equation 1) 
                         Weight of sample (g/nut)  
 
Percentage yield of oil =    Weight of extracted oil (g) x 100 (Equation 2) 
                                                Weight of sample (g/nut) 
 
2.2.1.5 Preparation of standard concentrations of African walnut, cashew and pumpkin 
oils with their respective extracts 
The procedure described in Benson's Microbiological Applications Laboratory Manual (2001) 
was used to prepare the standard concentration of the oils and extracts. Two grams of the 
individual oil and extract was weighed and diluted with 2 mL of DMSO (0.05%). The dilution 
of the oils and extracts with DMSO led to the concentration of 1000 mg/mL individually. 
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Resultant stock samples were stored at 4°C in a clear glass volumetric flask. Working 
concentration was prepared by performing 2-fold dilution from stock. 
2.3 Preliminary phytochemicals analysis of African walnut, cashew and pumpkin oils 
with their respective extracts  
Preliminary analysis of the various constituents of the oils and their respective extracts was 
performed to identify the possible phytochemical groups contained in each sample. In this 
study different qualitative phytochemical screens were performed on each oil sample and its 
extracts using various standard procedures (Mbatchou et al., 2011) to identify their active 
constituents. 
2.3.1 Determination of Flavonoids  
Shinoda’s Test 
Briefly, 2 mL of each oil sample was put in three different 250 mL beakers and dissolved with 
3 mL of ethyl alcohol each and reacted by few drops (10 drops) of diluted HCl followed by a 
magnesium ribbon. Formation of colours such as reddish, pink, or brown indicates the presence 
of flavonoids in the sample extract. This procedure was also used to determine flavonoids in 
each extract (Mbatchou et al., 2011). 
2.3.2 Determination of alkaloids 
Wagner’s Test 
500 µL of each oil sample was put in three different tubes and acidified with 1 mL of 1.5% 
(v/v) HCl and dissolved with 500 µL of Wagner’s reagent which is iodine prepared in 
potassium iodide solutions. Within 10 min a yellow or brown precipitate was observed. 
Appearance of yellow or brown precipitate indicates the presence of alkaloids. This procedure 
was used to determine alkaloids in each extract (Mbatchou et al., 2011). 
2.3.3 Determination of saponins  
Foam test 
To 2 mL of each oil sample and extract, 6 mL of deionised distilled water (ddH2O) was added 




2.3.4 Determination of tannins 
To 2 mL of each oil sample and extract, 500 μL of 10% of alcoholic ferric chloride was added; 
formation of brownish or blue-black colour indicates the presence of tannins. 
2.3.5 Determination of phenol 
To 2 mL of each oil sample and extract, 2 mL of 5% aqueous ferric chloride were added and 
formation of blue colour within 3 minutes indicates the presence of phenols in both the oils and 
sample extracts.  
2.3.6 Determination of terpenoids  
1 mL of each oil sample and extract of each solvent was placed into different 250 mL beakers 
and 500 μL of 100% chloroform was added followed by addition of 3-5 drops of concentrated 
sulphuric acid (100 %), formation of dark reddish-brown precipitate of each sample indicates 
the presence of terpenoids. 
2.4 Identification and investigation of biofilm production in MRSA 252 and S. aureus 
ATCC 6538 
2.4.1 Identification of S. aureus isolates  
The strains were confirmed by several procedures which include: 
• Morphological characteristics 
• Biochemical test 
• Antibiotic sensitivity test 
2.4.1.1 Morphological characteristics 
The characteristic colour and colony appearances (shapes) were determined using Habib et al., 
(2015). To determine the colour and shapes based on Berge’s method, one (1) to two (2) 
colonies of each bacterium was streaked onto TSA and CBAB plates respectively. After 
streaking, plates were then incubated at 37 oC for 24 h. After incubation colonial morphologies 
were determined. 
2.4.1.2 Biochemical tests 




(i) Catalase test 
To test for catalase activity, the method of Darwish and Asfour, (2013) was modified. 
Modification was the use of 100 mL instead of 10-20 drops. 100 mL of hydrogen peroxide was 
put in white clear vials. Bacterial colonies 4-5 from both ATCC 6538 and MRSA 252 were 
picked up with inoculation loop and transferred onto hydrogen peroxide in glass vial, to test 
catalase activity. The production of gas bubbles constitutes positive reaction. 
(ii) Coagulase test 
Tube coagulase test was used to test for coagulase. For detection of free coagulase 500 L of 
rabbit plasma was taken in a test tube. To this plasma 100 L of overnight broth culture of S. 
aureus strains was added. The tube was then rotated gently to mix the content together and 
then incubated at 37 oC, preferably in water bath for 2-4 h (Darwish and Asfour, 2013). Clotting 
of rabbit plasma by conversion of fibrinogen into fibrin by the Staphylococcal coagulase 
enzyme was considered as positive test. However, a weak coagulase positive strain will 
coagulate the plasma after overnight incubation. 
(iii) Lysostaphin tests 
100 mL of over-night cultures of MRSA 252 and ATCC 6538 were mixed with 200 mL of PBS 
and 200 mL of reconstituted lysostaphin (1 mg/mL) and samples were incubated for 37oC for 
2 h in an incubator. Samples were observed for turbidity and clean clear samples without 
turbidity were taken as positive. ATCC 12228 used as control was set up at the same time. 
2.4.1.3 Antibiotic sensitivity test 
Two main antibiotic discs namely cefoxitin (30 µg) and oxacillin (1 µg) essential for the 
identification of methicillin susceptible and resistant MRSA 252 and ATCC 6538 were used.  
2.4.2 Biofilm formation assays 
2.4.2.1 Phenotypic analysis 
(i)  Detection of slime production by congo red agar method 
Slime production was determined by cultivation of all S. aureus strains on congo red agar 
(CRA) plates as described by Darwish and Asfour, (2013). Briefly, CRA plates were prepared 
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using 3 g of TSA adding 0.1 g Congo red supplemented with 1 g (w/v) glucose in 100 mL of 
distilled water. The strains were inoculated in streaks and incubated at 37 °C under aerobic 
conditions for 24 h, followed by storage at room temperature for 48 h (Kaise and Nunes, 2012). 
Isolates were interpreted according to their colony phenotypes. Black colonies with dry 
consistency and rough surface edges were considered a positive indication of slime production, 
while black colonies with smooth, round and shiny surface and red colonies of dry consistency 
and rough edges were considered as intermediate slime producers. Red colonies with smooth, 
round, and shiny surface were indicative of negative slime production. 
(ii) Quantification of biofilm by microtiter plate (MTP) method  
MRSA 252, ATCC 12228 and S. aureus ATCC 6538 were grown overnight at 37 °C as pure 
cultures on TSA and CBAB plates. Groups of three single colonies morphologically similar 
were inoculated in 10 mL TSB. Suspensions were incubated for 18 h at 37°C (stationary phase 
>2.5) in a rotator shaker and then diluted at 1: 40 in a fresh sterile TSB with 2–7 × 107cfu/mL 
using 0.5 MacFarland standard tubes to compare the suspensions. This diluted suspension was 
used as the inoculum in the microtiter plate test. Microtiter plate test was performed according 
to Asthan et al., (2013) and Darwish and Asfour, (2013).  For each strain 1 mL aliquots of 
prepared suspension were inoculated into nine wells of the 24-well tissue culture plates 
(Corning Costa, UK) with the aid of a multichannel pipette. Each culture plate included a 
negative control, a negative biofilm former (ATCC 12228). The plates were incubated at 37°C 
for 12 h, 24 h and 48 h respectively and content of each well was removed by aspiration with 
1 mL pipette tips and the wells were rinsed three times with 1 mL each of deionized water 
(total of 27 mL of deionized water was used to rinse each plate). The plates were dried in 
inverted position for 20 min. The attached bacteria were later fixed for 15 min at room 
temperature by adding 1 mL of methanol per well (9 mL in total/plate) for 20 min before the 
plates were emptied and left to dry overnight. Each well of the biofilm plates were then stained 
with 1 mL each of 0.1% safranin (9 mL in total/plate) for 15 min. Excess stain was rinsed off, 
and the plates were washed three times with distilled water, left to dry overnight and the next 
day plates were visually inspected for biofilm formation. After the visual inspection of plates, 
the safranin dye that was bound to the adherent cells was dissolved with 95% ethanol per well, 
and optical density was measured at 595 nm (OD 595). The experiment was repeated three 
times. The optical density (OD595) of wells containing sterile. ATCC 12228 was used as the 
negative control. An OD 595 value of 0.5 was selected as the cut-off point to differentiate as 
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positive for biofilm formation. Biofilm formation for each strain was analyzed and categorized 
based on the absorbance value of the safranin-stained biofilms. Strains were considered as 
follows: 
                                               Strongly adherent ++++ (OD 595 > 3.0), 
                                                Highly adherent +++ (OD 595 > 2.0), 
2.5 Screening of oils and extracts for antimicrobial activity against MRSA 252 and 
ATCC 6538 
2.5.1 Growth of S. aureus strains for analysis 
2.5.1.1 Preparations of media for growth of bacterial strains 
Mueller Hinton Broth (MHB), Mueller Hinton agar (MHA), trypticase soy broth (TSB), 
trypticase soy agar (TSA) and Columbia blood agar base (CBAB) used as media for growth of 
bacterial cultures were sometimes made up in large volumes as follows: MHB, 23 g, MHA (38 
g), TSB, 30 g, TSA ( 30 g) and CBAB (30 g) were made up in 1 Litre of deionised water and 
sterilised at 121oC for 15 minutes at 15 psi pressure.  
2.5.1.2   Growth of S. aureus strains on solid media 
ATCC 6538, ATCC 12228 and MRSA 252 were grown on solid media (TSA, MHA and 
CBAB), based on the method described by Vitko and Richardson, (2013). At times these three 
media were prepared same day. TSA was prepared by weighing out 3 g of TSA, into 100 mL 
of sterile deionised water (dH2O) to dissolve. Similarly, 2.3 g of MHA was weighed in 100 
mL and 4.88 g of Columbia agar in 100 mL to dissolve. TSA, MHA and CBA media were then 
autoclaved at 121 °C for 60 min and poured into petri-plates to cool. After plates were cooled, 
sterile loops were used to streak out small amount of each bacterial strainsfrom the frozen stock 
(-80°C) onto the TSA, MHA and CBA plates. This was done to make the strains visible as 
distinct colonies at the end of the streaks. Most importantly the bacterial colony appearances 
and morphology of the strains used in this study were carefully studied. The plates were then 
incubated for 24 h at 37°C in an incubator. After incubation, the cultured plates were sealed 
with parafilm and stored in the refrigerator at 4 °C for further use.  
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2.5.1.3 Preparation of overnight culture  
Overnight cultures were prepared using the method described by Vitko and Richardson, (2013). 
Using aseptic technique, single colonies of ATCC 6538, ATCC 12228 and MRSA from the 
streaked plates were transferred with sterile loops into 10 mL TSB broth or 10 mL MHB 
(depending on the analysis to be performed next day) and the bacterial cultures were then 
grown overnight for 16 – 18 h at 37 °C with shaking (200 rpm) in N-BIOTEK shaking 
incubator. The shaking was done to increase aeration. After incubation, bacterial growth was 
checked, which was characterized by a cloudy haze in the medium and the optical density was 
determined using a spectrophotometer. Following the overnight growth, the bacterial culture 
was in stationary phase an OD600 = > 2.5. 
2.5.2 Maintenance of test organisms   
To be able to use the bacterial strains for a long period of time checks for no change in strain 
characteristics were performed. The bacterial strains were maintained for both short terms as 
well as for long term preservation.  
2.5.2.1  Short term maintenance 
For daily or weekly use of the bacterial strains short term maintenance method was followed. 
This was done to reduce the chance of the bacterial colony mutation when the culture is old. In 
this study, the strains were maintained for short time period (5 days) on agar plates. TSA and 
CBAB plates were used for this purpose. A single colony of each bacterium (ATCC 6538 and 
MRSA 252) was taken in a loop and was streaked on the agar plates by streak method to get 
more single colonies. The plates were incubated overnight at 37°C to get the colonies. 
Following day, the plates were sealed with parafilm and stored at 4°C refrigerator for the next 
use (Vitko, 2013). The parafilm helps to avoid any source of contamination in the plate while 
storing and it helps to maintain the moisture in the plate which prevents the bacterial colonies 
from drying. Using this method, the strains were stored in the refrigerator for a month. At times, 
the strains were sub-cultured on fifth day after culturing to maintain healthy bacterial colonies.  
2.5.2.2 Long term maintenance 
Long term bacterial maintenance is important because it helps to store the strain as stock sample 
(Vitko, 2013).  The bacteria could be revived again for later use if the short term maintained 
bacterial strains are mutated (Vitko, 2013).  For this study, long term maintenance of bacterial 
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strains was done in two ways: by keeping the bacterial strains supplied as stock in -80°C freezer 
or by preparing a glycerol stock in cryovials (as cryogenic stocks) containing 700 μL of 
overnight cultures in trypticase soy broth and 30% (v/v) glycerol (Vitko, 2013).  Every 6 
months, a loop full of each bacterial strain were thawed from the -80°C freezer, streaked on the 
agar plate and incubated overnight at 37°C to culture the bacterial strains. Next day, when the 
bacterial colonies were ready for use, four to five single colonies of the same morphology are 
picked up and inoculated in fresh TSB or MHB depending on the analysis to be conducted. 
2.5.3 Antimicrobial susceptibility testing of seed and nut oils 
The antimicrobial activity of the extracted oils and respective extracts were tested by three 
main methods: 
• Agar disc diffusion Method (Kirby Bauer) 
• Minimum Inhibitory Concentration (MIC) and Minimum Biofilm Inhibitory 
Concentration (MBIC) 
• Minimum Biofilm Eradication Concentration (MBEC) 
 
2.5.3.1  Agar diffusion method  
The agar diffusion assay is a method for quantifying the capacity of antimicrobial agents to 
inhibit bacterial growth (Boney et al., 2008).  It can be done in two ways, one is disk diffusion 
method, and another is well diffusion method. For this study the disk diffusion method was 
followed for the oils and the well diffusion was used for the extracts. Disc diffusion method 
for antimicrobial susceptibility testing was carried out based on recommendations given by the 
Clinical Laboratory Standards Institute, CLSI (CLSI, 2012; Jorgensen and Turnidge, 2015). 
The disk-diffusion method also called Kirby-Bauer sensitivity test was used to test the 
effectiveness of walnut oil, cashew oil, and pumpkin oil on S. aureus strains ATCC 6538 and 
MRSA 252. The effectiveness of these oils in combination with multiple commercial 
antibiotics was also determined using this method. This method was used as a preliminary 
check to select between efficient oils and antibiotics that could be used for further analysis and 
the synergism study. The disk diffusion method is performed using Mueller-Hinton Agar 
(MHA), which is the best medium for routine susceptibility tests because it has good 
reproducibility. Also, because MHA is low in trimethoprim, sulphonamide and tetracycline 
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inhibitors it gives satisfactory growth of most bacterial pathogens (Tendencia, 2004). This 
method was used to assess the antimicrobial activity of the oils only. 
 
(i)  Preparation of impregnated disc  
10 L of oils (concentration 1000 mg/mL) from African walnut, cashew and pumpkin were 
used to impregnate sterilized 6 mm diameter blank discs (Oxoid, UK). For the screening of 
plant oils with commercial antibiotics, 10 L of a final concentration of each oil sample was 
used to impregnate the commercial standard antibiotics with known concentrations. Dimethyl 
sulfoxide 0.05 % (v/v) loaded discs (10 L) was used as a negative control. All impregnated 
discs were ensured to be fully dried in 40 ºC incubator for 18 to 24 h prior to the application 
on Mueller Hinton Agar (MHA) plates. Standard antibiotic discs of all the discs impregnated 
with oils were used as positive controls and synergy test. 
(ii) Inoculum preparation for performing the disc diffusion test 
Inoculums for disc diffusion tests were prepared following the guidelines of the Clinical 
Laboratory Standards Institute, CLSI (CLSI, 2013) and National Committee for Clinical 
Laboratory Standards NCCLS (2012). Briefly, using aseptic techniques, bacteria strains 
(ATCC 6538 and MRSA 252) were cultured in 10 mL of Mueller Hinton Broth (MHB) 
overnight or to stationary phase (OD600 = >2.5). From the overnight culture, using streak plate 
method, a loop full of both strains were streaked across the MHA plate and incubated at 37 ºC 
for 24 hours. From the incubated MHA culture plates, inoculums were prepared by making a 
direct broth suspension of four to five S. aureus strains ATCC 6538 and MRSA 252 well 
isolated colonies of the same morphological type from an 18 to 24-hour culture into a freshly 
prepared 10 mL of Mueller Hinton Broth (MHB), and incubated in a shaking incubator 
(Camlab, UK) at 37 ºC, 200 rpm for 18 h with 200 rpm to stationary phase (OD600 >2.5). The 
bacterial suspensions were adjusted to achieve a turbidity equivalent to a 0.5 McFarland, 1.0 x 
108 to 1.5 x108colony forming units per millilitre CFU/mL. This was done by diluting the 
overnight cultures 1:100 by transferring 0.1 mL of the bacterial suspension to 9.9 mL of sterile 
TSB before growing back in the shaking incubator for approximately 2-3 hours (mid-log phase) 
to obtain 0.08 to 0.10 OD625 corresponding to 1.5 x 108 CFU/mL. The correct density of the 
turbidity standard was verified using a spectrophotometer with a 1-cm light path and matched 
cuvette (Star Labs, UK) to determine the absorbance at 625 nm. Blank of MHB alone was used 
to calibrate the spectrophotometer before measuring the samples. To ensure conformity of the 
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suspension’s turbidity with McFarland standard, both the suspension and the prepared 
McFarland standard were also compared visually. Furthermore, the inoculums suspension was 
used within 30 min of standardisation, which is a very important factor to avoid any change of 
the size of inoculums or loss of their viability. The viable cell density was confirmed by serially 
diluting and plating on TSA. 
 
(iii) Inoculation of test plates with standardized bacteria 
100 μL of standardised bacterial inoculums were spread over the plate’s surfaces containing 
Mueller-Hinton agar using a sterile cotton swab to get a uniform microbial growth on both 
control and test plates. For uniformity of bacterial growth, a sterile cotton swab was dipped 
into the standardised bacterial inoculum suspension, and then it was streaked over the entire 
dried surface of 40 mm MHA plates twice. The agar plate was swirled about 60oC each time 
to ensure that the inoculums were evenly distributed on the entire agar surface. To get rid of 
excess moisture from the inoculated plates their lids were left partly open for about 5-10 min 
in an oven but not less than 15 min.  
 
(iv) Application of impregnated discs to inoculated agar plates 
Using sterile forceps, the discs which had been impregnated with 10 μL of plant oil samples 
(African walnut oil, cashew nut oil and pumpkin oil) alone, with commercial antibiotics with 
known concentration were applied on the inoculated MHA once it has completely dried.  
Commercial antibiotics with known concentration impregnated with 10 μL of plant oil samples 
were also placed on the MHA plates.  The disks were pressed gently to ensure uniform contact 
with agar surface so that the oils can penetrate the agar. Furthermore, each one of the test plates 
was comprised of no more than four treated discs which were placed about equidistance to each 
other to avoid the overlapping of inhibition zone. The four treated discs includes: 1 disc 
moistened with 10 μL of 0.05% (v/v) DMSO was placed on the inoculated agar plate as a 
negative control, 1 disc moisten with 10 μL of oil sample (1000 mg/mL) only, 1 antibiotic disc 
of known concentration of antibiotics and another moistened with 10 μL oil sample. A wide 
range of antibiotic was used (Table 5). All agar petri-dishes were sealed with sterile laboratory 
parafilm to avoid evaporation of the test oil samples. The plates were left for 30 min at room 
temperature to allow the diffusion of oil, and then they were inverted and incubated at 37°C 
for 24 h. Control plates were prepared using DMSO and mineral oil. After the incubation 
period, the zones of inhibition around the treated discs were measured in millimeter (mm) with 
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a ruler and interpreted using the CLSI zone diameter interpretative standards. Zones were 
classified as resistant or susceptible based on the diameter of the zones. Studies were performed 
in triplicate to ensure reproducibility, and mean value was calculated. The means were analyzed 
by two-way analysis of variance (ANOVA). 
2.5.3.2 Minimum inhibitory concentration (MIC) of African walnut, cashew and 
pumpkin oils with their respective extracts 
To effectively identify the concentration range for biofilm experiments, initially the minimum 
inhibitory concentration (MIC) of African walnut oil, cashew oil and pumpkin oil and their 
respective extracts were determined by the micro broth dilution assay using 96 well microtiter 
plates described by Mahboubi et al., (2011) and Sallleh et al., (2016). The inoculum of MRSA 
252 and ATCC 6538 were prepared from 18 h overnight cultures and suspensions were 
standardized to 0.5 McFarland standard turbidity. The standardised oils were prepared in a 
concentration range of 0.98 – 500 mg/mL. In setting the 96 well microtiter plate, wells A-F 
were reserved in each plate for negative control. 100 μL of sterile TSB was added to the wells 
from rows B to H. After this, 100 μL of the stock solution of each oil sample (from 1000 
mg/mL) were added to the wells at rows A and B. Then both the mixture of samples and sterile 
broth 100 μL at row B was transferred to each well to obtain a two-fold serial dilution of the 
stock oil samples (concentration of 500, 250, 125, 62.5, 31.25, 15.6, 7.8, 3.9, 1.95 and 0.98 
mg/mL. After serially diluting the oil samples, 100 μL of each standardized inoculum (108 
CFU/mL) was added to each well. The final volume in each well was 200 μL.  Streptomycin 
sulphate for bacteria 20 μg/mL was used as positive control to monitor the results. The plates 
were then incubated at 37 ºC for 24 h. Thereafter, the optical density (OD) values of the samples 
in each well/plate were measured at 600 nm (OD600) wavelength. MIC was defined as the 
lowest walnut, cashew and pumpkin oil concentration resulting in no visible growth compared 
to the control bacterial suspension (growth control that is untreated control). Wells (G-H) with 
sterile TSB served as negative control.  
2.5.3.3 Determination of MICs of antibiotics 
Different concentrations of streptomycin, chloramphenicol and vancomycin, was prepared by 
diluting their powders in sterile distilled water. Rifampicin and trimethoprim were prepared by 
diluting the powders in dimethyl sulfoxide (DMSO) to completely dissolve since they do not 
dissolve in water. MICs of antibiotics namely vancomycin, chloramphenicol, rifampicin, 
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streptomycin and trimethoprim, gentamicin, for S. aureus strains in biofilm were determined 
using the broth micro-dilution method as recommended by the CLSI, (2013) and described by 
Xing et al., (2012). For this analysis, under a septic condition, biofilms were developed by 
growing cultures of S. aureus in MHB prepared overnight at 37°C for 18 h without shaking. 
Overnight cultures were diluted 10-fold (1:10) in fresh MHB giving OD600 = 0.4 resulting in 
5.0×105 cfu/mL. Following standardization 100 µL of the bacterial cultures were distributed 
into each well of the 96 well microtiter plate and incubated at 37°C for 24 h for biofilm 
formation. After 24 h incubation, the 96 well microtiter plate containing S. aureus biofilms 
were washed three times with 4 mL of sterile PBS to remove any free floating bacteria and a 
serial two-fold dilution of each antibiotic sample prepared in water or DMSO resulting in 
concentrations ranging from 50 μg/mL to 0.195 μg/mL for vancomycin and streptomycin, 125 
to 0.49 μg/mL for trimethoprim and rifampicin, 250 to 0.98 μg/mL for gentamicin and lastly 
100 to 0.41 μg/mL was added to each well in the 96-well plate (100 μL per well) and incubated 
at 37 °C for 24 h. Each of the antibiotics was separately tested.  Rows G-H in the plate served 
as negative control wells for media only and antibiotic alone, while column 12 served as 
positive controls containing biofilm and saline. After incubation, growth on the plates were 
assessed by measuring the optical density at 600 nm by using a FLUOstar Omega plate reader 
(LABTECH, UK).  
2.5.3.4 Minimum biofilm inhibitory concentration (MBIC) of African walnut, cashew and 
pumpkin oils with their respective extracts  
Plant oils and extracts which showed clear inhibition zone and is within the breakpoint 
established in the CLSI, (2012) guidelines for antibacterial susceptibility testing were further 
tested to determine their MBIC values by broth micro-dilution. MRSA 252 and ATCC 6538 
biofilms were first performed by placing 100 μL of the standardized inoculums 108 CFU/mL 
into rows B-H of the 96-well polystyrene tissue culture plates covered with lid and incubated 
for 24 h at 37 ºC. After 24 h of incubation, the bottom of each well of the 96 well microtiter 
plate was visually inspected for biofilm formation (adherent cells). When biofilm formation 
was confirmed, the free-floating cells (planktonic cells) in each well was carefully removed 
and each plate was rinsed with 200 μL of 1X sterile PBS to remove all free-floating cells from 
the wells. After washing, 100 μL of the freshly diluted TSB containing two–fold serial dilutions 
of each oil sample prepared to achieve concentration ranging from 0.98 -500 mg/mL was 
placed into each well. This dilution was to achieve a recommended final cell count of about 5 
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x 105 CFU/mL after incubation for 24 h at 37 °C. After the incubation time, supernatant from 
all wells was discarded and biofilms that adhered to the bottom of the wells were incubated 
with 200 μL of 0.1 mol/L of HCl (per well) for 90 min at room temperature. After this, HCl 
was replaced by 0.1 % safranin and the plates incubated for 35 min at room temperature (Figure 
12). Nonbounded safranin was removed by rinsing the wells three times (3X) with distilled 
water, and thereafter each well of the plates were incubated with 125 μL of 0.2 mol NaOH at 
37°C for 1 h. After incubation, 100 uL from the stained dissolved biofilm in each well was 
pipetted to a sterile new flat-bottom 96-well microtiter polystyrene plate and its intensity was 
measured at a wavelength of 600 nm using a plate reader. 
 
                       
Figure 12. Example of separately prepared plates with oils for biofilm inhibitory concentration determined 
by broth microdilution method and safranin staining. 
 
2.5.3.5 Determination of minimum biofilm eradication concentration of African walnut, 
cashew and pumpkin oils on preformed biofilms 
Protocol outlined in the MBEC procedural manual for high throughput antimicrobial 
susceptibility testing of biofilms was followed strictly for this analysis. Broth microdilution 
procedure was employed to investigate the antimicrobial efficacy particularly the inhibitory 
effect of walnut oil, cashew oil and pumpkin oil against MRSA 252 and ATCC 6538 preformed 
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biofilms. In addition, other similar procedures for determining MBEC described by Nair et al., 
(2016) and Deborah Corca-huber, (2012) was used. In this study MBEC was defined as the 
minimum concentration of oils that prevents a re-grow of MRSA 252 and ATCC 6538 biofilms 
or can eradicate their biofilms.  
 
(i) Growing subculture for MBEC assay 
In this assay, two subcultures of S. aureus strains were first prepared. A first subculture of S. 
aureus strains was streaked out on TSA plate and incubated statistically at 37 °C for 24 h. After 
24 h, the first subculture was checked for purity that is no contaminant. The second subcultures 
were streaked out from the first culture and incubated at 37 °C for 24 h again. 
(ii) Inoculation and biofilm formation 
To successfully grow biofilm for MBEC assay, the MBEC™ Biofilm Inoculator with 96 well 
Base was used. Overnight inoculums were diluted to give a final organism density of 
1.5×108 CFU/mL in TSB which was poured into a reagent reservoir. Using a multichannel 
pipette, 150 μL of the inoculum was added to each well of the 96 well microtiter base packaged 
with the MBEC™ Biofilm Inoculator. The biofilm inoculator with peg lids was placed onto 
the 96 well microtitre base. While dispensing the inoculum into the wells, it was ensured that 
the orientation of the plate matches the orientation of the lid (i.e. peg A1 was inserted into well 
A1 of the microtiter plate, this was to ensure that the device was fitted correctly. The volume 
of 150 μL inoculum was used in this step to ensure that the biofilm covers a surface area of the 
peg that is immersed, entirely, by the volume of plant oils used in the challenge plate set up 
described below. The microtiter plate was placed in the incubator at 37°C for 48 h without 
shaking at 110 rpm. 
(iii) Biofilm growth check 
The peg lids were checked for biofilm growth by preparing a rinse plate for the individual oil. 
This was done by filling each well of a new sterile 96-well Nunc plate (Innovotech USA) with 
200 μL of sterile distilled water (dH2O) to rinse the dispersed cells from the biofilms that have 
formed on the pegs of the MBEC™ device. Rinsing was done by immersing by the peg lid into 
the rinse plate for approximately 10 seconds. Following the rinse step and prior to the use of 
the antimicrobial challenge plate, the biofilm growth check (BGC) pegs (about 2 pegs) were 
broken off with sterilized (flamed) pliers and placed into 200 μL of TSB recovery media in 
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row A of a new sterile 96-well microtiter plate. The recovery plate was then transferred to the 
sonicator and sonicated on high amplitude for 30 minutes to dislodge the biofilm. Following 
sonication, 180 μL of TSB was placed into each well of rows B-H, directly below the BGC 
pegs in row A of the recovery plate. A serial dilution (100-107) was prepared by transferring 20 
μL from each well in row A to each well in row B and so on down each of the 8 rows, mixing 
well and discarding tips between each transfer. 20 μL from each well was removed and plated 
on TSA plates. Plates were incubated for 37°C for 48 h and colonies counted to determine the 
biofilm density on the pegs (Biofilm Growth Check).  
(iv) Preparation of the antimicrobial challenge plate 
Using a sterile nunc brand 96 well microtiter plate, the following steps described how the 
challenged plate was aseptically prepared. The challenge plate was prepared fresh on the day 
of the challenge for the three oil samples. 200 μL of TSB was added to each well in columns 
11 and 12 of the challenge plate. These wells served as the sterility controls, growth controls 
and biofilm growth checks. 100 μL of TSB for the oil sample was added to each well in columns 
1-10, rows B-H. 100 μL of the standardised oil sample was added to each well in columns 1 to 
10, row A of the microtiter plate and added to each well in columns 1-10, of rows B and C. 
Using a multichannel micropipette, the contents of columns were carefully and properly mixed 
in 1 to 10, row C by pipeting up and down. After mixing, 100 μL was transferred from the 
wells in row C to the corresponding wells in row D. The contents of columns 1-10, row D was 
mixed and 100 μL was transferred from each well to the corresponding wells in row E. The 
serial dilution and transfer process were repeated down the length of the microtiter plate until 
reaching row H. This dilution was performed for only the challenge columns (columns 1 to 
10). After this, a multichannel pipette, was used to remove 100 μL from each well in columns 
1-10, row H and discarded. Then 100 μL of TSB was added to each well in columns 1-10, rows 
C-H so that at the end each well of the challenge plate contains 200 μL. Aseptically, the freshly 
prepared challenge plate was covered with lid and allowed to stand at room temperature for 30 
min to equilibrate prior to use. Oxacillin was used as positive control in this analysis. 
(V)  Antimicrobial challenge and recovery of the biofilm  
Following the rinse step and after breaking off the BGC pegs, the MBEC™ lid was transferred 
with biofilm growth to the prepared challenge plate described above and incubated for 37°C 
for 24 h. A new recovery plate was prepared by placing 200 μL of TSB in each well (including 
growth and sterility control wells) of a new, sterile 96-well microtiter plate. The MBEC™ lid 
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from the challenge plate was transferred to the recovery plate and left to stand for 30 min to 
equilibrate. After the equilibration time, the recovery plate was transferred to the sonicator and 
sonicated on high speed for 30 min to dislodge the biofilms. After this the recovery plate is 
incubated at 37°C for 6, 12, 24 and 48 respectively. After each growth time conditions, the 
MBEC values, were determined by visually checking for turbidity in the wells of the recovery 
plate and plating out 100 μL of suspension per well on TSA. The mean of the viable counts of 
different concentrations of each oil sample per well for each bacterium was compared and 
analysed using one-way analysis of variance (ANOVA) with Bonferroni posttests. Result is 
reported in log reduction. 
2.6 Molecular study of MRSA 252 and S. aureus ATCC 6538 virulence genes 
2.6.1 Scanning electron microscopy  
2.6.1.1 Preparation of MRSA 252 and S. aureus ATCC 6538 biofilms for scanning 
electron microscopy (SEM) 
Before determining the appropriate timepoints for RNA extraction, changes in the 
morphological surfaces of each strain was initially observed using SEM along the different 
growth time point. Biofilms of MRSA 252 and ATCC 6538 cells for SEM analysis were grown 
on 24-well polystyrene tissue culture plates using the methods described by Asthan et al., 
(2013) and Stepanovic et al., (2007). Briefly, standardized inoculums of MRSA 252 and ATCC 
6538 cells were prepared from overnight culture. This was done by diluting overnight culture 
1:10 in fresh TSB supplemented with glucose (to enhance biofilm formation) and 5 ml aliquots 
were placed into each well (6 wells) of the polystyrene plate covered with lid. Plate for each 
strain was incubated in static position at 37 oC for 6 h, 12 h, 24 h and 48 h. After incubation at 
each time point, the plates were carefully washed two times with 4 ml deionized water to 
remove all planktonic cells. After washing, adhered cells were fixed with 4 % glutaraldehyde 
for 4 h. At each growth time point, the bottom of each well of polystyrene plate was cut to lens 
shape suitable for scanning electron microscopy. After cutting, the pieces were rinsed three 
times with 0.1 M sodium cacodylate buffer, and then fixed with osmium tetroxide for 1 h at 4 
oC and samples dehydrated with 90 % ethanol. The samples were then mounted on pin tubs. 





2.6.2 RNA isolation from and MRSA 252 and S. aureus ATCC 6538 
2.6.2.1 Preparation of S. aureus biofilm cells for RNA isolation process  
The method described by Qiu et al., (2011) and Atshan et al., (2013) was used for this analysis. 
MRSA 252 and ATCC 6538 biofilm cells (5×105 CFU/mL) was separately grown on 24-well 
polystyrene tissue culture plates for 24 h at 37 oC after which they were treated with using the 
MBIC values of 31.25 and 15.6 mg/mL of African walnut oil, 125 and 62.5 mg/mL of pumpkin 
oils for 12, 24 and 48 h. Thereafter, each well of the plates were washed twice with 200 ml of 
sterile distilled water (dH2O). Biofilm was also grown for 6 h but it was used as control sample. 
After washing, the adhering bacterial cells in each well were disrupted and re-suspended in 1 
mL of cold sterile distilled water by rapidly scraping them from the plate surface until no visible 
adherent layer was left. This was achieved using sterile micropipette tips and the bacterial 
suspensions were immediately incubated with 2 mL of RNA Protect (Qiagen) to stabilize the 
RNA before the bacterial cells were lysed. The bacterial suspensions were immediately 
vortexed for 5 s and incubated for 5 min at room temperature. The bacterial suspension was 
pelleted by centrifugation at 10000 xg for 10 min and the supernatant was discarded and 
residual supernatants were removed by gently dabbing the inverted tube onto a tissue paper 
and the cell pellets were obtained. 
2.6.2.2 RNA isolation  
To the cell pellets (0.56 g from 12 h pellet, 0.98 g from 24 h and 1.2 g from 48 h pellet) and 
obtained after centrifugation, 200 µL TE buffer (30 mM Tris-Cl, 1 mM EDTA, pH 8.0) 
containing lysostaphin (12.5 µg/mL of 1mg/mL) and 200µl Qiagen proteinase K was prepared 
and then added to the pellets which was mixed by vertexing for 10 s thereafter, the suspension 
was incubated on a heat block for 30 min. During incubation, suspension was vortexed for 10 
s at least every 5 – 10 min. After incubation, 700 µL RNeasy lysis buffer; RLT (with 10 µL β- 
mercapthoethanol per mL) was added and vortexed vigorously and centrifuged for 2 min at 
12000 xg. Then, the supernatant was transferred into a new Eppendorf tube and 70 % ethanol 
(500 µL) was added and it was mixed immediately by pipetting up and down five times. The 
half of the mixture (700 µL) was then transferred to a RNeasy spin column and centrifuged for 
15 s at 12000 ×g. The flow through was discarded after centrifugation and reinserted in the 
collection tube. This step was repeated thrice to collect all bacterial lysate. Bacterial lysate was 
washed by 350 µL buffer RW1 and centrifuged for 15 s at 12000 ×g and the flow through 
discarded.  DNase 1 was prepared according to the manufacture’s instruction. 10 µL DNase 1 
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was added to 70 µL Buffer RDD, and added directly onto the centre of the RNeasy spin column 
membrane before incubation at room temperature for 15 min. Genomic DNA (gDNA) was 
removed from the mini spin column by buffer RW1 (350 µL) by centrifuging for 15 s at 12000 
×g. The flow through was discarded and the mini spin columns placed in new tubes.  RPE 
buffer (500 µL) was added two times to the same RNeasy spin column in two separate steps 
and centrifuged at 12000 xg for 15 s and 2 min, respectively, prior to discarding the flow 
through from the collection tube. RNA was eluted into a new 1.5 mL collection tube by adding 
30 µl of RNase-free water directly to the spin column and centrifuging at 12000 ×g for 1 min. 
This step was repeated twice to elute all RNA.   
2.6.2.3 Determination of RNA concentration  
After isolation, the RNA was kept on ice while proceeding to determine the RNA concentration 
of the samples using Nanodrop 2000 spectrophotometer (ThermoScientific, UK). Nanodrop 
was used to assess the yield and purity of RNA samples. RNA samples with an absorbance 
ratio 260/280 between 1.9–2.2 and 260/230 greater than 2.0 were used for further analysis.  
2.6.3 Reverse transcription polymerase chain reaction (RT-PCR) 
2.6.3.1 cDNA synthesis 
The RNA extracted from both the treated and untreated biofilm cells were reverse transcribed 
into complementary DNA (cDNA) using a RevertAid first strand cDNA synthesis kit which 
consisted of three different steps which are described below. In the first step, random hexamer 
primer (1 µL), nuclease free water (1 µL), was added to 10 µL RNA (10 ng/µL) giving a total 
volume of 12 and incubated at 65 ºC for 5 min. After which the mixture was immediately 
placed on ice to chill. In the second step, reverse transcription master mix was prepared using 
the kit components supplemented with 12 µL of the already prepared template RNA giving a 
total volume of 20 µL (Table 4). In the third step, reverse transcription was performed in a 
thermal cycle. The thermal cycle settings were; primer annealing at 25 ºC for 5 min (step 1), 
then reverse transcription at 42 ºC for 60 min (step 2), and finally inactivation/termination of 
the enzyme at 70 ºC for 5 min to stop the reaction (step 3). The final cDNA products were 





Table 4. Reverse transcription master mix components and volume used for the second 








2.6.3.2 Reverse transcription PCR (RT-PCR)  
Complementary DNA sequences of the target genes used in this study were amplified through 
RT-PCR Table 5. The thermocycling time for the amplification of each adhesion and biofilm 
genes primer set (icaA, icaB, icaC, icaD, fnbA, fnbB, fib, clfA, clfB, cna, ebps and eno), 
antibiotic and food poisoning genes (mecA, blaZ, emrA, seA, seB) and selected reference genes 
(16S rRNA, tpiA, rrsC, gmk, glyA, proC, rho, pyK, gyrA and gapdh), is shown in tables 6-7 
below. 






Component  Volume (µL) Volume (µL) 
 Positive Sample Negative Sample 
Reverse transcription master mix   
5x reaction buffer 4  4  
Ribolock RNase inhibitor 1  1  
10 Mm dNTP mix 2  2  
Revert Aid M-MulV RT 1  1  
Template RNA 11 (varied) 0 
Random Hexamer 1 12  
Final volume 20  20  
Component Volume (µL) 
My Taq Red 2x mix 25 
Forward Primer 1  
Reverse Primer 1  
Template cDNA 2 
Nuclease free water 21 
Total volume 50 
75 
 
Table 6. The thermocycling temperatures and times used for RT-PCR amplification of 
each primer sets of adhesion and biofilm genes 
 
 
                              
 
Table 7. The thermocycling temperatures and times used for RT-PCR amplification of 





2.6.4 Quantitative real time PCR (qRT-PCR)  
2.6.4.1 Selection of optimal reference genes for normalization in quantitative RT-PCR 
of MRSA 252 and S. aureus ATCC 6538 biofilms 
Ten reference genes were tested based on their common usage as endogenous control genes 
in previous studies. The genes were tpiA, rrsC, proC, rho, rpoD, gyrA, glyA, gmk, pyk and 
16S rRNA. Although 9 genes were eventually tested. The primers were obtained from 
previous publications and were confirmed whether they are present in S. aureus strains 
tested. The methods of Eleaume, (2000) and Crawford et al., (2014) was used for the 
determination of the gene expression levels of the reference genes in MRSA 252 and ATCC 
6538. The expression levels of nine selected reference genes in S. aureus biofilms at 12 h, 24 
h and 48 h were calculated using cycle threshold values (Ct values) obtained after qRT-PCR 
analysis. Two reference gene normalization algorithms described in different software 
programs: geNorm (version 3.5) and NormFinder (version 0.953) was used to assess the 
expressional stability of the nine selected candidate reference genes.  
PCR phases Temperature (°C) Time (s) 
Initial denaturation 95 60 
Denaturation                                                     95 15  
Annealing 60 20  
 Elongation 72 10  
Final hold  4°C 
PCR phases Temperature (°C) Time (s) 
Initial denaturation 95 1800 
Denaturation                                                     95 5 
Annealing 55 30  
 Elongation 72 20  





2.6.4.2 Quantitative PCR analysis of target genes 
Quantitative real time PCR was carried out to quantify the expression of the target genes on 
cDNA from MRSA 252 and S. aureus ATCC 6538 using the SensiFast SYBR Lo-ROX Kit. 
Multiple reference genes (16 S rRNA, gmk and gyrA) identified to be suitable for the analysis 
were used for normalization. Amplification plots and melting curves were used to confirm the 
PCR primers. After extracting RNA from each growth time point, the RNA concentration of 
each extract was normalized, and cDNA was obtained. Five microlitres (5 μL) of cDNA from 
the reverse transcription reaction (20 μL) was added to 45 μL of nuclease free water to obtain 
a final volume of 50 μL and the standard curve was obtained by a 10-fold serial dilution which 
was made as follows: 100%, 10%, 1%, 0.1% and 0% cDNA. The qPCR reaction was set up as 
described in Table 8 and analysed using the MJ Opticon Monitor Version 3.1 software. 




2.6.4.3 Analysis qPCR results of the reference genes using the softwares 
(i) Using the geNorm (version 3.5) The Ct values were first transformed/converted into relative 
quantification data using the delta-ct method. To achieve this data, the delta-ct formula was 
used:  
                                      Q = E (Δ ct) 
                                      Q = E (min ct - sample ct) 
                            Q = Sample quantity relative to sample with highest expression 
                                       E = amplification efficiency (2 = 100%) 
                        Min = lowest Ct value = Ct of sample with highest expression 
Thus:  
a. The sample with the highest expression (lowest ct value) was set to 1 
b. The min Ct (lowest Ct value) was subtracted from the sample Ct. The result obtained 
was calculated in excel using the power function. And finally, the converted quantities; 
raw Cq values were directly analyzed by geNORM. 
PCR phase                                            Temperature (oC) Time (s) 
Denaturation 95 300 
Denaturation                                                     95 20  
Annealing 60 20  





The geNorm software calculates the expression stability value (M) which are used to evaluate 
each individual reference gene candidate or each combination of reference genes, called a 
normalization factor (NF). Graph showing the M values of each reference gene (produced by 
the geNorm software) was used to identify the best stable individual reference genes. The most 
stable expressed genes yielded the lowest M value. GeNorm helps to identify a suite of 
reference gene and ends up by suggesting a pair of genes that shows high correlation and should 
be suitable for normalization of qPCR studies in S. aureus.  
(ii) Analysis using the NormFinder software 
The NormFinder software computes a different type of stability value based on the intragroup 
and intergroup variation of the expression data. The software instructions from each package 
were followed when inputting the RT-qPCR data, fetching the output, and interpreting the 
analysis results. 
2.6.4.4 Primer sequences used in this study 
 
Table 9: Primer sequences used in this study 
Primer pairs of selected adhesion and biofilm formation genes.  


















adhesion gene)  
ATACCGGCGACTGGGTTTAT 
TTGCAAATCGTGGGTATGTGT 




























X62992.1 60 197 Atshan et 
al., (2013) 
fib (fibrinogen 
binding protein)  
CGTAACAGCAGATGCGAGCG 
TGCATCAGTTTTCGCTGCTGGTTT 
































AF065394.1 60 195 Atshan et 
al., (2013) 
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NC_10788 55 145 Crawford 
et al., 
(2014) 
16S rRNA GGGACCCGCACAAGCGGTGG 
GGGTTGCGCTCGTTGCGGCA 
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AP0031352 55 97 Eleaume 
(2004) 
RNAII 













 55 154 Qui (2011) 
 
2.6.4.5 Data analysis using the standard curve method 
The experiment of 22 selected genes at 12 h, 24 h and 48 h was calculated relative to the 
calibrator sample at 6 h and internal control 16 S rRNA, gmk and gyrA. The 6 h time point was 
chosen as calibrator since at this point of growth the strain did not form or showed any cell 
associated biofilm/fibrous material, in contrast to the 12 h, 24 h, and 48 h biofilm formation 
which was clearly seen on 24-well polystyrene plate. For each experimental sample, 
amplification plot, standard curves and melting curves were generated from 72oC to 90oC, 
reading every 1°C, hold at 30 s and data was subjected to analysis using the Livak method 
commonly known as the delta delta CT (ΔΔCT) or double delta CT and gene expression fold 
changes were calculated using 2^-(ddct)-method. 
2.6.4.6 Agarose gel electrophoresis  
The RNA samples after each extraction as well as RT- PCR samples from S. aureus biofilms 
at 6 h, 12 h, 24 h and 48 h were assessed by using 1 % agarose gel electrophoresis. The agarose 
gel was prepared by mixing 1 g of agarose with 100 mL of 0.5x TBE (Tris-borate EDTA) in a 
250 mL Duran bottle then heating the mixture in a microwave oven. After the agarose had 
cooled to 55oC, 4 µL of gel red was added and the content was swirled round severally to ensure 
proper mixing and poured into a gel tray to solidify/set for 35 min. The gel was subjected to 
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electrophoresis at 100 V for 120 min. The band sizes were imaged and recorded by UV-trans 
illumination and Gene Snap software.    
2.7 Screening of oils of African walnut, cashew and pumpkin oils for synergy, biofilm kill 
time and determining the efficacy of oils in the treatment of staphylococcal infections 
using Galleria mellonella as an in-vivo-model 
2.7.1 Synergy test 
2.7.1.1 Checker board assay 
Checkerboard method was used to further evaluate the synergic effect of walnut, cashew and 
pumpkin oil with conventional antibiotic drugs as observed in the disc diffusion test. 
2.7.1.2 Preparation of the microtiter plates for the checker board assay for antibiotics 
Overnight culture of S. aureus inoculum was diluted fresh with sterile MHB (1:100) to obtain 
a final concentration of 1× 106 cfu/ml. 100 µL of this suspension was first distributed into each 
well of the micro-dilution plates and incubated for 24 h at 37 °C. After 24 h of pre-formed 
biofilm, the cell suspensions were gently aspirated and fresh 100 µL of MHB was distributed 
into each well of the micro-dilution plates. Each of the antibiotic drugs tested (100 µL working 
solutions) were serially diluted in MHB along the first column, while the second drug (plant 
oils) solution were serially diluted along the first row. Dilutions were started from the last well 
with a higher concentration towards the first well for each of the drugs tested. These 
concentrations were then diluted along the ordinate (vertical axis) and abscissa (horizontal axis) 
to obtain varying concentrations of the combined drugs. Antibiotics that had their MICs 
previously determined were used for the assay. The different concentrations used for 
checkerboard assay was same as those used individually. The entire resulting checkerboard 
contained each double serial dilution/combination of the two antimicrobial agents (plant oils 
and antibiotics), with wells that contain the highest concentration of each antibiotic at opposite 
corners. Controls containing antibiotics alone, plant oil alone, growth control (bacteria 
suspension alone), sterility control inocula in TSB alone were all included in the experiment as 
described in previous sections. The microtiter plates were incubated at 37°C for 24 h, and the 
MIC of the combination of both antimicrobial compounds was determined by visual inspection 
and read using the plate reader.  
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2.7.1.3 Fractional inhibition concentration 
Calculation of the fractional inhibitory concentration (FIC) and FICI index (FICI) were 
determined as described by Mahboubi et al., (2014) using the following equation.  
         FIC of walnut oil = MIC (Walnut oil in combination with antibiotic)  
        MIC (Walnut oil alone)  Equation 3 
 
         FIC of pumpkin oil = MIC (pumpkin oil in combination with antibiotic)  
           MIC (pumpkin oil alone)  Equation 4 
 
All the antibiotics were calculated using the same equation. The (∑FIC) index determines the 
interaction between the plant oils and antibiotics where the interaction is interpreted according 
to a range of values; values less than 0.5 as synergistic, values greater than 0.5-1 as additives.  
2.7.2 Biofilm time-kill assay 
The rate of kill of S. aureus within biofilms upon treatment with African walnut, cashew and 
pumpkin oil was evaluated. MRSA 252 and S. aureus ATCC 6538 biofilms pre-formed over 
48 h were treated using in 24-well plate with 100 µL of 62.5 mg/mL and 31.25 mg/mL of 
African walnut oil and 100 µL of pumpkin oil at 250 mg/mL and 125 mg/mL dilution and 100 
µL of cashew oil at 500 mg/mL dilution previously made with TSB (MBEC concentrations 
were used). The biofilms were treated for 12, 24 and 48 h. The same procedure described in 
previous sections was used but the concentration of oils differs.  
2.7.3 Preliminary assessment of the pathogenicity of MRSA 252 and ATCC 6538 and 
efficacy of African walnut oil in treating staphylococcal infections 
2.7.3.1 Collection of Galleria mellonella  
Two hundred G. mellonella were purchased from Pet Home, Salford, UK. For the experiment, 
larvae in the fifth instar of their life cycle were used. The weights of the larvae varied, but on 
average their weights were between 100 and 290 mg. Very low weight and skin decolorization 
larvae with any obvious abnormalities were rejected. The larvae were used within a period of 
6 days of purchase and no food or water was given to them. This was to starve them before 
infecting them. The larvae boxes containing approximately 45 larvae each after sorting were 
stored in 15 oC before use in the laboratory as previously reported by (Tsai, Loh & Proft 2016). 
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2.7.3.2 Bacterial strain and preparation for larval infection 
Bacterial strains used in this experiment are MRSA 252 and ATCC 6538 strains. The method 
used to prepare bacterial strains for infection was a modification of the method described by 
Loh et al., (2013). Briefly, single colonies of MRSA 252 and ATCC 6538 were both inoculated 
into TSB in 10 mL conical sterile tubes and cultured at 200 rpm in a shaking incubator (Camlab, 
UK) overnight at 37°C for 18 h. Next day the overnight culture in TSB with an optical density 
of >2.5 at 600 nm (OD600= >2.5) was obtained. 1 mL of the cultures obtained for MRSA 252 
and ATCC 6538 strains were separately transferred into 2 mL Eppendorf tubes and centrifuged 
at 5000 xg for 10 min and re-suspended in PBS (1 mL) for washing and repeated centrifugation. 
Washing of the bacterial suspensions were done twice after which the washed cultures were 
re-suspended in 1 mL PBS again. Bacterial cultures were thereafter serially diluted with PBS 
saline to obtain dilutions of bacterial suspensions to final concentrations ranging from 100 to 
10-4 dilutions. These dilutions were prepared aseptically by transferring 100 µL of the washed 
bacterial cells into a sterile 1.5 mL Eppendorf which contained 900 µL sterile PBS, the 
suspension was mixed by gently shaking and pipetting the samples up and down two times. 
Another 100 µL of this dilution was removed and transferred to a new tube containing 900 µL 
sterile PBS. This process was again repeated the fourth time to produce 8 log dilutions. But 3 
dilutions (100, 10-1, 10-2 and 10-3) were used for this experiment. The infecting dose was 
confirmed for each experiment by serial dilution and viable count of bacteria using the spread 
plate method. To test for infecting dose of MRSA 252 and ATCC 6538, twenty (20) G. 
mellonella larvae were set up as follows for the experiment; 
Group A consisted of 20 non-infected larvae which served as negative control for the 
experiment  
Group B consisted of 20 larvae inoculated with PBS and 20 mg of ampicillin to serve as 
positive control.  
Group C consisted of 20 larvae for each dilution with 10 μL MRSA 252/ATCC 6538 bacterial 
suspension aliquots injected into them through the last left proleg. Each strain was injected 
separately. 
2.7.3.3 G. mellonella injection procedure 
A 10 μL Hamilton syringe (Fisher scientific, UK) 701N, with 10 μL volume, 26 s, needle size 
was used to inject 10 μL of PBS and ampicillin into them. Ampicillin was co-injected into them 
83 
 
to prevent infection by bacteria that are naturally present on the surface of the larvae (Tsai et 
al., 2016). Although the area to inject was cleaned with ethanol 70 % swab (Ramarao et al., 
2012). In addition, 10 μL of bacterial suspension of MRSA 252 and ATCC 6538 were also 
injected into the larvae. Similarly, the different bacterial dilutions prepared 100, 10-1, 10-2 and 
10-3 were also injected into the larvae groups. Both groups A, B and C were studied parallel in 
the infection investigation. 
2.7.3.4 Pathogenicity and monitoring of G. mellonella with MRSA 252 and ATCC 6538 
After injection, the different groups of larvae were incubated in petri-plates at 37°C in an 
incubator and survival was monitored every day (5 days). Daily, post infection check was 
carried out on G. mellonella larvae for the following features: melanisation, survival, cocoon 
formation. The number of dead versus survival larvae was recorded for each strain and group 
tested. An infective dose of bacteria was defined as one capable of causing an innate immune 
response, leading to the formation of melanin plaques around bacteria recognizable by the 
entire darkening of the cuticle. These plaques appear dark through the cuticle (Tsai et al., 2016). 
The groups of larvae were incubated at 37 °C for 5 days, as bacterial virulence changes with 
temperature and this experiment was designed to mimic the development of infection in 
humans. In addition, G. mellonella were considered dead when they showed no movement in 
response to slightest touch with forceps and the development of melanin (black coloration). 
Each experiment was repeated at least three times, and representative experiments are 
presented here. 
2.7.3.5 Assessing the efficacy of African walnut oil in the treatment of staphylococcal 
infections using G. mellonella 
To determine the efficacy of African walnut oil in treating infected G. mellonella, different 
formulated larvae groups were injected with lethal doses of MRSA 252 and ATCC 6538 (106 
CFU/mL) and then treated with 10 μL of 31.25 and 15.6 mg/mL of walnut oil and vancomycin. 
The groups of larvae were incubated at 37 °C for 5 days and G. mellonella were considered 
dead when they showed no movement in response to slightest touch with forceps and the 
development of melanin (black coloration). Each experiment was repeated at least three times, 




2.8 Identification of the most active oil 
Identification of the active compounds were conducted according to bioassay guided isolation 
protocol. Briefly the active oil (walnut oil) obtained from screw press was first trans-esterified 
and separated by vacuum fractional distillation, followed by bioassay test to determine which 
fraction were most likely to have the active substances. The different fractions were finally 
analysed by spectrometry technique to possibly identify their molecular structures. 
2.8.1 Analytical methods for identification of fatty acids in African walnut oil 
African walnut oil was extracted as described in section 3 of this thesis. In a bid to further 
confirm the activity of the screw pressed walnut oil and identify the fatty acids present in it, 
the oil was first trans-esterified into fatty acid methyl ester.  After transesterification, the 
antimicrobial activity of the methyl ester product was tested for antimicrobial activity on 
MRSA 252 and S. aureus ATCC 6538. Further analytical investigations including GC-MS, 
infra-red, NMR and UV visible was conducted to identify the fatty acids in the oil that may be 
responsible for its activity. Except otherwise mentioned all analytical analysis was conducted 
on walnut oil alone. 
2.8.1.1 Fatty acid methyl ester (FAME) analysis 
African walnut oil was trans-esterified into (FAME) and the fatty acids were analysed as fatty 
acid methyl esters. Transesterification (Boron trifluoride methanolysis-BF3-MeOH) of walnut 
oil was done in accordance with the guidelines of International Olive Oil Council (IOOC, 
2006). Briefly screw pressed walnut oil (1 g) sample was placed in a vial with screw cover and 
2 mL of 0.5 mol/L NaOH-methanol solution was added. The mixture was heated at 100oC for 
7 min and allowed to cool. After cooling, 3 mL of 14% BF3-MeOH reagent was added and the 
vial was sealed and heated for another 5 min at 100oC. After cooling, 3 mL of hexane and 7 
mL of saturated NaCl solution were added and shaking vigorously. The resulting hexane layer 
(3 mL) sample was dried with anhydrous sodium sulphate and was left in a rack at room 
temperature (25°C) to settle. The upper hexane layer that was clear containing methyl esters 




2.8.1.2 FAME standard mix preparation 
A standard known as Supelco 37 component FAME mix (Supelco, Merck, Bellefonte, UK) 
containing methyl esters of fatty acids ranging from C8 – C24 including monounsaturated and 
polyunsaturated fatty acids was used for the experiment as reference to aid in the identification 
of fatty acids. Stock of mixed supelco standard was prepared by weighing 100 mg into a 100 
mL volumetric flask and made up to volume with hexane (HPLC grade) therefore making a 1 
mg/mL stock.  
2.8.1.3 Gas liquid chromatography/mass spectrometry (GC-MS) analysis 
A trans-esterified sample of African walnut oil was sent to GlycoAnalytics Services, San 
Diego, United States) for accurate analysis. African walnut methyl ester sample was pre-
analysed by injecting 1µL and profiling of fatty acids were done using an Agilent 6890N Gas 
Chromatography device (Agilent Technologies, Wokingham, United States). Profiling and 
quantification of fatty acids were achieved using Restek-5MS (30 m x 30 mm x 0.25 µm) 
column. Column temperature was programmed at 80°C for 3 min, and then raised to 220°C at 
4°C min-1 and then held for 3 min. The carrier gas was helium with a column flow rate of 1.12 
cm3 and the Mass detector transfer line temp: 280C. The fatty acids were identified and 
quantified by comparing sample peak retention times with those of known mixed supelco 37 
standards of known composition and mass fragmentation pattern of standard mixture of FAME 
(Supleco, UK). Also, peaks were identified by comparing the mass spectra with the mass 
spectral data base in NIST Library 2008. 
2.8.2 Fractionation of the active African walnut oil 
2.8.2.1 Vacuum fractional distillation 
African walnut oil previously extracted using cold press method was further purified by 
fractional distillation. Fractional distillation is a process of separating a mixture of compounds 
into different fractions (Silvestre et al., 2016). Briefly, the method described by Torres et al., 
(2012) and Silvestre et al., (2016) was used for the analysis. Walnut oil was fractionated using 
vacuum distillation. Vacuum was used because the boiling of the expected fatty acid 
compounds is far above 230 C (230-361 C). A volume of 250 ml of walnut oil was introduced 
in a round bottom flask that has three different outputs for different purposes; output B had a 
capillary tube to control and stabilize the ebullition occurring in the round bottom flask; the 
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output temperature controller 1 (output TC1) was used to introduce a temperature sensor to 
monitor the oil temperature during the distillation process in order to prevent high 
temperatures, and lastly the third output (output B) was used to connect the packed column. 
Fractional distillation was done by heating the walnut oil sample and fractions evaporate and 
then condense in its own compartment. The size of the fractionating column was 1.5 m in height 
and it was packed with titanium alloy. This alloy material was selected to prevent corrosion. 
Temperatures in the condensers were controlled by a thermostatic bath TECNAL, Model TE 
2000) and the maintenance of the pressure of the system made by vacuum pump (TECNAL, 
Model TE 058). 
2.8.3 Molecular structure identification 
2.8.3.1 Attenuated total reflectance fourier transform infrared spectroscopy (ATR-
FTIR) 
Infrared spectrum of the oils and fractions were measured using ATR-FTIR (Fourier transform 
infrared) spectrometer (Nicolet iS10, ThermoScientific, UK). The spectrophotometer is 
equipped with a detector of deuterated triglycine sulphate and connected to the software of an 
OMNIC operating system. Drops of oil samples were covered on the surface in contact with 
attenuated total reflectance (ATR) on a multibounce plate of zinc crystal at room temperature 
25oC (Figure 13). FTIR spectra were collected in the frequency range of 4000 – 600 cm-1. At 
each point of measurement, the plate was carefully cleaned twice with acetone and dried with 
soft tissue before filling it with next sample. The spectra were recorded as transmittance values 
at each data point. 
 
Figure 13: ATR-FTIR spectrophotometer                              
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2.8.3.2 Ultraviolet visible spectroscopy analysis (Uv-visible) 
The molecular absorption UV-visible spectra of the oils and extracts were determined by 
measuring the absorbance at 200-900 wavelength. Prior to measurement all samples were 
dissolved 1:100 in their corresponding solvents. Background noise was removed by blanking 
with corresponding solvents (chloroform, petroleum ether and n-hexane). A computer control 
spectrophotometer (Cary 300, Varian, UK) was used with a glass quart cuvette of a 1 cm optical 
path (Figure 14). Spectrophotometers are set to have linear absorbances from 0 to 1. The 
software package was used for data acquisition and processing. 
                           
                               
Figure 14: UV-visible spectrophotometer 
 
2.8.3.3 Nuclear magnetic resonance (NMR) spectrometry 
NMR experiments were performed using Bruker AV400 NMR spectrometer (400 MHz) 
situated in the NMR laboratory of Salford Analytical Services centre. Samples of each fraction 
were dissolved in deuterated dimethyl sulfoxide-d6 (DMSO-d6) and placed in 5 mm NMR 
tubes (Norell, United States). A drop of tetramethylsilane (TMS) was added to the sample 
solutions to serve as reference for the proton nuclear magnetic resonance 1H, 13 Carbon attached 
proton test (APT) and carbon NMR (13C NMR) spectra δ (0) ppm. The NMR experiments were 





2.8.4 Antimicrobial activity of fractions 
2.8.4.1 Disc diffusion assay of fractions  
Standardisation of bacterial cultures were performed as described in section 2.5.5.1 of this 
thesis. Briefly, freshly cultured test organisms were adjusted to a 0.5 Mc Farland standard 
turbidity, and then the bacteria strains were inoculated on Mueller Hinton (MHA) agar plates, 
respectively. The solution (15 μL) of each pure fraction (100 %) was embedded onto 6 mm 
sterile paper discs. The impregnated discs were placed onto inoculated agar plates and 
incubated at 37 °C for 24-48 h. At the end of the incubation time, the diameter of the zone sides 
of the paper discs were recorded in millimeters. All tests were performed under sterile 
















Chapter 3. Extraction of Plant Seed and Nut Oils and their Respective 
Extracts 
3.1 Introduction 
In recent years, many plant oils and their various constituents have been extensively studied 
for their antimicrobial properties against bacterial pathogens (Bansod and Rai, 2008). Oils from 
plants have been reported useful for the cure of various human health problems (Bansod and 
Rai, 2008). Oils have been used to treat skin infections, wounds and other health conditions. 
Their antimicrobial, antibacterial and antifungal properties make them active against bacterial 
pathogens. Nigeria has a wide variety of plant seed and nuts cultivated in different climatic 
regions of the country. Many compounds existing naturally in these crops have been reported 
useful for therapeutic purposes since ancient times (Tulp and Bohlin, 2004). Therefore, for this 
study African walnut, cashew and pumpkin were choosen based on their reported potentials in 
ancient times for treatment of bacterial infections 
Seed and nuts oil extraction was carried out by screw press method, in order to preserve vital 
constituents contained in walnut, cashew and pumpkin. Having found that these plants contain 
an abundant quantity of secondary metabolites, which encompass physicochemical properties 
and to maximise the oil quality, the method of extraction helped to reduce the loss of active 
components. Plant extract was also extracted using soxhlet extraction method decribed by Jokić 
et al., (2014).  
This study used a screw press method and solvent extraction method that relies mainly on the 
capability of the solvents used to breakopen the cell wall of the seed and nuts, diffuse into the 
cells, solubilize the metabolites and lastly diffuse into the extractants. This procedure does not 
require the use of any other treatments to the seed and nut that may possibly affect the 
secondary metabolites that was extracted.  
Ionescu et al., (2017) investigated that oils can be obtained from seed or nuts through solvent 
extraction or mechanical methods and that pressing of oils involves the application of pressure 
using screw press or hydraulic press to force out oil. Thus, Ionescu and his co-authors thought 
that mechanical pressing is however, preferable because it yields good quality oil and it costs 
less to extract oils.  
Puspita, (2015) determined that oil extraction is usually performed by a polar organic solvent 
such as ethanol and methanol targeting to extract a few compounds, this can be linked to the 
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ability of the solvents to increase cell wall permeability, facilitating the most efficient 
extraction of large amounts of polar and medium to low polarity compounds. Also, the use of 
less polar solvents such as hexane and chloroform are useful for the extraction of non-polar 
substances for example terpenoids and lipids.  
This chapter is focussed on the extraction of plant oils and their extracts, physical 






















3.2     Results  
3.2.1 Extraction of African walnut, cashew and pumpkin oils   
3.2.1.1 Preparation of seed and nuts for extraction  
The nuts and seed of African walnut, cashew and pumpkin were obtained from the healthy 
seeds and nuts which were sorted, oven dried and milled into powder. The milled seeds and 
nuts were then grounded into fine powder. The powders were packaged in airtight containers 
to maintain optimal conditions before extraction.  
3.2.1.2 Extraction and yield of African walnut, cashew and pumpkin oils   
Oil was extracted from African walnut, cashew nut and pumpkin seeds using the screw press 
method. This involved pressing each respective seed and nut sample using an oil expelling 
machine. The recovery of oils after each extraction was recorded and a total average of the 
recovery of three extractions was used to calculate the percentage yield of oils sample (Table 
10). A graphical representation of the percentage oil yields is presented in Figures 15. 
Furthermore, the physical appearances of the pressed oils are as shown below (Figure 17). 






Yield of oils (in gram) Average yield 





  1st extraction 2nd extraction 3rd 
extraction 
  
Pumpkin 200 25.00 25.67 24.50 25.06 12.53 
Cashew 200 50.00 52.00 51.99 51.33 25.67 
African 
walnut 
200 18.00 17.90 18.02 17.97 8.99 
 
A graphical illustration of the percentage oil yields is presented in Figures 15. 
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Figure 15. A graphical representation of the average percentage yield of African walnut, cashew and 
pumpkin oils. 
 
Figure 15 shows the calculated percentage yield of extracted oils from African walnut, cashew 
and pumpkin. Each value on the graph depicts the mean yield of African walnut, cashew and 
pumpkin oils calculated after three independent extractions using the oil expeller. Percentage 
values above the bars represent the % yield of each oil sample. Bar values are represented as 
mean ± SD. Using the screw press method, the percentage oil yield of African walnut, cashew 
and pumpkin was 8.99, 25.67 and 12.53 %. Cashew oil had the highest yield (25.67), followed 
closely by pumpkin oil (12.53 %) and lastly walnut oil (8.99 %).  
3.2.1.3 Extraction and percentage yield of African walnut, cashew and pumpkin extracts  
In this study African walnut, cashew and pumpkin seed extracts were extracted with n-hexane, 
petroleum ether and chloroform using the soxhlet’s extractor for 8 hours. The extracts were 
quantified after evaporating the solvents in a rotatory vaccum for 2 hours. The average yield 
of each extract was then determined as dry weight and percentage yield of each extract was 
calculated (Table 11, 12 and 13). Also graphical representation of the yield of African walnut, 
cashew and pumpkin extracts is shown below (Figure 16). 











Average yield/recovery of 
extract after evaporation, dry 
weight (grams) 
% Yield of 
extract 
1 30 200 n-hexane 5.42 18.06 
2 30 200 Petroleum 
ether 
3.75 12.5 
3 30 200 chloroform 3.59 11.97 
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Table 12. Average yields and percentage yield of cashew (Anacardium occidentalis) 
 
 
Table 13. Average yields and percentage yield of fluted pumpkin (Telfaira occidentalis) 
 
 
According to Table 11-13, average dry weight and % yield of each plant extracts differs based 
on the type of solvent used for the extraction. African walnut (Tetracapidium conophorum) 
extracts obtained from n-hexane, petroleum ether and chloroform gave different dry weights 
of extracts and % yield. Based on Table 11, African walnut n-hexane extract dry weight was 
5.42 gram with 18.02 % yield. Petroleum extract of walnut dry weight was 3.75 g with a % 
yield of 12.5 %. Chloroform extract of walnut dry weight was 3.59 g with a % yield of 11.97 
%. From this result n-hexane extract of walnut gave the highest dry weight and % yield of 
extract followed closely by petroleum ether extract of walnut with a dry weight of 3.75 g and 
12.5 % yield.  Chloroform extract gave the least dry weight of 3.59 g and 11.97 % yield of 
extract. 
Furthermore, Table 12 shows cashew (Anacardium occidentalis) extracts. The case of cashew 
oil was not too different from African walnut and pumpkin. The n-hexane, petroleum ether and 
chloroform also gave varied dry weights of cashew extracts and % yield. Hexane extract of 
cashew dry weight was 12.0 g giving 40.25 % yield. Petroleum ether extract of cashew dry 
weight was 6.41 g giving a % yield of 21.35 % and lastly chloroform extract of cashew dry 
weight was 5.01 g giving a % yield of 16.70 %. Of all the results obtained in Table 11-13 n-
hexane extract of African walnut, cashew and pumpkin gave better dry weights and % yield. 
Also, the result shows that the nuts of African walnut, cashew and seed of pumpkin dissolved 









Name of solvent Average yield /recovery 
of extract after 
evaporation, dry weight 
(grams) 
% Yield of 
extract 
1 30 200 n-hexane 12.0 40.25 
2 30 200 Petroleum ether 6.41 21.37 









Name of solvent Average yield /recovery of 
extract after evaporation, 
dry weight (grams) 
% Yield 
of extract 
1 30 200 n-hexane 9.03 30.01 
2 30 200 Petroleum ether 7.76 25.86 
3 30 200 chloroform 5.96 19.86 
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good for the African walnut, cashew seed and pumpkin nut extraction. This is probably because 
n-hexane and petroleum ether extract are non-polar solvents capable of dissolving non-polar 
vegetable oils. 
Based on Table 13 pumpkin seed (Telfaira occidentalis) extracts obtained from n-hexane, 
petroleum ether and chloroform also gave different dry weights of extracts and % yield. 
Pumpkin n-hexane extract dry weight was 9.03 g giving 30.01 % yield. Petroleum extract dry 
weight was 7.76 g with a % yield of 25.86 %. Chloroform extract of pumpkin dry weight was 
5.96 g with a % yield of 19.56 %. From this result, the n-hexane extract of pumpkin gave the 
highest dry weight and % yield of extract. The second highest dry weight and percentage of 
yield was obtained from petroleum ether extract which gave a dry weight of 7.76 g and % yield 
of 25.86 %. Lastly chloroform extract of pumpkin gave the least dry weight of extract 5.96 g 
and 19.86 % yield. 
 
 
Figure 16. Graphical representation of the percentage yield of African walnut, cashew and pumpkin 
extracts 
 
Figure 16 shows the average yield after consecutive extractions, and percentage yield of 
African walnut, cashew and pumpkin extracts compared to the initial weight of starting 
materials, the solvent types (petroleum ether, chloroform and n-hexane) used for the extraction. 
Each value on the graph represents the mean yield of each extracts obtained at three 
independent experiments ± SD (n=3); two-way ANOVA using Bonferroni post-tests was used 
to test for significance difference between the extracts. Asterisks represent significant 
differences ***p<0.001 between the three solvents used and between hexane and chloroform 
extracts.  The average yield of each extract (dry weight) was determined after extraction, drying 




3.2.2 Physical characteristics of oils and extracts of African walnut, cashew and pumpkin 
Both the screw pressed oils and extracts were assessed physically before using them for further 
analysis. After obtaining the wet extracts of African walnut, cashew and pumpkin seed from 
n-hexane, petroleum ether and chloroform, the wet extracts were dried separately in a rotator 
vacuum to get rid of the solvents and this became the dry weight samples. The dry extracts 
were then filtered and their physical characteristics in terms of colour and texture were recorded 
(Figure 18). For the screw pressed oils drying was not necessary so after extraction the physical 
characteristics were assessed immediately (Figure 17). Physical appearance of each oil and 
extracts was observed and results presented tables below.  
                              
   Table 14. Physical appearances of screw pressed oils 
 
   
Figure 17. Physical appearances of each oil sample as observed after extraction. 
The screw pressed oil extraction was started with the healthy nuts and seed of African walnut 
(Tetracapidium conophorum), cashew (Anacardium occidentalis) and pumpkin (Telfaira 
occidentalis). The extraction resulted in light slightly brown oil, light and yellow oil of cashew 
and thick golden-brown oil of pumpkin. 
Physical appearance of African walnut, cashew and pumpkin extracts are presented in Table 
15 to 17 and Figure 18 below. 
Alphabetical order Name of oil samples Oil samples description 
A African walnut Light brown 
B Pumpkin Thick and brownish 
C Cashew Light and yellowish 
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Name of extract and 
solvent used 
Extract description 
A African walnut  
 Hexane Light and golden brown in color 
 Chloroform Light and golden brown in color 
 Petroleum ether Light and slightly brown in color 
Alphabetical order Name of extract and 
solvent used 
Extract description 
B Cashew  
 Hexane Light and yellow in color 
 Chloroform Light and yellow in color 
 Petroleum ether Light and yellow in color 
Alphabetical order Name of extract and 
solvent used 
Extract description 
C African walnut  
 Hexane Thick and brown in color 
 Chloroform Thick and brown in color 




                  Figure 18. Physical appearances of extracts of walnut, cashew and pumpkin 
Figure 18 shows the appearances and characteristic colours of African walnut, cashew and 
pumpkin extracts after extraction with n-hexane, petroleum ether and chloroform. Solvent 
extraction of African walnut with n-hexane, chloroform and petroleum ether yielded a light 
and golden-brown extracts. Solvent extraction of cashew with hexane, chloroform and 
petroleum ether yielded light yellow extracts. Solvent extraction of pumpkin with hexane, 
chloroform and petroleum ether yielded thick brown and golden-brown extracts. 
3.2.3 Phytochemical screening of oils of African walnut, cashew and pumpkin with their 
respective extracts 
Initial screening of the oils and crude extracts constituents was performed to ascertain the 
phytochemical groups contained in each preparation. The results revealed the presence of 
saponin, terpenoid alkaloid, flavonoid, phenol and tannin in the screw pressed oils of African 
walnut and pumpkin. Alkaloids and terpenoids were not detected in chloroform and petroleum 
ether extracts of walnut and pumpkin. Saponin was not detected in screw pressed oil of cashew 
as well in its n-hexane and petroleum ether extract. Flavonoid was not detected in the cashew 
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chloroform and petroleum ether extract. From the results, oils of walnut, cashew and pumpkin 
had most of the vital photochemical present in them. Phytochemical results are presented in 
Tables 18-20. 
 



















Phytochemical tests  African walnut and extracts 




Flavonoids + + + + 
Alkaloids + - - + 
Saponins + + + + 
Tannins + + + + 
Terpenoids - - - + 
Phenol + - - + 
Phytochemical 
tests 
Cashew and extracts 
 Hexane Chloroform Petroleum ether Screw/Cold 
pressed oil 
Flavonoids + + - + 
Alkaloids + - - + 
Saponins - - + - 
Tannins + + + + 
Terpenoids + + + - 
 
Phytochemical tests 
Pumpkin oil and extracts 




Flavonoids + + + + 
Alkaloids + + - + 
Saponins + + + + 
Tannins - + + + 
Terpenoids + - - + 
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3.2.4 Ultraviolet absorption of plant oils and extracts 
The ultraviolet absorption spectra of African walnut, cashew and pumpkin oils and extracts 
were measured from a solution consisting of a 1:100 dilution of the oils and crude extracts 
extracted with n-hexane, chloroform and petroleum ether. The UV-visible spectrophotometer 
used for the analysis was Cary 300 (Varian, UK). During measurements, background readings 
were first removed by measuring the spectra against the corresponding solvents (chloroform, 
petroleum ether and n-hexane). Glass quart cuvette of a 1 cm optical path was used to measure 
the absorbance. Due to nature of the colour of both the oils and extracts, the wavelength range 
for measurement was taken from 200 to 900 nm to cover all the pigment spectral range 
occurring in extracts (Puspita, 2015).  
          
Figure 19. Ultra-violet absorption spectrum of African walnut, cashew and pumpkin oils. 
Figure 19 shows the visible spectrum of screw pressed oils of African walnut, cashew and 
pumpkin. In the ultra violet region strong absorption peaks between 200 nm and 300 nm were 
observed for the oils. Oils of African walnut, cashew and pumpkin has the maximum 
absorption at a value of λ= 266 nm, λ=230 nm and λ=269 nm. Based on the data on the graphs, 




       
Figure 20. Ultra-violet absorption spectrum of African walnut, cashew and pumpkin chloroform extracts. 
Figure 20 shows the visible spectrum of chloroform extracts of African walnut, cashew and 
pumpkin. In the ultra violet region strong absorption peaks between 200 nm and 300 nm were 
observed for the chloroform extracts. Chloroform extracts of African walnut has the maximum 
absorption at a value of λ=242 nm. Cashew has maximum absorption at a value of λ=264 nm 
while pumpkin extract has λ=266 nm. It can be seen from the graphs that the three extracts 
showed absorption values less than 1. Although African walnut and pumpkin extracts showed 




              
Figure 21. Ultra-violet absorption spectrum of African walnut, cashew and pumpkin petroleum ether 
extracts. 
Figure 21 shows the visible spectrum of petroleum ether extracts of African walnut, cashew 
and pumpkin. In the ultra violet region strong absorption peaks between 200 nm and 300 nm 
were observed for the petroleum ether extracts. Petroleum ether extracts of African walnut has 
the maximum absorption at a value of λ=230 nm. Cashew has maximum absorption at a value 
of λ=230 nm while pumpkin extract has λ=230 nm. it can be seen from the graphs that the three 





          
Figure 22. Ultra-violet absorption spectrum of African walnut, cashew and pumpkin hexane extracts. 
Figure 22 shows the visible spectrum of hexane extracts of African walnut, cashew and 
pumpkin. In the ultra violet region strong absorption peaks between 200 nm and 300 nm were 
observed for the hexane extracts. Hexane extracts of African walnut has maximum absorption 
at a value of λ=236 nm. Cashew has maximum absorption at a value of λ=234 nm while 
pumpkin extract has λ=235 nm. It can be seen from the graphs that the three extracts showed 
absorption values less than 1.  
3.2.5 FTIR spectra analysis  
ATR-FTIR of the oils were measured by the instrument Nicolet iS10 (ThermoScientific, UK). 
Infrared (IR) spectra were identified and analysed by OMNIC spectra software in a controlled 
computer. FTIR spectrophotometer was used to identify the functional groups of the active 
components present in oils from African walnut, cashew and pumpkin based on the peak values 
in the region of IR radiation. The IR spectra were accounted in % transmittance and the wave 
number region for analysis was 4000–600 cm-1 (mid-infrared range). The results of FTIR 
analysis confirmed the presence of alkanes, alkenes, alkynes, aliphatics, aldehydes and esters 




3.2.5.1 FTIR spectra of African walnut oil     
                  
 
Figure 23. FTIR spectrum of African walnut oil. 
 













The IR frequencies in this study was assigned according to Tay et al., (2002) and Liang et al., 
(2012). Results presented in table 21 shows the position of absorption bands with the 
appropriate vibration in spectral range from 4000 to 600 cm-1 for walnut oil. 
Frequency (cm-1) Peak assignment 
3010 = C-H (cis) stretch Fatty acid back bone 
2924 C-H methyl stretch asymmetrical 
2853 C-H methyl stretch symmetrical Aliphatic group of 
triglycerides 
2678 -CH2 asymmetrical stretch 
1742 -C=O stretch 
1706 -C=O stretch 
1462 C-H methylene scissoring 
1435 C-H methylene scissoring 
1412 C-H methylene scissoring 
1282 -C-O stretch 
1244 -C-O ester weak bending 
1169 -C-O stretch; -CH2 weak bending 
936 C–H bending conjugated 
721 cis-CH=CH bending conjugated 
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3.2.5.2 FTIR of cashew oil 
 
Figure 24. FTIR spectrum of cashew oil. 
 












The IR frequencies in this study was assigned according to Tay et al., (2002) and Liang et al., 
(2012). Results presented in table 22 shows the position of absorption bands with the 
appropriate vibration in spectral range from 4000 to 600 cm-1 for cashew oil. 
Frequency (cm-1) Peak assignment  
3006 Trans C-H stretch Fatty acid back bone 
2822 -CH2 symmetrical stretch, alphatics group triglycerides 
2052 -CH2 asymmetrical stretch 
1743 -C=O in ester stretch 
1484 -CH2 bending 
1417 cis = C-H bending 
1377 -C-H or -CH3 bending 
1237 C-O or –CH2 stretch 
1160 C-O stretch or CH2 bending 
1116 Trans RCH=CHR 
1096 -HC=CH trans bending 
1000 -HC=CH trans bending 
825 =CH2 wagging 
722 cis-CH=CH bending conjugated 
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3.2.5.3 FTIR of pumpkin oil 
        
 
Figure 25. FTIR spectrum of pumpkin oil. 
 













The IR frequencies in this study was assigned according to Tay et al., (2002) and Liang et al., 
(2012). Results presented in table 23 shows the position of absorption bands with the 
appropriate vibration in spectral range from 4000 to 600 cm-1 for pumpkin oil.  
Frequency (cm-1) Peak assignment 
3638 Trans C-H stretch Fatty acid back bone 
3751 Trans C-H stretch Fatty acid back bone 
3467 Trans C-H stretch Fatty acid back bone 
3006 Trans C-H stretch Fatty acid back bone 
2922 --C—H, CH2 symmetrical stretch 
2852 -C-H, -CH2 asymmetrical stretch. Aliphatic group 
of triglycerides 
1742 -C=O ester stretch 
1712 -C=O in acid 
1464 cis = C-H bending 
1416 -C-H, -CH3 bending 
1377 -C-H, -CH3 bending 
1239 -C-O stretch or - CH2 bending 
1162 -C-O stretch or - CH2 bending 
1116 -C-O stretch or - CH2 bending 
1006 - C-O stretch 
991 -HC=CH trans bending out of plane 




In this study, screw press method and solvent extraction was used to extract oils and extracts 
from African walnut, cashew and pumpkin to determine the efficient method in terms of 
antibacterial activity and yield of material. Results obtained in this experiment suggests that 
screw pressed oil has better antimicrobial activity than solvent extracted samples. Although, 
solvent extraction of three different solvents with different polarities gave higher yield of 
extracts. In the srew pressed oil samples, cashew oil produced the highest percentage yield of 
oil 25.67 %, followed by pumpkin oil 12.5% and lastly by walnut oil 8.99 %. The solvent 
extracts; chloroform, petroleum ether and n-hexane extract of walnut had percentage yield of 
11.97%, 12.5 % and 18.06%, cashew had 16.70 %, 21.37 % and 40.25 %, pumpkin had 19.86 
%, 25.86 % and 30.01 % respectively. N-hexane gave the highest yield of extracts. Physical 
observations of the screw pressed oil samples, African walnut, pumpkin and cashew oils were 
brown to yellow. Similarly, physical observation of the extracts, n-hexane, chloroform and 
petroleum ether were golden brown to yellow in colour. This result correlates with the findings 
of a research study performed by Odewole and colleaques (2015), who performed soxhlet 
extraction using various organic solvents to obtain pumpkin extracts. The authors reported that 
the yield was high when polar and non-polar solvents such as methanol, n-hexane and 
petroleum ether were used. Of the three solvents used by the authors, n-hexane produced the 
highest yield followed by petroleum ether and methanol. The result obtained was also like that 
of Okpashi and his colleagues (2013) who conducted soxhlet extraction using n-hexane and 
petroleum ether. The authors reported that the two solvents yielded high percentage of pumpkin 
extracts. However, n-hexane gave the highest yield. The increase in yield was thought to vary 
due to the different boiling points of the solvents used. 
Phytochemical study of the oils and extracts shows the presence of saponin, alkaloid, flavonoid, 
tannin, and terpenoids in the extracts of cashew and pumpkin with n-hexane having the highest 
combinations of phytochemicals. The n-hexane extract of walnut shows the presence of various 
phenols, flavonoids, alkaloids, saponins and tannins, which seem to be different to that of 
cashew and pumpkin. Phytochemical-analysis presented in this thesis appears similar to the 
literatures. Iyewoka and co-workers (2016) reported that, from GC-MS analysis, walnut oil 
showed a positive result for alkaloids, terpenes, phenols, flavonoids and tannins. Also, the n- 
hexane extracts of walnut obtained from soxhlet extraction reported by Nyong et al., (2009), 
gave positive result for alkaloids, tannins flavonoids, saponins. Mbatchou and Kosoona (2011) 
reported that from soxhlet extraction of cashew with n-hexane, alkaloids, flavonoids, steroids, 
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terpenoids were present and tannins was absent. Similarly, the result obtained corroborates the 
finding of Dorathy and Karpagam (2017). They authors conducted a preliminary 
phytochemical screening of cashew, using soxhlet extraction method with chloroform, 
petroleum ether and many other extracts. The authors found that the extracts showed the 
presence of alkaloids, saponin, phenol, tannin but absent for flavonoids. 
Characterization of the oil samples and crude extracts was performed by using the uv-vis 
spectroscopy. All oil samples and extracts exhibited main bands within the range of wavelength 
200-300 nm region in which the UV absorption for majority of the organic compounds such as 
flavonoids, tannin and phenols fall (Harborne, 1998; Tay et al., 2002; Maduabuchi and 
Onyebuchi 2016).  
Furthermore, FTIR spectroscopy analysis was used to screen the oils constituents, as it is a 
sensitive technique in identifying the functional groups present in samples (Rohman and Man, 
2010). FTIR is used in phytochemical studies as a fingerprinting instrument for comparing the 
purified natural compound with a known standard (Christy et al., 2004; Puspita, 2015; Altemini 
et al., 2017). Therefore, the mass spectra presented in this study represents a fingerprint for the 
molecules. This fingerprint can be used to identify the compound to determine the purity of the 
natural compounds or the presence of contaminants resulting from the complex extraction and 
purification procedures. The absorbance of the FTIR light by the organic compound present in 
the oil samples corresponded to the energy required to cause the stretching or bending of the 
molecular bonds within each molecule. Different types of bonds require specific amounts of 
energy to initiate such molecular vibrations and accordingly, absorbed different frequencies of 
the FTIR radiation. Consequently, the absorption peaks plotted in each of the spectra reflects 
the types of chemical bonds present in the molecules. The FTIR spectra obtained for African 
walnut, cashew and pumpkin oils exhibited well defined spectral regions varied in the range of 
4000–600 cm-1. The FTIR spectrum of African walnut oil shows, alkanes, alkene, esters and 
aldehyde compounds were present in the spectral range of 3010-2678 cm-1 and 1462-1412 cm-
1, 936-721 cm-1, 1282-1169 cm-1 and 1742-1706 cm-1. Cashew oil also had alkanes, alkenes, 
esters and aldehydes in the range of 3006-2052 cm-1 and 1484-1377 cm-1, 1096-722 cm-1, 1160-
1237 cm-1 and 1743 cm-1. Pumpkin also had alkanes in the range of 3638-2852 cm-1 and 1377-
1464 cm-1, esters 1006-1239 cm-1, aldehyde 1742-1712 cm-1 and alkenes 991-525 cm-1. While 
comparing FTIR spectra of the oils, cashew oil spectra appear to have similar fingerprints with 
similar functional groups with those of pumpkin oil with minor shifts. Similar peaks with 
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frequency (cm-1) was observed at regions of 1116 cm-1, 1377 cm-1 and 3006 cm-1 in both 
cashew and pumpkin oils and 1742 cm-1 was observed in both African walnut and pumpkin 
oil. These similar peak regions denote the C – O stretching, C – H bending and C = O stretch 
of ester, alkane and aldehyde which indicate the roles of the oils in lysis of bacterial cell wall 
as the exhibit antimicrobial activity through formation of a complex with the bacterial cell wall. 
According to Nazzaro et al., (2013), alkanes and aldehyde group has good antibacterial activity 
on bacteria.   
In conclusion, the extraction of African walnut, cashew and pumpkin using both the screw 
method and solvent extraction with various solvents with different ranges and polarity gave 
varying yield of oils and extracts. African walnut and cashew had the highest yield of oils while 
the n-hexane extracts yielded more extract. The oils and extracts gave positive results for 
various phytochemicals such as tannin, saponins, phenols, alkaloids and flavonoids as the UV-
visible spectrums. The IR spectra also suggested the occurrence of numerous functional groups 
related to oils and extracts. Overall, the data presented in this study provides confirmatory 
evidence of the rich mixture of constituents within the African walnut, cashew and pumpkin 
plant oils that could potentially play vital role in the biological and therapeutic uses as observed 












Chapter 4. Establishing the Methodology for the Identification and Biofilm 
formation of Methicillin Resistant (MRSA 252) and Susceptible S. aureus 
(ATCC 6538)  
4.1    Introduction  
Staphylococci pathogenic strains are the main cause of acute and severe infections due to their 
capability to form biofilms (Asthan et al., 2012; Gowrishankar et al., 2016). Although biofilm 
forming characteristics have been demonstrated by the pathogenic strains of the genus 
Staphylococcus, particularly, S. aureus and S. epidermidis, it is not well investigated in 
methicillin resistant staphylococcus aureus (MRSA) which have evolved from numerous clonal 
lineages of MRSA through acquisition of Staphylococcal cassette chromosome mec 
(SCCmec), known as mobile genetic element (DeLeo et al., 2011; Gowrishankar et al., 2016). 
The biofilm forming ability of MRSA has led to difficulty in treating Staphylococcal infections 
including its enhanced tendency to spread and cause deleterious human diseases across the 
globe. The initial monolayer of the bacteria that get stuck to a polymeric surface changes within 
few days to a common biofilm that includes bacteria and a slimy polymeric substance called 
extracellular slime material (Stoodley et al., 2002). The spread of the bacteria and EPS 
production results in an increased drug resistance because antibiotics are prevented from 
reaching the bacteria that are protected by biofilm (Asthan et al., 2012). Numerous studies have 
reported that the production of biofilm is caused by attachment at late phases of bacterial 
development (Stepanovic et al., 2007; Archer et al., 2011; Asthan et al., 2012; Gowrishankar 
et al., 2016). In this process, the bacterial attaches to each other by polysaccharide intercellular 
adhesion called PIA, which is produced by icaADBC operon (Archer et al., 2011).  
This chapter is focused on establishing the methodology of the identification of S. aureus 
strains, biofilm forming ability of MRSA 252 and S. aureus ATCC 6538. Finally, a discussion 











4.2.1 Confirmation of the strains 
The strains used for this study were confirmed. 
4.2.1.1 Colony morphology of the strains on different agar media 
MRSA 252 and S. aureus ATCC 6538 were grown on solid media so as to confirm them 
through their characteristic morphological appearances. MRSA 252 and S. aureus 6538 were 
confirmed before using them for analysis. TSA a general-purpose media was used to grow 
ATCC 6538. TSA was used to allow enough nutrients for the strain to grow. Columbia blood 
base agar, a selective media was used to grow MRSA 252 to specifically identify the strain. S. 
aureus ATCC 6538 and MRSA 252 were grown on TSA and Columbia agar to study their 
colony appearances and morphologies by visual observations. Visual observation of both 
strains was carefully conducted on the plates after streaking out a loop full of the frozen stock 
and overnight culture of each respective strain on TSA and Columbia agar and incubating the 
plates at 37oC for 24 h (Figure 26). Colony appearances and morphologies of each strain as 
observed visually are shown in Table 24.  
Table 24. Colony and morphological characteristics of MRSA 252 and S. aureus ATCC 








Colony appearances and 
morphologies 
ATCC 6538  MRSA 252 
 Growth on TSA Growth on Columbia blood 
base agar 
Shape  Circular Circular 
Elevation convex convex 
Size moderate moderate 
Texture rough rough 
Appearance shiny shiny 




Figure 26. Appearance of ATCC6538 and MRSA 252 on TSA and Columbia blood base agar 
Figure 26 shows Plate A: ATCC 6538 on TSA agar plate, plate B: MRSA 252 on Columbia blood base 
agar plate. Streaks showing growth of ATCC 6538 and MRSA 252 on TSA and Columbia agar. (A) 
Golden yellow colonies observed for ATCC 6538 on TSA (B) creamy colonies observed for MRSA 
252 on Columbia blood base agar (B). Their growth on both plates was used to confirm the strains 
before using them for further analysis. 
4.2.1.2 Biochemical tests of S. aureus strains   
Both MRSA 252 and S. aureus ATCC 6538 tested positive for catalase and lysostaphin tests 
which is a 2-5 h test. Both strains were also positive for coagulase test. These three methods 
were used for the rapid detection of the staphylococcus strains. 
 
Figure 27. Catalase test results of MRSA 252 and S. aureus ATCC 6538 
Figure 27 shows the formation of bubbles because of the breakdown of H2O2 into oxygen and 
water. (A)  Bubble formation from a loop full of 4-8 colonies of MRSA 252. (B) Negative 
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control: hydrogen peroxide solution alone (C) Bubble formation in S. aureus ATCC 6538 after 
placing 4-8 colonies into 20 mL of H2O. 
4.2.2   Antibiotic sensitivity test 
Based on the CLSI method, MRSA 252 and ATCC 6538 were both screened for susceptibility 
and resistance using oxacillin 1 μg and cefoxitin 30 μg. Screening was performed using the 
disc diffusion method and the resulting clear zones were measured in diameter (mm). 
 
Figure 28. Antibiotic confirmatory test of ATCC 6538 and MRSA 252 
Cefoxitin drug had a clear zone of 21 mm while oxacillin gave 19 mm. Similarly, MRSA 252 
had a zone of 21 mm without a clear zone and no zones was obtained for oxacillin. Result 
therefore indicates that MRSA 252 is resistant to cefoxitin and oxacillin confirming that it is 
a methicillin resistant strain. Whereas ATCC 6538 is sensitive to both cefoxitin and oxacillin. 
4.2.3 Biofilm formation assay 
4.2.3.1 Phenotypic detection of MRSA 252 and S. aureus ATCC 6538 slime production 
on Congo red agar  
The qualitative slime production was assessed on the basis of the color of S. aureus colonies 
developed on Congo red agar. Congo red agar was used to detect the ability of MRSA 252 and 
ATCC 6538 to form biofilm (slime) before using them for further analysis. To carry out this 
assay, Congo red agar was supplemented with glucose to help support the growth of the 






Figure 29. Biofilm (slime) productions by ATCC 12228, ATCC 6538 and MRSA 252 on CRA plates 
Figure 29 show Plate A: Red colonies, non-biofilm former (negative biofilm producer); Plate 
B: black colonies of ATCC 6538, positive biofilm former; Plate C: black colonies of MRSA 
252 positive biofilm former. Result shows that MRSA 252 and ATCC 6538 are positive biofilm 
formers producing black colonies on Congo red agar while ATCC 12228 was considered a 
negative biofilm producer. Based on the colony colors produced by each strain on Congo red, 
they were classified into very black, black and pink biofilm former showing various degrees of 
biofilm production.  
4.2.4 Quantification of biofilm formation by microtiter plate (MTP) method 
4.2.3.2   Visual inspection of biofilm formation on 24-well tissue culture plates 
The biofilm forming ability of MRSA 252, ATCC 6538 and ATCC 12228 were visually 
examined for biofilm formation (adhered cells) on the 24 well polystyrene microtiter plates 
using the microtiter plate method (MTP). MRSA 252 and ATCC 6538 were grown separately 
in 24-well tissue culture plates containing TSA supplemented with 1% glucose. Figure 30 and 





Figure 30. Biofilm formation of ATCC 6538 on 24-well tissue culture microtiter plate. 
Figure 30 shows biofilm formation of ATCC 6538 on 24 –well polystyrene microtiter plate 
with surfaces stained with safranin. Visual observations of the microtiter plates revealed that 
there was evidence of biofilm formation for ATCC 6538 at 12 h, 24 h and 48 h. Biofilm 
formation was seen to be strong at 24 h and stronger at 48 h. At 48 hours the biofilm looked 
thicker on the 24-well plate. However, no biofilm formation was observed on the plates for 
ATCC 12228 which served as a negative control. At 12 h, microtiter plates had small biofilms 
formed compared to 24 and 48 hours. The results were reproduced at least three times and were 
confirmed in subsequent experiments. This result suggests that ATCC 6538 is a strong adherent 
biofilm former and capable of forming strong biofilms from 24 hours. Based on the result 





Figure 31. Biofilm formation of MRSA 252 on 24-well tissue culture microtiter plate. 
 Figure 31 shows biofilm formation of MRSA 252 on 24 –well polystyrene microtiter plate 
with surfaces stained with safranin. Visual observations of the microtiter plates showed that 
there was evidence of biofilm formation for MRSA 252 at 12 h, 24 h and 48 h, Biofilm 
formation was strong at 12 h and highly strong at 24 h and 48 h. Biofilm at 12 hours appears 
fairly strong, stronger and highly adherent at 24 and 48 hours. Compared to ATCC 6538, 
MRSA 252 seems to form stronger biofilms. However, no biofilm formation was observed on 
the plates for ATCC 12228 which served as a negative control. The results were reproduced at 
least three times with three technical replicates and were confirmed in subsequent experiments. 
Based on the result, MRSA 252 is a strongly adherent biofilm former. 
4.2.3.3   Quantification of S. aureus biofilms 
Invitro biofilm formation was spectrophotometrically quantified by performing polystyrene 
microtiter plate (MTP) assay as described above. After the visual inspection of ATCC 12228, 
ATCC 6538 and MRSA 252 microtiter plates for biofilm formations at 12, 24 and 48 hours, 
the safranin dye that was bound to the adherent cells was dissolved with 95% ethanol per well, 
and absorbance was measured at 595 nm (OD 595 nm). The optical density reading of wells 
containing ATCC 12228 was used as the negative control and an optical density value of 0.5 
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was selected as the cut-off point to differentiate as positive for biofilm formation and each 
strain was categorized based on the optical density value of the safranin-stained biofilms.  
               
 
Figure 32. Quantification of ATCC 12228, ATCC 6538 and MRSA 252 biofilms formed on polystyrene 
microtiter plate after 12 h, 24 h and 48 hours at OD 595 nm. 
Figure 32 shows that MRSA 252, ATCC 6538 produced biofilms that were adherent at varied 
levels: S. aureus strains were tested at three growth time point 12, 24 and 48 hours. Bar graphs 
represent the mean of biofilm formations ± SD on 24-well tissue culture plates. The mean 
values refer to the mean OD values ± standard deviation of three to four independent 
experiments with three technical replicates per condition. The OD595 of the adherent cells 
bound to safranin stained wells were measured at OD595. In addition, biofilm formation of S. 
aureus strains seems to progressively increase with time of incubation because at 12 hours, 
optical densities of MRSA 252 and ATCC 6538 were low as 1.96 and 1.8. At 24 hours, OD of 
both MRSA 252 and ATCC 6538 were 3.91 and 2.71. Surprisingly at 48 hours an increased 
OD of 5.5 and 3.87 was measured. Therefore, based on the results ATCC 6538 was highly 
adherent with OD 595 values nm of >3.0. The MRSA 252 was strongly adherent with an 
OD595 nm value of >4.0. While ATCC 12228 strain was negatively adherent (OD 595 < 0.5) 
which is less than the cut off selected to differentiate the positive biofilm formers. Bar graphs 
represent the mean of biofilm formations ± SD on 24-well tissue culture plates. Data were 
analyzed by two-way ANOVA using Bonferroni post-tests. Significant interactions 
***p<0.001; **p<0.01) were observed. Two-way ANOVA revealed significant differences 
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between growth and time points of biofilm formation. Significant effects for growth (F (213.97) 
































4.3 Discussion  
In this study, conventional methods were used for identification of MRSA 252 and S. aureus 
ATCC 6538 which are methicillin resistant and susceptible S. aureus strains. Initial 
identification of S. aureus strains was performed using different biochemical methods. The 
bacterial strains ATCC 6538 and MRSA 252 isolates colonial and morphological appearances 
were examined on TSA and CBAB. These agar media (TSA and CBAB) are general purpose 
media that allows robust growth and promotes distinct colony morphology, good pigmentation 
and well-defined haemolytic reactions (Vitko and Richardson, 2013). In this study trpticase 
soy agar and Columbia blood base agar supported the growth of ATCC 6538 and MRSA 252 
producing circular shapes, convex elevations, moderate sizes, shiny appearances with golden 
yellow and creamy pigmentations on TSA and CBAB plates. Carotenoid pigment called 
staphyloxanthin is responsible for the characteristics golden yellow colour observed in ATCC 
6538. Catalase is a protein enzyme that breaks down hydrogen peroxide secreted by 
phagocytes. Catalase does not appear to be of necessary for the normal growth of S. aureus 
strains but it serves as a defense mechanism against destruction by phagocytic cells (Dezfulian 
et al., 2010). Lysostaphin is a metalloenzyme consisting of zinc which is capable of exhibiting 
a lytic action against S. aureus (Dezflulian et al., 2010). From this study biochemical tests 
results showed that S. aureus ATCC 6538 and MRSA 252 were both catalase and lysostaphin 
positive.  
S. aureus has the ability to produce biofilm (Vasudevan 2003; Caizza and O’Toole, 2003; 
López, Vlamakis & Kolter 2010), which assist bacteria to adhere to biotic or abiotic surfaces 
(Goyal et al., 2014) and is capable to adhere and produce biofilm consequently causing 
infections and morbidity (López, Vlamakis & Kolter 2010; Ribet and Cossart, 2015).The 
ability of S. aureus to form biofilm is the vital reason for eradication of infections and recurring 
infection of skin (Montgomery et al., 2015), blood (Corey, 2009), heart valves (in human (Pollit 
et al., 2018). Biofilm formation facilitates adhesion of S. aureus to the surfaces of skin, blood 
vessels and tissues. It also facilitates persistence of bacteria in the human tissue by protecting 
the bacterial cells against the various mechanisms of the host defense (Ribet and Cossart, 
2015). In this study, phenotypic expression of biofilm formation in S. aureus was investigated 
by modified Congo red agar assay and microtiter tissue culture plate method. These two 
methods were chosen to detect slime production and to quantify the adherence level since 
biofilm formation is to be further studied. Figure 29 shows a variable biofilm formation of 
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MRSA 252 and S. aureus ATCC 6538 tested. Based on the results S. aureus 6538 and MRSA 
252 was considered biofilm producers by Congo red agar method, in which MRSA 252 
produced very black colonies compared to ATCC 6538 that produced black colonies. Similar 
findings have been reported in previous studies. A study on biofilm formation conducted by 
Yousefi et al., (2016), reported varying degrees of black colonies ranging from very black to 
black colonies in MSSA strains and MRSA clinical isolates. In another work carried out by 
Gowrishankar and co-workers (2016), they found MRSA strains to be slime producers, 
producing varying degrees of black colonies. Growing S. aureus strains on Congo red agar 
plates were also in agreement with Hammadi et al., (2014) and findings of Arslan and 
Ozkardes, (2007). The authors recorded that Congo red agar was important in detection of S. 
aureus slime formation from human. The S. aureus strains they tested produced black colonies 
with smooth round and shiny surfaces. Black colonies produced by ATCC 6538 and MRSA 
252 in this study were black colonies with smooth shiny surfaces. While the pink colonies 
produced by ATCC 12228 was considered negative biofilm former. This result appears to be 
in constrast with the report of Cucarella and his colleagues who considered black or pink rough 
colonies as positive result after their biofilm formation study (Cucarella et al., 2009). However, 
the result correlates with those of Yousefi et al., (2016) and Atshan et al., (2012). 
Safranin-staining is predominantly used to detect the presence of extracellular substances and 
is used to measure quantify the amount of biofilm formed by S. aureus (Stepanovic et al., 
2000). Biofilm formation of MRSA 252 and S. aureus ATCC 6538 was evaluated first by visual 
observation of the 24 well polystyrene microtiter plates at 12, 24 and 48 h and secondly by 
safranin staining technique. Visual observation showed that MRSA 252 and ATCCC 6538 
were biofilm formers, forming biofilm in different capacities. Both strains form fairly strong 
biofilms at 12 h while much stronger and highly adherent biofilms were formed at 24 and 48 
h. It is worthy to note that at 12 h, ATCC 6538 biofilms were not much compared to that MRSA 
252. For the safranin technique (Figure 30 and 31) the optical density was measured and was 
observed that OD readings of MRSA 252 and S. aureus ATCC 6538 were low at 12 h (OD 595 
= 1.96 and 1.8), at 24 h (OD 595 = 3.91 and 2.71) and surprisingly at 48 h (OD 595 = 5.5 and 
3.87) an increased biofilm formation was observed. These values were far higher than the cut-
off value of OD 595<0.5 set for positive biofilm formers indicating that MRSA 252 was a strong 
and highly adherent biofilm former while ATCC 6538 was a moderately strong adherent 
biofilm former. According to Stepanovic et al., (2000) the ability of biofilm formation can be 
classified into 4 main categories: non-adherent, weakly, moderately and strongly adherent 
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based on the OD 595. However, following Stepanovic et al., (2000) classification method, 
MRSA 252 and ATCC 6538 tested in this study were classified as strongly and moderately 
adherent. In this study, the tested MRSA 252 and ATCC 6538 were both cultured in TSB with 
1 % glucose for enhancement of biofilm formation which is composed of polysaccharides 
called Poly-N acetylglucosamine or Polysaccharide intercellular adhesion (PIA). Furthermore, 
safranin resolubilized with 95 % ethanol resulted in high OD because it resolubilized the dye 




























Chapter 5. Screening of Plant Seed and Nut Oils and their Respective 
Extracts for Antimicrobial Activity against MRSA 252 and S. aureus ATCC 
6538  
5.1 Introduction 
S. aureus has a remarkable ability to adapt to the human environment and huge capacity to 
quickly develop resistance to numerous antibiotics (Bastista et al., 2017). S. aureus is a gram 
positive bacterium that resides permanently on the surface of human skin and in the nose of 
healthy individuals across the globe causing a range of human infections ranging from mild 
infections such as superficial or epidermal skin lesions, to very chronic infections including 
inflammation of the inner lining of the heart (endocarditis), bone infections (osteomyelitis), 
inflammation of the alveoli (pneumonia), inflammation of the lining of the brain and spinal 
cord (meningitis), blood infections (septicaemia), presence of viable bacteria in the blood 
(bacteraemia) and inflammation by exotoxins (toxic shock syndrome) (Qiu et al., 2011; Kim  
et al., 2015).  In addition, S. aureus is known to form biofilms, and the bacteria residing in 
biofilm have been reported to be very resistant to antibiotics (Nair et al., 2016). A biofilm is 
composed of microbial cells living together within an EPS composed of extracellular DNA 
(eDNA), polysaccharides intercellular adhesion (PIA), proteins, and amyloid fibrils (Garret 
2008). In nature, S. aureus has been found to form biofilm on both biotic (living) and abiotic 
(non-living) surfaces, including indwelling hospital devices for example bone and joint 
prostheses, heart valves, implanted catheters), human tissues, food and food processing 
facilities (Chamdit and Siripermpool, 2011). Because of their complexity, biofilms confer 
microorganisms enclosed in the extracellular matrix very high levels of antibiotic resistance 
(Chamdit and Siripermpool, 2011). Previous research studies have showed that microbes 
enclosed in biofilm become less susceptible to antibiotics thereby hindering the effectiveness 
of antimicrobial drugs, leading to both persistent and severe infections which are of global 
concerns (Chamdit and Siripermpool, 2011; Atshan et al., 2013; Chamdit and Siripermpool, 
2011; Dakheel et al., 2016; Belbase et al., 2017; Reffuveille et al., 2017). 
Some decades ago, S. aureus strains resistant to a range of betalactam antibiotics such as 
oxacillin, cefotaxime and methicillin emerged not long after the introduction of penicillin. 
These strains cannot be treated with most conventional betalactams, thus making glycopeptides 
(vancomycin otherwise known as teicoplanin) and cyclic lipopeptides (daptomycin) the only 
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drug of choice for staphylococcal infections. But surprisingly, MRSA also emerged as major 
causes of hospital acquired, and community acquired infections and as resistant strains of 
vancomycin and daptomycin thus making infections increasingly very difficult to treat (Nair et 
al., 2016). The emergence of MRSA worsened the problem of staphylococcal infections as the 
newly introduced drugs; vancomycin, daptomycin and linezolid which was the last resort drug 
after all other drug options failed to produce adequate response to treatment of staphylococcal 
infections (Nair et al., 2016). In 1997 vancomycin resistant S. aureus strains was first isolated. 
Shortly after this year VRSA isolates were also identified in USA and across the globe (Chen 
and Huang, 2014). Similarly, vancomycin - intermediate S. aureus (VISA) with MIC of 8 μg/ml 
was reported in France, Germany, United State, United Kingdom and Japan. This pattern of 
developing resistance to antibiotics by S. aureus has also been identified in much newer 
antibiotics developed between year 2000 and 2010. Linezolid the new oxazolidinone 
antimicrobial which was introduced in 2000 led to the first linezolid - resistant methicillin 
resistant strain recovered from a patient after treatment with linezolid for peritonitis associated 
with dialysis (Tsiodras et al., 2001). Furthermore, daptomycin a semi synthetic lipopeptide 
antibiotic was introduced in 2003 and within 2 years daptomycin resulted in the first 
daptomycin – resistant MRSA strain reported in patient suffering from high grade MRSA 
bacteremia (Mangili et al., 2005). In view of all this resistance issues, MRSA is a global 
problem and particularly worrisome is the significant increase of MRSA with reduced 
susceptibility to the newly identified drugs in the class of glycopeptides and cyclic lipopeptide.  
Plant oils have been used for different purposes including alternative medicine, pharmaceutical 
therapies, and natural therapies for decades (Kayode and Kayode 2011). Cashew, (Anacardium 
occidentale) is a genus in the family Anacardiaceae and it is found in tropical regions such as 
Brazil. Cashew nut oil has been known for years for its therapeutic purpose. Cashew oil from 
leaves, barks, flower and fresh shoots has been reported to possess several biological activities 
which includes antimicrobial, antioxidant, and antitumor. In a study conducted by Hassan et 
al., (2016), cashew nut oil showed activity against gram positive strains such as Acinetobacter 
anitratus, methicillin resistant S. aureus (MRSA), Proteus vulgaris, Pseudomonas aeruginosa, 
S. aureus, S. epidermidis, Serratia marcescens and fungal species including Candida albicans 
and Candida tropicalis. The potency of the oil was evaluated using standard Kirby Bauer disc 
diffusion and minimum inhibition concentration (MIC) which showed clear zones and MIC 
values ranging from 6250 – 12500 μg/mL and 6250 – 50000 μg/mL for all the bacterial strains 
and Candida tropicalis while C. albicans had the lowest MIC value of 3125 μg/mL. In another 
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research study, da Silva et al., (2016) evaluated the antimicrobial activity of oil from cashew 
flower against Streptococcus mutans, Lactobacillus acidophilus, S. aureus, MRSA, 
Enterococcus faecalis, Streptococcus pyogenes, Pseudomonas aeruginosa, Proteus mirabilis, 
Escherichia coli, Klebsiella pneumoniae, Helicobacter pylori, Salmonella cholerae suis, 
Candida albicans and Candida tropicalis using agar diffusion. With this method, they found 
that cashew flower oil was able to inhibit the growth of both the bacterial and fungal species. 
Similarly, Parasa et al., (2011) investigated the ability of 70% of three organic solvent extract 
of cashew oil (acetone extract, methanol extract and chloroform extract) to inhibit about 15 
clinical isolates of MRSA from different hospitals in South India. They used the well-diffusion 
method and found that with 70% acetone extract 19-25 mm clear zones of inhibition were 
produced by cashew oil against the clinical isolates. 
Fluted pumpkin (Telfaira occidentalis) is a tropical vine grown in many West African 
countries, but is mainly cultivated in Nigeria, Benin and Cameroon as a leaf vegetable which 
is used in herbal medicine (Oyewole and Abalaka, 2012; Dada, 2017). Fluted pumpkin is a 
genus in the family of Cucurbitaceae. The leafy vegetable has been known for decades to 
possess both antimicrobial and antiviral properties (Dada, 2017). Many researchers have 
reported the medicinal activities of fluted pumpkin. Nwakanma et al., (2014) investigated the 
effect of Telfaira occidentalis leaf oil against two commonly known pathogenic strains - S. 
aureus and E. coli. In the study, the disc diffusion method and dilution techniques were used. 
The oil from the leaf of Telfaira occidentalis was found to produce 1.00 mm diameter clear 
zones of inhibition against S. aureus and a 2.00 mm diameter zone against E. coli. Also, the 
dilution test showed that 8 μg/ml of the oil was able to inhibit the growth of S. aureus. In 
another study, Oyewole and Abalaka (2012) investigated the activity of leaf extract of fluted 
pumpkin on Salmonella typhi, E. coli and Streptococcus faecalis using both the disc diffusion 
method and MIC method. In the study, they found that the leaf extract showed high 
antibacterial activity against S. faecalis (6 ± 1.10 mm at 5.0 mg), E. coli (20 ± 0.58 mm at 500 
mg/mL) and S. typhi (11±0.70 mm at 50mg/mL). The MIC was 0.5 mg/mL, 5.0 mg/mL and 
500 mg/mL for E. coli, S. typhi and S. faecalis.  
African walnut (Tetracapidium conophorum) is a genus in the family Euphorbiaceae. 
Tetracapidium conophorum is cultivated in Cameroon and Nigeria (Ayoola et al., 2011). It is 
commonly called African walnut. African walnut oil has been known for decades as healing 
oil. Walnut oil is widely used in medicine for the treatment of fungal infections, skin infections, 
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respiratory diseases and ulcers. African walnut oil has been reported to possess antimicrobial, 
antioxidant, antimicrobial, antiviral and immunosuppressive activities. Only few publications 
have reported the antimicrobial activity of walnut oil isolated from the leaves and roots of this 
walnut specie (Ajaiyeoba and Fadare, 2006; Ogbolu, 2012). Walnut oil has been shown to be 
very effective against bacterial species. In one study, the disc Kirby Bauer diffusion method 
was used to determine the activity of T. conorphorum on both gram positive and gram-negative 
strains including Bacillus subtilis, Bacillus licheniformis, S. aureus and Klebsiella pneumonia 
and it was suggested that clear zones of inhibition seen on cultured plates signify the 
antimicrobial activity of walnut oil (Saxenaa et al., 2009). Also, Rhati et al., (2014) reported 
that walnut oil has antibacterial activity against S. aureus, Proteus vulgaris, Pseudomonas 
aeruginosa, Bacillus subtilis and E. coli. They reported that the activity of walnut oil was due 
mainly to the presence of alkaloids a phytochemical that is present in significant amount. 
Similarly, Orhan et al., (2009) has demonstrated walnut oil and hazel nut oil had antibacterial 
effects against S. aureus, E. faecalis and E. coli, Proteus mirabilis, K. pneumonia with MIC of 
8 μg mL, 4 μg mL, 16 μg mL and 32 μg mL respectively.  
Most research studies are based on the antimicrobial activities of extracts obtained from leaves, 
flowers, roots, and shoots of walnut, cashew and fluted pumpkin and as such only very little 
information is available on the nut and seed oils and its effect on S. aureus biofilm formation. 
Based on the findings of previous studies, firstly, the Kirby Bauer disc diffusion assay was 
performed to check for the activity of walnut oil, pumpkin oil and cashew oil against S. aureus. 
This served as a preliminary screening for subsequent experiments. Secondly, exploration 
whether the oil samples that were active in the disc diffusion assay are also effective in 
inhibiting or eradicating S. aureus biofilm was performed. To do this, the Minimum Inhibition 
Concentration (MIC), Minimum Biofilm Inhibition Concentration (MBIC) and Minimum 
Biofilm Eradication Concentration (MBEC) methods were used to determine the concentration 
needed to inhibit or eradicate S. aureus biofilm. All these tests determined if the plant oil 








5.2.1 Antibiotic sensitivity testing of seed and nut oils against MRSA 252 and S. aureus 
ATCC 6538 
Preliminary evaluation of the antibacterial activity of African walnut, cashew and pumpkin oils 
against MRSA 252 and ATCC 6538 and some selected antibiotics was evaluated before using 
the oils for further analysis. In determining the antibacterial activities of walnut, cashew and 
pumpkin oils, the Kirby-Bauer disk diffusion assay was first conducted. In this assay, resultant 
zones of inhibitions produced by oils alone, antibiotic disks and combination disks were 
measured in millimetre (mm) with a ruler and interpreted using the CLSI zone diameter 
interpretative standards. Studies were performed in triplicate to ensure reproducibility, and 
mean value was calculated. 
5.2.1.1 African walnut oil effect on MRSA 252 
African walnut (Tetracapidium conophorum) oil showed significant antibacterial activity 
against the tested MRSA 252 (Figure 33 and 34). The results of the antibacterial activity of 
African walnut oil against the tested MRSA 252 showed that MRSA 252 was susceptible to a 
range of antibiotics belonging to the class of nucleic acid inhibitors and cell wall synthesis 
inhibitors, intermediary metabolism inhibitors and protein synthesis inhibitors. Antibacterial 
susceptibility testing with African walnut oil alone produced larger zones of inhibitions 
indicating that it is highly capable of killing MRSA 252. For test with antibiotics alone, MRSA 
252 was seen to be susceptible to antibiotics such as streptomycin, vancomycin, linezolid and 
gentamicin, rifampicin, and chloramphenicol. The bacterium was susceptible because it 
produced clear zones of inhibitions. However, MRSA 252 was observed to be very resistant to 
drugs such as trimethoprim, penicillin G, ciprofloxacin, oxacillin, and erythromycin. This was 
because no zones were produced by the antibiotics. However, because trimethoprim and 
carbenicillin produced clear zones that are not up to 12 mm diameter, MRSA 252 was still 
classified as been resistant to the drugs. The antibiotics produced varied effects in combination 
with walnut oil. Combination of walnut oil with chloramphenicol, rifampicin, gentamicin and 
linezolid antibiotics showed an indifference effect against MRSA 252. The diameter of zone 
(mm) of the resultant combination did not show difference between the African walnut oil 
alone and antibiotic disk alone. The combination of trimethoprim, vancomycin, carbenicillin 
and streptomycin led to a synergistic effect on MRSA 252. In this case the diameter of the 
zones obtained resulted in a combination effect of both the antibiotic disc alone and African 
walnut oil. In the synergistic effect, the applied antibiotics and essential oil work together to 
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produce an effect more potent than if each antibiotic or oil were applied singly. This explains 
the synergistic effect of carbenicillin which appears to be enhanced by activity of African 
walnut oil even though it did not produce much inhibitory effect alone. While combination of 
African walnut oil with erythromycin, oxacillin, penicillin G and ciprofloxacin led to a 
potentiating effect where no zone was recorded for the antibiotics alone. For the control 
(DMSO) no growth was observed in all the plates.  
                
Figure 33. Resistant pattern of MRSA 252 to commercial antibiotics and synergy effect of African walnut 
oil with antibiotics 
Data on the graph is the diameter of clear zones of inhibition (mm). Bars represent the means 
standard deviation (SD) of three repeated experiments (n=3). Statistical analysis was performed 
using the two-way ANOVA with Bonferroni posttests and significant differences in the data 
were established at P<0.05 (P<0.0001). The green bar and blue bars represent the mean 
diameter zone of African walnut oil alone and antibiotic alone while the white bars represent 
the diameter of zones of combination effect of antibiotic with African walnut oil on MRSA 
252. The line represents a threshold that limits the zones of inhibition of walnut oil against 
MRSA 252. 






Antibacterial activities (zones of inhibition) of African walnut oil and its synergistic effect 





Figure 34. Disk diffusion assay identifies African walnut oil and some selected commercial antibiotics 
with antimicrobial activity. 
Figure 34 shows the representative plates for disk diffusion assay. Disks diffusion assay was 
conducted by impregnating 6 mm disks separately with African walnut oil, antibiotics and 
combination of antibiotics with standard concentrations of antibiotics and allowed to dry in the 
oven for 30 minutes before placing them individually on plates and incubated for 24 hours. 
Control disc in all the plates contains 10 μL of DMSO. (A). Antibacterial activity of African 
walnut oil, linezolid 10 μg and combination of 10 μL African walnut oil + linezolid 10 μg. (B). 
Antibacterial activity of walnut oil, gentamicin 10 μg and combination of 10 μL walnut oil + 
gentamicin 10 μg. (C). Antibacterial activity of African walnut oil, ciprofloxacin 5 μg and 
combination of 10 μL walnut oil + ciprofloxacin 5 μg. (D). Antibacterial activity of walnut oil, 
trimethoprim 1.25 μg and combination of 10 μL African walnut oil + trimethoprim 1.25 μg. 
(E). Antibacterial activity of walnut oil, rifampicin 15 μg and combination of 10 μL walnut oil 
+ rifampicin 15 μg. (F). Antibacterial activity of African walnut oil, penicillin G 15 μg and 
combination of 10 μL walnut oil + penicillin G 15 μg. (G). Antibacterial activity of African 
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walnut oil, vancomycin 30 μg and combination of 10 μL walnut oil + streptomycin 30 μg. (H). 
Antibacterial activity of walnut oil, oxacillin 30 μg and combination of 10 μL African walnut 
oil + oxacillin 30 μg. (I). Antibacterial activity of African walnut oil, streptomycin 10 μg and 
combination of 10 μL walnut oil + streptomycin 10 μg. (J). Antibacterial activity of walnut oil, 
carbenicillin 10 μg and combination of 10 μL African walnut oil + carbenicillin 10 μg. (K). 
Antibacterial activity of walnut oil, erythromycin 15 μg and combination of 10 μL walnut oil 
+ erythromycin 15 μg. (L). Antibacterial activity of African walnut oil, chloramphenicol 10 μg 
and combination of 10 μL walnut oil + chloramphenicol 10 μg. 
5.2.1.2 Cashew oil effect on MRSA 252 
Cashew (Anacardium occidentalis) oil showed low inhibitory activity against the tested MRSA 
252 (Figure 35 and 36). The result of antibacterial susceptibility testing represented in Figure 
33 below showed that MRSA 252 was susceptible to a range of antibiotics belonging to 
different classes of drugs. Antibacterial susceptibility testing with cashew oil alone showed 
that cashew oil produced smaller zones of inhibitions compared to walnut oil indicating that it 
has low activity against MRSA 252. For tests with antibiotics alone, MRSA 252 was seen to 
be susceptible to a range of antibiotics such as streptomycin, linezolid and rifampicin, 
vancomycin, gentamicin and chloramphenicol. The antibiotics were susceptible because they 
produced clear zones of inhibitions. However, MRSA 252 was observed to be very resistant to 
drugs such as trimethoprim, penicillin G, ciprofloxacin, oxacillin, carbenicillin and 
erythromycin which were similar to walnut oil. This was because no clear zones were produced 
by the antibiotics. For combination test, the antibiotics produced varied effects when combined 
with cashew oil. Combination of cashew oil with trimethoprim, chloramphenicol, rifampicin, 
vancomycin and carbenicillin gave a synergistic effect with cashew oil which shows that the 
diameter of the zone obtained for combination was equal to that of walnut oil and the individual 
antibiotics. Chloramphenicol and rifampicin exhibited a key-hole synergy against MRSA 252. 
An indifferent effect was observed when cashew oil was combined with linezolid, gentamicin, 
and streptomycin, in this case the diameter of the zones obtained was just the same as that of 
antibiotic alone or slightly greater. Although the combination zone obtained for gentamicin 
was smaller. Since no zone was produced by ciprofloxacin, erythromycin, oxacillin and 
penicillin G, combination of cashew oil with the antibiotics led to a potentiating effect where 
no zone was recorded for the antibiotics alone but clear zones were obtained for combination 
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which was almost equal to cashew oil zone alone. For the control (DMSO) no growth was 
observed in all the plates.  
              
Figure 35.  Resistant pattern of MRSA 252 to commercial antibiotics and synergy effect of cashew oil with 
antibiotics. 
Data on the graph is the diameter of clear zones of inhibition (mm). Bars represent the means 
standard deviation (SD) of three repeated experiments (n=3. Significant differences in the data 
were established at P<0.05 (P<0.0001) using two-way ANOVA with Bonferroni post-tests. 
The green and brown bars represent the mean diameter zone of cashew oil alone and antibiotic 
alone while the white bars represent the diameter of zones of combination effect of antibiotic 
with cashew oil on MRSA 252. The line represents a threshold that limits the zones of 
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Figure 36. Disk diffusion assay identifies cashew oil and some selected commercial antibiotics with 
antimicrobial activity. 
 
Figure 36 shows the representative plates for disk diffusion assay showing the antibacterial 
activity of cashew oil against MRSA 252. Control disc in all the plates contained 10 μL of 
DMSO. (A). Antibacterial activity of cashew oil, linezolid 10 μg and combination of 10 μL 
cashew oil + linezolid 10 μg. (B). Antibacterial activity of cashew oil, gentamicin 10 μg and 
combination of 10 μL cashew oil + gentamicin 10 μg. (C). Antibacterial activity of cashew oil, 
ciprofloxacin 5 μg and combination of 10 μL cashew oil + ciprofloxacin 5 μg. (D). 
Antibacterial activity of cashew oil, trimethoprim 1.25 μg and combination of 10 μL cashew 
oil + trimethoprim 1.25 μg. (E). Antibacterial activity of cashew oil, rifampicin 15 μg and 
combination of 10 μL cashew oil + rifampicin 15 μg. (F). Antibacterial activity of cashew oil, 
penicillin G (15 μg) and combination of 10 μL cashew oil + penicillin G (15 μg). (G). 
Antibacterial activity of cashew oil, vancomycin 30 μg and combination of 10 μL cashew oil 
+ vancomycin 30 μg. (H). Antibacterial activity of cashew oil, oxacillin 30 μg and combination 
of 10 μL cashew oil + oxacillin 30 μg. (I).  Antibacterial activity of cashew oil, streptomycin 
10 μg and combination of 10 μL cashew oil + streptomycin 10 μg. (J). Antibacterial activity of 
cashew oil, carbenicillin 10 μg and combination of 10 μL cashew oil + carbenicillin 10 μg. (K). 
Antibacterial activity of cashew oil, erythromycin 15 μg and combination of 10 μL cashew oil 
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+ erythromycin 15 μg. (L). Antibacterial activity of cashew oil, chloramphenicol 10 μg and 
combination of 10 μL cashew oil + chloramphenicol 10 μg. Studies were performed in triplicate 
to ensure reproducibility, and mean value was calculated. 
5.2.1.3 Fluted pumpkin oil effect on MRSA 252  
Fluted pumpkin (Telfaria occidentalis) oil showed significant inhibitory activity against 
MRSA 252 (Figure 37 and 38). The result of antibacterial susceptibility testing presented below 
showed that MRSA 252 was susceptible to a range of antibiotics belonging to different classes 
of drugs. Antibacterial susceptibility testing with pumpkin oil alone showed that the oil 
produced moderately bigger and clear zones of inhibitions compared to cashew oil indicating 
that it has high activity against MRSA 252. According to the results, MRSA 252 appears to be 
susceptible to a range of antibiotics such as streptomycin, rifampicin, vancomycin, gentamicin 
and resistant to ciprofloxacin, erythromycin, trimethoprim and carbenicillin. Clear zones with 
different diameter (mm) were obtained for streptomycin, rifampicin, vancomycin, gentamicin 
while no zones were obtained for ciprofloxacin, and carbenicillin. Combination of pumpkin oil 
with gentamicin, streptomycin, trimethoprim, chloramphenicol led to a synergistic effect 
against MRSA 252. Whereas combination of pumpkin oil with linezolid and vancomycin led 
to indifference effect against MRSA 252. A potentiation effect was obtained when pumpkin 
oil was combined with antibiotics such as ciprofloxacin, erythromycin and carbenicillin. For 
the control (DMSO) no growth was observed in all the plates.  
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Figure 37. Resistant pattern of MRSA 252 to commercial antibiotics and synergy effect of fluted pumpkin 
oil with antibiotics. 
Data on the graph is the diameter of clear zones of inhibition (mm). Bars represent the means 
standard deviation (SD) of three repeated experiments (n=3). Significant differences in the data 
were established at P<0.05 (P<0.001) using two-ANOVA with Bonferroni posttests. The green 
and purple bars represent the mean diameter zone of fluted pumpkin oil alone and antibiotic 
alone while the white bars represent the diameter of zones of combination effect of antibiotic 
alone with pumpkin oil on MRSA 252. The line represents a threshold that limits the zones of 
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Figure 38 shows the representative plates for disk diffusion assay. The representative plates for 
disk diffusion assay showing the antibacterial activity of pumpkin oil against MRSA 252. 
Control disc in all the plates contained 10 μL of DMSO. (A). Antibacterial activity of pumpkin 
oil, linezolid 10 μg and combination of 10 μL pumpkin oil + linezolid 10 μg. (B). Antibacterial 
activity of pumpkin oil, gentamicin 10 μg and combination of 10 μL pumpkin oil + gentamicin 
10 μg. (C). Antibacterial activity of pumpkin oil, vancomycin 30 μg and combination of 10 μL 
pumpkin oil + vancomycin 30 μg. (D). Antibacterial activity of pumpkin oil, carbenicillin 10 
μg and combination of 10 μL pumpkin oil + carbenicillin 10 μg. (E). Antibacterial activity of 
pumpkin oil, chloramphenicol 10 μg and combination of 10 μL pumpkin oil + chloramphenicol 
10 μg. (F). Antibacterial activity of pumpkin oil, rifampicin 15 μg and combination of 10 μL 
pumpkin oil + rifampicin 15 μg. (G). Antibacterial activity of pumpkin oil, streptomycin 10 μg 
and combination of 10 μL pumpkin oil + streptomycin 10 μg. (H). Antibacterial activity of 
cashew oil, ciprofloxacin 5 μg and combination of 10 μL cashew oil + ciprofloxacin 5 μg. (I) 
Antibacterial activity of cashew oil, erythromycin 15 μg and combination of 10 μL cashew oil 
+ erythromycin 15 μg. (J). Antibacterial activity of cashew oil, trimethoprim 1.25 μg and 
combination of 10 μL cashew oil + trimethoprim 1.25 μg. Studies were performed in triplicate 
to ensure reproducibility, and mean values were calculated. 
5.2.1.4 African walnut oil effect on S. aureus ATCC 6538 
African walnut (Tetracapidium conophorum) oil showed significant inhibitory activity against 
ATCC 6538 (Figure 39 and 40). The results obtained from the disc diffusion test showed that 
ATCC 6538 was susceptible to most of the antibiotics tested. Antibacterial susceptibility 
testing with African walnut oil alone produced larger zones of inhibitions indicating that walnut 
oil has the capability to kill ATCC 6538. For test with antibiotics alone, ATCC 6538 was 
susceptible to trimethoprim, erythromycin, oxacillin, ciprofloxacin, streptomycin, 
vancomycin, linezolid, rifampicin and chloramphenicol. This result confirms the susceptibility 
character of ATCC 6538. For combination test, the antibiotics produced varied effects in 
combination with walnut oil. Combination of walnut oil with ciprofloxacin, erythromycin, 
rifampicin, gentamicin chloramphenicol and linezolid showed an antagonistic effect against 
ATCC 6538 because the combination zones were smaller than zones of African walnut oil and 
antibiotics alone. Combination of African walnut oil with ciprofloxacin, gentamicin, 
trimethoprim, vancomycin, oxacillin and streptomycin led to a synergistic effect against ATCC 
6538. Gentamicin exhibited a strong synergistic effect with African walnut oil against ATCC 
137 
 
6538 indicated by the key hole formation. Carbenicillin exhibited a key-hole synergy against 
ATCC 6538. For the control no growth was observed in all the plates. 
 
                
Figure 39. Resistant pattern of ATCC 6538 to commercial antibiotics and synergy effect of African walnut 
oil with antibiotics 
Data on the graph is the diameter of clear zones of inhibition (mm). Bars represent the means 
standard deviation (SD) of three repeated experiments (n=3). Significant differences in the data 
were established at P<0.05 (P<0.0001) using two-way ANOVA with Bonferroni posttests. The 
red and blue bars represent the mean diameter zone of walnut oil alone and antibiotics alone 
while the white bars represent the zones of combination effect of antibiotics alone with African 
walnut oil on ATCC 6538. The line represents a threshold that limits the zones of inhibition of 
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Figure 40. Disk diffusion assay identifies walnut oil and selected commercial antibiotics with antimicrobial 
activity. 
Figure 40 shows the representative plates for disk diffusion assay of walnut oil against ATCC 
6538. Control disc in all the plates contained 10 μL of DMSO. (A). Antibacterial activity of 
walnut oil, linezolid 10 μg and combination of 10 μL walnut oil + linezolid 10 μg. (B). 
Antibacterial activity of walnut oil, gentamicin 10 μg and combination of 10 μL walnut oil + 
gentamicin 10 μg. (C). Antibacterial activity of walnut oil, ciprofloxacin 5 μg and combination 
of 10 μL walnut oil + ciprofloxacin 5 μg. (D). Antibacterial activity of walnut oil, trimethoprim 
1.25 μg and combination of 10 μL walnut oil + trimethoprim 1.25 μg. (E). Antibacterial activity 
of walnut oil, rifampicin 15 μg and combination of 10 μL walnut oil + rifampicin 15 μg. (F). 
Antibacterial activity of walnut oil, oxacillin 30 μg and combination of 10 μL walnut oil + 
oxacillin 30 μg. (G). Antibacterial activity of walnut oil, vancomycin 30 μg and combination 
of 10 μL walnut oil + vancomycin 30 μg. (H). Antibacterial activity of walnut oil, erythromycin 
15 μg and combination of 10 μL walnut oil + erythromycin 15 μg. (I). Antibacterial activity of 
walnut oil, erythromycin 15 μg and combination of 10 μL walnut oil + erythromycin 15 μg. 
(J). Antibacterial activity of walnut oil, streptomycin 10 μg and combination of 10 μL walnut 
oil + streptomycin 10 μg. (K) Antibacterial activity of pumpkin oil, carbenicillin 10 μg and 
combination of 10 μL pumpkin oil + carbenicillin 10 μg. (L). Antibacterial activity of pumpkin 
oil, chloramphenicol 10 μg and combination of 10 μL pumpkin oil + chloramphenicol 10 μg.  
Studies were performed in triplicate to ensure reproducibility, and mean values were 
calculated. 
5.2.1.5 Cashew oil effect on S. aureus ATCC 6538 
Cashew (Anacardium occidentalis) oil showed low inhibitory activity against ATCC 6538 
(Figure 41 and 42). The result of antibacterial susceptibility testing presented below shows that 
ATCC 6538 was susceptible to most of the antibiotics such as trimethoprim, erythromycin, 
gentamicin, streptomycin, vancomycin, linezolid, penicillin G and chloramphenicol. Cashew 
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oil alone produced smaller zones (13 mm) indicating that it has low activity against ATCC 
6538. For combination test, the antibiotics produced varied effects in combination with cashew 
oil. Combination of cashew oil with trimethoprim and penicillin G produced synergistic effect. 
Combination of cashew oil with gentamicin produced an antagonistic effect whereas 
combination with vancomycin, erythromycin and chloramphenicol produced an indifference 
effect. 
              
Figure 41. Resistant pattern of ATCC 6538 to commercial antibiotics and synergy effect of cashew oil with 
antibiotics 
Data on the graph is the diameter of clear zones of inhibition (mm). Bars represent the means 
standard deviation (SD) of three repeated experiments (n=3). Significant differences in the data 
were established at P<0.05 (P<0.001) using two-way ANOVA with Bonferroni posttests. The 
red and purple bars represent the mean diameter zone of cashew oil alone and antibiotics alone 
while the white bars represent the zones of combination effect of antibiotics alone with cashew 
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Figure 42. Disk diffusion assay identifies cashew oil and selected commercial antibiotics with antimicrobial 
activity. 
Figure 42 shows the representative plates for disk diffusion assay of cashew oil against ATCC 
6538. Control disc in all the plates contained 10 μL of DMSO. A. Antibacterial activity of 
cashew oil, linezolid 10 μg and combination of 10 μL cashew oil + linezolid 10 μg. B. 
Antibacterial activity of cashew oil, gentamicin 10 μg and combination of 10 μL walnut oil + 
gentamicin 10 μg. C. Antibacterial activity of cashew oil, trimethoprim 1.25 μg and 
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combination of 10 μL cashew oil + trimethoprim 1.25 μg. D. Antibacterial activity of cashew 
oil, penicillin G (15 μg) and combination of 10 μL cashew oil + penicillin G (15 μg). E. 
Antibacterial activity of cashew oil, vancomycin 30 μg and combination of 10 μL cashew oil 
+ vancomycin 30 μg. F. Antibacterial activity of cashew oil, erythromycin 15 μg and 
combination of 10 μL cashew oil + erythromycin 15 μg. I. Antibacterial activity of cashew oil, 
erythromycin 15 μg and combination of 10 μL cashew oil + erythromycin 15 μg. G. 
Antibacterial activity of cashew oil, chloramphenicol 10 μg and combination of 10 μL cashew 
oil + chloramphenicol 10 μg. Resultant zones of inhibitions produced by cashew oil alone, 
antibiotic disks and combination disks were measured in millimetre (mm) with a ruler and 
interpreted using the CLSI zone diameter interpretative standards. Studies were performed in 
triplicate to ensure reproducibility, and mean values were calculated. 
5.2.1.6 Fluted pumpkin oil effect on S. aureus ATCC 6538 
Fluted pumpkin (Telfaria occidentalis) oil showed significant inhibitory activity against ATCC 
6538 (Figure 43 and 44). The disc diffusion test showed that ATCC 6538 was susceptible to 
most of the antibiotics tested. Antibacterial susceptibility testing with pumpkin oil alone 
produced moderately large zones of inhibitions indicating that pumpkin oil has the capability 
to kill ATCC 6538. For test with antibiotics alone, ATCC 6538 was susceptible to 
erythromycin, oxacillin, ciprofloxacin, streptomycin, vancomycin, linezolid, rifampicin, 
penicillin G and chloramphenicol. This result confirms the susceptibility character of ATCC 
6538. For combination test, the antibiotics produced varied effects in combination with 
pumpkin oil. Combination of pumpkin oil with vancomycin, rifampicin and erythromycin led 
to a synergistic effect against ATCC 6538. Synergy between rifampicin and erythromycin was 
indicated by key-hole formation which was different from vancomycin synergy. An 
antagonistic effect was observed when pumpkin oil was combined with penicillin G. 
Combination of pumpkin oil with chloramphenicol and streptomycin resulted in an 
indifference effect against ATCC 6538. Because the combination results for ciprofloxacin and 
oxacillin were high and didn’t result into synergy; their activities were categorized as 




             
 
Figure 43. Resistant pattern of ATCC 6538 to commercial antibiotics and synergy effect of fluted pumpkin 
oil with antibiotics 
Data on the graph is the diameter of clear zones of inhibition (mm). Bars represent the means 
standard deviation (SD) of three repeated experiments (n=3). Significant differences in the data 
were established at P<0.05 (P<0.0001) using two-way ANOVA. The red and pink bars 
represent the mean diameter zone of pumpkin oil alone and antibiotics alone while the white 
bars represent the zones of combination effect of antibiotics alone with pumpkin oil on ATCC 
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Figure 44 shows the representative plates for disk diffusion assay of pumpkin oil against ATCC 
6538. Control disc in all the plates contained 10 μL of DMSO.  (A). Antibacterial activity of 
pumpkin oil, vancomycin 30 μg and combination of 10 μL pumpkin oil + vancomycin 30 μg. 
(B). Antibacterial activity of pumpkin oil, gentamicin 10 μg and combination of 10 μL pumpkin 
oil + gentamicin 10 μg. (C). Antibacterial activity of pumpkin oil, ciprofloxacin 5 μg and 
combination of 10 μL cashew oil + ciprofloxacin 5 μg. (D). Antibacterial activity of cashew 
oil, rifampicin 15 μg and combination of 10 μL cashew oil + rifampicin 15 μg. (E). 
Antibacterial activity of pumpkin oil, chloramphenicol 10 μg and combination of 10 μL 
pumpkin oil + chloramphenicol 10 μg. (F). Antibacterial activity of pumpkin oil, linezolid 10 
μg and combination of 10 μL pumpkin oil + linezolid 10 μg. (G). Antibacterial activity of 
pumpkin oil, streptomycin 10 μg and combination of 10 μL pumpkin oil + streptomycin 10 μg. 
(H). Antibacterial activity of pumpkin oil, oxacillin 30 μg and combination of 10 μL pumpkin 
oil + oxacillin 30 μg. (I). Antibacterial activity of pumpkin oil, erythromycin 15 μg and 
combination of 10 μL pumpkin oil + erythromycin 15 μg. (J). Antibacterial activity of pumpkin 
oil, penicillin G (15 μg) and combination of 10 μL pumpkin oil + penicillin G (15 μg). Studies 
were performed in triplicate to ensure reproducibility, and mean values were calculated.  
5.2.2 Oil control plates and well diffusion results of African walnut, cashew and fluted 
pumpkin extracts 
Control plates of ATCC 6538 and MRSA 252 cultured with DMSO and mineral oil did not 
show any zone of inhibitions as compared to the clear zones obtained previously for African 
walnut, cashew and pumpkin oils and extracts.  
5.2.2.1 Oil control    
The oil control plates show no zones of inhibition were produced by MRSA 252 and ATCC 




             
 
Figure 45. Control plates of ATCC 6538 and MRSA 252 showing no zone of inhibitions with DMSO and 
mineral oil. 
5.2.2.2 Effect of African walnut extracts on MRSA 252 and S. aureus ATCC 6538 
A well diffusion assay was used to test the antibacterial activity of extracts of African walnut, 
cashew and pumpkin. The extracts were obtained from three solvents-hexane, chloroform and 
petroleum ether. This assay was used as a preliminary test to ascertain the activity of each 





            
Figure 46. Representative plates for well diffusion of African walnut extracts against MRSA 252 and ATCC 
6538.                      
Figure 46 shows that the pressed oil, hexane and petroleum extract of African walnut had 
significant activity against MRSA 252 and ATCC 6538. The diameter of the zones of ATCC 
6538 were higher than those of MRSA 252, For MRSA 252 the zones were clear with 14 mm 
(petroleum ether), 16 mm (hexane), 10 mm (chloroform) and 17 mm (pressed oil). For ATCC 
6538, the zones were also clear with large zones 18 mm (petroleum ether), 20 mm (hexane) 
and 25 mm (pressed oil). No zone was observed for chloroform.  However, the result indicated 
that the hexane and the pressed oil had more activity against the two strains. In this assay 20 
uL of each extract was used. In addition, control discs contained 20 uL of DMSO alone. 20 uL 
was used to allow a proper diffusion of the extracts into the agar plate. 
5.2.2.3 Effect of fluted pumpkin extracts on MRSA 252 and S. aureus ATCC 6538 
       




Figure 47 shows that the pressed oil, hexane and petroleum extract of African walnut had 
significant activity against both MRSA 252 and ATCC 6538. The diameter of the zones of 
ATCC 6538 were higher than those of MRSA 252, For MRSA 252 the zones were clear with 
12 mm (petroleum ether), 14 mm (hexane), 9 mm (chloroform) and 17 mm (pressed oil). For 
ATCC 6538, the zones were also clear with large zones >10mm (7 mm petroleum ether and 
chloroform 9 mm), 12 mm (hexane) and 24 mm (pressed oil).   However, the result indicates 
that the hexane and the pressed oil had more activity against the two strains. In this assay 20 
uL of each extract was used. In addition, control discs contained 20 uL of DMSO alone. 
5.2.3 Minimum inhibitory concentration and minimum biofilm inhibitory concentration 
of oils against MRSA 252 and S. aureus ATCC 6538 planktonic and biofilms 
The antibacterial activity testing of MRSA 252 and ATCC 6538 was determined to ascertain 
whether the staphylococci strains were susceptible to African walnut oil, cashew oil and 
pumpkin oil along with their respective extracts. For the antibacterial susceptibility testing the 
assays Minimum Inhibition Concentration (MIC), Minimum Bactericidal Concentration, 
Minimum Biofilm Inhibitory Concentration (MBIC) and Minimum Bactericidal Eradication 
Concentration (MBEC) were performed to determine whether African walnut, cashew and 
pumpkin oils with their extracts that were active in the disc diffusion assay are effective in 
inhibiting planktonic growth and biofilm formation of MRSA 252 and S. aureus ATCC 6538. 
To effectively determine the antibacterial activity of African walnut, cashew and pumpkin oil 
and identify their concentration range for the following biofilm experiments, initially the MICs 
of walnut oil, cashew oil and pumpkin oil was determined following the CLSI Standard Broth 
Micro-dilution procedure. The activities of each oil sample on MRSA 252 and ATCC 6538 
planktonic growth were investigated by determination of MICs of MRSA 252 and ATCC 6538 
growth in TSB medium. S. aureus ATCC 6538 and MRSA 252 were cultured separately in the 
presence of different concentrations of walnut oil, cashew oil and pumpkin oil for 24 hours at 
37°C to determine their MICs. In the context of this study, MIC was defined as the lowest oil 
concentration at which no visible turbidity was seen after 24 h hours of culture. All MIC and 
experiments were carried out in triplicate with three independent repetitions. MIC was defined 
as the lowest oil concentration with no growth after 24 h culture.  
MBICs was defined as the lowest concentration of oil required to inhibit the growth of MRSA 
252 and S. aureus ATCC 6538 biofilms or, in other words, it was considered as the lowest 
concentration of oil that prevents visible growth medium used to collect biofilms. For 
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determining the MBECs of the individual oils, the MBEC™-HTP plate method was used to 
monitor the reduction in MRSA 252 and S. aureus ATCC 6538 counts of 48 h preformed 
biofilms in a recovery medium after challenging the strains with African walnut, cashew and 
pumpkin oils in a concentration range of 0.98 to 500 mg/mL and each oil sample has its MBEC 
value within this range. MBECs was defined as the lowest concentration of oil required to 
eradicate the biofilms of MRSA 252 and S. aureus ATCC 6538 or, in other words, it was 
considered as the lowest concentration of oil that prevents visible growth in the recovery 
medium used to collect biofilms.  
5.2.3.1 MICs and MBICs of African walnut oil against MRSA 252 and ATCC 6538 
planktonic and biofilm growth 
African walnut oil significantly (Dunnett’s test = P < 0.05) inhibited the planktonic growth of 
MRSA 252 and S. aureus ATCC 6538 after 24 h of incubation (Figure 48 A & C). Figure 48 
A & C showed that MRSA 252 and S. aureus ATCC 6538 ATCC 6538 were both susceptible 
to walnut oil at different concentrations tested. MICs of African walnut oil against planktonic 
cells of MRSA 252 was 15.6 mg/mL and ATCC 6538 was 7.8 mg/mL (Figure 48 A & C). 
Based on the results obtained African walnut oil revealed remarkable antibacterial effect 
against MRSA 252 and S. aureus ATCC 6538. MBIC values of MRSA 252 and ATCC 6538 
biofim cells were 31.25 and 15.6 mg/mL. MBIC results in Figure 48 B & D showed that walnut 
oil exhibited high antibacterial activity against MRSA 252 and S. aureus ATCC 6538 biofilms. 
From the data on the graph, walnut oil proved to be dose dependently successful in its ability 
to significantly (P < 0.05) (Dunnett’s test) inhibit biofilm formation of S. aureus ATCC 6538 
and MRSA 252 in the 96-well plate after incubation for 24 hours at 37oC. Although the MBIC 
values are higher than the MIC values, they are considered low showing that African walnut 






Figure 48. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of African 
walnut oil tested against MRSA 252 and S. aureus ATCC 6538 planktonic cells and preformed biofilms 
after 24 hours of incubation at 37°C in 96-well tissue culture polystyrene plate. 
Figure 48 shows (a) MRSA 252 planktonic growth inhibition by African walnut oil (b) MRSA 
252 biofilm formation inhibition by African walnut oil (c) ATCC 6538 planktonic growth 
inhibition by African walnut oil and (d) ATCC 6538 biofilm formation inhibition by African 
walnut oil. Data on the graphs represent the mean OD values (Mean ± SD) of three independent 
experiments (n=3) and the error bars indicate standard deviations of the means. For MIC, the 
OD of the planktonic growth cultures of MRSA and ATCC 6538 are shown, and MBIC, the 
absorbance of safranin stained cells attached to the surface of the 96-well plates after washing 
are showed for MRSA and ATCC 6538. Statistical analysis of the mean OD600 nm was 
performed using one-way ANOVA with Dunnett’s comparison test. Asterisks (***) above the 
columns indicates significant difference of each mean with walnut oil with the corresponding 
growth control group (p < 0.0001). No significant (ns) difference at P>0.05. Two controls were 
used: Media only without oil was used as negative blank and bacterial suspension used as 
positive growth control.  
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5.2.3.2 MICs and MBICs of cashew oil against MRSA 252 and ATCC 6538 planktonic 
and biofilm growth 
MICs of 125 mg/mL was obtained for MRSA 252 and ATCC 6538 planktonic growth cells 
(Figure 49 A & C).  Cashew oil inhibited the growth planktonic cells of MRSA 252 and S. 
aureus ATCC 6538 significantly (Dunnett’s test = P < 0.05). Cashew oil showed very moderate 
inhibitory effect on S. aureus strains. Compared to walnut oil, cashew oil required higher 
concentrations to be an effective antimicrobial agent. MRSA 252 and S. aureus ATCC 6538 
showed low susceptibility to cashew oil exhibiting the highest MICs of 125 mg/mL for both 
MRSA 252 and ATCC 6538 planktonic growth. (Figure 49 A & C).  
In addition, MBIC results of cashew oil effect on MRSA 252 and S. aureus ATCC 6538 is 
shown in Figure 49 B & D.  Cashew oil had an MBIC value of 250 mg/mL for MRSA 252 and 
250 mg/mL for S. aureus ATCC 6538 indicating that a higher concentration is needed to inhibit 
biofilm formation in both strains. These values are higher than their MIC values. However, a 
weak antibacterial activity was observed and as such cashew oil was regarded as an 
antibacterial agent that is less active at inhibiting biofilm formation of MRSA 252 and S. aureus 
ATCC 6538. 
 





Figure 49. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of cashew oil 
tested on MRSA 252 and S. aureus ATCC 6538 planktonic cells and preformed biofilms formed after 24 
hours of incubation at 37°C in 96-well tissue culture polystyrene plates. 
Figure 49 shows (a) MRSA 252 planktonic growth inhibition by cashew oil (b) MRSA 252 
biofilm formation inhibition by cashew oil (c) ATCC 6538 planktonic growth inhibition by 
cashew oil and (d) ATCC 6538 biofilm formation inhibition by cashew oil. Data on the graphs 
represent the mean OD values (Mean ± SD) of three independent experiments (n=3) and the 
error bars indicate standard deviations of the means. For MIC, the OD of the planktonic growth 
cultures of MRSA 252 and ATCC 6538 are shown, and MBIC, the absorbance of safranin 
stained cells attached to the surface of the 96-well plates after washing are showed for MRSA 
252 and ATCC 6538. Statistical analysis of the mean OD600 nm was performed using one-
way ANOVA with Dunnett’s test. Asterisks (***) above the columns indicates significant 
difference of each column with walnut oil with the corresponding growth control group (p < 
0.0001). No significant (ns) difference at P>0.05. Two controls were used: Media only without 




5.2.3.3 MICs and MBICs of fluted pumpkin oil against MRSA 252 and ATCC 6538 
planktonic and biofilm growth 
MIC of fluted pumpkin oil is presented in (Figure 50 A & C).  Pumpkin oil inhibited the growth 
of planktonic cells of MRSA 252 and S. aureus ATCC 6538 significantly (Dunnett’s test) and 
the inhibitory effect was observed to be concentration dependent. After 24 h of incubation with 
pumpkin oil, MRSA 252 and S. aureus ATCC 6538 showed high susceptibility to pumpkin oil 
exhibiting low MICs of 31.25 mg/mL and 62.5 mg/mL respectively.  
MBIC results for fluted pumpkin oil activity against MRSA 252 and S. aureus ATCC 6538 is 
presented in Figure 50 B & D. The MBIC value varied between the strains and result indicates 
that pumpkin oil has high inhibitory activity against MRSA 252 and S. aureus ATCC 6538 
biofilm formation. Pumpkin MBIC values for MRSA 252 and ATCC 6538 was 125 and 62.5 
mg/mL. Pumpkin oil was considered an effective antibacterial agent. 
 
Figure 50. Minimum inhibitory concentration and minimum biofilm inhibitory concentration fluted 
pumpkin oil tested on MRSA 252 and S. aureus ATCC 6538 planktonic cells and preformed biofilms 
formed after 24 hours of incubation at 37°C in 96-well tissue culture plates. 
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Figure 50 shows (a) MRSA 252 planktonic growth inhibition by fluted pumpkin oil (b) MRSA 
252 biofilm formation inhibition by pumpkin oil (c) ATCC 6538 planktonic growth inhibition 
by pumpkin oil and (d) ATCC 6538 biofilm formation inhibition by pumpkin oil. Data on the 
graphs represent the mean OD values (Mean ± SD) of three independent experiments (n=3) 
and the error bars indicate standard deviations of the means. For MIC, the OD of the planktonic 
growth cultures of MRSA and ATCC 6538 are shown, and MBIC, the absorbance of safranin 
stained cells attached to the surface of the 96-well plates after washing are showed for MRSA 
and ATCC 6538. Statistical analysis of the mean OD600 nm was performed using one-way 
ANOVA with Dunnett’s test. Asterisks (***) above the columns indicates significant 
difference of each column with walnut oil with the corresponding growth control group (p < 
0.0001). No significant (ns) difference at P>0.05. Two controls were used: Media only without 
oil was used as negative blank and bacterial suspension used as positive growth control.  
 
In summary,  a comparison of the results of inhibitory activity of walnut oil (Figure 48 A - D), 
pumpkin oil (Figure 49 A - D) and cashew oil (Figure 50 A - D) on MRSA 252 and ATCC 
6538 planktonic and biofilm growth shows that low concentrations of walnut oil and pumpkin 
oil are required to inhibit the growth MRSA 252 and ATCC 6538 cells and the oils are 
considered effective antimicrobial agent on MRSA 252 and ATCC 6538 strains. In addition, 
cashew oil exhibited weak activity against MRSA 252 and ATCC 6538. However, of the three 
oils tested, walnut oil had the highest activity. Cashew oil was referred to as a weak 
antibacterial agent.  
 
5.2.4 MICs and MBICs of African walnut, cashew and fluted pumpkin extracts against 
MRSA 252 and S. aureus ATCC 6538 planktonic and biofilms 
African walnut, cashew and pumpkin extracts obtained from hexane, petroleum ether was 
tested. Chloroform extracts were not tested because the zone of inhibition obtained was smaller 
than 12 mm diameter as specified in CLSI guidelines. All the hexane and petroleum extracts 
of walnut, cashew and pumpkin were able to significantly (Dunnett’s test = P < 0.05) inhibit 
growth of planktonic cells of the two tested bacterial strains. The MIC and MBIC values varied 
among the various extracts tested. The effects of the different extracts on cell growth in 96-
well microtiter plates was also dose dependent.  
All the active and weak extracts of walnut, pumpkin and cashew were further used to determine 
the MBIC of the various extracts against MRSA 252 and S. aureus ATCC 6538. Some of the 
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MBIC values were relatively higher than the MIC values of both MRSA 252 and S. aureus 
ATCC 6538. Biofilm formation of MRSA 252 and S. aureus ATCC 6538 were observed to be 
significantly inhibited slightly by the active hexane extracts of walnut and pumpkin oil. 
5.2.4.1 MICs and MBICs of hexane extract of African walnut against MRSA 252 and 
ATCC 6538 planktonic and biofilm growth 
The lowest concentration considered as the MIC values of hexane extract that completely 
inhibited the growth of both MRSA 252 and S. aureus ATCC 6538 planktonic cells was 125 
and 62.5 mg/mL since no turbidity was observed at these concentrations in the 96-well 
microtiter plates (Figure 51 A & C). This result showed that both strains were susceptible to 
African walnut hexane extract at high (125 mg/mL) and low (62.5 mg/mL) concentrations. The 
hexane extract exhibited concentration dependent concentrations. OD600 readings of the TSB 
culture medium for each strain decreased with increased extract concentration. This result 
suggests that hexane extract of African walnut possess high antibacterial activity on ATCC 
6538.   
The hexane extract of African walnut oil significantly (P>0.05) inhibited biofilm formation of 
MRSA 252 and S. aureus ATCC 6538 in microtiter plates at a concentration of 250 and 125 
mg/mL. The inhibitory activity of walnut hexane extract on MRSA 252 and ATCC 6538 was 
good compared to MBICs of other extracts indicating that hexane extract of walnut possesses 
strong antibacterial activity. The hexane extract appeared to be active on ATCC 6538 than 




Figure 51. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of hexane 
extract African walnut tested on S. aureus ATCC 6538 and MRSA 252 planktonic cells and biofilms formed 
after 24 hours of incubation at 37°C in 96-well tissue culture polystyrene plates 
Figure 51 shows (a) MRSA 252 planktonic growth inhibition by African walnut hexane extract 
(b) MRSA 252 biofilm formation inhibition by African walnut hexane extract (c) ATCC 6538 
planktonic growth inhibition by African walnut hexane extract and (d) ATCC 6538 biofilm 
formation inhibition by African walnut hexane extract. Data on the graphs represent the mean 
OD values (Mean ± SD) of three independent experiments (n=3) and the error bars indicate 
standard deviations of the means. For MIC, the OD of the planktonic growth cultures of MRSA 
252 and ATCC 6538 are shown, and MBIC, the absorbance of safranin stained cells attached 
to the surface of the 96-well plates after washing are showed for MRSA and ATCC 6538. 
Statistical analysis of the mean OD600 nm was performed using one-way ANOVA with 
Dunnett’s test. Asterisks (***) above the columns indicates significant difference of each 
column with walnut oil with the corresponding growth control group (p < 0.0001). No 
significant (ns) difference at P>0.05. Two controls were used: Media only without oil was used 
as negative blank and bacterial suspension with walnut extract was used as positive growth 
control to monitor the growth of MRSA 252 and S. aureus ATCC 6538. 
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5.2.4.2 MICs and MBICs of petroleum ether extract of African walnut against MRSA 252 
and ATCC 6538 planktonic and biofilm growth 
Petroleum ether extract of African walnut inhibited the planktonic growth of both MRSA 252 
and S. aureus ATCC 6538 at higher concentrations of 500 mg/mL and 125 mg/mL (Figure 52 
A & C). However, ATCC 6538 was more susceptible to petroleum ether extract at this 
concentration tested (Figure 52 C). Whereas, MRSA 252, inhibition at 500 mg/mL 
concentration is high and does not show that the strain was susceptible to petroleum ether 
extract. Compared to hexane extract, petroleum ether extract requires higher concentrations of 
500 mg/mL to successfully inhibit the growth of MRSA 252 planktonic cells. Based on the 
results, petroleum ether extract exhibited weak activity against ATCC 6538 and a much weaker 
effect on MRSA 252.  
On the other hand, petroleum ether extract of African walnut inhibited biofilm formation in 
MRSA 252 and S. aureus ATCC 6538 at very high concentrations of 500 and 250 mg/mL. On 
the basis of these results, hexane extract of walnut appeared more effective than the petroleum 




Figure 52. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of African 
walnut petroleum ether extract tested on S. aureus ATCC 6538 and MRSA 252 planktonic cells and biofilms 
formed after 24 hours of incubation at 37°C in 96-well tissue culture polystyrene plate 
Figure 52 shows (a) MRSA 252 planktonic growth inhibition by African walnut petroleum 
ether extract (b) MRSA 252 biofilm formation inhibition by African walnut petroleum ether 
extract (c) ATCC 6538 planktonic growth inhibition by African walnut petroleum ether extract 
and (d) ATCC 6538 biofilm formation inhibition by African walnut petroleum ether extract. 
Data on the graphs represent the mean OD values (Mean ± SD) of three independent 
experiments (n=3) and the error bars indicate standard deviations of the means. For MIC, the 
OD of the planktonic growth cultures of MRSA 252 and ATCC 6538 are shown, and MBIC, 
the absorbance of safranin stained cells attached to the surface of the 96-well plates after 
washing are showed for MRSA and ATCC 6538. Statistical analysis of the mean OD600 nm 
was performed using one-way ANOVA with Dunnett’s test. Asterisks (***) above the columns 
indicates significant difference of each column with walnut oil with the corresponding growth 
control group (p < 0.0001). No significant (ns) difference at P>0.05. Two controls were used: 
Media only without oil was used as negative blank and bacterial suspension with African 
walnut extract was used as positive growth control to monitor the growth of MRSA 252 and S. 
aureus ATCC 6538. 
5.2.4.3 MICs and MBICs of hexane extract of cashew against MRSA 252 and ATCC 6538 
planktonic and biofilm growth  
The MIC values of the tested cashew extracts against MRSA 252 and S. aureus ATCC 6538 
are shown in Figure 53 A & C. The hexane extract of cashew exhibited considerably high MIC 
values of 250 and 500mg/mL against MRSA 252 and S. aureus ATCC 6538 planktonic cells. 
Result showed that cashew extract possesses much weaker antibacterial activity and will 
require 250 and 500 mg/mL to completely inhibit planktonic growth of MRSA 252 and ATCC 
6538.  
Biofilm formation of MRSA 252 and S. aureus ATCC 6538 were inhibited at 500 mg/mL 
concentrations. The MBIC values for the hexane extract of cashew against MRSA 252 and S. 
aureus ATCC 6538 were considerably higher indicating that a higher concentration is required 




Figure 53. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of cashew 
hexane extract tested on S. aureus ATCC 6538 and MRSA 252 planktonic cells and biofilms formed after 
24 hours of incubation at 37°C in 96-well tissue culture polystyrene plate 
Figure 53 shows (a) MRSA 252 planktonic growth inhibition by hexane extract (b) MRSA 252 
biofilm formation inhibition by hexane (c) ATCC 6538 planktonic growth inhibition by hexane 
and (d) ATCC 6538 biofilm formation inhibition by hexane. Data on the graphs represent the 
mean OD values (Mean ± SD) of three independent experiments (n=3) and the error bars 
indicate standard deviations of the means. For MIC, the OD of the planktonic growth cultures 
of MRSA 252 and ATCC 6538 are shown, and MBIC, the absorbance of safranin stained cells 
attached to the surface of the 96-well plates after washing are showed for MRSA and ATCC 
6538. Statistical analysis of the mean OD600 nm was performed using one-way ANOVA with 
Dunnett’s test. Asterisks (***) above the columns indicates significant difference of each 
column with walnut oil with the corresponding growth control group (p < 0.0001). No 
significant (ns) difference at P>0.05. Two controls were used: Media only without oil was used 
as negative blank and bacterial suspension with cashew extract was used as positive growth 
control to monitor the growth of MRSA 252 and S. aureus ATCC 6538. 
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5.2.4.4 MICs and MBICs of petroleum ether extract of cashew against MRSA 252 and 
ATCC 6538 planktonic and biofilm growth 
In the case of petroleum ether extract, the MIC value of the tested extract against MRSA 252 
and S. aureus ATCC 6538 are shown in Figure 54 A & C.  Petroleum ether extract of cashew 
failed to inhibit the growth of MRSA 252 and ATCC 6538 planktonic cells even at the highest 
concentration of 500 mg/ml of cashew extract tested. This therefore indicates that more than 
500 mg/mL of the extract is required to significantly inhibit the growth of both MRSA 252 and 
ATCC 6538 respectively.  
Similarly, the antibacterial activity of petroleum ether extract from cashew nut could not inhibit 
biofilm formation in MRSA 252 and S. aureus ATCC 6538 even at a higher concentration. A 
higher concentration of the extract >500 mg/ml is needed to inhibit biofilm formation of MRSA 
252 and ATCC 6538 in biofilms. The result indicates that cashew extracts possessed weak 
antibacterial activity (Figure 54 B & D). 
Based on the results, both the hexane and petroleum extracts of cashew appeared very weak to 
inhibit the growth of MRSA 252 and S. aureus ATCC 6538 planktonic cells. Compared to 




Figure 54. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of cashew 
petroleum ether extract tested on S. aureus ATCC 6538 and MRSA 252 planktonic cells and biofilms 
formed after 24 hours of incubation at 37°C in 96-well microtiter polystyrene plate 
Figure 54 shows (a) MRSA 252 planktonic growth inhibition by cashew petroleum ether 
extract (b) MRSA 252 biofilm formation inhibition by cashew petroleum ether extract (c) 
ATCC 6538 planktonic growth inhibition by cashew petroleum ether extract and (d) ATCC 
6538 biofilm formation inhibition by cashew petroleum ether extract. Data on the graphs 
represent the mean OD values (Mean ± SD) of three independent experiments (n=3) and the 
error bars indicate standard deviations of the means. For MIC, the OD of the planktonic growth 
cultures of MRSA 252 and ATCC 6538 are shown, and MBIC, the absorbance of safranin 
stained cells attached to the surface of the 96-well plates after washing are showed for MRSA 
and ATCC 6538. Statistical analysis of the mean OD600 nm was performed using one-way 
ANOVA with Dunnett’s test. Asterisks (***) above the columns indicates significant 
difference of each column with walnut oil with the corresponding growth control group (p < 
0.0001). No significant (ns) difference at P>0.05. Two controls were used: Media only without 
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oil was used as negative blank and bacterial suspension with cashew extract was used as 
positive growth control to monitor the growth of MRSA 252 and S. aureus ATCC 6538. 
5.2.4.5 MICs and MBICs of hexane extract of fluted pumpkin against MRSA 252 and 
ATCC 6538 planktonic and biofilm growth 
 
The MIC values of the tested fluted pumpkin seed extracts against MRSA 252 and S. aureus 
ATCC 6538 are shown in Figure 55 A & C. Hexane extract of pumpkin inhibited planktonic 
growth of MRSA 252 and S. aureus ATCC 6538 at a concentration of 250 and 62.5 mg/mL. 
From the result, ATCC 6538 planktonic appears to very susceptible to hexane extract than 
MRSA 252 planktonic cells. MRSA 252 planktonic cell was weakly susceptible. The result 
obtained showed that hexane extract had high antibacterial activity on the growth of ATCC 
6538 planktonic cells alone. 
The MBIC value of fluted pumpkin hexane on MRSA 252 and S. aureus ATCC 6538 was 500 
and 125 mg/mL. MRSA 252 and ATCC 6538 were inhibited at higher concentrations of 
pumpkin extract suggesting that a higher concentration of the hexane extract is needed to 




Figure 55. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of pumpkin 
hexane extract tested on S. aureus ATCC 6538 and MRSA 252 planktonic cells and biofilms formed after 
24 hours of incubation at 37°C in 96-well tissue culture polystyrene plate 
Figure 55 shows (a) MRSA 252 planktonic growth inhibition by pumpkin hexane extract (b) 
MRSA 252 biofilm formation inhibition by pumpkin hexane extract (c) ATCC 6538 planktonic 
growth inhibition by pumpkin hexane extract and (d) ATCC 6538 biofilm formation inhibition 
by pumpkin hexane extract. Data on the graphs represent the mean OD values (Mean ± SD) of 
three independent experiments (n=3) and the error bars indicate standard deviations of the 
means. For MIC, the OD of the planktonic growth cultures of MRSA 252 and ATCC 6538 are 
shown, and MBIC, the absorbance of safranin stained cells attached to the surface of the 96-
well plates after washing are showed for MRSA and ATCC 6538. Statistical analysis of the 
mean OD600 nm was performed using one-way ANOVA with Dunnett’s test. Asterisks (***) 
above the columns indicates significant difference of each column with walnut oil with the 
corresponding growth control group (p < 0.0001). No significant (ns) difference at P>0.05. 
Two controls were used: Media only without oil was used as negative blank and bacterial 
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suspension with pumpkin extract was used as positive growth control to monitor the growth of 
MRSA 252 and S. aureus ATCC 6538.   
5.2.4.6 MICs and MBICs of petroleum ether extract of fluted pumpkin against MRSA 
252 and ATCC 6538 planktonic and biofilm growth 
For petroleum ether extract, MIC value of the tested extract against MRSA 252 and S. aureus 
ATCC 6538 are shown in Figure 56 A & C. MIC value for MRSA 252 and S. aureus ATCC 
6538 was 250 and 500 mg/mL. This result indicates that the extract possesses weak 
antibacterial activity against the staphylococcus strains. The MBIC of petroleum ether extract 
was 500 mg/mL for both MRSA 252 and ATCC 6538. However, the hexane extract still 
appears more effective than the petroleum ether 56 B & D.  
A critical examination of the activity of hexane extract and petroleum ether extracts of pumpkin 
seed showed that only the hexane extract of walnut oil possessed higher antibacterial activity 









Figure 56. Minimum inhibitory concentration and minimum biofilm inhibitory concentration of pumpkin 
petroleum ether tested on S. aureus ATCC 6538 and MRSA 252 planktonic cells and biofilms formed after 
24 hours of incubation at 37°C in 96-well tissue culture polystyrene plate 
Figure 56 shows (a) MRSA 252 planktonic growth inhibition by pumpkin ether extract (b) 
MRSA 252 biofilm formation inhibition by pumpkin petroleum ether extract (c) ATCC 6538 
planktonic growth inhibition by pumpkin petroleum ether extract and (d) ATCC 6538 biofilm 
formation inhibition by pumpkin petroleum ether extract. Data on the graphs represent the 
mean OD values (Mean ± SD) of three independent experiments (n=3) and the error bars 
indicate standard deviations of the means. For MIC, the OD of the planktonic growth cultures 
of MRSA 252 and ATCC 6538 are shown, and MBIC, the absorbance of safranin stained cells 
attached to the surface of the 96-well plates after washing are showed for MRSA and ATCC 
6538. Statistical analysis of the mean OD600 nm was performed using one-way ANOVA with 
Dunnett’s test. Asterisks (***) above the columns indicates significant difference of each 
column with walnut oil with the corresponding growth control group (p < 0.0001). No 
significant (ns) difference at P>0.05. Two controls were used: Media only without oil was used 
as negative blank and bacterial suspension with pumpkin extract was used as positive growth 
control to monitor the growth of MRSA 252 and S. aureus ATCC 6538. 
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5.2.5 Minimum biofilm eradication concentration of African walnut, cashew fluted 
pumpkin oils against MRSA 252 and S. aureus ATCC 6538 biofilms 
Biofilm eradication activities of the oils were determined using the minimum biofilm 
eradication concentration high throughput (MBEC™-HTP) procedure which is in two main 
stages. (i) Determination of biofilm growth on MBEC™-HTP pegs and (ii) recovery of biofilm 
cells after a challenge with antibacterial agents at different concentrations. The results are 
presented below. To effectively quantify the eradication effect of the different oil sample, the 
minimum biofilm eradication concentration (MBEC) assay was used to determine the total 
number of viable cells in the treated versus non-treated MRSA 252 and S. aureus ATCC 6538 
biofilms. In doing this assay, firstly biofilm growth check of MBEC™-HTP pegs cultured 
differently with aliquots of 100 μL (108 CFU/mL) of MRSA 252 and S. aureus ATCC 6538 
incubated for 48 h at 37 oC was first performed. The 48 h biofilms formed by each bacterium 
on the MBEC peg was regarded as their respective preformed biofilms. Viable bacteria count 
of the MBEC™-HTP pegs was also regarded as the mean cell density of each bacterium. 
Biofilm growth check of the MBEC™-HTP pegs was necessary to have an idea of the total 
biofilm viable count of each bacteria per well. Secondly, each individual well having pegs with 
biofilms was then challenged with different concentrations of African walnut, cashew and 
pumpkin oils in the range of 0.98 - 500 mg/mL and recovered with fresh 100 μL of TSB broth 
placed in wells of new 96-well microtiter plate. After challenging each well with oil 
concentrations in the range of 0.98 - 500 mg/mL, recovery of MRSA 252 and ATCC 6538 
biofilm cells were determined by total viable count using the spread plate method for direct 
spot counting. The reduction in total viable count after treatment is reported in log10 CFU/mL. 
(i) Biofilm growth check on MBEC pegs 
Biofilms of MRSA 252 and S. aureus ATCC 6538 were grown to an overall mean density of 
8.37 ± 0.49 and 8.33 ± 0.30 log10 cfu peg
-1 (respectively) in trypic soy broth medium enriched 
with glucose (Figure 57 and 58). This growth was for 48 h of incubation at 37°C. Mean and 
standard deviation calculations for cell densities were based on pooled data from three to four 
growth experiments performed with control. The mean viable cell counts and standard 
deviation (SD) for S. aureus ATCC 6538 and MRSA 252 on the pegs of A1-H1 row of the 
MBEC™-HTP assay are presented in (Figure 57 and 58). The cell density of biofilms grown 
on the different rows of pegs in the MBEC™-HTP assay were not statistically significant (p = 
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0.1914 for MRSA 252; p = 0.7332 for ATCC 6538. Both strains also formed statistically 
equivalent biofilms across the different rows of pegs (A-H) in the microtiter plates. 
                     
Figure 57. Preformed biofilms of ATCC 6538 on MBEC pegs. 
                                          
                      
Figure 58. Preformed biofilms of MRSA 252 on MBEC pegs. 
  
Figure 57 and 58 shows mean cell density of ATCC 6538 and MRSA 252 biofilms on the pegs 
in different rows of the MBEC assay after 48 hours of incubation. Each value is expressed as 
the mean and standard deviation of 3 to 4 trials. There is no significant difference between cell 
density of biofilms in the different rows (p = 0.6709 using one-way ANOVA, the Bonferonni’s 
multiple comparison test to compare all means). Mean cell density of ATCC 6538 on the pegs 
in different rows of the MBEC assay. Each value is expressed as the mean and standard 
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deviation of 3 to 4 trials. There is no significant difference between cell density of biofilms in 
the different rows (p = and 0.7332 using one-way ANOVA). Based on the p-values obtained, 
the biofilm cell density of MRSA 252 and ATCC 6538 were significant different. 
(ii) Eradication activity of African walnut oil against MRSA 252 and ATCC 6538. 
In order to effectively determine whether African walnut oil, cashew oil and pumpkin oil could 
also act as bactericidal agents in biofilms using the MBEC™-HTP plate, the colony forming 
unit (CFU) reduction was monitored in MRSA 252 and S. aureus ATCC 6538 48 h preformed 
biofilms with initial count of 8.37 log10 CFU/mL and 8.33 log10 CFU/mL per peg of bacteria 
treated with different concentrations of African walnut, cashew and pumpkin oil respectively 
for 48 h. MBEC was used to evaluate the ability of African walnut, cashew and pumpkin oils 
to disrupt/eradicate preformed biofilm of MRSA 252 and S. aureus ATCC 6538. The bacterial 
count of biofilm cells of MRSA 252 and ATCC 6538 at 6, 12, 24 and 48 h in recovery media 
after challenging the cells on the pegs with different concentrations of African walnut, cashew 
and pumpkin oils (0.98 -500 mg/mL) was calculated and the results are expressed as Log10 
cfu/mL (log reduction) of the treated versus non-treated bacterial sample. The results are 
reported as log reductions to know whether the oils are effective in reducing the pathogens 
tested. The greater the log reduction value, the more effective the oil is at killing the bacterial 
strains. Results are presented in table 25. 
 
Table 25. MRSA 252 and S. aureus ATCC 6538 counts in 12 h, 24 h and 48 h-biofilms, in 
growth recovery media expressed as log10 cfu/mL, after exposure to different 





Viable cell count reduction in 6 h, 12, 24 and 48 h biofilms of MRSA 252 and ATCC 6538 after exposure to 
African walnut oil. Results are expressed as log10 cfu/mL 
 
 MRSA 252 S. aureus ATCC 6538 
 6 h 12 h 24 h 48 h 6 h 12 h 24 h 48 h 
Growth 
control 
8.37 ± 0.49 8.44 ± 0.42 8.60 ± 0.53 8.64 ± 0.60 8.33 ± 0.30 8.43 ± 0.64 8.46 ± 0.59 8.53± 0.48 
0.98 8.29 ± 0.56 6.59 ± 0.71 5.34 ± 0.41 3.34 ± 0.41 8.43 ± 0.43 8.16 ± 0.54 5.34 ± 0.41 3.78 ± 0.86 
1.95 7.60 ± 0.78 5.99 ± 1.09 4.66 ± 1.16 2.99 ± 0.58 7.88± 0.70 7.82 ± 0.78 4.66 ± 1.29 3.33 ± 0.88 
3.9 7.21 ± 0.81 6.02 ± 1.44 4.02 ± 0.72 1.85 ± 0.52 7.28 ± 0.96 6.68 ± 0.58 3.85 ± 0.51 2.52 ± 0.51 
7.8 6.95 ± 0.33 5.43 ± 1.21 3.43 ± 1.21 1.69 ± 0.56 7.72 ± 0.80 5.94 ± 0.65 4.36 ± 0.59 2.03 ± 0.97 
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15.6 4.88 ± 1.00 3.63 ± 0.59 3.13 ± 0.71 1.54 ± 0.14 4.88 ± 0.94 4.35 ± 0.87 3.21 ± 0.66 1.52 ± 0.94 
31.5 3.66 ± 1.52 3.16 ± 0.92 2.25 ± 0.16 0.27 ± 0.08 4.32 ± 0.57 2.83 ± 0.60 1.37 ± 0.89 1.01± 0.58 
62.5 3.21 ± 0.97 2.21 ± 0.58 1.89 ± 0.42 0.29 ± 0.13 3.21 ± 0.59 2.21 ± 0.58 No counts No counts 
125 2.48 ± 0.95 1.77 ± 0.89 No counts No counts 2.55 ± 0.49 1.76± 0.56 No counts No counts 
250 2.07 ± 0.48 1.41 ± 0.48 No counts No counts 1.51 ± 0.58 1.41 ± 0.55 No counts No counts 
500 1.70 ± 0.43 1.24 ± 0.51 No counts No counts 1.50 ± 0.46 1.24 ± 0.65 No count No counts 
20 mg/mL 
Oxacillin 
0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 
 
Table 25. Shows the viable count of recovery cells in the recovery medium after 6 h, 12 h, 24 
h and 48 h incubation periods. Results at different growth time points shows log reduction of 
viable counts of MRSA 252 and ATCC 6538 biofilms after treatment with African walnut oil.    
 
 
Figure 59. Reduction of MRSA 252 preformed biofilm on pegs following exposure to increasing 




Figure 59 shows the bactericidal effect of African walnut oil on MRSA 252 preformed 
biofilms. In addition, data on the graph shows the log of the mean CFU/peg after 6, 12, 24 and 
48 h incubation of the TSB recovery medium at 37oC.  The control in this experiment CFU/peg 
obtained for the untreated peg after the total 48 h incubation period and biofilm growth check 
with 8.37 log10 CFU/mL per/peg served as the reference (growth control) for treatment 
efficacy. Data were obtained from three independent experiments (n=3). Significant 
differences in comparison to the untreated controls (growth control) and the negative control 
oxacillin 20 mg/mL were performed. Statistical analysis was performed using one-way 
ANOVA: ***, P<0.0001 with Bonferroni’s post-tests. Both the positive and negative controls 




Figure 60. Reduction of S. aureus ATCC 6538 preformed biofilm on pegs following exposure to increasing 
concentrations of African walnut oil at 0.98-500 mg/mL after 6, 12, 24 and 48 h of incubation at 37oC. 
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Figure 60 shows the bactericidal effect of African walnut oil on S. aureus ATCC 6538 
preformed biofilms. In addition, data on the graph shows the log of the mean CFU/peg after 6, 
12, 24 and 48 h incubation of the TSB recovery medium at 37oC. The control in this experiment 
CFU/peg obtained for the untreated peg after the total 48 h incubation period and biofilm 
growth check with 8.33 log10 CFU/mL per/peg served as the reference (growth control) for 
treatment efficacy. Data were obtained from three independent experiments (n=3). Significant 
differences in comparison to the untreated controls (growth control) and the negative control 
oxacillin 20 mg/mL were performed. Statistical analysis was performed using one-way 
ANOVA: ***, P<0.0001 with Bonferroni’s post-tests. Both the positive and negative controls 
were included in the experiment to monitor the recovery of the bacterial isolate in biofilm. 
From the MBEC result of MRSA 252 and ATCC 6538, the challenge of MRSA 252 and S. 
aureus ATCC 6538 with African walnut oil resulted in significant decrease of viable biofilm 
cells in recovery medium at 6 h, 12 h, 24 h and 48 h (Figure 59 - 60). Bacterial counts in both 
MRSA 252 and ATCC 6538 biofilms started to decrease drastically in viable count after 
exposure to 15.6 mg/mL of African walnut oil for 6 h. (Figure 59 – 60). However, despite the 
decrease at this concentration, at 24 and 48 h a better reduction in viable count was observed 
at 62.5 mg/mL and 31.25 mg/mL concentration of MRSA 252 and ATCC 6538 biofilm. MBEC 
was considered the lowest oil concentration able to prevent a recovery of microbial growth. 
Using this definition, it could be seen that the MBEC of African walnut oil was 62.5 mg/mL 
and 31.25 mg/mL concentration active against MRSA 252 causing approximately 5 log 
reductions and ATCC 6538 causing >7 log reduction after 24 and 48h. Therefore, African 
walnut oil was considered highly effective because it was able to eradicate staphylococcal 
strains progressively starting from 6, 12, 24 and 48 hours at low concentration as seen on the 
graph. 
(iii) Eradication activity of Cashew oil against MRSA 252 and ATCC 6538 
Cashew oil was considered weakly effective because it was weak in eradicating MRSA 252 
and ATCC 6538 biofilm cells progressively from 6, 12, 24 and 48 hours at the different 
concentrations tested. Cashew oil exhibited similar eradication activity against MRSA 252 and 
ATCC 6538 at 500 mg/mL concentration for MRSA 252 and ATCC 6538 respectively. 
Bacterial counts of MRSA 252 and ATCC 6538 biofilm cells started to decrease significantly 
(p < 0.0001) immediately after exposure to 31.25 mg/mL of walnut oil for 6 h. The data on the 
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graphs and table 26 shows a time and concentration-dependent decrease of bacterial counts 
recorded as log reduction. (MBEC).  
Table 26. MRSA 252 and S. aureus ATCC 6538 counts in 12 h, 24 h and 48 h-biofilms, in 
growth recovery media expressed as log10 cfu/mL, after exposure to different 




Viable cell count reduction in 6 h, 12, 24 and 48 h biofilms of MRSA 252 and ATCC 6538 after exposure to 
cashew oil. Results expressed as log10 cfu/mL. 
 MRSA 252 S. aureus ATCC 6538 
 6 h 12 h 24 h 48 h 6 h 12 h 24 h 48 h 
Growth 
control 
8.37 ± 0.49 8.64 ± 0.40 8.64 ± 0.56 8.66 ± 0.56 8.33 ± 0.30 8.33 ± 1.07 8.34 ± 0.62 8.39 ± 0.87 
0.98 8.15 ± 0.69 7.16 ± 0.54 6.42 ± 0.93 4.18 ± 0.80 7.52 ± 0.91 7.16 ± 0.54 6.15 ± 0.51 4.99 ± 0.69 
1.95 7.69 ± 0.68 6.59 ± 1.10 5.17 ± 0.19 3.26 ± 1.18 7.39 ± 0.93 6.60 ± 1.09 5.67 ± 0.47 4.81 ± 1.29 
3.9 7.39 ± 0.78 5.68 ± 1.26 4.81 ± 0.47 3.68 ± 0.87 6.69 ± 1.32 5.68 ± 1.26 4.48 ± 0.55 3.81 ± 0.62 
7.8 7.08 ± 0.47 5.37 ± 1.14 5.17 ± 0.97 3.00 ± 0.58 6.16 ± 1.26 5.37 ± 1.14 4.43 ± 0.52 3.10 ± 1.1 
15.6 6.28 ± 0.61 4.97 ± 0.96 4.37 ± 0.61 2.61 ± 1.00 6.03 ± 0.73 4.97 ± 0.96 4.44 ± 0.67 2.66± 0.90 
31.5 5.09 ± 0.18 3.93 ± 1.00 3.00 ± 0.87 .36 ± 1.26 4.88 ± 1.00 3.93 ± 1.00 2.89 ± 0.17 2.44 ± 0.68 
62.5 4.91 ± 0.97 3.54 ± 1.16 2.38 ± 0.78 2.65 ± 0.74 4.79 ± 1.0 3.54 ± 1.16 2.54 ± 0.65 1.27 ± 0.68 
125 3.27 ± 0.57 2.13 ± 0.51 1.58 ± 0.59 1.12 ± 0.89 4.42 ± 0.75 3.13 ± 0.51 2.15 ± 0.63 1.15 ± 0.68 
250 2.34 ± 0.51 1.40± 0.36 1.37 ± 0.39 1.31 ± 1.06 4.37 ± 0.71 1.57 ± 1.08 1.06 ± 0.52 1.15 ± 0.68 
500 1.70 ± 0.16 1.41 ± 0.56 1.03 ± 0.13 No 
colonies 







0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 
 
Table 26 shows the viable count of recovery cells in the recovery medium after 6 h, 12 h, 24 h 
and 48 h incubation periods. Results at different growth time points shows log reduction of 




Figure 61. Reduction of MRSA 252 preformed biofilm on pegs following exposure to increasing 
concentrations of cashew oil at 0.98-500 mg/mL after 6, 12, 24 and 48 h of incubation at 37oC. 
Figure 61 shows the bactericidal effect of cashew oil on MRSA 252 preformed biofilms. In 
addition, data on the graph shows the log of the mean CFU/peg after 6, 12, 24 and 48 h 
incubation of the TSB recovery medium at 37oC. The control in this experiment CFU/peg 
obtained for the untreated peg after the total 48 h incubation period and biofilm growth check 
with 8.37 log10 CFU/mL per/peg served as the reference (growth control) for treatment 
efficacy. Data were obtained from three independent experiments (n=3). Significant 
differences in comparison to the untreated controls (growth control) and the negative control 
oxacillin 20 mg/mL were performed. Statistical analysis was performed using one-way 
ANOVA: ***, P<0.0001 with Bonferroni’s post-tests. Both the positive and negative controls 




 Figure 62. Reduction of S. aureus ATCC 6538 preformed biofilm on pegs following exposure to increasing 
concentrations of cashew oil at 0.98-500 mg/mL after 6, 12, 24 and 48 h of incubation at 37oC. 
Figure 62 shows the bactericidal effect of cashew oil on ATCC 6538 preformed biofilms. In 
addition, data on the graph shows the log of the mean CFU/peg after 6, 12, 24 and 48 h 
incubation of the TSB recovery medium at 37oC. The control in this experiment CFU/peg 
obtained for the untreated peg after the total 48 h incubation period and biofilm growth check 
with 8.33 log10 CFU/mL per/peg served as the reference (growth control) for treatment 
efficacy. Data were obtained from three independent experiments (n=3). Significant 
differences in comparison to the untreated controls (growth control) and the negative control 
oxacillin 20 mg/mL were performed. Statistical analysis was performed using one-way 
ANOVA: ***, P<0.0001 with Bonferroni’s post-tests. Both the positive and negative controls 
were included in the experiment to monitor the recovery of the bacterial isolate in biofilm. 
From the MBEC result of MRSA 252 and ATCC 6538, the challenge of MRSA 252 and S. 
aureus ATCC 6538 with cashew oil resulted in minimal significant decrease of viable biofilm 
cells in recovery medium at 6 h, 12 h, 24 h and 48 h (Figure 61-62). However, bacterial counts 
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in MRSA 252 and ATCC 6538 biofilms started to decrease drastically in viable count after 
exposure to 31.25 mg/mL of cashew oil after 6 h. Despite the decrease at this concentration, 
better reduction in viable count was observed at 24 and 48 h with 500 mg/mL concentration. 
These concentrations led to MRSA 252 and ATCC 6538 causing approximately >7 log 
reduction after 6, 12, 24 and 48 h. Therefore, cashew oil was considered weakly effective 
because its MBEC concentration was high and will require much concentration of cashew oil 
to eradicate the strains. In addition, based on the data on the graph, MBEC activity of cashew 
oil was seen to be concentration dependent and time dependent. 
(iii) Eradication activity of fluted pumpkin oil on MRSA 252 and ATCC 6538 
Fluted pumpkin oil was considered slightly effective because it could effectively eradicate 
MRSA 252 and ATCC 6538 biofilms progressively from 6, 12, 24 and 48 h at the different 
concentrations tested. The MBEC of pumpkin oil was 250 mg/mL and 125 mg/mL for MRSA 
252 and ATCC 6538 respectively. Bacterial counts in MRSA 252 and ATCC 6538 biofilms 
started to decrease significantly (p < 0.0001) immediately after exposure to 125 mg/mL of 
pumpkin oil after 6 h. (Figure 63 and 64). The data on the graphs below also showed a time 
and concentration-dependent decrease of bacterial counts recorded as log reduction (MBEC). 
The challenge of MRSA 252 with pumpkin oil resulted in significant reduction of viable 
bacterial cells in recovery medium after 6 h, 12 h, 24 h and 48 h. 
 
Table 27. MRSA 252 and S. aureus ATCC 6538 counts in 12 h, 24 h and 48 h-biofilms, in 
growth recovery media expressed as log10 CFU/mL, after exposure to different 





Viable cell count reduction in 6 h, 12, 24 and 48 h biofilms of MRSA 252 and ATCC 6538 after exposure to 
pumpkin oil. Results expressed as log10 CFU/mL 
 MRSA 252 S. aureus ATCC 6538 
 6 h 12 h 24 h 48 h 6 h 12 h 24 h 48 h 
Growth 
control 
8.37 ± 0.49 8.37 ± 0.49 8.60 ± 0.53 8.64 ± 0.55 8.33 ± 0.30 8.34 ± 0.65 8.46 ± 0.62 8.53 ± 0.48 
0.98 7.15 ± 1.23 7.03 ± 0.23 5.92 ± 0.89 3.57 ± 1.02 7.65 ± 0.10 6.75 ± 0.38 5.25 ± 0.45 3.57 ± 1.00 
1.95 6.99± 0.34 6.99± 0.34 5.23 ± 1.02 3.33 ± 0.56 7.26 ± 1.30 5.98 ± 0.62 4.92 ± 0.32 2.66 ± 0.52 
3.9 7.32 ± 0.78 5.69 ± 0.98 5.05 ± 0.43 3.21 ± 0.41 7.10 ± 1.49 5.36 ± 0.98 4.72 ± 0.56 2.21 ± 0.56 




Table 27 shows the viable count of recovery cells in the recovery medium after 6 h, 12 h, 24 h 
and 48 h incubation periods. Results at different growth time points shows log reduction of 
viable counts of MRSA 252 and ATCC 6538 biofilms after treatment with pumpkin oil. 
 
             
 
Figure 63. Reduction of MRSA 252 preformed biofilm on pegs following exposure to increasing 
concentrations of fluted pumpkin oil at 0.98-500 mg/mL after 6, 12, 24 and 48 h of incubation at 37oC. 
15.6 6.30 ± 0.49 4.91 ± 0.31 3.31 ± 0.30 2.68 ± 0.59 6.57 ± 0.97 4.91± 0.32 2.64 ± 0.57 2.00 ± 0.48 
31.5 6.47 ± 0.83 3.84 ± 1.03 2.36± 0.62 2.05 ± 0.17 6.32 ± 0.57 3.84 ± 1.03 1.16 ± 0.25 1.05 ± 0.17 
62.5 5.92 ± 1.03 3.92 ± 0.49 1.92 ± 0.58 2.21± 0.40 5.97 ± 1.00 3.92 ± 1.07 1.12 ± 0.32 1.04 ± 0.34 
125 5.58 ± 1.51 2.23 ± 1.04 1.50 ± 0.58 1.19 ± 0.34 2.58 ± 0.30 1.58 ± 0.43 1.00 ± 0.21 No colonies 
250 4.21 ± 0.68 1.88 ± 0.78 1.48 ± 0.56 1.01 ± 0.38 2.34 ± 0.50 1.50 ± 0.45 No colonies No colonies 




0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 0.91 ± 0.16 
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Figure 63 shows the bactericidal effect of fluted pumpkin oil on MRSA 252 preformed 
biofilms. In addition, data on the graph shows the log of the mean CFU/peg after 6, 12, 24 and 
48 h incubation of the TSB recovery medium at 37oC.  The control in this experiment CFU/peg 
obtained for the untreated peg after the total 48 h incubation period and biofilm growth check 
with 8.37 log10 CFU/mL per/peg served as the reference (growth control) for treatment 
efficacy. Data were obtained from three independent experiments (n=3). Significant 
differences in comparison to the untreated controls (0 mg/mL-growth control) and the negative 
control oxacillin 20 mg/mL were performed. Statistical analysis was performed using one-way 
ANOVA: ***, P<0.0001 with Bonferroni’s post-tests. Both the positive and negative controls 
were included in the experiment to monitor the recovery of the bacterial isolate in biofilm. 
 
                  
 
Figure 64. Reduction of ATCC 6538 preformed biofilm on pegs following exposure to increasing 
concentrations of fluted pumpkin oil at 0.98-500 mg/mL after 6, 12, 24 and 48 h of incubation at 37oC. 
Figure 64 shows the bactericidal effect of fluted pumpkin oil on ATCC 6538 preformed 
biofilms. In addition, data on the graph shows the log of the mean CFU/peg after 6, 12, 24 and 
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48 h incubation of the TSB recovery medium at 37oC.  The control in this experiment CFU/peg 
obtained for the untreated peg after the total 48 h incubation period and biofilm growth check 
with 8.33 log10 CFU/mL per/peg served as the reference (growth control) for treatment 
efficacy. Data were obtained from three independent experiments (n=3). Significant 
differences in comparison to the untreated controls (growth control) and the negative control 
oxacillin 20 mg/mL were performed. Statistical analysis was performed using one-way 
ANOVA: ***, P<0.0001 with Bonferroni’s post-tests. Both the positive and negative controls 
were included in the experiment to monitor the recovery of the bacterial isolate in biofilm. 
In summary, the MBEC results of MRSA 252 and ATCC 6538 showed that the challenge of 
MRSA 252 and S. aureus ATCC 6538 with fluted pumpkin oil resulted in significant decrease 
of viable biofilm cells in recovery medium at 6 h, 12 h, 24 h and 48 h (Figure 63 - 64). Bacterial 
counts in both MRSA 252 and ATCC 6538 biofilms started to decrease drastically in viable 
count after exposure to 15.6 mg/mL pumpkin oil for 6 h. However, despite the reduction at this 
concentration, at 24 and 48 h a better reduction in viable count was observed although a higher 
concentration at 250 mg/mL and 125 mg/ml for MRSA 252 and ATCC 6538 respectively. 
MBEC was considered the lowest oil concentration able to prevent a recovery of microbial 
growth after antimicrobial exposure. Using this definition, it could be seen that pumpkin oil 
was active at 125 mg/mL and 250 mg/mL concentration against ATCC 6538 and MRSA 252 
causing approximately 5 log reduction and >7 log reduction after 24 and 48h. Therefore, fluted 
pumpkin oil was considered effective at 125 mg/mL against ATCC 6538 and less active at 250 













In this study, different oils of African walnut, cashew and pumpkin showed significant 
antibacterial activity against methicillin resistant and susceptible S. aureus as assessed by the 
diameter of zone of inhibition of the oils. In addition, a few of the respective extracts of walnut, 
cashew and pumpkin also showed significant antibacterial activity. Although the low values 
recorded for some plant oils and extract may be attributed to fact that the oils and extracts in 
crude forms contain very little quantity of bioactive components. At the same time, many 
workers have reported their findings on bioactivity of crude extracts of plants with such range 
of diameter of zones obtained (El-Bashiti et al., 2017). Although leaves, flowers, roots and 
shoot extracts of African walnut (Tetracarpidium conophorum), fluted pumpkin Telfairia 
occidentalis) and cashew (Anacardium occidentale) has been widely studies for their 
antimicrobial activity but the antimicrobial potential of the oils of these plants has not been 
extensively explored. The oils of African walnut in general showed a high inhibitory activity 
against MRSA 252 and ATCC 6538 in a zone of clearance (disc diffusion assay) indicating 
that they are bactericidal towards MRSA 252 and ATCC 6538. In this study, disc diffusion 
data presented in this study showed that African walnut, cashew and pumpkin oils exhibited 
antibacterial activity against MRSA 252 and S. aureus ATCC 6538 with African walnut oil at 
a concentration of 1000 mg/mL (10 μL/disc) exhibiting stronger activity compared to cashew 
and pumpkin oils. Using the Kirby baurer (Disc diffusion) test the oils of African walnut, 
cashew and pumpkin used in this study produced activity against MRSA 252 and ATCC 6538 
with different diameter of zones. All the tested bacteria were sensitive to the three oils. From 
the results African walnut oil, had larger zone (23.04 ± 0.21 mm), pumpkin oil had large zone 
(15.33 ± 0.21 mm) and cashew had moderately sized zones (13.01 ± 0.21 mm) against MRSA 
252. Similarly, African walnut oil had large zones (19.00 ± 0.22), pumpkin had large zones 
(17.04± 0.22 mm) and cashew had relatively sized zones (13.50 ± 0.22 mm) against ATCC 
6538. Results obtained in this study are similar with the findings of Rathi et al., (2014) who 
tested antimicrobial activity of black walnut oil. The dried chopped nut was extracted using the 
cold press method. The oil was tested using the agar well diffusion method against both the 
gram negative (Klebsiella pneumonia, Pseudomonas aeruginosa, Escherichia coli, Proteus 
vulgaris), gram positive (Bacillus subtilis, S. aureus) for its antimicrobial activity. The authors 
found that walnut oil showed antimicrobial activity against all the pathogens tested. S. aureus 
(31 mm), Bacillus subtilis 11 mm, Klebsiella pneumonia (24 mm), Pseudomonas aeruginosa 
(22 mm) and Proteus vulgaris (12 mm). But the result indicated that black walnut oil produced 
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larger zone against S. aureus compared to other strain. Therefore, the result showed that black 
walnut oil had the potential to cure bacterial infections caused by the pathogenic strains. In 
addition, results obtained for pumpkin oil was similar to those of Adeel et al., (2014) who 
reported that pumpkin seed oil exhibited strong antibacterial activity against S. aureus. The 
activity of pumpkin seed oil showed an average diameter of 17.03 mm. Similarly, pumpkin oil 
result was in line with those of Chonoko and Rufai, (2011) who found that pumpkin oil 
exhibited strong antibacterial activity against S. aureus (15.2 mm). In summary, the three oils 
tested had antibacterial effect against MRSA 252 and ATCC 6538 with significant difference 
in contrast to control. However walnut, pumpkin and cashew oil showed significant (P < 
0.0001) antimicrobial activity against MRSA 252 and ATCC 6538 compared to cashew oil. 
All diameter of zones measured in this study were based on CLSI, (2013) guidelines.  
Furthermore, the findings in this study indicated that African walnut, cashew and pumpkin 
extracts exhibited antibacterial activities against S. aureus at the concentration of 1000 mg/mL 
(20 μL/well). The antibacterial activity of extracts of African walnut, cashew and pumpkin 
obtained from solvent extraction with hexane, petroleum ether and chloroform were evaluated 
against MRSA 252 and ATCC 6538 using agar disc diffusion and agar well diffusion test. 
MRSA 252 and ATCC 6538 tested were sensitive to hexane and petroleum ether extracts only. 
Hexane extract of African walnut had 16 mm and 20 mm clear zones of diameter against MRSA 
252 and ATCC 6538. Petroleum ether extract had 14 mm and 18 mm diameters of zones while 
chloroform did not produce zones against ATCC 6538 and less than 10 mm against MRSA 
252. In addition, extracts of pumpkin showed activity against MRSA 252 producing clear zones 
of 12 mm, 14 mm and 9 mm for petroleum ether, hexane and chloroform extracts. Whereas 
against ATCC 6538, petroleum ether, hexane and chloroform extracts produced 7 mm, 12 mm 
and 9 mm were produced. Results obtained in this study were in accordance with those obtained 
in previous studies. For example, Ukpai Grace et al., (2016) tested antimicrobial activity of 
nuts of Tetracarpidium conophorum on S. aureus, Streptococcus pyogenes, Escherichia coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Candida albicans, and Aspergillus Spp. 
Aqueous, ethanol and hexane extract of T. conophorum nut was used. For ethanol and hexane 
20 g of the material was macerated into 200 mL of each solvent and extraction was done in air 
tight container to prevent evaporation of solvent. Hexane and ethanol extracts were dried in a 
warm air oven at 50oC for the solvents to evaporate. The result showed that the inhibition zone 
of diameter of the hexane and ethanol extracts of T. conophorum plant on gram positive S. 
aureus ranged from 10-14 mm, the zone of S. pyogenes was 12-17 while the zones of diameter 
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of the gram-negative bacterial species were in range of 12-18 mm and However, the hexane 
and ethanol extract of T. conophorum was found to produce better inhibitory activity against 
S. pyyogenes than S. aureus. In another study carried out Allaie et al., (2018) examined the 
antibacterial activity of nut extracts of Juglans regia against some clinical isolates (E. coli, S. 
aureus, S. saprophyticus, K.  pneumonia, Proteus mirabilis, and P. aeruginosa responsible for 
urinary tract infection. The result showed that among the three nut extracts tested against the 
isolates causing UTIs, hexane extract was moderately active on gram positive (S. aureus (9 
mm) and S. saprophyticus (7 mm) strains compared to the ethyl acetate, and methanolic 
extracts that were highly effective.  
In the present study, the possible effects of conventional antibiotics and combination effect of 
plant oils with antibiotics were evaluated. In the disc diffusion assay, antibiotics alone and 
combination with African walnut, cashew and pumpkin oils exhibited antibacterial activity 
against MRSA 252 and ATCC 6538 but at different concentrations. In this combinational 
study, MRSA 252 and ATCC 6538 exhibited different patterns of resistance and susceptibility. 
This combination might prove the benefit of using a combination with the lower dose of 
antibiotic alone (Aminnezhad et al., 2013). In this study lower antibiotic doses were used for 
the combinational study to allow effective combination of the drugs and oils. MRSA 252 was 
observed to be susceptible to drugs like streptomycin, vancomycin, linezolid, gentamicin, 
rifampicin chloramphenicol but resistant to trimethoprim, penicillin G, ciprofloxacin, oxacillin, 
carbenicillin and erythromycin. However, combination of African walnut oil with antibiotics 
such as trimethoprim, vancomycin, carbenicillin and streptomycin led to synergy. Combination 
of cashew oil with trimethoprim, chloramphenicol, rifampicin, vancomycin and carbenicillin 
led to synergy. Combination of pumpkin oil with gentamicin, streptomycin, trimethoprim, 
chloramphenicol led to a synergistic effect against MRSA 252. Based on the results, MRSA 
252 appears to have better synergy with drugs in the class of aminoglycosides, glycopeptide, 
sulphonamides and chloramphenicol. Against ATCC 6538, combination of African walnut oil 
with streptomycin, carbenicillin, vancomycin, oxacillin, gentamicin, ciprofloxacin and 
trimethoprim resulted in synergy. Combination of cashew oil with trimethoprim and penicillin 
G led to synergy while combination of pumpkin oil with vancomycin, rifampicin and 
erythromycin led to synergy aminoglycosides, glycopeptide, sulphonamides. In general, 
African walnut oil and pumpkin oil resulted in better synergistic effects with antibiotics against 
MRSA 252 and ATCC 6538.  
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Plants edible oils have already been known to exhibit strong antimicrobial properties 
(Tabassum and Vidyasagar, 2014). However, the effect of edible oils on the formation of 
biofilms has not been thoroughly investigated. The effect of African walnut, cashew and 
pumpkin oils from nuts and seed on the formation of bacterial biofilm has never been reported 
before. The ability of S. aureus to form biofilm is a major virulence factor and contributes to 
the success of disease development (Batista et al., 2017). Previous studies on other plant oils 
have showed that bacteria in the biofilm mode of growth are much more resistant to 
antibacterial agents than their planktonic counterparts (Nostro et al., 2007; Nuryastuti et al., 
2009; Chamdit and Siripermpool 2012; Kavanaugh et al., 2012; Al-Shuneigat et al., 2014). 
The greater resistance of S. aureus in the mature biofilm EPS, when compared to that of its 
cells in planktonic cell culture can be linked to the bacterial biofilms ability to reduce the entry 
and dissemination of antimicrobials in its interior. Once a bacterium is enveloped in matrix 
(biofilm), the cells are protected from antimicrobials, environment and the immune response 
of the host. In this study, results obtained have demonstrated that walnut oil and pumpkin oil 
has an excellent antibacterial potential against MRSA 252 and ATCC 6538 planktonic and 
biofilm cells. At higher concentration, African walnut, cashew and pumpkin oils exerted an 
antibacterial activity. Against MRSA 252 and ATCC 6538 the MIC of walnut oil were 15.6 
and 7.8 mg/mL. Cashew oil had an MIC of 125 and 125 mg/mL. Pumpkin had an MIC value 
of 62.6 and 31.25 mg/mL. MBICs values for both strains were 31.25 mg/mL and 15.6 mg/mL 
(walnut oil), 125 and 62.5 mg/mL (pumpkin oil), 250 mg/mL for both MRSA 252 and ATCC 
6538 (Cashew oil). Based on the result, African walnut and pumpkin oil showed strong 
inhibitory activity on the growth of MRSA 252 and ATCC 6538 planktonic and biofilm cells.  
However, cashew oil exhibited weak inhibitory activity against MRSA 252 and ATCC 6538.  
MIC of hexane and petroleum ether extracts of African walnut, cashew and pumpkin against 
MRSA 252 and ATCC 6538 planktonic and biofilm cells were determined using the broth 
micro-dilution technique. MIC of hexane extract of the African walnut oil against MRSA 252 
and ATCC 6538 was 125 and 62.5 mg/mL while MIC of petroleum ether extract against MRSA 
252 and ATCC 6538 was 500 and 125 mg/mL. MICs of hexane extract of cashew against 
MRSA 252 and ATCC 6538 was 250 and 500 mg/mL (hexane extract) and MICs of petroleum 
ether extracts was 500 mg/mL for both strains. For pumpkin oil, MICs of hexane extract against 
MRSA 252 and ATCC 6538 was 250 and 62.5 mg/mL and MICs of petroleum ether extracts 
was 250 and 500 mg/mL for both strains. MBIC of hexane and petroleum ether extracts of 
African walnut against MRSA 252 and ATCC 6538 was 250 and 125 mg/mL, and 250 and 500 
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mg/mL. MBIC of hexane and petroleum ether extracts of cashew against MRSA 252 and 
ATCC 6538 was 500 mg/mL for the two strains, MBIC of hexane and petroleum ether extracts 
of pumpkin against MRSA 252 and ATCC 6538 was 500 and 125 mg/mL, and lastly 500 
mg/mL for the two strains. 
Treatment with antibacterial drugs may kill free-floating cells but fail to eradicate bacteria 
embedded within biofilm, which can then act as a source responsible for human recurrent 
infection (Tabassum and Vidyasagar, 2014). After treatment with standard antibiotic, a few of 
drug resistant bacteria may still exist that repopulates the biofilm. Subsequent retreatment of 
the biofilms that repopulated resulted in reduced bacterial counts indicating that the 
repopulated biofilm is very resistant to antibiotics. In this study, the ability of oils of walnut, 
cashew and pumpkin to eradicate biofilms formed by MRSA 252 and ATCC 6538 at different 
time point was investigated. This was done to firstly ascertain whether the oils can eradicate 
the established biofilms of the strains, secondly, to determine the appropriate concentration and 
time that the oils will be able to eradicate the biofilms of the strains.To effectively perform the 
experiments, mature biofilms of MRSA 252 and ATCC 6538 in a 96-well Nunc plate grown 
for 48 h with an initial count of 8.37 and 8.33 log10 CFU/mL per peg/well of bacteria were 
treated with walnut, cashew and pumpkin oils at ten concentrations. African walnut, cashew 
and pumpkin oil were found to significantly reduce viabilities of biofilm cells. Whereas, the 
cell viability of MRSA 252 and ATCC 6538 growth control was observed to increase to 8.64 
log10 CFU/mL per peg/well and 8.53 log10 CFU/mL per peg/well. Pumpkin oil was also able 
to reduce cell viabilities of MRSA 252 and ATCC 6538 biofilms from an initial count from 
8.37 and 8.33 log10 CFU/mL per peg/well. The use of African walnut, cashew and pumpkin 
oils for the susceptibility tests in this study showed which oils are more efficient against MRSA 
252 and ATCC 6538 preformed biofilms after 48 h. African walnut oil was significantly 
efficient against S. aureus MRSA 252 and ATCC 6538 embedded in biofilms as it was 
observed to eradicate MRSA 252 and ATCC 6538 biofilms at low concentrations of 31.25 and 
62.5 mg/mL after 12 h but with more better eradication after 24 and 48 h giving low or no 
counts of viable cells in recovery media. Cashew oil could not completely eradicate the 
biofilms of MRSA 252 and ATCC 6538 but significantly decreased its cells re-occurring 
growth rate after 24 h of incubation in different concentrations but better at 500 mg/mL 
concentration. After African walnut oil, pumpkin oil showed better activity against ATCC 6538 
at 125 mg/mL concentration compared to MRSA 252 at 250 mg/mL. 
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Results by Unachukwu, Nwakanma & Ekuma, (2018), is in line with the results of our study. 
They carried out an antibacterial evaluation of T. occidentalis leaf extract against S. aureus and 
two E. coli clinical strains using both the disc diffusion and dilution methods. The leaf extract 
produced no inhibitory activity on E. coli isolates but inhibited the growth of S. aureus. In 
another study, Apagu and coworkers (2017), studied the antibacterial activity of the leaf 
extracts of T. occidentalis on S. typhi, E. coli, P. auriginosa, S. aureus and S. feacalis, using 
disc diffusion method with standard antibiotic drugs as positive control for comparison. T. 
occidentalis extract produced higher antibacterial activity against S. aureus. Similarly, Ayepola 
and Ishola, (2009) investigated the antibacterial activity of the leaves and stem bark of cashew 
(A. occidentale) on gram-positive and gram-negative organisms including K. pneumoniae, S. 
aureus, B. subtilis, S. typhi, C. albicans and E. coli using disc diffusion with ampicillin as a 
standard control. The mean diameter of the zones of inhibition exhibited by the extracts was 
between 13 mm and 22 mm. S. aureus and B. subtilis showed the highest zones of inhibition 
(13 and 22 mm) to the leaf extracts. Agedah, Bawo & Nyananyo, (2010) investigated the 
antimicrobial capabilities of plant extract derived from the leaves of the cashew plant, A. 
occidentale on two common human pathogens of clinical importance, E. coli and S. aureus 
using disc diffusion method and ampicillin as a standard antibiotic. The two clinical strains 
were sensitive to the extracts, but S. aureus was more sensitive with a larger zone of inhibtion 

















Chapter 6. Molecular study of MRSA 252 and S. aureus ATCC 6538 
Virulence Genes 
6.1 Introduction  
S. aureus is a prominent gram-positive pathogen capable of causing infections associated with 
indwelling medical devices. The ability of this pathogen to form biofilm on surfaces of either 
biotic or abiotic surfaces is perhaps the major factor contributing to S. aureus acquired 
infections. Biofilm formation involves the attachment of the bacteria to solid materials which 
results in the subsequent assemblage of microbial communities embedded in polymeric 
substances (Atshan et al., 2013). Therefore, infections caused by this notorious pathogen are 
becoming chronic in wound infections and on hospital devices including orthopaedic and 
prosthetic implants such as wires, pins, prosthetic joints, screws, nails, external fixators, plates, 
and mini-large fragment implants. However, other devices that are prone to S. aureus biofilm 
infection include the indwelling hospital devices such as urinary, intravevenous and 
endotracheal catheters and heart valves (Archer et al., 2011). In the on-set of S. aureus 
infections, adhesion is a vital step in the formation of biofilm communities which is enhanced 
by the production of a variety of protein and non-protein adhesins that mediate attachment to a 
great multitude of human factors which include extracellular matrix and plasma protein, 
intercellular adhesion or human host cells which is vital for biofilm formation and 
accumulation (Heilmann, 2011).  
Protein adhesins are classified either in the MSCRAMMs family which are the covalently 
anchored proteins or in the family of proteins that are non-covalently anchored to the cell wall 
but by other means such as ionic and hydrophobic means. Examples of such proteins include 
the SERAM proteins (secretable expanded repertoire adhesive molecule) family, or membrane 
spanning proteins. Non-protein adhesins is composed of the polysaccharide intercellular 
adhesin (PIA), teichoic acids and lipoteichoic acid (Heilmann, 2011). During implant infection, 
the implant becomes coated with host extracellular matrix (ECM) proteins including fibrinogen 
(fib), fibrinonectin A and B (fnbA and fnbB), collagen (cna), laminin (eno), clumping factors 
A and B (clfA and clfB), elastin (ebps), providing a suitable surface for MSCRAMMs to bind. 
MSCRAMMs can bind to one or more host molecules and thus escape immune system and 
then develop infections. MSCRAMMs are proteinaceous adhesins on S. aureus surface that 
mediate the adhesion of the bacterium to ECM. These MSCRAMMs are attached covalently 
to the cell wall of S. aureus by sortase enzymes (Abdolmajid et al., 2015) and sec pathway. 
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Furthermore, MSCRAMMs play vital role in staphylococcal biofilm formation, in addition to 
the ica locus that produces the PIA. The development of S. aureus biofilm is mostly facilitated 
by the production of polysaccharide intercellular adhesion (PIA). The production of this PIA 
matrix results in complex cell clustering with several distinct layers. In S. aureus PIA is a 
polysaccharide composed of poly-β (1-6)-N-acetylglucosamine (PNAG), with partially 
deacetylated residues, positively charged, whose synthesis is mediated by the icaADBC operon. 
It serves as a protective outer covering around the cells, protecting them against human immune 
defences and drug treatment (Atshan et al., 2013; Mirzaee et al., 2014). The intercellular 
adhesion (ica) operon is composed of the icaADBC genes that encodes protein and are 
responsible for the production of PIA and capusular polysaccharide adhesion in majority of 
staphylococcal strains. The gene icaA is encoding the N-acetylglucosamyltransferase. This 
enzyme is not always active and stable in vitro, but of both icaA and icaD helps to increase N-
acetylglucosamyltransferase activity and production of slime (Arciola et al., 2006; Mirzaee et 
al., 2014). Gene icaB encodes an extracellular protein with an unknown function and is 
responsible for the deaceylation of fully developed PIA. IcaC encodes a transmembrane protein 
which is believed to be involved in the secretion and elongation of polysacchardides. Therefore, 
experiments conducted in this chapter identified virulence genes in S. aureus ATCC 6538 and 
MRSA 252 associated with biofilm formation, adhesion to biotic surfaces, antibiotic resistance, 
quorum sensing and food poisoning. Also, experiments were geared towards determining the 
expression levels of the virulence genes that were found to be present in the strains, then their 













6.2.1 Preparation of MRSA 252 and ATCC 6538 for SEM 
S. aureus bacteria undergo gradual morphological changes at different growth phases during 
biofilm formation therefore it was necessary to initially determine the growth phases at 
different time points exhibited by MRSA 252 and ATCC 6538 biofilms (using SEM) at which 
they produce morphological structures before performing, RNA extraction and RT-PCR 
analysis. To effectively determine this, MRSA 252 and ATCC 6538 biofilm growth curves 
were performed. This was performed by growing their standardized suspension (1.5 x 10-6 
cells) on 6-well polystyrene tissue culture plates and their growth was monitored over a period 
of 48 h by measuring their absorbance at optical density of 600 nm using the spectrophotomer. 
Result is presented in Figure 65. Based on the growth curve results, biofilms formed at 6, 12, 
24 and 48 h corresponding to lag, log and stationary phases of growth were examined for 
morphological changes, using Scanning electron microscopy (SEM). Result is presented in 
Figure 65-69. 
                  
Figure 65. Growth curve of MRSA 252 and ATCC 6538 grown in trypicase soy broth enriched with 1 % 
glucose at 37 oC for 48 h. 
Values on the graph are means of three repeated OD readings and error bars indicate standard 
deviations of the means. As shown in Figure 65, the OD is plotted versus time and the growth 
of MRSA 252 seem to be slightly faster than ATCC 6538 entering exponential phase at 6 h. In 
this graph, bacterial biofilm formation MRSA 252 and ATCC 6538 on 96-well plates was 
monitored at 0, 6, 12,18, 24, 30, 36, 42, 46 and 48 h using quantitative culturing. As shown 
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in Figure 65, three distinct patterns of biofilm formation were observed for each strain (lag, 
exponential and stationay phase): biofilm formation by S. aureus MRSA 252 and ATCC 6538 
progressed at an early (lag) phase characterized by a rapid biofilm formation in 6-8 h without 
thick fibrous biofilm materials, followed by a slow intermediate phase observed up to 18 h. 
After the 18 h growth time point, S. aureus biofilm growth reached stationary phase. Growth 
pattern of biofilm formation by ATCC 6538 was slightly diffent from that of MRSA 252 at 6 
h to 24 h. In addition, biofilm formation by MRSA 252 and ATCC 6538 gradually increased 
in growth up to 24 and 48 h. Biofilms grown to 12 h, 24 and 48 h were used in subsequent 
experiments. These observations are similar with that reported by Szczotka-Flynn et al., (2009) 
and Atshan et al., (2013). Szczotka-Flynn et al., (2009) observed that S. aureus strains formed 
biofilms on lenses exhibiting three main phases of growth which includes lag, exponential and 
staitionary phases. Atshan et al., (2013) showed that the growth of S. aureus clones in trypic 
soy broth was faster with clones entering an exponential phase early at 6 h and reaching a 
plateau phase of growth at 22 h. 
6.2.2 Scanning electron microscopy (SEM) 
6.2.2.1 SEM of MRSA 252 
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Figure 66. SEM images (A-D) of MRSA 252 grown in trypticase soy broth enriched with glucose for 6, 12, 
24 and 48 h respectively, then imaged with FEI Quanta FEG 250 FESEM. Images of MRSA 252 shows 
clusters of biofilms at 6 h, mesh-like biofilm at 12 h, thick fibrous biofilm at 24 h and dense mesh-like 
structures with arrow heads at 48 h as depicted with red, orange, green and blue coloured arrows.  
On the biofilm micrographs, HV and det (Everhart-Thornley Detector) represents the 
accelerating emission volatage, which is 7 kv and 5 kv. Spot on the micrographs means the 
resolution of the images and magnification at 50,000 x is the enlargement of the image. (A) 
Clusters of biofilms at 6 h (B) Biofilm at 12 h with meshwork like structures sticking the cells 
together (C) Biofilm with thick fibrous material observed at 24 h. (D) Biofilm with increased 
meshwork like structures which became denser with arrow head. The orange arrow used in 
labelling B shows the meshwork and arrow head of MRSA 252 biofilm formed at 12, green 
arrows in C shows fibrous materials formed at 24 h and blue arrows indicates dense layers of 
meshwork holding the cells together.  
6.2.2.2 SEM of S. aureus ATCC 6538           
 
Figure 67. SEM images (A-D) of ATCC 6538 grown in trypticase soy broth enriched with glucose for 6, 12, 
24 and 48 h respectively, then imaged with FEI Quanta FEG 250 FESEM. Images of ATCC 6538 shows 
clusters of biofilms at 6 h, mesh-like biofilm at 12 h, thick fibrous biofilm at 24 h and dense mesh-like 
structures with arrow heads at 48 h as depicted with red, yellow, green and blue coloured arrows. 
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On the biofilm micrographs, HV and det (Everhart-Thornley Detector) represents the 
accelerating emission volatage, which is 7 kv and 5 kv. Spot on the micrographs means the 
resolution of the images and magnification at 50,000 x is the enlargement of the image. (A) 
Clusters of biofilms at 6 h (B) Biofilm at 12 h with meshwork like structures sticking the cells 
together (C) Biofilm with thick fibrous material observed at 24 h. (D) Biofilm with increased 
meshwork like structures which became denser with arrow head. The yellow arrow used in 
labelling B shows the little meshwork like structures and arrow head of ATCC 6538 biofilm 
formed at 12, green arrows in C shows little fibrous materials formed at 24 h and blue arrows 
indicates dense layers of meshwork holding the cells together. 
 
Figure 68. SEM images (A-D) of MRSA 252 grown in trypticase soy broth enriched with glucose for 6, 12, 
24 and 48 h respectively, then imaged with FEI Quanta FEG 250 FESEM. Images of MRSA 252 shows 
clusters of biofilms at 6 h, mesh-like biofilm at 12 h, thick fibrous biofilm at 24 h and dense mesh-like 
structures with arrow heads at 48 h as depicted with red, yellow, green and blue coloured arrows. 




Figure 69. SEM images (A-D) of ATCC 6538 grown in trypticase soy broth enriched with glucose for 6, 12, 
24 and 48 h respectively, then imaged with FEI Quanta FEG 250 FESEM. Images of ATCC 6538 shows 
clusters of biofilms at 6 h, mesh-like biofilm at 12 h, thick fibrous biofilm at 24 h and dense mesh-like 
structures with arrow heads at 48 h as depicted with red, yellow, green and blue coloured arrows. 
Magnification of images is at 10,000 x. 
In summary, as observed in Figure 66 to 69, morphological observations of MRSA 252 and 
ATCC 6538 biofilm cultures at 12, 24 and 48 h showed that both strains started to exhibit little 
surface mesh like sturctures at 12 h with arrow heads which became denser with fibrous 
materials at 24. However, no fibrous materials and arrow heads was observed at 6 h. This 
observation correlates with other reports. Szczotka-Flynn et al., (2009) observed that S. aureus 
strains formed biofilms on lotrafilcon A as dense mesh networks of bacterial cells arranged in 
clusters with visible extracellular matrix. Similarly, Asthan et al., (2013) reported that S. 
aureus clones grew in trypic soy broth at different stages of growth, forming thick and dense 
meshwork like structures particularly at 24 and 48 h. Asthan and his coworkers were of the 
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opnion that the S. aureus clones exhibited different morphological structures (Asthan et al., 
2013). Based on the observation in this study MRSA 252 biofilms appears to exhibit 
pronounced and steady surface structural changes at 12 h, 24 h and 48 h compared to ATCC 
6538. As such, 12, 24 and 48 h time points were further studied with 6 h growth time point 
which was used as time control. 
6.2.3 RNA extraction and gel electrophoresis of the RNA extracted from MRSA 252 and 
S. aureus ATCC 6538 biofilms. 
RNA extracted from ATCC 6538 and MRSA 252 were of good purity. The quality and quantity 
of RNA extracted from 6, 12, 24 and 48 h biofilms at different growth time points was found 
to be intact before and after walnut, cashew and fluted pumpkin oil treatments.  
6.2.3.1 Gel electrophoresis of RNA extracted from MRSA 252 and S. aureus ATCC 6538 
biofilms at 6, 12, 24 and 48 h. 
                    
Figure 70. Agarose gel electrophoresis of RNA extracted from MRSA 252 and S. aureus ATCC 6538 
biofilms at 6 h.   
Lane 1; H is 1Kb base ladder marker. H, Hyperladder 1 Kb size marker Lanes 3 and 4 (7 µL each) of RNA 
extracted from S. aureus ATCC 6538 biofilm and Lanes 7, 8 and 9 (7 and 8 µL each) of RNA extracted from 
MRSA 252 biofilm at 6 h respectively. 
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Figure 71. Agarose gel electrophoresis of RNA extracted from MRSA 252 and S. aureus ATCC 6538 
biofilms at 12 h, 24 h and 48 h. 
Lane 1; H is 1Kb base ladder marker. H, Hyperladder 1 Kb size marker. Lanes; 2, 3 and 4 (7 µL each) of RNA 
extracted from S. aureus ATCC 6538 biofilm and Lanes 7, 8 and 9 (8 µL each) of RNA extracted from MRSA 
252 biofilm at 12 h, 24 h and 48 h respectively.  
The gels show that the RNA extraction was successful indicated by the presence of intact 
ribosomal RNA bands from MRSA 252 and S. aureus ATCC 6538 biofilms. 
6.2.3.2 Agarose gel electrophoresis of RNA extracted from MRSA 252 biofilms after 
treatment with fluted pumpkin, African walnut and cashew oils. 
             
Figure 72. Agarose gel electrophoresis of RNA extracted from MRSA 252 biofilms after 12 h, 24 h and 48 
h treatment with fluted pumpkin, African walnut and cashew oils. 
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Lane 1 of A, B and C; H, Hyperladder 1kb size marker. (A) Lanes; 2 (12 h), 3 (24 h) and 5 (48 h) (7 µL each) of 
RNA extracted from MRSA 252 biofilm treated with pumpkin oil. Lane 4; (24 h) is 8 µL of RNA extracted from 
MRSA 252 treated with pumpkin oil. (B) Lanes 3 (12 h), 4 (24 h and 5 (48 h) (7 µL each) of RNA extracted from 
MRSA 252 biofilm treated with walnut oil. Lastly, Lanes 3 (12 h); 5 (24 h) and 6 (48 h) (7 µL each) of RNA 
extracted from MRSA 252 biofilm treated with cashew oil.  
Figure 72 show that the RNA extraction after treatment of MRSA 252 with oils was successful 
confirming the presence of intact ribosomal RNA bands (23S & 16S) 1200 and 800 bp for total 
RNA extracted from MRSA 252 biofilm after treatment with fluted pumpkin, African walnut, 
cashew oils at 12 h, 24 h and 48 h. This indicates that the RNA is still likely intact in the three 
samples. 
6.2.3.3 Agarose gel electrophoresis of RNA extracted from S. aureus ATCC 6538 after 
treatment with African walnut, cashew and fluted pumpkin oils 
                      
Figure 73. Agarose gel electrophoresis of rna extracted from S. aureus atcc 6538 biofilms after 12 h, 24 h 
and 48 h treatment with African walnut, cashew and fluted pumpkin oils. 
Lanes 1, 6 and 10; H, Hyperladder 1kb size marker. Lanes; 2 (12 h), 3 (24 h) and 4 (48 h) (7 µL each) of RNA 
extracted from ATCC 6538 biofilm treated with African walnut oil. Lane 7; (12 h), 8 (24 h), and 9 (48 h) (7 µL 
each) of RNA extracted from ATCC 6538 biofilm treated with cashew oil. Lanes; 11 (12 h), 12 (24 h) and 13 (48 
h) (7 µL each) of RNA extracted from ATCC 6538 biofilm treated with fluted pumpkin oil. 
Figure 73 show that RNA extraction after treatment with oils was successful confirming the 
presence of intact ribosomal RNA bands (23S & 16S) 1200 and 800 bp for total RNA extracted 
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from ATCC 6538 biofilm after treatment with fluted pumpkin, African walnut, cashew oils at 
12 h, 24 h and 48 h. This indicates that the RNA is still likely intact in the three samples. 
6.2.4 Reverse transcription PCR products from RNA extracted from ATCC 6538 and 
MRSA 252 biofilms. 
6.2.4.1 RT-PCR products of selected reference genes  
The cDNA synthesis generated enough products and all the primers used in this study showed 
single bands. Reverse transcription polymerase chain reaction (RT-PCR) was carried out on 
cDNA obtained from ATCC 6538 and MRSA 252 using specific primers of the reference and 
target genes to confirm that the PCR products yielded a single band of correct size.The RT-
PCR products of selected reference genes namely; 16S rRNA, gmk, gyrA, proC, tpiA, glyA, 
pyK, gapdh, rho and rpoD were identified and genes that were successfully amplified were 
considered present in strains tested and were further assessed for suitability in gene expression 
analysis. 
Amplified PCR products for 16S rRNA, gmk, gyrA and proC of MRSA 252 and S aureus 
ATCC 6538 biofilms at 12 h, 24 h and 48 h. 
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Figure 74. Agarose gels showing the RT-PCR products of the 16S rRNA, gmk, gyrA and proC genes of 
(A) S. aureus ATCC 6538 and (B) MRSA 252 biofilms at 12, 24 and 48 h. 
(A) Lane H represents Hyperladder 100 (100bp). Lane 1-3, 16S rRNA; lane 5-7, gmk; lane 9-11, gyrA; lane 13-
15, proC. Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA and lane 16, proC. Control lanes are 
negative primer control lanes for the PCR products. (B) Lane H represents Hyperladder 100 (100bp). Lane 1-3, 
16S rRNA; lane 5-7, gmk; lane 9-11, gyrA; lane 13-15, proC. Control lanes are Lane 4, 16S rRNA; lane 8, gmk; 
lane 12, gyrA and lane 16, proC. Control lanes are negative primer control lanes for the PCR products. 
Figure 74 shows the amplification of 16S rRNA, gmk, gyrA and proC genes were idenfied 
using gel electrophoresis. However, the gel of ATCC 6538 revealed the presence of proC, 16S 
rRNA, gmk and gyrA genes. For MRSA 252, 16S rRNA, gmk, gyrA and proC were present. 
Furthermore, the amplification of 16S rRNA, gmk and gyrA of both MRSA 252 and ATCC 
6538 resulted in amplification of single products of 16S rRNA, gmk, gyrA with clear bands at 









Amplified PCR products for tpiA, glyA, pyk and gapdh of S. aureus ATCC 6538 and 
MRSA 252 biofilms at 12 h, 24 h and 48 h. 
                      
                         
Figure 75. Agarose gels showing the RT-PCR products of the tpiA, glyA, pyk and gapdh genes of (A) S. 
aureus ATCC 6538 and (B) MRSA 252 biofilms. 
(A) Lane H represents Hyperladder 100 (100bp). Lane 1-3, tpiA; lane 5-7, glyA; lane 9-11, pyk; lane 13-15, gapdh. 
Control lanes are Lane 4, tpiA; lane 8, glyA; lane 12, pyk and lane 16, gapdh. Control lanes are negative primer 
control lanes for the PCR products. (B) Lane H represents Hyperladder 100 (100bp). Lanes 1-3, tpiA; lane 5-7, 
glyA; lane 9-11, pyk; lane 13-15, gapdh. Control lanes are Lane 4, tpiA; lane 8, glyA; lane 12, pyk and lane 16, 
gapdh. Control lanes are negative primer control lanes for the PCR products. 
Figure 75 shows the reference genes; tpiA, glyA, pyk and gapdh were idenfied using gel 
electrophoresis. ATCC 6538 was positive for tpiA, glyA and pyk except gadph. Whereas MRSA 
252 was positive for tpiA and glyA only and absent of pyk and gapdh genes. In addition, the 
amplification of tpiA, glyA and pyk genes in ATCC 6538 resulted in amplification of single 
products of 145, 98 and 89 bp. Similarly, MRSA 252 was positive for tpiA and glyA giving 
clear bands at 145 and 98 bp regions. No bands can be seen in the primer control lanes. 
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Amplified PCR products for rho and rpod of S. aureus ATCC 6538 and MRSA 252 
biofilms at 12 h, 24 h and 48 h. 
               
 
Figure 76. Agarose gels showing the RT-PCR products of the rho and rpod genes of (a) S. aureus ATCC 
6538 and (b) MRSA 252 biofilms. 
(A) Lane H represents Hyperladder 100 (100bp). Lane 1-3, rho and lane 5-7, rpod. Control lanes are Lane 4, rho 
and lane 8, rpod. (B) Lane H represents Hyperladder 100 (100 bp). Lanes 1-3, rpod and lanes 5-7, rho. Control 
lanes are Lane 4, rpod and lane 8 rho. Control lanes are negative primer control lanes for the PCR products. 
Figure 76 shows that primer pairs of rho and rpod resulted in amplification of genes rho and 
rpod in both MRSA 232 and ATCC 6538. These agarose gels revealed single products of rho 








Amplified PCR products for rrsC of S aureus ATCC 6538 and MRSA 252 biofilms at 12 
h, 24 h and 48 h. 
                                        
Figure 77. Agarose gel electrophoresis of RT-PCR products of rrsc gene for S. aureus ATCC 6538 and 
MRSA 252 biofilms. 
Lanes 1-3, rrsC of MRSA 252 and lane 5-7, rrsC of ATCC 6538. H represents Hyperladder 100 (100bp). Control 
lanes are Lane 4 and lane 8. Control lanes are negative primer control lanes for the PCR products. 
Figure 77 shows that the primer resulted in the amplification of single products of rrsC. This 
indicates that ATCC 6538 and MRSA 252 are positive for rrsC giving visible bands at 82 bp 
regions. No additional bands were observed.  
6.2.4.2 RT-PCR products of adhesion and biofilm genes in ATCC 6538 and MRSA 252 at 
different growth time points. 
RT-PCR was used to identify the adhesion (icaA, icaB, icaC and icaD) and biofilm genes 
(fnbA, fnbB, fib, clfA, clfB, cna, ebps and eno) present in S. aureus ATCC 6538 and MRSA 









(i) Amplified PCR products at 6 h growth time point 
Amplified PCR products for 16S rRNA, gmk, gyrA, icaA, icaB, icaC and icaD of S 
aureus ATCC 6538 and MRSA 252 cultured cells at 6 h. 
                  
              
 
Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, icaA, icaB, icaC 
and icaD genes for (A) S. aureus ATCC 6538 and (B) MRSA 252 cultured for 6 h.  
(A) Lane 1, 16S rRNA; lane 3, gmk; lane 5, gyrA; lane 7, icaA; lane 9, icaB; lane 11, icaC; lane 13, icaD. H 
represents Hyperladder 100 (100bp). Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, icaA; 
lane 10, icaB; lane 12, icaC; lane 14, icaD. Control lanes are negative primer control lanes for the PCR products. 
(B) (A) Lane 1, 16S rRNA; lane 3, gmk; lane 5, gyrA; lane 7, icaA; lane 9, icaB; lane 11, icaC; lane 13, icaD. H 
represents Hyperladder 100 (100bp). Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, icaA; 
lane 10, icaB; lane 12, icaC; lane 14, icaD. Control lanes are negative primer control lanes for the PCR products. 
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The gels show that all the intercellular adhesion target genes are expressed in MRSA 252 and 
S. aureus ATCC  6538 at 6 h. 16S rRNA, gmk, gyrA, icaA, icaB, icaC and icaD bands seems 
to be intense. In addition, Clear bands were observed at the expected 191 bp, 121 bp, 98 bp, 
151 bp, 140 bp, 209 bp and 211 bp regions. No bands can be seen in the primer control lanes 
showing that amplification was not due to contamination of materials.  
Amplified PCR products for 16S rRNA, gmk, gyrA, fnbA, fnbB, fib, ebps and eno of S 




Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA fnbA, fnbB, fib, 
ebps and eno for (A) ATCC 6538 and (B) MRSA 252 cells cultured for 6 h.  
 
(A) Lane 1, 16S rRNA; lane 3, gmk; lane 5, gyrA; lane 7, fnbA; lane 9, fnbB; lane 11, fib; lane 13, ebps; lane 15, 
eno. H represents Hyperladder 100 (100bp). Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 
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8, fnbA; lane 10, fnbB; lane 12, fib; lane 14, ebps. Control lanes are negative primer control lanes for the PCR 
products. (B) Lane 1, 16S rRNA; lane 3, gmk; lane 5, gyrA; lane 7, fnbA; lane 9, fnbB; lane 11, fib; lane 13, ebps; 
lane 15, eno. H represents Hyperladder 100 (100bp). Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, 
gyrA; lane 8, fnbA; lane 10, fnbB; lane 12, fib; lane 14, ebps. Control lanes are negative primer control lanes for 
the PCR products.  
The gels show the amplification of 16S rRNA, gmk, gyrA, fnbA, fnbB, fib, ebps and eno in 
MRSA 252 and S. aureus ATCC 6538. Clear bands of the target genes were observed at the 
expected 191 bp, 121 bp, 98 bp, 121 bp, 197 bp, 239 bp, 191 bp and 195 bp regions. Gene ebps 
was present in ATCC 6538 but was conspicuously absent in MRSA 252. Also, no additional 
band sizes were observed. No bands can be seen in the primer control lanes because no cdna 
template was used. 
Amplified PCR products for 16S rRNA, gmk, gyrA, clfA, clfB and cna of S aureus 
ATCC 6538 and MRSA 252 cultured cells at 6 h. 
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Figure 78. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, clfA, 
clfB and cna of (a) MRSA 252 and (b) ATCC 6538 cells cultured at 6 h. 
(A) Lane 1, 16S rRNA; lane 3, gmk; lane 5, gyrA; lane 7, clfA; lane 9, clfB; lane 11, cna H represents Hyperladder 
100 (100bp). Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, clfA; lane 10, clfB; lane 12, 
cna. Control lanes are negative primer control lanes for the PCR products. (B) Lane 1, 16S rRNA; lane 3, gmk; 
lane 5, gyrA; lane 7, clfA; lane 9, clfB; lane 11, cna. H represents Hyperladder 100 (100bp). Control lanes are Lane 
2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, clfA; lane 10, clfB; lane 12, cna. Control lanes are negative primer 
control lanes for the PCR products because no cDNA template was used.  
Figure 78 shows that MRSA 252 and S. aureus ATCC 6538 is positive for 16S rRNA, gmk, 
gyrA, clfA, and clfB giving visible clear bands at the expected 191 bp, 121 bp, 98 bp, 245 bp 
and 159 bp regions. ATCC 6538 is cna negative while MRSA 252 is cna positive giving band 
in the 156 bp region. The reason for cna not showing any visible band is unknown, the PCR 










Amplified PCR products for 16S rRNA, gmk, gyrA, RNAII, RNAIII, Sea and Seb of S 
aureus ATCC 6538 and MRSA 252 cells cultured at 6 h. 
                   
               
Figure 79. Agarose gel electrophoresis of RT-PCR amplification products of 16S RNA, gmk, gyrA, RNAII, 
RNAIII, sea, and seb genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 cells. 
 (A) Lane 1, 16S rRNA; lane 3, gmk; lane 5, gyrA; lane 7, RNAII; lane 9, RNAIII; lane 11, sea and lane 13, seb. H 
represents Hyperladder 100 (100bp). Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, 
RNAII; lane 10, RNAIII; lane 12, sea and lane 14, seb). (B) Lane 1, 16S rRNA; lane 3, gmk; lane 5, gyrA; lane 7, 
RNAII; lane 9, RNAIII; lane 11, sea and lane 13, seb. H represents Hyperladder 100 (100bp). Control lanes are 
Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, RNAII; lane 10, RNAIII; lane 12, sea and lane 14, seb). 
Control lanes in gels A and B are negative primer control lanes for the PCR products because no cDNA template 
was used. 
Figure 79 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, RNA II, and RNA III genes at 6 h. However, at this same time point only 
MRSA 252 was positive for sea. Gene sea was not seen in ATCC 6538. All the bands of the 
genes appeared indicating that their amplification was successful and resulted in single clear 
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visible bands observed at the expected 191 bp, 121 bp, 98 bp, 73 bp, 53bp and 154 bp regions. 
No bands can be seen in the primer control lanes. 
Amplified PCR products for 16S rRNA, gmk, gyrA, mecA, emrA, and blaZ of S aureus 
ATCC 6538 and MRSA 252 cells cultured at 6 h.  
                
           
Figure 80. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, mecA, 
emrA and blaZ genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 cultured cells. 
(A) Lanes 1, 16S rRNA; lanes 3, gmk; lanes 5 gyrA; lane 7, mecA, lane 9, emrA and lanes 14, blaZ. H represented 
Hyperladder 100 (100bp). Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, mecA; lane 10, 
emrA and lane 12, blaZ. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1, 16S 
rRNA; lanes 3, gmk; lanes 5, gyrA; lanes 7 mecA, lanes 9, emrA and blaZ. H represented Hyperladder 100 (100bp). 
Control lanes are Lane 2, 16S rRNA; lane 4, gmk; lane 6, gyrA; lane 8, mecA, lanes 10, emrA and Lanes 11, blaZ. 
Control lanes are negative primer control lanes for the PCR products.  
Figure 80 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, mecA, emrA and blaZ genes at 6 h. However, mecA and blaZ were not seen 
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in ATCC 6538. MRSA 252 contained mecA and blaZ genes probably because it is a methicillin 
resistant strain. Most of the bands of the genes in both gels appeared indicating that their 
amplification resulted in single clear visible bands observed at the expected 191 bp, 121 bp, 98 
bp, 139 bp and 173 bp regions. No bands can be seen in the primer control lanes. 
Amplified PCR products for 16S rRNA, gmk, gyrA and agrA genes of S aureus ATCC 
6538 and MRSA 252 cells cultured at 6 h. 
           
Figure 81. Agarose gel electrophoresis of RT-PCR amplification products of agrA gene for S. aureus ATCC 
6538 and MRSA 252 biofilms. 
Lanes 7, agrA for ATCC 6538; lanes 9, agrA for MRSA 252. H represented Hyperladder 100 (100bp). Control 
lanes are Lane 8 and 10. Control lanes are negative primer control lanes for the PCR products.  
Figure 81 shows that MRSA 252 and S. aureus ATCC 6538 cells are positive for agrA gene at 
6 h. All the agrA bands appeared indicating that the amplification resulted in single clear visible 







(ii) Amplified PCR products at 12 h, 24 h and 48 h growth time point. 
Amplified PCR products for 16S rRNA, gmk, gyrA, icaA and icaB of S aureus ATCC 
6538 and MRSA 252 biofilms at 12 h, 24 h and 48 h. 
 
                          
Figure 82. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, icaA 
and icaB genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms. 
(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, icaA and lanes 17-19, icaB. H represented 
Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, icaA and 
lanes 20, icaB. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 16S rRNA; 
lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, icaA and lanes 17-19, icaB. H represented Hyperladder 100 (100bp). 
Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, icaA and lanes 20, icaB. Control lanes 
are negative primer control lanes for the PCR products. 
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Figure 82 shows that the control genes and target genes are expressed in MRSA 252 and S. 
aureus ATCC 6538 biofilms at 12, 24 and 48 h. This shows that the control genes; 16S rRNA, 
gmk, gyrA as well as the target genes; icaA and icaB are present in MRSA 252 and ATCC 6538 
at 12 h, 24 h and 48 h. Genes gmk and gyrA appeared faint but despite the faint bands, 
amplification resulted in single clear visible bands observed at the expected 121 and 98 bp. 
Also, 16S rRNA, icaA and icaB gave single clear visible bands at 12, 24 and 48 h with the 
bands observed at the expected 191 bp, 151 bp and 141 bp regions. No bands can be seen in 
the primer control lanes. 
Amplified PCR products for 16S rRNA, gmk, gyrA, icaC and icaD of S aureus ATCC 
6538 and MRSA 252 biofilms at 12 h, 24 h and 48 h.     
                                      
        
Figure 83. Agarose gel electrophoresis of RT-PCR amplification products of 16S RNA, gmk, gyrA, icaC 
and icaD genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms. 
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(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, icaC and lanes 17-19, icaD. H 
represented Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, 
icaC and lanes 20, icaD. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 16S 
rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, icaC and lanes 17-19, icaD. H represented Hyperladder 100 
(100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, icaC and lanes 20, icaD. 
Control lanes are negative primer control lanes for the PCR products. 
Figure 83 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, icaC and icaD genes at 12, 24 and 48 h. All the bands of the genes appeared 
prominent indicating that their amplification was successful and resulted in single clear visible 
bands observed at the expected 191 bp, 121 bp, 98 bp, 209 bp and 211 bp regions. No bands 
can be seen in the primer control lanes. 
Amplified PCR products for 16S rRNA, gmk, gyrA, fnbA and fnbB of S aureus ATCC 
6538 and MRSA 252 biofilms at 12 h, 24 h and 48 h.     




    
Figure 84. Agarose gel electrophoresis of RT-PCR amplification products of 16S RNA, gmk, gyrA, fnbA 
and fnbB genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms 
(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, fnbA and lanes 17-19, fnbB. H 
represented Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, 
fnbA and lanes 20, fnbB. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 
16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, fnbA and lanes 17-19, fnbB. H represented Hyperladder 
100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, fnbA and lanes 20, fnbB. 
Control lanes are negative primer control lanes for the PCR products. 
Figure 84 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, fnbA and fnbB genes at 12, 24 and 48 h. All the bands of the genes appeared 
indicating that their amplification was successful and resulted in single clear visible bands 
observed at the expected 191 bp, 121 bp, 98 bp, 121 bp and 197 bp regions. No bands can be 









Amplified PCR products for 16S rRNA, gmk, gyrA, fib and cna of S aureus ATCC 6538 
and MRSA 252 biofilms at 12 h, 24 h and 48 h. 
                      
                   
Figure 85. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, fib and 
cna genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms. 
(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, fib and lanes 17-19, cna. H represented 
Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, fib and lanes 
20, cna. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 16S rRNA; lanes 5-
7, gmk; lanes 9-11, gyrA; lanes 13-15, fib and lanes 17-19, cna. H represented Hyperladder 100 (100bp). Control 
lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, fib and lanes 20, cna. Control lanes are negative 
primer control lanes for the PCR products. 
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Figure 85 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, fib and cna genes at 12, 24 and 48 h. All the bands of the genes appeared 
prominent indicating that their amplification was successful and resulted in single clear visible 
bands observed at the expected 191 bp, 121 bp, 98 bp, 239 bp and 156 bp regions. Despite the 
faintness of gyrA band in MRSA 252 it was seen at the 98 bp region as expected.  Gene cna 
was not observed in ATCC 6538 but was present in MRSA 252. No bands can be seen in the 
primer control lanes. 
Amplified PCR products for 16S rRNA, gmk, gyrA, clfA and clfB of S aureus ATCC 6538 
and MRSA 252 biofilms at 12 h, 24 h and 48 h. 
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Figure 86. Agarose gel electrophoresis of RT-PCR amplification products of 16S RNA, gmk, gyrA, clfA 
and clfB genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms 
(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, clfA and lanes 17-19, clfB. H represented 
Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA and lane 16, clfA. 
Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; 
lanes 9-11, gyrA; lanes 13-15, fib and lanes 17-19, cna. H represented Hyperladder 100 (100bp). Control lanes 
are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA and lane 16, clfA. Control lanes are negative primer control 
lanes for the PCR products. 
Figure 86 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, clfA and clfB genes at 12, 24 and 48 h. All the bands of the genes appeared 
prominent indicating that their amplification resulted in single clear visible bands observed at 
the expected 191 bp, 121 bp, 98 bp, 165 bp and 159 bp regions. No bands can be seen in the 








Amplified PCR products for 16S rRNA, gmk, gyrA, ebps and eno of S aureus ATCC 6538 
and MRSA 252 biofilms at 12 h, 24 h and 48 h. 
                   
        
Figure 87. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, ebps 
and eno genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms. 
(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, ebps and lanes 17-19, eno. H represented 
Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, ebps and 
lanes 20, eno. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 16S rRNA; 
lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, ebps and lanes 17-19, eno. H represented Hyperladder 100 (100bp). 
Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, ebps and lanes 20, eno. Control lanes 
are negative primer control lanes for the PCR products. 
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Figure 87 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, ebps and eno genes at 12, 24 and 48 h. However, ebps was not seen in 
MRSA 252. Most of the bands of the genes appeared indicating that their amplification resulted 
in single clear visible bands observed at the expected 191 bp, 121 bp, 98 bp, 191 bp and 195 
bp regions. No bands can be seen in the primer control lanes. 
6.2.5 RT-PCR products of selected antibiotic and staphylococcal food poisoning genes.  
Amplified PCR products for 16S rRNA, gmk, gyrA, mecA and blaZ genes of S aureus 
ATCC 6538 and MRSA 252 biofilms at 12 h, 24 h and 48 h. 
                     
                        
Figure 88. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, mecA 
and blaZ genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms. 
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(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, mecA and lanes 17-19, blaZ. H 
represented Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, 
mecA and lanes 20, blaZ. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 
16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, mecA and lanes 17-19, blaZ. H represented Hyperladder 
100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, mecA and lanes 20, blaZ. 
Control lanes are negative primer control lanes for the PCR products.  
Figure 88 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, mecA and blaZ genes at 12, 24 and 48 h. However, mecA and blaZ were not 
seen in ATCC 6538. MRSA 252 contained the mecA and blaZ probably because it is a 
methicillin resistant strain. Most of the bands of the genes appeared indicating that their 
amplification resulted in single clear visible bands observed at the expected 191 bp, 121 bp, 98 
bp, 162 bp and 173 bp regions. No bands can be seen in the primer control lanes. 
Amplified PCR products for 16S rRNA, gmk, gyrA, sea and seb genes of S aureus ATCC 
6538 and MRSA 252 biofilms at 12 h, 24 h and 48 h. 
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Figure 89. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, sea 
and seb genes for (A) S. aureus ATCC 6538 and (B) MRSA 252 biofilms. 
(A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, sea and lanes 17-19, seb. H represented 
Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, sea and lanes 
20, seb. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 16S rRNA; lanes 5-
7, gmk; lanes 9-11, gyrA; lanes 13-15, sea and lanes 17-19, seb. H represented Hyperladder 100 (100bp). Control 
lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA and lane 16, sea. Control lanes are negative primer control 
lanes for the PCR products.  
Figure 89 shows that MRSA 252 biofilm was positive for 16S rRNA, gmk, gyrA and sea genes 
and no seb gene at 12, 24 and 48 h. However, sea and seb genes were absent in ATCC 6538. 
MRSA 252 contained the sea gene probably because it is associated with staphylococcal food 
poisoning. The bands of the genes that are present in MRSA 252 indicates that their 
amplification resulted in single clear visible bands observed at the expected 191 bp, 121 bp, 98 










6.2.6 RT-PCR products of selected quorum sensing genes  
Amplified PCR products for 16S rRNA, gmk, gyrA, RNA II, RNA III and agrA genes of S 
aureus ATCC 6538 and MRSA 252 biofilms at 12 h, 24 h and 48 h. 
                 
                  
Figure 90. Agarose gel electrophoresis of RT-PCR amplification products of 16S rRNA, gmk, gyrA, RNAII 
and RNAIII genes for (a) S. aureus ATCC 6538 and (b) MRSA 252 biofilms. 
 (A) Lanes 1-3, 16S rRNA; lanes 5-7, gmk; lanes 9-11, gyrA; lanes 13-15, RNA II and lanes 17-19, RNA III. H 
represented Hyperladder 100 (100bp). Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, 
RNA II. Control lanes are negative primer control lanes for the PCR products. (B) Lanes 1-3, 16S rRNA; lanes 5-
7, gmk; lanes 9-11, gyrA; lanes 13-15, RNA II and lanes 17-19, RNA III. H represented Hyperladder 100 (100bp). 
Control lanes are Lane 4, 16S rRNA; lane 8, gmk; lane 12, gyrA; lane 16, RNA II. Control lanes are negative 
primer control lanes for the PCR products.  
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Figure 90 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for 16S 
rRNA, gmk, gyrA, RNA II and RNA III genes at 12, 24 and 48 h. All the bands of the genes 
appeared indicating that their amplification was successful and resulted in single clear visible 
bands observed at the expected 191 bp, 121 bp, 98 bp, 101 bp and 97 bp regions. No bands can 
be seen in the primer control lanes. 
Amplified PCR products for 16S rRNA, gmk, gyrA and agrA genes of S aureus ATCC 
6538 and MRSA 252 biofilms at 12 h, 24 h and 48 h 
 
                    
Figure 91. Agarose gel electrophoresis of RT-CR amplification products of agrA gene for S. aureus 
ATCC 6538 and MRSA 252 biofilms. 
(A) Lanes 3-5, agrA for ATCC 6538; lanes 8-10, agrA for MRSA 252. H represented Hyperladder 100 (100bp). 
Control lanes are Lane 6 and 11. Control lanes are negative primer control lanes for the PCR products.  
Figure 91 shows that MRSA 252 and S. aureus ATCC 6538 biofilms are positive for agrA gene 
at 12, 24 and 48 h. All the agrA bands appeared indicating that the amplification resulted in 
single clear visible bands observed at the expected 111 bp regions. No bands can be seen in 





6.2.7 Analysis of the quantitative real time PCR (qRT-PCR) results of selected reference 
genes 
Quantitative real time PCR is a fluorescent based technique used to measure the level of 
expression of target genes with the aid of fluorescent dye such as SYBR Green (Bioline, UK). 
By plotting fluorescence against the cycle number, an amplification plot that represents the 
accumulation of product over the duration of the PCR reaction was generated.  
Appropriate normalization was performed to sort out experimental errors that may arise from 
extraction of RNA and generation of cDNA. The use of multiple stable reference genes is 
generally accepted as the method of choice for RT-qPCR data normalization (Turabelidze et 
al., 2010; Crawford et al., 2016). Thus, multiple reference genes (16S rRNA, gmk and gyrA) 
was used in this study for accurate normalization of the target genes, as it is assumed that their 
expression levels are constant in the bacterial cells. Each run of qPCR has a standard curve that 
was generated through serial dilution of cDNA. 
6.2.7.1 Amplification efficiency and determination of PCR efficiency of reference genes 
The quantification cycle (Ct) for each gene expression reaction was plotted against the log of 
cDNA concentration, and the slopes of the curves were used to calculate the PCR efficiency 
values for the reference genes, which ranged from 95 to 105 for ATCC 6538 and 88 to 100 for 
MRSA 252 with regression coefficients and target genes which ranged from 95 to 102 for 
ATCC 6538 and 95 to 103 for MRSA 252 with regression coefficients (Table 28). For melting 
points of the qPCR products all primers amplified well. Melting curve analysis showed a single 
peak for both the reference genes studied. For RT-PCR analysis of the target genes, only the 
genes found to be positive and present in both MRSA 252 and ATCC 6538 were assessed for 
expression levels in the strains. This was to allow a relative comparison of the expression levels 







Table 28. Reference and target genes efficiency determination, amplicon melting points 
and r 2 values for the curves. 
 
6.2.7.2 Assessment of stability and validation of reference genes 
Relative expression levels (Ct values) of the reference genes investigated in ATCC 6538 and 
MRSA 252 biofilms were entered into the geNorm Microsoft Excel (Microsoft Canada, 
Mississauga, ON) application which calculated stability values (M values) for each gene listed 
above. GeNorm excel was also used to calculate normalization factors using combinations of 
the most stably expressed genes and calculated the pairwise variation between these factors to 
identify the optimum number of reference genes to use. The three genes with the lowest 
individual M values were used in combination (16S rRNA, gmk, gyrA) for subsequent 
expression analysis. M-value results are present in Figure 92 and 93.  
 ATCC 6538      MRSA252 ATCC 6538      MRSA252 ATCC 6538     MRSA252 
Reference 
genes 
r2 on the amplification curve PCR amplification efficiency (%) Melting temperature (oC) 
tpiA 0.964 0.991 102 100 80 80 
rrSC 0.997 0.891 101 100 80 80 
proC 0.913 0.796 95 88 80 80 
rho 0.981 0.698 103 90 79 79 
rpod 0.991 0.987 103 95 80 80 
gyrA 0.991 0.975 97.6 97.6 80 80 
glyA 0.976 0.876 95.9 99 80 80 
gmk 0.987 0.997 96 100 75-80 75-80 
16S rRNA 0.995 0.666 105 100 85 85 
       
 ATCC 6538      MRSA252 ATCC 6538      MRSA252 ATCC 6538     MRSA252 
Target 
genes 
r2 on the amplification curve PCR amplification efficiency (%) Melting temperature (oC) 
icaA 0.908 0.78 100 100 80 80 
icaB 0.942 0.803 104 100 80 80 
icaC 0.995 0.994 95 102 80 80 
icaD 0.717 0.942 100 99           80 80 
fnbA 0.976 0.771 101 97 80 80 
fnbB 0.948 0.843            100 98 80 80 
fib 0.678 0.78 100 99 80 80 
clfA 0.699 0.664 102 101 80 80 
clfB 0.994 0.993 100 100 80 80 
agrA 0.913 0.991 99 103 80 80 
eno 0.993 0.976 100 95 80 80 
mecA - 0.866 - 95 85 85 
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Figure 92. Mean Ct values obtained from RT-qPCR expression levels of nine reference genes in ATCC 
6538. Values are means of triplicate readings. Error bars are standard deviation of means of ct values. 
                     
Figure 93. Mean Ct values obtained from RT-qPCR expression levels of nine reference genes in MRSA 252. 
Values are means of triplicate readings. Error bars are standard deviation of means of ct values 
Figure 92 and 93 shows the histogram representing the mean Ct values of nine 
housekeeping/reference genes determined in three different time points: 12 h, 24 h and 48 h 
biofilm formation. For each condition, Ct was measured from three independent cDNA (12 h, 
24 h and 48 h cDNA); the means are represented in the histogram. The genes showed a wide 







16S tpiA gmk proC rho gyrA rpoD glyA rrsC















gmk 16s tpia gyrA proC rho rpod rrsC glyA









expression with low mean Ct value (8.22 ± SD 0.11), gmk (6.43 ± SD 0.24), tpiA (13.49 ± SD 
0.12), rho (14.84 ± SD 0.13) proC (14.45 ± SD 0.24) and gyrA (18.34 ± SD 0.40). Figure 8.6 
B, shows MRSA 252, 16S rRNA presented the highest expression with low mean Ct value 
(7.15 ± SD 0.16), gmk (5.34 ± SD 0.15), tpiA (14.49 ± SD 0.18), rho (15.84 ± SD 0.16) proC 
(16.45 ± SD 0.19) and gyrA (15.84 ± SD 0.40). Low Ct value indicates higher gene expression.  
In Figure 94 and 95 below, the expression stability (M) assessment of the nine reference genes 
as obtained using the geNorm applet was done by first transforming the mean Ct values into 
quantities for relative comparison. The transformed relative quantities were entered into the 
Microsoft Excel visual basic application geNorm, which calculated stability values (M values) 
for nine references based on the mean Ct values. The genes with the lowest M values have the 
most stable expression. The reference genes all achieved high expression stability criterion, 
with M <0.788, which is well below the default limit of 1.5 recommended by geNorm to 
identify reference genes with stable expression.  
               




                 
Figure 95. The stability value ranking of the reference genes in MRSA 252, as determined by geNorm. 
Figure 94 and 95 shows that M represents the mean pairwise variation between an individual 
reference gene and all other tested reference genes. The most stable reference genes are those 
that are still included, i.e., those that exhibit the lowest M values. Shown is the stability ranking 
of the reference genes in all samples. Genes are ranked from left to right in order of increasing 
expression stability (decreasing M value). The summary of the stability value of each gene 
generated by geNorm software is given in Table 29-30. 
Table 29. Stability (M) value calculated using the GeNorm software  
Reference genes geNORM (M values) 
M < 1.5 values 
Reference genes geNORM (M values) 
M < 1.5 values 
ATCC 6538                                                        MRSA 252 
rho 0.788 tpiA 0.692 
tpiA 0.656 glyA 0.621 
rpod 0.588 rpod 0.583 
glyA 0.531 gyrA 0.521 
proC 0.485 rrsC 0.432 
gyrA 0.412 rho 0.222 
rrsC 0.421 16 s 0.120 
gmk 0.189 gmk 0.09 
16 s 0.189 proC 0.09 
 
In this analysis, all the reference genes presented M values less than the geNorm threshold of 
1.5, which is considered as stable. However, the two genes with the lowest individual M values 
and one with minimally low M value were used in combination for subsequent expression 
analysis. The stability was again assessed using the normFinder software for a better 
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confirmation. Using the NormFinder program the nine reference genes were further assessed 
for their expression stability (M). 
Table 30. Stability (M) values calculated using the NormFinder software 
 
Stability value Predicted stability with combinations geNORM (M 
values) 
M < 1.5 values 
Gene name ATCC6538 MRSA 252   
16S 0.058 0.048 M value of ATCC 6538  
tpiA 0.305 0.256 Stability value of 16S with stability value 
of gmk 
0.031 
rrsC 0.199 0.221   
proC 0.135 0.176   
rho 0.198 0.178 M value of MRSA 252  
rpod 0.334 0.231 Stability value of proC with stability value 
of gmk 
0.093 
gyrA 0.080 0.095   
glyA 0.305 0.062   
gmk 0.008 0.009 
  
     
 
The result obtained from both the geNorm and NormFinder programs for the stability test of 
the nine reference genes tested indicates that 16S and gmk are the two most stable genes. These 
results seem to correlate each other. However, normFinder suggests that gmk is the most stable 
gene. Other stable genes identified by geNorm include proC, rrsC and gyrA. Thus, 16S, gmk 
and gyrA were choosen for this study.  
6.2.7.3 Analysis of the quantitative real time PCR (qRT-PCR) results of selected target 
genes  
RT-PCR expression results of selected target genes in MRSA 252 and ATCC 6538 biofilms at 
different growth time points before and after treatment with African walnut, cashew and 
pumpkin oils are presented below. 








Expression results of icaA gene in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 96. The expression of icaA gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and after 
treatment with African walnut and fluted pumpkin oils. 
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MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of icaA in MRSA 252 
and ATCC 6538 was monitored by quantitative real time PCR (qRT-PCR) and data presented 
on the graph is log base 2-fold change. Expression of icaA was normalized to untreated control 
sample (calibrator) at 6 h and three reference genes (16S rRNA, gmk and gyrA). (A) expression 
of icaA in ATCC 6538 biofilm before and after treatment with African walnut oil (B) 
expression of icaA in MRSA 252 biofilm before and after treatment with African walnut oil 
(C) expression of icaA in ATCC 6538 biofilm before and after treatment with pumpkin oil (D) 
expression of icaA in MRSA 252 biofilm before and after treatment with pumpkin oil. The data 
on the graphs are values of three biological replicates with three technical replicates performed 
independently for each oil treatment. Error bars (n=3) represents standard deviation of log 
transformed values of fold change and were analysed using t-test. 
Based on the data on the graph, no oil controls of MRSA 252 and ATCC 6538 exhibited varying 
degrees of expression at 12 h, 24 and 48 h. Generally, at 12 h, icaA was down-regulated, at 24 
h, it was up-regulated and at 48 it was down-regulated. However, after treatment of ATCC 
6538 biofilm with pumpkin oil icaA gene was down-regulated at 12 and 24 h with fold change 
0.536 and 0.433 (P = 0.01) (t-test) and up regulated at 48 h (3.16) (P = 0.02). In MRSA 252 
biofilm, icaA gene was down-regulated at 12 h (0.111), 24 h (0.475) and up-regulated at 48 h 
(3.08) (P = 0.01). On the other hand, African walnut oil significantly down-regulated icaA in 
ATCC 6538 and MRSA 252 biofilms giving fold changes of -1.446 (P = 0.04), -0.133 (P = 
0.02), -1.211 and -1.248 (P = 0.016), -0.29, -1.36 (P = 0.01) at 12, 24 and 48 h. Result shows 
that at 24 h when the gene was up-regulated, both oils were able to down-regulate the gene. 
But an up-regulation was observed at 48 h in both strains after pumpkin oil treatment. The 
expression pattern of icaA gene in both MRSA 252 and ATCC 6538 was completely different 








Expression results of icaB gene in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 97. The expression of icaB gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and after 





MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of icaB in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
fold change. Expression of icaB was normalized to untreated control sample (calibrator) at 6 h 
and three reference genes (16S rRNA, gmk and gyrA). (A) expression of icaB in ATCC 6538 
biofilm before and after treatment with African walnut oil (B) expression of icaB in MRSA 
252 biofilm before and after treatment with African walnut oil (C) expression of icaB in ATCC 
6538 biofilm before and after treatment with pumpkin oil (D) expression of icaB in MRSA 252 
biofilm before and after treatment with pumpkin oil. The data on the graphs are values of three 
biological replicates with three technical replicates performed independently for each oil 
treatment. Error bars (n=3) represents standard deviation of log transformed values of fold 
change and were analysed using t-test. 
Quantitative RT-PCR results shows that icaB was down-regulated in MRSA 252 and ATCC 
6538 biofilms after treatment with oils. Based on the data on the graph, no oil controls of 
MRSA 252 and ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. 
Generally, at 12 h, icaB was down-regulated, at 24 h, it was up-regulated and at 48 it was down-
regulated. After treatment of ATCC 6538 biofilm with pumpkin oil surprisingly, icaB gene was 
up-regulated at 12 h (3.32), 24 h (2.664) (P = 0.02) and down-regulated at 48 h (-2.737) (P = 
0.01). In MRSA 252 biofilm, icaB gene was also up-regulated at 12 h (2.032), 24 h (7.786) and 
down-regulated at 48 h (-2.737) (P = 0.03). On the other hand, African walnut oil significantly 
down-regulated icaB in ATCC 6538 and MRSA 252 biofilms giving fold changes of -1.569 (P 
= 0.01), -2.237, -1.211 (P = 0.03) and -2.301, -0.536 and -3.442 (P = 0.02) at 12, 24 and 48 h. 
But at 12 h, icaB gene was up-regulated in ATCC 6538. Treatment of ATCC 6538 bioilms 
with pumpkin oil seem to provoke an up-regulation of icaB gene at 12 and 24 h instead of a 
down-regulation. The expression pattern of icaB gene in both MRSA 252 and ATCC 6538 was 







Expression results of icaC gene in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 98. The expression of icaC gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and after 





MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of icaC in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
fold change. Expression of icaC was normalized to untreated control sample (calibrator) at 6 h 
and three reference genes (16S rRNA, gmk and gyrA). (A) expression of icaC in MRSA 252 
biofilm before and after treatment with African walnut oil (B) expression of icaC in ATCC 
6538 biofilm before and after treatment with African walnut oil (C) expression of icaC in 
MRSA 252 biofilm before and after treatment with pumpkin oil (D) expression of icaC in 
ATCC 6538 biofilm before and after treatment with pumpkin oil. The data on the graphs are 
values of three biological replicates with three technical replicates performed independently 
for each oil treatment. Error bars (n=3) represents standard deviation of log transformed values 
of fold change and were analysed using t-test.  
Figure 98 shows that icaC was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. Based on the data on the graph, no oil controls of MRSA 252 and ATCC 
6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. Generally, at 12 h, icaC was 
down-regulated, at 24 h, it was up-regulated and at 48 it remained up-regulated which was 
quite different to the pattern of growth regulation exhibited by icaABD. However, it was 
observed that the treatment of MRSA 252 and ATCC 6538 biofilms at 12, 24 and 48 h with 
pumpkin oil led to a significant down-regulation of icaC in the strains giving fold changes of 
0.536, 0.43, 3.16 (P = 0.01 and P = 0.03 for 24 and 48 h) and 0.941, 1.321 and 2.815 (P = 0.03). 
Furthermore, treatment of MRSA 252 biofilm with walnut oil significantly resulted in down-
regulation of icaC gene with fold changes of -1.569 (P = 0.03), -0.133, and -1.211 (P = 0.018) 
at 12, 24 and 48 h. This pattern was different in ATCC 6538 which gave fold change values of 
-3.293(P = 0.23), 0.02 and -2.380 with (P = 0.04 for 12, and 48 h). Again, the expression pattern 
of icaC gene observed after African walnut and pumpkin oil treatments of both MRSA 252 and 







Expression results of icaD gene in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 99. The expression of icaD gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and 
after treatment with African walnut and fluted pumpkin oils 
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MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of icaD in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
fold change. Expression of icaD was normalized to untreated control sample (calibrator) at 6 h 
and three reference genes (16S rRNA, gmk and gyrA). (A) expression of icaD in MRSA 252 
biofilm before and after treatment with African walnut oil (B) expression of icaD in ATCC 
6538 biofilm before and after treatment with African walnut oil (C) expression of icaD in 
MRSA 252 biofilm before and after treatment with pumpkin oil (D) expression of icaD in 
ATCC 6538 biofilm before and after treatment with pumpkin oil. The data on the graphs are 
values of three biological replicates with three technical replicates performed independently 
for each oil treatment. Error bars (n=3) represents standard deviation of log transformed values 
of fold change and were analysed using t-test. 
Figure 99 shows that icaD was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. According to the data on the graph, no oil controls of MRSA 252 and 
ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. Generally, at 12 h, 
icaD was down-regulated, at 24 h, it was up-regulated and at 48 it was down-regulated. It was 
observed that the treatment of MRSA 252 and ATCC 6538 biofilms with pumpkin oil resulted 
to down-regulation of icaD in the strains giving fold changes of 0.903, 0.722, -0.8365 (P = 
0.026) and 0.731, 0.623 (P = 0.04) and -2.321 (P = 0.01). Although, icaD gene was generally 
down-regulated, it appeared more down-regulated in ATCC 6538 with fold change value of -
2.321. Expression of icaD gene after walnut oil treatment in MRSA 252 and ATCC 6538 was 
also down-regulated giving fold change values of -1.800, -1.556 (P = 0.13), -0.168 and -1.727, 
0.688 and 0.163 (P = 0.02). Treatment of MRSA 252 and ATCC 6538 bioilms with oils did 
not cause any up-regulation of icaD gene. The expression pattern of icaD gene observed after 
treating MRSA 252 and ATCC 6538 biofilms with African walnut and pumpkin oils were 










Expression results of fnbA gene in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 100. The expression of fnbA gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and 




MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h.  Expression of fnbA in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
fold change. Expression of fnbA was was normalized to untreated control sample (calibrator) 
at 6 h and three reference genes (16S rRNA, gmk and gyrA). (A) expression of fnbA in MRSA 
252 biofilm before and after treatment with African walnut oil (B) expression of fnbA in ATCC 
6538 biofilm before and after treatment with African walnut oil (C) expression of fnbA in 
MRSA 252 biofilm before and after treatment with pumpkin oil (D) expression of fnbA in 
ATCC 6538 biofilm before and after treatment with pumpkin oil. The data on the graphs are 
values of three biological replicates with three technical replicates performed independently 
for each oil treatment. Error bars (n=3) represents standard deviation of log transformed values 
of fold change and were analysed using t-test. 
Figure 100 shows that fnbA was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. Based on the data on the graph, no oil controls of MRSA 252 and ATCC 
6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. Based on the results, the 
pattern of expression of fnbA in MRSA 252 and ATCC 6538 appears very different compared 
to that of icaABDC genes. In the expression pattern observed before treatment of biofilms, fnbA 
gene in no oil control at 12, 24 and 48 h were up-regulated. Thus, it was further observed that 
after the treatment of MRSA 252 and ATCC 6538 biofilms with pumpkin oil, fnbA was down-
regulated in the strains giving fold changes of -0.120 (P = 0.01), -2.120, -1.599 (P = 0.02) and 
-0.120, -0.152 and 0.251 (P = 0.22). Similarly, African walnut oil treatment of MRSA 252 and 
ATCC 6538 biofilms, down-regulated fnbA gene giving fold change values of -0.355 (P = 
0.01), -1.358, -1.776 (P = 0.03) and 3.167 (P = 0.10), -0.761 and -1.023 (P = 0.04). African 
walnut oil appears to cause an up-regulation of fnbA gene at 12 h. The expression pattern of 
fnbA gene observed after oil treatments of both MRSA 252 and ATCC 6538 biofilm was 








Expression results of fnbB gene in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 101. The expression of fnbB gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and 
after treatment with African walnut and fluted pumpkin oils. 
MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of fnbB in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
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fold change. Expression of fnbB was normalized to untreated control sample (calibrator) at 6 h 
and three reference genes (16S rRNA, gmk and gyrA). (A) expression of fnbB in MRSA 252 
biofilm before and after treatment with African walnut oil (B) expression of fnbB in ATCC 
6538 biofilm before and after treatment with African walnut oil (C) expression of fnbB in 
MRSA 252 biofilm before and after treatment with pumpkin oil (D) expression of fnbB in 
ATCC 6538 biofilm before and after treatment with pumpkin oil. The data on the graphs are 
values of three biological replicates with three technical replicates performed independently 
for each oil treatment. Error bars (n=3) represents standard deviation of log transformed values 
of fold change and were analysed using t-test.  
Figure 101 shows that fnbB was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. According to the data on the graph, no oil controls of MRSA 252 and 
ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. The pattern of 
expression of fnbA in MRSA 252 and ATCC 6538 seem similar to that of fnbB gene with up-
regulation at 12, 24 and 48 h growth time points. However, treatment of biofilms of MRSA 
252 and ATCC 6538 with pumpkin oil resulted in the repression of fnbB at 12, 24 and 48 h 
giving fold change values of -0.943 (P = 0.03), -1.029, -1.490 (P = 0.05) and -0.286 (P = 0.02), 
-1.358 (P = 0.04) and -2.251 (P = 0.03). Whereas, the treatment of MRSA 252 and ATCC 6538 
biofilms with walnut oil led to down-regulation of -0.556, -0.533 (P = 0.05) -1.776 (P = 0.15) 
and -0.136 (P = 0.001), -1.029 (P = 0.03). and 1.775 (P = 0.13). The expression pattern of fnbB 
gene observed after walnut and pumpkin oil treatments of both MRSA 252 and ATCC 6538 











Expression results of fib gene in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 102. The expression of fib gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and after 
treatment with African walnut and pumpkin oils 
MRSA 252 and ATCC 6538 were cultured with 31.25 and 15.6 mg/mL (African walnut oil) 
and pumpkin oil (125 and 62.5 mg/mL) of African walnut and pumpkin oils for 12, 24 and 48 
h. Expression of fib in MRSA 252 and ATCC 6538 was monitored by qRT-PCR and data 
presented on the graph is log base 2-fold change. Expression of fib was normalized to untreated 
control sample (calibrator) at 6 h and three reference genes (16S rRNA, gmk and gyrA). (A) 
expression of fib in ATCC 6538 biofilm before and after treatment with walnut oil (B) 
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expression of fib in MRSA 252 biofilm before and after treatment with walnut oil (C) 
expression of fib in MRSA 252 biofilm before and after treatment with pumpkin oil (D) 
expression of fib in ATCC 6538 biofilm before and after treatment with pumpkin oil. The data 
on the graphs are values of three biological replicates with three technical replicates performed 
independently for each oil treatment. Error bars (n=3) represents standard deviation of log 
transformed values of fold change and were analysed using t-test. 
Figure 102 shows that fib was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. According to the data on the graph, no oil controls of MRSA 252 and 
ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. The pattern of 
expression of fib in MRSA 252 and ATCC 6538 appears different to that of fnbA and fnbB 
gene.  In its normal expression before treatment, fib was down-regulated at 12 h, 24 h and 48 
h. Gene with up-regulation at 12, 24 and 48 h growth time points. However, treatment of 
biofilms of MRSA 252 and ATCC 6538 with pumpkin oil resulted in the further down-
regulation of fib giving fold change values of -1.89, (P = 0.21) -1.12, -1.49 (P = 0.05) and -
2.25, -2.56- (P = 0.14) and -1.21 (P = 0.04). African walnut oil, down-regulated fib giving fold 
changes of -2.47, -2.06 (P = 0.12) and -1.78 in MRSA 252 and -0.377, -0.246 (P = 0.02) and -
1.356 (P = 0.04) in ATCC 6538. The expression pattern of fib gene observed after walnut and 
pumpkin oil treatments of both MRSA 252 and ATCC 6538 was completely different from the 












Expression results of clfA genes in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 103. The expression of clfA gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and 
after treatment with African walnut and fluted pumpkin oils. 
MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of clfA in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
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fold change. Expression of clfA was normalized to untreated control sample (calibrator) at 6 h 
and three reference genes (16S rRNA, gmk and gyrA). (A) expression of clfA in MRSA 252 
biofilm before and after treatment with African walnut oil (B) expression of clfA in ATCC 
6538 biofilm before and after treatment with African walnut oil (C) expression of clfA in ATCC 
6538 biofilm before and after treatment with pumpkin oil (D) expression of clfA in MRSA 252 
biofilm before and after treatment with pumpkin oil. The data on the graphs are values of three 
biological replicates with three technical replicates performed independently for each oil 
treatment. Error bars (n=3) represents standard deviation of log transformed values of fold 
change and were analysed using t-test. 
Figure 103 shows that clfA was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. According to the data on the graph, no oil controls of MRSA 252 and 
ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. The pattern of 
expression of clfA gene observed in MRSA 252 and ATCC 6538 is a down-regulation of the 
gene at 12, 24, 48 h. Therefore, treatment of MRSA 252 and ATCC 6538 biofilms with African 
walnut and pumpkin oil only further down-regulated the gene. Gene clfA was down-regulated 
after walnut oil treatment with fold changes of -0.358 (P = 0.02), -1.79, -2.38 (P = 0.038), and 
-0.811, -0.863 (P = 0.03) and -2.96 (P = 0.14) in MRSA 252 and ATCC 6538. Whereas 
pumpkin oil down-regulated the gene giving fold change values of -0.184, -1.943, -0.13 (P = 













Expression results of clfB genes in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
 
Figure 104. The expression of clfB gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and 
after treatment with African walnut and fluted pumpkin oils. 
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MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of clfB in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
fold change. Expression of clfB was normalized to untreated control sample (calibrator) at 6 h 
and three reference genes (16S rRNA, gmk and gyrA). (A) expression of clfB in MRSA 252 
biofilm before and after treatment with African walnut oil (B) expression of clfB in ATCC 
6538 biofilm before and after treatment with African walnut oil (C) expression of clfB in 
MRSA 252 biofilm before and after treatment with pumpkin oil (D) expression of clfB in 
ATCC 6538 biofilm before and after treatment with pumpkin oil. The data on the graphs are 
values of three biological replicates with three technical replicates performed independently 
for each oil treatment. Error bars (n=3) represents standard deviation of log transformed values 
of fold change and were analysed using t-test. 
Figure 104 shows that clfB was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. According to the data on the graph, no oil controls of MRSA 252 and 
ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. The pattern of 
expression of clfB gene observed in MRSA 252 and ATCC 6538 is that the gene is up-regulated 
all through the different time points. However, treatment of MRSA 252 and ATCC 6538 
biofilms with African walnut and pumpkin oil down-regulated the gene at 12, 24 and 48 h. 
Gene clfB was down-regulated with fold changes of -0.354 (P = 0.01), -1.79, -2.40 (P = 0.21) 
in MRSA 252 and -2.252 (P = 0.04), -1.25 (P = 0.02), -3.06 (P = 0.14) in ATCC 6538. Whereas 
pumpkin oil up-regulated the gene giving 2.316 (P = 0.26), 3.151 (P = 0.33), -1.10 (P = 0.03) 
fold changes in MRSA 252 and down-regulation in ATCC 6538 with -0.12 (P = 0.01), -1.538 










Expression results of agrA genes in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
    
Figure 105. The expression of agrA gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and 




MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of agrA in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
fold change. Expression of agrA was normalized to untreated control sample (calibrator) at 6 
h and three reference genes (16S rRNA, gmk and gyrA). (A) expression of agrA in ATCC 6538 
biofilm before and after treatment with African walnut oil (B) expression of agrA in MRSA 
252 biofilm before and after treatment with African walnut oil (C) expression of agrA in MRSA 
252 biofilm before and after treatment with pumpkin oil (D) expression of agrA in ATCC 6538 
biofilm before and after treatment with pumpkin oil. The data on the graphs are values of three 
biological replicates with three technical replicates performed independently for each oil 
treatment. Error bars (n=3) represents standard deviation of log transformed values of fold 
change and were analysed using t-test. 
Figure 105 shows that agrA was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. According to the data on the graph, no oil controls of MRSA 252 and 
ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. The pattern of 
expression of agrA gene observed in MRSA 252 and ATCC 6538 is that the gene is up-
regulated at 12 and 24 h time points. However, treatment of MRSA 252 and ATCC 6538 
biofilms with walnut oil down-regulated the gene at 12, 24 and 48 h. Walnut oil down-regulated 
agrA gene giving fold changes of -0.934 (P = 0.02), -1.385 (P = 0.25), -4.152 (P = 0.14) and 
0.89 (P = 0.01), -1.184, (P = 0.02) -3.418 (P = 0.17) in MRSA 252 and ATCC 6538. Whereas 
in MRSA 252 pumpkin oil down-regulated the gene at 12 h and 24 h with 0.1, -0.535- (P = 
0.03) and -2.377 (P = 0.30) -fold changes. On the other hand, pumpkin oil also down-regulated 










Expression results of eno genes in MRSA 252 and S. aureus ATCC 6538 biofilms before 
and after treatment with African walnut and fluted pumpkin oils. 
     
Figure 106. The expression of eno gene in biofilms of MRSA 252 and S. aureus ATCC 6538 before and 




MRSA 252 and ATCC 6538 were cultured with African walnut oil (31.25 and 15.6 mg/mL) 
and pumpkin oil (125 and 62.5 mg/mL) for 12, 24 and 48 h. Expression of eno in MRSA 252 
and ATCC 6538 was monitored by qRT-PCR and data presented on the graph is log base 2-
fold change. Expression of eno was normalized to untreated control sample (calibrator) at 6 h 
and three reference genes (16S rRNA, gmk and gyrA). (A) expression of eno in MRSA 252 
biofilm before and after treatment with African walnut oil (B) expression of eno in ATCC 6538 
biofilm before and after treatment with African walnut oil (C) expression of eno in MRSA 252 
biofilm before and after treatment with pumpkin oil (D) expression of eno in ATCC 6538 
biofilm before and after treatment with pumpkin oil. The data on the graphs are values of three 
biological replicates with three technical replicates performed independently for each oil 
treatment. Error bars (n=3) represents standard deviation of log transformed values of fold 
change and were analysed using t-test. 
Figure 106 shows that eno was down-regulated in MRSA 252 and ATCC 6538 biofilms after 
treatment with oils. According to the data on the graph, no oil controls of MRSA 252 and 
ATCC 6538 exhibited varying degrees of expression at 12 h, 24 and 48 h. The pattern of 
expression of eno gene observed in MRSA 252 and ATCC 6538 is that the gene is up-regulated 
only at 12 h only. However, treatment of MRSA 252 and ATCC 6538 biofilms with African 
walnut oil and pumpkin oil only further down-regulated the gene at 12, 24 and 48 h. Although 
pumpkin oil up-regulated the gene in MRSA 252 at 48 h. Based on the results, African walnut 
oil down-regulated eno gene giving fold changes of 0.749, -0.578 (P = 0.03), -2.184 (P = 0.13) 
and -1.286 (P = 0.05), -1.359 (P = 0.03), -2.381(P = 0.24) in MRSA 252 and ATCC 6538. 
Whereas in ATCC 6538 and MRSA 252 pumpkin oil down-regulated the gene but at 48 h a -










Expression results of mecA and blaZ genes in MRSA 252 biofilms before and after 
treatment with African walnut and fluted pumpkin oils. 
The expression levels of antibiotic resistance genes (mecA and blaZ genes) were assessed in 
MRSA 252 biofilm because it was only positive in this strain.  
       
Figure 107. The expression of mecA and blaZ gene in biofilms of MRSA 252 before and after treatment 
with African walnut and fluted pumpkin oils. 
MRSA 252 were cultured with African walnut oil (31.25 mg/mL) and pumpkin oil (125) for 
12, 24 and 48 h. Expression of mecA and blaZ in MRSA 252 was monitored by qRT-PCR and 
data presented on the graph is log base 2-fold change. Expression of mecA and blaZ was 
normalized to untreated control sample (calibrator) at 6 h and three reference genes (16S rRNA, 
gmk and gyrA). (A) expression of mecA in MRSA 252 biofilm before and after treatment with 
African walnut and pumpkin oil oils at different growth time points.  (B) expression of blaZ in 
MRSA 252 biofilm before and after treatment with African walnut and pumpkin oils. The data 
on the graphs are values of three biological replicates with three technical replicates performed 
independently for each oil treatment. Error bars (n=3) represents standard deviation of log 
transformed values of fold change and were analysed using t-test. 
Figure 107 shows that mecA and blaZ genes were down-regulated in MRSA 252 biofilms after 
treatment with African walnut oil. On the other hand, an up-regulation was observed after 
pumpkin oil treatment. According to the data on the graph, no oil controls of MRSA 252 
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exhibited varying degrees of expression at 12 h, 24 and 48 h. The pattern of expression of mecA 
and blaZ genes observed in MRSA 252 is that the genes are up-regulated only at 12, 24 and 48 
h. However, treatment of MRSA 252 biofilms with walnut oil succeeded in down-regulating 
the mecA gene giving fold changes of -3.23, -3.623 (P = 0.16) and -4.852 (P = 0.02) and blaZ 

























To establish the molecular process of biofilm formation in staphylococcal strains; MRSA 252 
and ATCC 6538, this study attempted to ascertain the levels of expression of genes involved 
in biofilm production which includes fnbA, fnbB, clfA, clfB, fib, eno, ebps and intercellular 
adhesion genes A, B, C and D (icaADBC) genes.  In addition, the expression levels of antibiotic 
resistance genes (blaZ, mecA) as well as regulatory gene (agrA) were ascertained. In this study, 
scanning electron microscopy (SEM) was used to show the growth phases of MRSA 252 and 
S. aureus ATCC 6538 biofilms on 24-well microtiter polystyrene tissue plates model for 6 h, 
12 h, 24 h, 48 h.This model shows that the biofilm growth at the different growth time points 
studied was satisfactory and allows gradual changes (such as slime production, formation of 
arrow heads and division) in the complexity of the biofilms be observed (Figure 63 and 64).  
In addition, RNA extraction from the biofilms of MRSA 252 and S. aureus ATCC 6538 grown 
on 24-well polystyrene plates for 12 h, 24 h, 48 h and the amplification of RT-PCR products, 
visualized on agarose gels electrophoresis allows the confirmation of the presence of 21 genes 
found to be strongly associated with their pathogenicity. Each of these genes have been 
identified in literature to play significant roles in adhesion, biofilm formation, antibiotic 
resistance, food poisoning genes and biofilm regulatory genes (Asthan et al., 2013). Although 
some of the confimed genes were only present in MRSA 252 strain probably because of its link 
in antibiotic resistance. The genes include intercellular adhesion genes icaADBC, biofilm 
related genes such as fibrinogen (fib), fibrinonectin A and B (fnbA and fnbB), collagen (cna), 
laminin (eno), clumping factors A and B (clfA and clfB), elastin (ebps), staphylococcal food 
poisoning genes including enterotoxin genes (Sea), antibiotic resistant genes (mecA ermA, 
blaZ), and quorum sensing transcripts of the agrA system (agrA, RNAII and RNAIII). 
Staphylococcal food poisoning genes are just associated with food poisoning only. However, 
ATCC 6538 contained all of the ica genes, biofilm related genes except cna, agrA transcripts, 
no enterotoxin genes (Sea) and antibiotic resistant genes (mecA ermA, blaZ). MRSA 252 has 
all of the genes except ebps. 
In gene expression analysis, a few authors have emphasized the need to perform qRT-PCR 
using suitable reference genes. Crawford and his co-workers who worked on choosing suitable 
reference genes in Staphylococcus pseudintermedius reported that multiple reference genes 
particularly three genes with M values below 1 is necessary for obtain accurate results 
(Crawford et al., 2014). Similarly, Shito et al., (2014) identified suitable reference genes that 
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could be used to normalise S. aureus in acidic and stress adaptation models. In another study, 
Thesis and his friends used qRT-PCR to identify suitable internals controls that could be used 
for gene expression studies in MRSA strains since they are of the opinion that housekeeping 
genes are easily affected by growth in the presence of antimicrobial compounds. In this study 
multiple reference genes whose stability was firstly determined by the geNORM and 
normFinder softwares were used to study gene expression in MRSA 252 and S. aureus ATCC 
6538 strains. The most stable genes; 16S rRNA, gmk and gyrA were selected as stable based 
on their gene stability measure M values (Figure 95 and 96). The multiple reference genes were 
used inorder to measure the gene expression levels of each target gene correctly. However, 
because 16S rRNA is known to produce multiple gene copies that might cause overflow of the 
signal systems in qPCR, other genes such as gmk and gyrA which are single copy housekeeping 
genes were included in the analysis. 
Gene expression analysis was performed on selected virulence genes found to be present in 
MRSA 252 and ATCC 6538. In staphylococcal biofilms, production of icaADBC and 
extracllular slime play significant role in staphylococcal biofilm formation (Lister and Horswill 
2014; Nourbakhsh and Namvar 2016; Saba et al., 2018). One of the main objectives of this 
study is to determine whether the biofilm genes coding for icaADBC, biofilm related genes, 
antibiotic resistant genes as well as regulatory genes are expressed at different levels along the 
growth time points of biofilm formation and whether the expressions of these genes could be 
down-regulated with natural antimicrobials such as oils of walnut and pumpkin. A previous 
study conducted by Resch and his co-workers on biofilm and planktonic cells, showed that 
intercellular adhesion gene expression is essential for formation of biofilm in staphylococci 
between 6 and 8 h of growth which they found to be the beginning of biofilm development. 
However, the result obtained in this study are contradictory, where the icaADBC expression 
levels were found to be down-regulated at 6 and 12 h in MRSA 252 and ATCC 6538. However, 
in a similar study by Asthan et al., (2013), icaADBC genes were found to be down-regulated 
between 6-12 h, up-regulated at 24 h and down-regulated at 48 h in MRSA clones. Results 
obtained in this study seem to correlate with that of Asthan et al., (2013), where icaABCD were 
down-regulated at 6 and 12 h, up-regulated at 24 h and down-regulated again at 48 h. Of all the 
icaADBC genes tested icaC expression levels have been found to increase in MRSA 252 and 
ATCC 6538 biofilms at the exponential and post exponential phase. Similarly, it has been 
shown by Vandecasteele et al., (2003) and Asthan et al., (2013) that icaC was the only gene 
that is highly expressed at 24 and 48 h in icaA gene family. Its increase at 48 h was linked to 
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factors such as environmental factors, growth media and the nature of the strain which play 
significant roles in the regulation of biofilm gene expression (Vandecasteele et al., 2003; 
Beloin et al., 2006).  
A confirmation of a series of microbial surface components known to facilitate adhesion of 
staphylococci to host factors were also performed. These surface components are known as 
MSCRAMMs and they can bind to one or more host ECM factors including fibrinogen (fib), 
fibrinonectin A and B (fnbA and fnbB), collagen (cna), laminin (eno), elasting binding protein 
(ebps), clumping factors A and B (clfA and clfB). Many of these MSCRAMMs showed high 
level of expression at 12 h and the level of expression of the genes remained up-regulated 
during the entire biofilm growth time points. ClfB expression level was high at 12 h, followed 
by fnbA, B and ebps which showed increased fold change at 24 h and 48 h in MRSA 252 and 
ATCC 6538. In a previous report, Ytheir et al., (2012), reported that the expression level of 
clfA in Newman strain was up-regulated after 24 h growth time point. Surprisingly, genes fnbA 
and fnbB encoding fibronectin binding protein A and B was highly expressed in early and in 
mature growth phases of biofilm cells observed at 12 h, 24 h and 48 h. Therefore, in this present 
study, six out of the eight MSCRAMMs were up-regulated all through the different growth 
time points tested. Gene clfA and fib were not up-regulated at all. The results presented in our 
study are contradictory to the results obtained by Kot, Sytykiewicz & Sprawka, (2018) who 
showed that among the biofilm genes, fib gene was significantly enhanced after 12 h. In this 
study, fib gene was down-regulated at the different growth time points before treatment with 
oils. In this study, as in the case of genes encoding MSCRAMMs, the icaADBC genes are up-
regulated at 24 h signifying the beginning and peak of biofilm formation. This indicates that 
products of these genes are associated with the initial colonization phase during biofilm 
formation by S. aureus, rather than maturation and its persistence (Asthan et al., 2013). At the 
later colonization stage (stationary phase), when the cells are already attached to the surface 
and biofilm formation begins and growing of cells is retarded due to nutrient depletion, increase 
of expression levels of these icaADBC genes is probably no more necessary. Our results were 
in concordance with the results obtained by Beenken et al. (2004), who did not observe an 
increase in icaD expression at exponential stage but at postexponential stages of biofilm 
formation (24 h). Overall, the gene expression levels of the icaADBC genes was observed to 
flunctuate over time in MRSA 252 and ATCC 6538 tested with variations in expression levels.  
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It has been reported that antimicrobial drugs that exhibit little or no effect on bacterial growth 
can affect the expression of S. aureus virulence factors when used at subinhibitory 
concentrations. The antibiotics may induce regulation of the virlence genes or result in 
aggravation or attenuation of the infection (Qiu et al., 2012). Similarly, after confirming the 
presence of icaABDC genes, biofilm related genes and a few antibiotic resistant genes in MRSA 
252 and ATCC 6538 biofilms, the test whether walnut and pumpkin oils found to be active in 
MICs and MBICs would mediate the inhibition of the virulence genes was determined. Using 
qRT-PCR, walnut oil was found to significantly decrease the expression of icaABDC genes as 
well as other biofilm associated and mostly especially the agrA gene that coordinately regulate 
most of the virulence genes studied.  After the treatment of MRSA 252 and ATCC 6538 
biofilms with varying concentrations of walnut oil and pumpkin oil, all the icaABCD genes 
and MSCRAMMs were found to be down-regulated although there was some up-regulation of 


















Chapter 7. Screening African Walnut, Cashew and Pumpkin Oils for 
Synergy, Kill Kinetics and Establishing the Efficacy of African Walnut Oil 
in the Treatment of Staphylococcal Infections using Galleria mellonella as an 
in-vivo model 
7.1 Introduction 
S. aureus is an important hospital and community acquired pathogen (Wang and Ruan, 2017). 
S. aureus has been established to be responsible for infections acquired in the hospital causing 
diseases in 3% of all patient admissions in UK and 10% in Nigeria and other countries like 
Ethiopia and Burkina Faso (David and Daum, 2010; Thwaites, 2010; Ige et al., 2011; Mbim et 
al., 2016). Not only does this pathogen cause numerous infections, but S. aureus in many 
hospitals across the world are becoming increasingly resistant to numerous antibiotics (Fair 
and Tor, 2014, Mbim et al., 2016). The rise in staphylococcal infections involving resistant and 
multidrug resistant bacteria and of resistance to antibiotics has limited the therapeutic options 
of treating staphylococcal infections (Magiorakos et al., 2012, Blair et al., 2015). Increased 
resistance presents a major challenge to public health since it reduces the effectiveness of 
antimicrobial drugs as well as increases mortality (Smith and Coast, 2002, Ventola, 2015).  
The burden of infectious diseases is high in developed and underdeveloped countries as is the 
emergence of multidrug pathogens that arise due to poor infection control in hospitals and 
health-care facilities (Okeke et al., 2007; Ventola, 2015), absence of new antibiotics being 
discovered (Newell et al., 2010), availability and lastly misuse of antibiotics (Elder et al., 
2016). Methicillin resistant S. aureus (MRSA) and enterococci resistant to vancomycin are 
important resistant organisms among the Gram-positive bacteria associated with nosocomial 
infections in human (Rice, 2006, Hughes et al., 2018). Many hospitals in the developed and 
under-developed countries including parts of Europe, Japan, and the US, 40-60% of all hospital 
S. aureus are now MRSA (Levy and Marshall, 2004). Worse of it is that a higher percentage 
70-80% of all hospital S. aureus in Nigeria and the neighbouring countries like Cameroon and 
Chad are also now resistant to methicillin (Boswihi and Udo, 2018; Tadesse et al., 2018). The 
emergence of resistance in Klebsiella pneumonia, Pseudomonas aeruginosa, Escherichia coli, 
Acinetobacter which are Gram negative bacteria are also making the treatment of hospital 
infections difficult to treat (Nordmann et al., 2009). Recently it has been reported that majority 
of the drugs that have previously been used in the past in the treatment of infections have 
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suddenly become less effective against the deleterious pathogens (Ventola, 2015, Kok, et al., 
2015). Hence, there is an urgent need to find natural antimicrobials that could serve as 
alternative therapy for the treatment of multidrug resistant pathogens (Savoia, 2012, Upadhyay 
et al., 2014, Cheesman et al., 2017). 
Based on history, plants have been reported useful in folk medicine across the world. In earlier 
days people use local herbs to treat staphylococcal infections because they found them as 
remedies. In those days people first used plants as food and if allows proper digestion, the 
plants are then linked with some curative properties. Till today many vegetable oils including 
those from walnut, pumpkin, cashew have been used in folk medicine throughout the world 
and the medicinal potentials of these oils have been investigated (Petrovska, 2012, Pan et al., 
2014, Yuan et al., 2016). African walnut, cashew and pumpkin oils have been reported to 
possess antifungal, antibacterial, antiviral, anti-inflammatory and analgesic properties (Olajide 
et al., 2004; Souza et al., 2017; Ajileye et al., 2015) and have also found application in food, 
cosmetic and pharmaceutical products. The oils have been used for relieving cold symptoms 
such as cough, cold, sore throat and other staphylococcal infections. In addition, the oils are 
sometimes used as an antiseptic, treatment of skin infections such as heat rash, and respiratory 
disorders (Hayes et al., 2016).  Oils from African walnut, cashew and pumpkin could be 
obtained from the leaves, roots barks, shoots, nuts, seeds and suppose to possess powerful 
antimicrobial properties (Akinhanmi et al., 2008; Bou et al., 2016). However, none of walnut 
and cashew oils obtained from nuts have received adequate attention about their activity against 
drug resistant and susceptible bacteria although the chemical composition of the oils has been 
extensively studied (Crews et al., 2005; Dogan and Akgul, 2005; Uzunova et al., 2015; Poggetti 
et al., 2018;). On the other hand, synergies of walnut, cashew and pumpkin oils in combination 
with antibiotics have not been examined.  
Recently, the use of models in the study of human pathogens has gain momentum over the 5 
years. Very few simple animal models exist which reflect either the biofilm nature of growth 
of pathogens or the treatment of infection influenced by biofilm development in vivo. Using 
G. mellonella model to study interaction between the host and microbe provides many 
advantages for example low cost rearing, convenience ethical status (Bokhari et al., 2017). Of 
recent, G. mellonella, the greater wax moth, emerged as a reliable host model to study the 
pathogenesis of many multidrug resistant pathogen (Bokhari et al., 2017). 
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Surprisingly, the wax worm has the ability to survive under optimum temperature at 37oC just 
as most human pathogens do and which is vital for synthesis of virulence factors. To date, a 
correlation between the capability of a human pathogen to kill wax worm has been established 
(Desbois and Coote, 2011). Here, experiments conducted in this chapter aimed to evaluate the 
bactericidal activity of oils from African walnut, cashew and fluted pumpkin on MRSA 252 
and ATCC 6538 biofilms. This was evaluated using biofilm time kill assay or growth curves 
to really ascertain the time and concentration of each oil sample that is sufficient to kill the 
strains. Investigate the possible synergistic action of the oils with drugs belonging to different 
categories that have been popularly useful in the treatment of staphylococcal infections but 
because of the insurgent of antibiotic resistance has now developed reduced potency/activity 
and lastly study the efficacy of the active oil in treating staphylococcal infections using G. 


















7.2 Result   
7.2.1 Biofilm time-kill assay 
The time kill kinetics of African walnut, cashew and pumpkin oil was performed to determine 
their rate of bactericidal action on MRSA 252 and ATCC 6538 biofilms after been found out 
to have bactericidal effects when the MBEC experiment was performed. This investigation was 
performed against MRSA 252 and S. aureus ATCC 6538 biofilms grown to stationary phase 
(48 hours). Results of the time kill curves of MRSA 252 and ATCC 6538 biofilms are presented 
below.  
Biofilm time kill assay of MRSA 252 and ATCC 6538 after treatment with African walnut 
oil 
The time exposure viability curve for the addition of 100 µL of African walnut oil at 62.5 
mg/mL and 31.25 mg/mL dilution made with TSB to preformed MRSA 252 and ATCC 6538 
formed within 48 h with a viable count of (2.32 X 108 = log 8.37) and (2.12 X 108= log 8.33) 
is presented in Figure 108 and 109. Approximately 5 log cycle reductions of MRSA 252 
biofilm cells were detected and the time kill curve obtained showed that the bacterial count 
decreased rapidly 5 log reductions in 2 h, 6 logs in 4 and 6 h. Then over 8 h bacterial count 
decreased gradually. The viability of MRSA 252 isolate was abolished within 8 h. Therefore, 
the time at which 90% of the bacterial biofilm killed by African walnut oil for this experiment 
was approximately in the period between 6 and 8 h. Therefore, from the result African walnut 
oil at MBEC concentration 62.5 mg/mL was bactericidal against MRSA 252 biofilms as it 
rapidly achieved approximately 5 log (99.999 %) reductions in 2 h, 6 logs in 4 and 6 h. 
However, killing of MRSA 252 and ATCC 6538 at 8 h and 2 h indicates that very little time is 
required by walnut oil to kill MRSA 252 and ATCC 6538.Therefore African walnut oil is 
regarded as highly effective antibacterial oil. Similarly, for ATCC 6538 biofilm 6 log cycle 
reductions of ATCC 6538 biofilm cells was detected and the time kill curve obtained showed 
that the bacterial count decreased rapidly at 2 h. Then over 4 h bacterial count decreased 
gradually. The viability of MRSA 252 biofilm was abolished early within 6 h (Figure 108). 
However, killing of ATCC 6538 biofilms at 2 h indicates that very little time is required by 
walnut oil to kill ATCC 6538. Result shows that African walnut oil at MBEC value of 31.25 
mg/mL was highly bactericidal against ATCC 6538 biofilms as it rapidly achieved 
approximately 6 log reductions in 2 h (Figure 109).    
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Table 31. Biofilm time-killing of African walnut oil against MRSA 252 and S. aureus 
ATCC 6538 
In the above table, the values represent the mean±SD (n=3), SD: standard deviation, CFU: colony forming unit. 
      
 
Figure 108. Time exposure viability curve (log10CFU/mL over 24 h) for mature MRSA 252 biofilm 
incubated with African walnut oil at MBEC (62.5 mg/mL) for 24 h at 37oC 
Data on the graph represent the log of the mean colony forming units of three independent experiments (n=3). 
Values are the mean±SD (n=3), CFU: colony forming unit, time (X-axis): time intervals needed for killing MRSA 
252. Log (CFU/mL) (Y-axis) shows viability of MRSA 252 at different times. The line drawn across the graph 
indicates that bacterial count was from l02. Statistical analysis was performed with Bonferroni’s post-test (Two-
way Anova), asterisk on the graph signifies a significant difference between the mean CFU/mL compared with 
control ***P<0.0001 (P<0.05). 
 
Microorganism MRSA 252 
Time (h) 0 2 4 6 8 10 12 22 24 
Count 
(CFU/mL) 
2.32 x 108 3.20 x 103 2.15 x 103 2.06 x 103 0 0 0 0 0 
log10 
CFU/mL 
8.37 3.72 3.15 2.08 0 0 0 0 0 
 Microorganism S. aureus ATCC 6538  
Time (h) 0 2 4 6 8 10 12 22 24 
Count 
(CFU/mL) 
2.12 x 108 2.23 x 108 0 0 0 0 0 0 0 
log10 
CFU/mL 
8.33 3.83 0 0 0 0 0 0 0 
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Figure 109. Time exposure viability curve (log10CFU/mL over 24 h) for preformed ATCC 6538 biofilm 
incubated with African walnut oil at MBEC (31.25 mg/mL) for 24 h at 37oC. 
Data on the graph represent the log of the mean colony forming units of three independent experiments (n=3). 
Values are the mean±SD (n=3), CFU: colony forming unit, time (X-axis): time intervals needed for killing ATCC 
6538. Log (CFU/mL) (Y-axis) shows viability of ATCC 6538 at different times. Asterisk on the graph signifies a 
significant difference between the mean CFU/mL compared with control ***P<0.001 (P<0.05). 
Biofilm time killing assay of cashew oil against MRSA 252 and ATCC 6538  
The time exposure viability curve for the addition of 100 µL of cashew oil at 500 mg/mL 
dilution previously made with TSB to preformed MRSA 252 and ATCC 6538 formed within 
48 h with a viable count of (2.32 X 108 = log 8.37) and (2.12 X 108= log 8.33) is presented in 
Figure 110 and 111. For MRSA 252 biofilm 4 log cycle reductions (99.99 %) of MRSA 252 
biofilm cells was detected and the time kill curve obtained showed that the bacterial count 
decreased rapidly at 4 h. Then over 4 h bacterial count decreased gradually. The viability of 
MRSA 252 biofilm was abolished within 24 h. However, killing of MRSA 252 biofilms at 22 
h indicates that much longer time is required by cashew oil to kill MRSA252. Result shows 
that cashew oil at MBEC value of 500 mg/mL was not bactericidal against MRSA 252 biofilms 
despite that it rapidly achieved approximately 4 log reductions in 4 h. Similarly, approximately 
4 log cycle reductions (99.99 %) of ATCC 6538 biofilm cells were detected and the time kill 
curve obtained showed that the bacterial count decreased rapidly at 4 log reductions in 2 h. 
Then over 4 h bacterial count decreased gradually. The viability of ATCC 6538 isolate was 
abolished within 22 h. Therefore, the time at which 99.99% of the bacterial biofilm were killed 
by cashew oil for this experiment was approximately in the period between 24 and 22 h. 
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Therefore, from the result cashew oil at MBEC concentration 500 mg/mL was not bactericidal 
against ATCC 6538 biofilms this is because despite that it rapidly achieved approximately 4 
log reductions in 2 h, killing still progressed to 22-24 h in both strains. However, killing of 
MRSA 252 and ATCC 6538 at 24 and 22 h indicates that much longer time is required by 
cashew oil to kill MRSA 252 and ATCC 6538. Therefore, cashew oil is regarded as weak 
antibacterial oil.  
Table 32. Biofilm time-killing of cashew oil against MRSA 252 and S. aureus ATCC 6538 
Microorganism:  MRSA 252 
Time (h) 0 2 4 6 8 10 12 22 24 
Count 
(CFU/mL) 









8.37 6.25 4.23 5.26 5.13 5.00 4.13 4.00 0 
Microorganism:  S. aureus ATCC 6538 












8.33 4.33 4.18 3.45 3.17 2.30 2.15 0 0 
          





                       
 
Figure 110. Time exposure viability curves (log10CFU/mL over 24 h) for preformed MRSA 252 biofilm 
incubated with cashew oil at MBEC (500 mg/mL) at 37oC. 
Data on the graph represent the log of the mean colony forming units of three independent experiments (n=3). 
Values are the mean±SD (n=3), CFU: colony forming unit, time (X-axis): time intervals needed for killing MRSA 
252. Log (CFU/mL) (Y-axis) shows viability of MRSA 252 at different times. Asterisk on the graph signifies a 
significant difference between the mean CFU/mL compared with control ***P<0.0001 (P<0.05). 
 
                             
 
Figure 111. Time exposure viability curves (log10CFU/mL over 24 h) for preformed ATCC 6538 biofilm 
incubated with cashew oil at MBEC (500 mg/mL) at 37oC      
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Data on the graph represent the log of the mean colony forming units of three independent experiments (n=3). 
Values are the mean±SD (n=3), CFU: colony forming unit, time (X-axis): time intervals needed for killing ATCC 
6538. Log (CFU/mL) (Y-axis) shows viability of ATCC 6538 at different times. Asterisk on the graph signifies a 
significant difference between the mean CFU/mL compared with control ***P<0.0001 (P<0.05). 
Biofilm time kill assay of MRSA 252 and ATCC 6538 after treatment with pumpkin oil   
The time exposure viability curve for the addition of 100 µL of pumpkin oil at 250 mg/mL and 
125 mg/mL dilution previously made with TSB to preformed MRSA 252 and ATCC 6538 
formed within 48 h with a viable count of (2.32 X 108 = log 8.37) and (2.12 X 108= log 8.33) 
is presented in Figure 112 and 113. Approximately 4 log cycle reductions of MRSA 252 
biofilm cells at 2 h was detected and the time kill curve obtained showed that the viable count 
of bacteria decreased rapidly from 4 h then over 12 h bacterial count decreased gradually to 
over 24 h. The viability of MRSA 252 isolate was abolished within 12 and 24 h. Therefore, the 
time at which 99.99% of the bacterial biofilm is killed by pumpkin oil in this experiment is 
between 12 and 24 h. Therefore, from the result pumpkin oil at MBEC concentration of 250 
mg/ml was only minimally bactericidal against MRSA 252 biofilms as killing of MRSA 252 
seem to require more time. Similarly, for ATCC 6538 biofilm approximately 5 log reductions 
(99.999) was detected and the time kill curve obtained showed that the bacterial count 
decreased rapidly at 2 h. Then over 6 h bacterial count decreased gradually. The viability of 
ATCC 6538 biofilm was abolished within 10 h. However, killing of ATCC 6538 biofilms at 
10 h indicates that not much time is required by pumpkin oil to kill ATCC 6538. Result shows 
that pumpkin oil at MBEC value of 125 mg/mL was bactericidal against ATCC 6538 biofilms 













Time (h) 0 2 4 6 8 10 12 22 24 
Count 
(CFU/mL) 
2.32 x 108 2.2 x 104 1.5 x 103 2.80 x 102 1.5.x 101 1.1.x 101 0 0 0 
log10 CFU/mL 8.37 4.34 3.18 2.45 1.17 1.04 0 0 0 




Figure 112. Time exposure viability curve (log10CFU/mL over 24 h) for preformed MRSA 252 biofilm 
incubated with pumpkin oil at MBEC (250 mg/mL) for 24 h at 37oC 
Data on the graph represent the log of the mean colony forming units of three independent experiments (n=3). 
Values are the log of mean±SD (n=3) CFU/mL, CFU: colony forming unit, time (X-axis): time intervals needed 
for killing MRSA 252. Log (CFU/mL) (Y-axis) shows viability of MRSA 252 at different times. Asterisk on the 
graph signifies a significant difference between the mean CFU/mL compared with control ***P<0.0001 (P<0.05). 
 
ATCC 6538 
Time (h) 0 2 4 6 8 10 12 22 24 
Count 
(CFU/mL) 
2.12 x 108 1.8 x 103 1.7 x 103 1.7 .x 102 2.10 x 102 0 0 0 0 




Figure 113. Time kill exposure viability curve (log10CFU/mL over 24 h) for preformed ATCC 6538 
biofilm incubated with pumpkin oil at MBEC (125 mg/mL) for 24 h at 37oC 
Data on the graph represent the log of the mean colony forming units of three independent experiments (n=3). 
Values are the log of mean±SD (n=3) CFU/mL, CFU: colony forming unit, time (X-axis): time intervals needed 
for killing ATCC 6538. Log (CFU/mL) (Y-axis) shows viability of ATCC 6538 at different times. Asterisk on the 
graph signifies a significant difference between the mean CFU/mL compared with control ***P<0.0001 (P<0.05). 
7.2.2 Synergy activity of plant oils with antibiotics. 
7.2.2.1 Checkerboard assay 
A series of 4 trials of the individual MIC determination assays for antibiotics were performed 
in triplicates and consistent results were obtained. The MIC was determined as the smallest 
antimicrobial concentration that inhibited bacterial growth as indicated by the darkest purple 
colour. For example, where there was ambiguity in the colour determination, the well with the 
darker purple coloured was chosen as the MIC. The purple colour was chosen because they 
indicate complete inhibition of the bacteria while the light purple colour indicates partial 
inhibition. However, the MICs of individual antibiotic as observed in the plate below indicates 







Figure 114. Representative trial microtiter plate for the individual MIC determination trials. 
In testing for the efficacy of oils with antibiotics, cashew oil was not used because of its weak 
activity. The efficacy of African walnut and pumpkin oil combined with antibiotics were 
determined by checkboard assay, and the results are presented below. In most of the antibiotics 
tested, the MIC value of African walnut oil and pumpkin oil combined with many antibacterial 
agents decreased predominantly, suggesting that both oils exhibited synergistic activity. This 
is the first report concerning the synergistic effects of walnut and pumpkin oil in combination 
with antibiotics against methicillin susceptible and resistant strains. In the checkerboard assay, 
several dilutions below the MIC to above the MICs were tested for each oil sample and 
antibiotic tested against MRSA 252 and ATCC 6538. Antibiotic combinations and oils tested 
includes; 
 
- Vancomycin, streptomycin with walnut oil against MRSA 252  
- Vancomycin, trimethoprim and streptomycin with African walnut oil against S. 
aureus ATCC 6538.  
- Gentamicin, chloramphenicol with pumpkin oil against MRSA 252  
- Vancomycin and rifampicin with pumpkin oil against S. aureus ATCC 6538. 
 
Antibiotics used in testing for drug interactions are those found promising in the disc diffusion 
test. Interpretation of FICI index was carried out for each combination treatments with African 
walnut and pumpkin oils tested on MRSA 252 and ATCC 6538 (tables 34-37). FICI index 
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values were calculated considering all combinations of the oils and antibiotics. In this analysis, 
synergistic activity of African walnut oil with vancomycin was 0.37 (FICI 0.50) and 
streptomycin (FICI 0.75) when tested against MRSA 252. However, combination of African 
walnut oil with vancomycin was 0.50 (FICI 0.50), trimethoprim (FICI 0.19) and streptomycin 
(FICI 0.56) when tested on S. aureus ATCC 6538. The “best combination” of African walnut 
oil and vancomycin, and trimethoprim are the ones giving the lowest FIC Index value (FIC 
Index ≤0.5) against MRSA 252 and ATCC 6538, an indifference interaction (FIC Index >0.5) 
was observed in the combination of African walnut oil with streptomycin for the two strains. 
 
Table 34. Fractional inhibitory concentration (FIC) indices of African walnut oil 
combined with antibiotics. 
 
Key: 
              The MIC concentrations of each antibiotic is highlighted in yellow 
The MIC concentrations of each antibiotic and oil combination is highlighted in pink 
The MIC concentrations of each oil in combination with drug is highlighted in green 







 MRSA 252 
Antimicrobials 1 2 3 4 5 6 7 8 9 
Vancomycin (µg/mL) 50 25 12.5 6.25 3.125 1.56 0.78 0.39 0.195 
Streptomycin (µg/mL) 50 25 12.5 6.25 3.125 1.56 0.78 0.39 0.195 
Walnut oil (mg/mL) 250 125 62.5 31.25 15.6 7.8 3.9 1.95 0.98 
 S. aureus ATCC 6538 
Vancomycin (µg/mL) 50 25 12.5 6.25 3.125 1.56 0.78 0.39 
 
0.195 
Trimethoprim (µg/mL) 125 62.5 31.25 15.6 7.8 3.9 1.95 0.98 0.49 
Streptomycin (µg/mL) 50 25 12.5 6.25 3.125 1.56 0.78 0.39 0.195 
Walnut oil(mg/mL) 250 125 62.5 31.25 15.6 7.8 3.9 1.95 0.98 
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Table 35.  FIC and FIC index results from the combination of African walnut oil and 






FIC of oil and drug FICI Interpretation 




FICI calculation   
Vancomycin African walnut 
oil + 
Vancomycin 
0.78/3.125 1.95/15.6 0.249 0.125 0.37 Synergy 
Streptomycin African walnut 
oil + 
Streptomycin 
1.56/6.25 7.8/15.6 0.25 0.5 0.75 Indifference 
 
Table 36. Fractional inhibitory concentration (FIC) and (FIC) indices (FICI) of pumpkin 
oil combined with antibiotics on MRSA 252 and ATCC 6538 
                               
Key: 
              The MIC concentrations of each antibiotic is highlighted in yellow 
The MIC concentrations of each antibiotic and oil combination is highlighted in pink 
The MIC concentrations of each oil in combination with drug is highlighted in green 
              The MIC concentrations of pumpkin oil alone is highlighted in brown. 





FIC of oil + drug FICI Interpretation 
  FIC drug FIC oil FICI calculation  
Vancomycin African walnut 
oil + 
vancomycin 
0.78/3.125 1.95/7.8 0.249 0.25 0.50 Synergy 
Trimethoprim African walnut 
oil + 
trimethoprim 
0.98/15.6 0.98/7.8 0.06 0.13 0.19 Synergy 
Streptomycin African walnut 
oil + 
streptomycin 
0.39/6.25 3.9/7.8 0.06 0.5 0.56 Synergy 
 MRSA 252 
Antimicrobials 1 2 3 4 5 6 7 8 9 
Gentamicin (µg/mL) 250 125 62.5 31.25 15.6 7.8 3.9 1.95 0.98 
Chloramphenicol 
(µg/mL) 
100 50 25 12.5 6.25 3.125 1.625 0.813 0.406 
Pumpkin oil (mg/mL) 500 250 125 62.5 31.25 15.6 7.8 3.9 1.9 
 S. aureus ATCC 6538 
Vancomycin (µg/mL) 50 25 12.5 6.25 3.125 1.56 0.78 0.39 0.195 
Rifampicin (µg/mL) 125 62.5 31.25 15.6 7.8 3.9 1.95 0.98 0.49 
Pumpkin oil (mg/mL) 500 250 125 62.5 31.25 15.6 7.8 3.9 1.9 
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FIC of oil + drug FICI Interpretation 
  FIC of drug FIC of 
oil 
FICI calculation  


















5 = 0.5 
Indifference 
 
7.2.3 Assessing the efficacy of African walnut oil in the treatment of staphylococcal 
infections using G. mellonella as an in vivo model. 
7.2.3.1 Establishing pathogenicity of MRSA 252 and ATCC 6538 against G. mellonella. 
To effectively study the pathogenicity of staphylococcal strains; MRSA 252 and ATCC 6538, 
three main groups A, B and C was constituted as explained below. However, group C was 
further expanded to contain dilution series infected with infective doses of the strains. Except 
otherwise mentioned, each infective dose stated in group C was constituted for each strain. 
Group A consisted of 20 non-infected larvae which served as negative control for the 
experiment  
Group B consisted of 20 larvae inoculated with PBS and 20 mg of ampicillin to serve as 






FIC of oil + drug             FICI Interpretation 
  FIC of drug FIC of oil             FICI calculation  
Vancomycin Pumpkin oil + 
vancomycin 
1.56/3.125 3.9/31.25 0.50 0.125 0.625 indifference 
Rifampicin Pumpkin oil + 
trimethoprim 
7.8/15.6 1.95/31.25 0.5 0.06 0.56 Indifference 
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Group C consisted of 20 larvae for each dilution (100, 10-1, 10-2 and 10-3) of MRSA 252 and 
S. aureus ATCC 6538.  
Numerous studies have shown that melanisation and development of black thick plaques on 
the body surface of G. mellonella after infection is an important marker indicating that the 
immune response of the worm has been affected (Loh et al., 2013; Tsai et al., 2016; Yang et 
al., 2017). In this present study, melanisation was found to develop gradually on the body 
surfaces of the infected G. mellonella larvae after infecting them with MRSA 252 and ATCC 
6538. This was found to increase gradually, and more deaths were recorded.  Figure 115 show 
melanisation in G. mellonella larvae. 
 
Figure 115. Observed changes in G. mellonella before, after infection and with combinational treatment. 
G. mellonella infection model a) A healthy caterpillar prior to injection with infective doses of MRSA 
252 and ATCC 6538 biofilm cells. (b) Infected larvae developed melanin and move sluggishly. (c) 
Larvae develop a different colour after treatment with walnut oil, with this colour larvae were not 
sluggish and dead. (d) Subsequent death of the caterpillar with a high level of melanisation and 
hardening. 
To determine the infective dose of each bacterial strain to be used the total viable count was 
determined. In order to enumerate viable bacterial colonies, an assumption was made that each 
bacterial colony that grew on an agar plate when cultured arose from one living (viable) cell, 
therefore it was possible to determine the total viable bacterial count defined as colony forming 
units (CFU) per ml of the original culture. The general acceptance range for counting colony 
forming units on agar plates is 30 to 300 colonies (Loh et al., (2013). In this present study, 
dilution 10-5 of both strains fell within the acceptance range of 186 and 172 colony forming 
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units grown on the agar plate. The CFU/mL of the original culture was calculated using the 
following formula: CFU/mL = number of colonies per ml plated/Total dilution factor. 
 A log dilution of 10-5 showed 186 colonies, however only 100 µL of the dilution was plated, 
therefore the number of colonies was divided by 0.1 ml before being divided by the total 
dilution factor.  
Therefore; CFU/mL = (186/0.1mL)/10-5 = 1860 x 10-5 = 1.86 x 10-8 CFU/mL 
The above calculation was used to determine the CFU/mL; however, the larvae were only 
injected with 10 µL of each culture, a dilution of 10-2. Therefore, it was possible to determine 
that 10 µL of the original culture contained 1.86 x 10-6 CFU for MRSA 252 and 1.72 x 10-6 
CFU for ATCC 6538. From this the dilutions injected into the larvae were obtained (Table 38). 
Table 38. CFU/Larvae per 10 µL injections of infecting doses of MRSA 252 and ATCC 
6538 calculated from the original CFU counts. 
Dilution               CFU/Larva Amount injected in 10 µL 
MRSA 252                                 ATCC 6538 
100 1.86 x 10-6 1.72 x 10-6 
10-1 1.86 x 10-5 1.72 x 10-5 
10-2 1.86 x 10-4 1.72 x 10-4 
10-3 1.86 x 10-3 1.72 x 10-3 
 
Different groups of G. mellonella larvae were infected with 100 (1.86 x10-6), 10-1 (1.86 x 10-5), 
10-2 (1.86 x 10-4), and 10-3 (1.86 x 10-5), dilutions of MRSA 252 and 100 (1.72 x10-6), 10-1 (1.72 
x 10-5), 10-2 (1.72 x 10-4), and 10-3 (1.72 x 10-3) dilutions of ATCC 6538 at the stationary phase 
of growth. Bacterial infecting doses of MRSA 252 and ATCC 6538 strains represent a virulent 
and susceptible strain doses. The survival of the larvae was monitored over a period of 5 days 
following injection of the bacterial suspensions (infective doses). MRSA 252 strain caused 
time-dependent larval death that was determined by touch-induced lack of larval movement 
and in most cases, larval death was accompanied by quick melanisation of the larvae. 
Compared to ATCC 6538, MRSA 252 induced higher larval mortality at the different bacterial 
inoculum infection dose particularly with the 100 dilution used after 1 day indicating an 
increased virulence exhibited by this strain in this model. G. mellonella larvae infected with 
MRSA 252 were observed to develop high level of melanisation and hardening. In the control 
PBS-injected larvae, no mortality was observed in the control PBS-injected larvae. In addition, 
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no melanisation was even observed. ATCC 6538 was observed to exhibit an avirulent 
behaviour because only 10 deaths were recorded within the 5 days. These results obtained in 
this experiment show that, G. mellonella larvae succumb to S. aureus infection and appear to 
show strain differences and pathogenicity. Results for G. mellonella death and survival 
recorded within 5 days is presented in Figure 116 
 
Figure 116. One day (24 h) post inoculation of G. mellonella larvae infected with 10 μL of 100 infecting 
doses of MRSA 252 and ATCC 6538 biofilm cultures (stationary phase cultures). 
G. mellonella used for each group test were injected with 10 μL of 100 infecting dose aliquots of MRSA 252 and 
ATCC 6538, injected into them through the last left proleg. (A) One day (1 day) post inoculation of G. 
mellonella infected with 10 μL of PBS and ampicillin (B) G. mellonella infected with 10 μL MRSA 252 and (C) 
G. mellonella larvae infected 10 μL ATCC 6538. 
Below, both the dead and survivors were continually monitored for other lower infective doses 
of the strains that were also used. Pathogenicity test result of S. aureus ATCC 6538 against G. 
mellonella larvae on day 5 shows that a greater number of larvae survived after been infected 
with 10-3 (80 %) biofilm cells compared with the groups infected with 100 (45 %), 10-5 (45 %) 
and 10-4 (55 %). In contrast, MRSA 252 biofilm cells exhibited virulence at all levels with the 
10-6 cells (0 % survivor) been the most effective. Survivors were also recorded at 10-5 (19.0 
%), 10-4 (30 %) with 10-3 (35 %) being the least effective culture. Figure 117 and 118 below 
shows day 5 survivors of G. mellonella larvae after been infected with 10 μL biofilm cells of 




              
Figure 117. Representative photographs of petri-plates containing G. mellonella infected with MRSA 252 
biofilm cultures. 
(A) Healthy larvae of G. mellonella larvae. (B) G. mellonella infected with MRSA 252 (1.86 × 10-5 CFU/larvae). 
(C) G. mellonella infected with MRSA 252 (1.86 × 10-4 CFU/larvae). (D) G. mellonella larvae injected with PBS 
and ampicillin (10 μL). (E) G. mellonella injected with MRSA 252 (1.86 × 10-3 CFU/larvae). Photographs were 
obtained 5 days after the infection of each strain. 20 G. mellonella were used for each group tested. 
Figure 117 show that G. mellonella gradually developed melanin which appear intense as 
observed in the picture. With time, the larvae appeared sluggish to any slightest touch with 
forcep. The results obtained show that G. mellonella was susceptible to MRSA 252. Within 5 
days each group recorded few deaths. Death was recorded as dose dependent. Dose 10-6 was 
the most effective. This tested was repeated three times for thorough observation. Figure 118 
show the percentage of dead and survivors from MRSA 252 infecting doses in each group 




                  
Figure 118. The survival of G. mellonella larvae infected with MRSA 252. 
G. mellonella larvae (n=20 per group) were infected with varying concentration of MRSA 252 or PBS by injection 
of 10 ul of each infective dose obtained from stationary phase biofilm cultures via the proleg while restrained 
between the thumbs. Kaplan-Meier survival curves were drawn for inoculums of 100 (1.86 x10-6), 10-1 (1.86 x 10-
5), 10-2 (1.86 x 10-4), and 10-3 (1.86 x 10-5) dilutions. Statistical analysis show *p < 0.05 (0.0001) was obtained 
using the Log Rank Mantel-Cox test indicating significant difference between survivals per day. 
Table 39. Survivors and dead recorded between day 1 to 5 after infecting G. mellonella 






Based on the result presented in Figure 117 and Table 39, a greater survival by larval group 
that has been infected with 10-3 CFU/larva (35%) was observed compared with the groups that 
had been infected with 10-4 (30%), 10-5 (19%) and 10-6 CFU/Larva (0%). 
Figure 119 and 120 below shows day 5 survivors of G. mellonella larvae after infected with 10 
μL biofilm cells of S. aureus ATCC 6538 at the different infecting doses.  
Days PBS (control) 10-6 10-5 10-4 10-3 











15.000 33.33333 45.000 70.000 
4 
 
0.000 19.04762 30.000 35.000 
5 100.000 0.000 19.04762 30.000 35.000 
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Figure 119. Representative photographs of petri-plates containing G. mellonella infected with S. aureus 
ATCC 6538 
 (A) G. mellonella infected with ATCC 6538 (1.72 × 10-5 CFU/larvae) (B) G. mellonella infected with S. 
aureus ATCC 6538 (1.72 × 10-4 CFU/larvae) (C) G. mellonella injected with S. aureus ATCC 6538 (1.72 × 10-
3 CFU/larvae). (D) G. mellonella larvae injected with PBS and ampicillin (10 μL) and (E) Healthy larvae of G. 
mellonella. Photographs were obtained 5 days after the infection of each strain. 20 G. mellonella were used for 
each group tested. 
Figure 119 shows that G. mellonella gradually developed melanin which was not too intense 
as observed in the picture. Although with time, the larvae appeared sluggish to any touch with 
forcep. The results obtained show that G. mellonella was susceptible to ATCC 6538 even 
though it is a methicillin susceptible strain. Within 5 days each group recorded few deaths. 
Death was recorded as dose dependent. However, dose 10-6 was the effective dose.  This tested 
was repeated three times for thorough observation. Figure 120 below shows the percentage of 




      
Figure 120. The survival of G. mellonella larvae infected with ATCC 6538 
G. mellonella larvae (n=20 per group) were infected with varying concentration of ATCC 6538 or PBS by 
injection of 10 μL of each infective dose obtained from stationary phase biofilm cultures via the proleg while 
restrained between the thumbs. Kaplan-Meier survival curve were drawn at an inoculum of 100 (1.72 x10-6), 10-1 
(1.72 x 10-5), 10-2 (1.72 x 10-4), and 10-3 (1.72 x 10-3) dilutions at the end of 5 days. However, daily deaths and 
survivors were recorded individually. Statistical value *p < 0.05 (0.0001) was obtained using the Log Rank 
Mantel-Cox test indicating significant difference between survivals per day. 
Table 40. Survivors and dead recorded between day 1 to 5 after infecting G. mellonella 








Based on the result presented in Figure 119 and Table 40, a greater survival by larval group 
that has been infected with 10-3 CFU/larva (80%) was observed compared with the groups that 
had been infected with 10-4 (55%), 10-5 (45%) and 10-6 CFU/Larva (45%). A higher percentage 
survival was obtained for ATCC 6538 compared to MRSA 252. PBS control larvae group had 
100 % survivors. 
 
Days PBS (control) 10-6 10-5 10-4 10-3 







80.000 80.000 85.000 90.000 
3. 
 
60.000 55.000 65.000 80.000 
4. 
 
45.000 45.000 55.000 
 
5. 100.000 45.000 45.000 55.000 80.000 
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7.2.3.2 Combination therapy with African walnut oil  
The efficacy of African walnut oil against MRSA 252 infections, groups of 15-20 larvae were 
challenged with 10-6 lethal doses of MRSA 252 then treated against melanisation with single 
dose of African walnut oil. Vancomycin was included in this experiment to serve as antibiotic 
commonly used in the treatment of staphylococcal infection and control. Two different 
concentrations (15.6 mg/mL, 31.25 mg/mL and 62.5mg/mL) of African walnut oils (found to 
have inhibitory activity) was prepared in DMSO but two dilutions, 15.6 mg/mL and 31.25 
mg/mL was used for the experiment.  
 
Figure 121. Visual observation of G. mellonella before and after treatment with antibiotic and African 
walnut oil for 5 days 
(A) Healthy G. mellonella larvae. (B) G. mellonella larvae infected with MRSA 252 and treated with vancomycin 
(100 µg/mL). (C) G. mellonella larvae infected with MRSA 252 and treated with African walnut oil (31.25 mg/mL 
by injecting this amount into the larave). (D) G. mellonella larvae infected with ATCC 6538 and treated with 
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African walnut oil (15.6 mg/mL by injecting this amount into the larvae). Infecting dose of MRSA and ATCC 
6538 found effective 100 (1.86 x10-6) CFU/mL and 100 (1.72 x10-6) was used. 
Figure 121 shows the efficacy of African walnut oil in the treatment of staphylococcal 
infections using G. mellonella as an in vivo model. This efficacy was assessed in the post 
inoculated G. mellonella larvae by checking for melanin development and sluggishness. Larvae 
group infected with 10 μL of infecting dose of MRSA 252 and treated with 10 μl of 100 µg/mL 
of vancomycin were observed to have started dying on the second day after treatment and death 
was within day 2 to 4. Larvae group infected with 10 μL of infecting dose of MRSA 252 and 
treated with walnut oil 31.25 mg/mL were observed to survive gradually but death was 
recorded with day 2 to 4. Although 7 survivors were still observed on day 5. Larvae group 
infected with 10 μl of infecting dose of ATCC 6538 were observed to survive until day 5 even 
after treatment with 15.6 mg/mL of walnut oil. However, the development of brownish pellicles 
was observed in both the MRSA 252 and ATCC 6538 treated with walnut oil which was quite 
different to the blackish melanin observed in vancomycin and 24 h infected MRSA 252 and 
ATCC 6538. Also observed is that sluggishness characterized as death symptom was not also 
observed. This shows a promising indicator of survival in G. mellonella larvae even after 
infection with staphylococcal infections. This test was repeated three times for thorough 
observation. Figure 122 shows the percentage of dead and survivors from MRSA 252 and 
ATCC 6538 infected groups and treated with antibiotic and African walnut oil. The test in each 
group was within 5 days.  
 
Figure 122. Percentage survival from G. mellonella (n=15-20 per group) groups infected MRSA 252 and 
ATCC 6538 and treated with antibiotic and African walnut oil. 
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Kaplan-Meier survival curve were drawn at an inoculum of 100 (1.86 x10-6) MRSA 252 and 100 (1.72 x10-6) ATCC 
6538 dilutions at the end of 5 days. However, daily deaths and survivors were recorded individually. Statistical 
value *p < 0.05 (0.0001) was obtained using the Log Rank Mantel-Cox test indicating significant difference 
between survivals per day. 
Table 41. Survivors and dead recorded between day 1 to 5 after infecting G. mellonella 
with ATCC 6538 and MRSA 252 infecting dose (10-6 CFU/Larva) and treatment with 
antibiotic and African walnut oil. 
 
Based on the result presented in Figure 122 and table 41 a greater survival by larval group that 
was infected with 10-6 CFU/larva was recorded after injection with vancomycin, 15.6 mg/mL 
and 31.25 mg/mL of African walnut oil. After injection of 15.6 mg/mL African walnut oil into 
G. mellonella infected with ATCC 6538, 100% survivors were recorded although brownish 
pellicles were observed. After injection of 31.25 mg/mL walnut oil into G. mellonella infected 
with MRSA 252, 35% survivors were recorded although similar brownish pellicles alongside 
melanin were observed. Whereas G. mellonella injected with 10-6 CFU/larva of MRSA 252 
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To consider oils of African walnut and pumpkin as natural antimicrobials with potential for 
the development of a new chemotherapy drug for the treatment of staphylococcal infections, 
it is important to consider its antimicrobial action on cells enclosed in biofilms (Batista et 
al., 2017). For that purpose, biofilm time kill assay was performed which determines the 
time of action of a compound antimicrobial activity. The used strains are S. aureus ATCC 
6538 and MRSA 252 the sensitive and resistant strains that had their growth in mature 
biofilm eradicated by the oils particularly African walnut and pumpkin oil at the tested 
concentration (MBEC = 62.5 and 31.25mg/mL for walnut oil) and (MBEC = 125 and 250 
mg/mL for pumpkin oil). Biofilm kinetic time assay for walnut oil and pumpkin oil has 
provided a platform to visually observe antibacterial action of minimum bactericidal 
concentrations of walnut and pumpkin oils against MRSA 252 and ATCC 6538 biofilm growth. 
Visually in the sense that bacterial colonies from exposed cultures of MRSA 252 and ATCC 
6538 were counted at growth time points after plating on TSA plates and log CFU/mL was 
calculated. From the results, ATCC 6538 strain with reduced/low biofilm production, 31.25 
mg/mL achieved bactericidal activity at 2 h after exposure. In contrast, MRSA 252 observed 
to be a strong biofilm former, 62.5 mg/mL African walnut oil achieved bactericidal activity at 
6 h. indicating that despite the high biofilm produced by MRSA 252, bactericidal activity was 
achieved early. Although not as early as the 2 h observed for ATCC 6538. An initial 6-log 
reduction at 2 and 4 h for MRSA 252 and a rapid 2-log reduction at 2 h for ATCC 6538 after 
which the bacterial count dropped to zero. The mean CFU/mL assessed after 48 h from the 
preformed biofilms were significantly different between the low-and high-biofilm-producing 
strains (2.12 and 2.32 CFU/mL, respectively; P < 0.001). Cashew oil appeared to be low in 
bactericidal activity against MRSA 252 and ATCC 6538 because already, its MBEC value was 
high and exhibited low activity on the strains. Against MRSA 252 bactericidal killing was 
achieved at 24 h while killing of ATCC 6538 was at 22 h then viable count dropped to zero. 
Bactericidal killing of pumpkin oil was achieved at 10 h and 8 h for MRSA 252 and ATCC 
6538 with an initial log reduction 4-5 log reduction in the strain. Overall, results obtained for 
the bactericidal activity the oils on the strains shows that the varying biofilm forming ability of 
the strains manifested in the bactericidal activity of the individual oil tested. However, African 
walnut oil achieved bactericidal activity promptly on both the susceptible and resistant 
staphylococcal strains.  
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The concept of synergism is applied to treat infections caused by harmful pathogens to tackle 
the complex multiple-drug resistance problems (Yap et al., 2014). A review by Rayner and 
Munckhof, (2005) complied antibiotics belonging to different categories with failure rates due 
to increased resistance. It is for this reason; synergism of African walnut oil and pumpkin were 
examined for their synergistic activity with antibiotics with a view finding alternative therapies 
to staphylococcal infections. Vancomycin and trimethoprim were the drug of choice for MRSA 
infections for several decades, increased treatment failure rates coinciding with the spread of 
vancomycin S. aureus (VISA) have cast doubt on the reliable use of vancomycin and other 
drugs. The synergistic effect of vancomycin and trimethoprim was investigated, and FIC index 
interpretations have demonstrated that the African walnut and pumpkin oils appear to work 
synergistically with glycopeptide and sulphonamide drugs such as vancomycin and 
trimethoprim. This was evidently depicted in the FIC index interpretation which affirmed the 
synergistic action of African walnut oil with MRSA 252 and ATCC 6538 with FICI indexes of 
0.37 and 0.5 (FICI<0.5). Similar activity was observed for trimethoprim with FICI (0.19) for 
ATCC 6538.   
Adequate infection models that have similar genetic and immune responses to human disease 
are the key to analysing the molecular basis of bacterial pathogenesis (Tsai et al., 2016). 
Recently, the larva of the greater wax moth G. mellonella has been reported as an easy-to-use 
model organism for several pathogenic bacteria (Pollitt et al., 2018; Yang et al., 2017). Because 
of these similarities, the response against MRSA 252 and ATCC 6538 infection by various 
means, such as the bacterial concentration capable of killing G. mellonella, infection, 
morphology and melanization in response to infection was investigated. One main limitation 
of G. mellonella larvae is their ability to survive at either 30oC - 37oC. the mammalian body 
temperature. In this study larval death caused by MRSA 252 and ATCC 6538 was not 
dependent on the post-infection incubation temperature, as evidenced by the killing rate at 37 
oC. The strains used herein are all capable of causing disease, as they were obtained from 
human lesions and wounds with clinical signs of skin infections. In this study, for the first time 
the use of G. mellonella larva as an alternative host for studying MRSA 252 and ATCC 6538 
virulence is investigated. One of the aspects of the present work was to investigate the 
pathogenicity of MRSA 252 and ATCC 6538 against G. mellonella. To establish S. aureus 
infection, standardized stationary phase biofilm cultures of MRSA 252 and ATCC 6538 in two 
concentrations were used to challenge G. mellonella for 5 days. Groups of G. 
mellonella infected with 10 uL of 10-6 MRSA 252 strain all died within 24 h while lesser death 
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was recorded in 10-5 – 10-4. Therefore, indicating that 100 % of MRSA 252 inoculum induced 
death in the larvae. However, ATCC 6538 infected with the same CFU/mL 10-6 could not 
induce high death. This difference is probably due to a threshold over which processes leading 
to larval death are induced via the overwhelming activation of the innate immune system 
(Grounta et al., 2016).  
Surprisingly inspection of the morphology and survival rate of G. mellonella group infected 
with single doses of MRSA 252 and vancomycin (100 μg/mL) showed that the larvae started 
to developed melanin characterized as death on the second day of infestation and all through 
within the 5 days study period. Group of G. mellonella infected with MRSA 252 and African 
walnut oil 31.25 mg/mL had some members of the group developing brownish pellicle on the 
second day which was different from the blackish melanized pellicle observed in group infected 
with MRSA 252 and vancomycin and the infected non-treated group. While some in the group 
developed melanin. The members with brownish pellicle were seen to survive three days after 
this development with only few dead. The group infected with MSSA 15.6 mg/mL had greater 
survival with no dead recorded after 5 days. But from the third day of infestation, brownish 
pellicles were observed. Considering the results, overall greater survival of G. mellonella was 












Chapter 8. Identification of Active type of Components in African Walnut 
Oil  
8.1 Introduction 
African walnut (Tetracarpidium conophorum- Mull. Arg) is a perennial climbing shrub which 
grows mainly in Africa, particularly in the Western regions of Africa (Uzunova et al., 2015). 
It is mainly found in Nigeria and other neighbouring countries such as Equatorial Guinea and 
Cameroon, Gambia, Sierra Leone and Gabon (Ojeda-Amador et al., 2018). Nuts of African 
walnuts grow in pods which contains 2 to 5 nuts. The nut is composed of two cotyledons which 
are encased in a hard-shell-like case. Usually, after maturity, the nuts are harvested between 
month of June and September. In Nigeria, the nuts are consumed as snacks. Also, the flour is 
used as a soup thickener especially by the Yoruba tribe (Bada et al., 2010). In ethnobotanical 
medicine, the nut is extensively used in decoctions for treatment of several ailments such as 
dysentery, constipation, abdominal cramps and general fever, as well as in management of 
chronic diseases such as diabetes, malaria, male sterility dysfunctions, cancer and high blood 
pressure (Bada et al., 2010; Rahimi et al., 2011; Kris-Etherton, 2014; Zibaeenezhad et al., 
2016). African walnut leaves are scrubbed between the hands to get exudates for first hand 
treatments of wounds and as home remedies for skin infections such as rash, eczema 
(Ajaiyeoba and Fadare, 2006; Lin, Zhong & Santiago 2017; Dawid-Pać, 2013). African Walnut 
oil is known for its curative potential, general body nourishment and hence ability to boost the 
immune system of the humans (Ajaiyeoba and Fadare, 2006). 
African walnuts contain kernels that have high amount of glyceride oil (Uzunova et al., 2015). 
It varies widely (53-76%), depending on the cultivation place, variety, place of growing and 
irrigation process of walnut trees. Regarding the fatty acid composition of African walnut 
unsaturated fatty acids are predominant particularly – linolenic, oleic and linoleic acid. The 
different ratio of these acids determines the nutritional content of African walnut oil. In 
addition, monounsaturated fatty acids also have a beneficial effect on human health (Crews et 
al., 2005; Ojeda-Amador et al., 2018). The present study is a preliminary investigation of the 







8.2.1 Identification of fatty acid methyl esters (FAMEs) of Supelco 37 standards mix 
using GC-MS spectrometry 
8.2.1.1 Fatty acid profile of Supelco 37 standard FAME mix 
 
GC-MS was used to separate and identify the compounds in FAME mix (C8 - C24) standard. 
In the FAME mix, 33 out of 37 compounds were identified and their retention times are 
presented. Table 42 presents the list of the FAME compounds identified. Identification of 
FAME standards were necessary to allow effective comparison of their retention times with 
those of African walnut oil. 
 
Table 42. Elution order and retention times of compounds observed in standard FAME 
mix (C8 - C24) from GC-MS analysis. 
S/N FAME C8-C24 mix components Retention time (min) 
 
1 Caprylic acid (C8:0) 5.193 
2 Capric acid (C10:0) 8.135 
3 Undecylic acid (C11:0) 11.247 
4 Lauric acid (C12:0) 14.163 
5 Tridecanoic acid (C13:0) 17.309 
6 Myristoleic acid (C14:1) 20.151 
7 Myristic acid (C14:0) 20.561 
8 Pentadecanoic acid (C15:1, cis 10) 23.404 
9 Pentadecanoic acid (C15:0) 23.800 
10 Palmitic acid (C16:0) 26.309 
11 Palmitoleic acid (C16:1 26.989 
12 Heptadecanoic acid (C17:1, cis 10) 29.420 
13 Heptadecanoic acid (C17:0) 30.073 
14 α-linolenic acid (C18:3, 32.387 
15 Linoleic acid (C18:2) 32.087 
16 Oleic acid (C18:1, cis 9) 32.275 
17 Linolelaidic acid (C18:2) 32.350 
18 Elaidic acid (C18:1, trans 9) 32.470 
19 Stearic acid (C18:0) 33.054 
20 Arachidonic acid (C20:4 n6), 36.776 
21 Arachidonate acid (C20:4), 36.964 
22 Ticosatrienoic acid (C20:3, cis 11) 37.286 
23 Eicosadienoic acid (C20:2, cis11) 37.821 
24 Eicosenoic acid (C20:1, cis 11) 37.599 
25 Eicosenoic acid (C20:2, trans 11) 37.807 
26 Arachidic acid (C20:0) 38.688 





The table above shows the profile of fatty acids methyl esters. Arrangement of the compounds 
was from Frau and Frau, (2010). 
 
 




Figure 123. GC-MS chromatogram showing peaks of fatty acid methyl esters (C8:C17) and their 




28 Docosahexaenoic acid (C22:6) 41.943 
29 Erucic Acid (C22:1) 43.246 
30 Behenic Acid (C22:0) 43.907 
31 Tricosylic acid (C23:0) 46.464 
32 Nervonic acid (C24:1) 48.720 




Figure 124. GC-MS chromatogram showing peaks of fatty acid methyl esters (C18:C20) and their 
retention times identified in Supelco standard FAME mix. 
 
 
Figure 125. GC-MS chromatogram showing peaks of fatty acid methyl esters (C21:C24) and their retention 






8.2.2 Fatty acid profile of African walnut oil (GC-MS results of walnut oil FAME) 
The fatty acid profile of Afrcan walnut oil was determined as corresponding methyl 
esters, using gas chromatography. Chromatogram of fatty acid methyl esters identified in 
African walnut oil is presented in Figure 127. The chromatogram clearly shows that there are 
5 (five) major peaks with retention times ranging from 18.68 to 32.39 min. Although 4 (four) 
other minor peaks were also observed. The peak with the greatest abundance is shown by the 
highest peak with retention time of 32.39 min having relative percentage of 80.59%. Further 
analysis by mass spectrometry indicates that this peak is methyl linolenate, characterized by a 
molecular ion at m/z = 292, which is in very good agreement with the molecular weight of 
methyl linolenate. Mass spectra of other peaks showed good evidence that the final product of 
transesterification is purely a mixture of fatty acid methyl esters. Furthermore, the distribution 
of fatty acids based on percentage area (Figures 126), shows that the five main fatty acids 
methyl esters identified included saturated, monounsaturated and polyunsaturated fatty acids. 
The saturated fatty acids identified include palmitic acid and stearic acid. Only one 
monounsaturated fatty acid eicosenoic acid was identified. Also, the polyunsaturated fatty 
acids were dominantly linoleic and linolenic acid otherwise called α linolenic acid (alpha 
linolenic acid). Besides the fatty acids reported other minor fatty acids observed include 
caprylic acid (C8:0 this means the compound has 8 carbon atoms and zero bonds), myristic 
acid (C14:0), palmitoleic acid (C16:1), heptadecanoic acid (C17:1, cis 11), heptadecanoic acid 
(C17:0) and arachidic acid. List of fatty acid methyl esters identified in African walnut oil is 
presented in Table 43. In addition, a pie chart showing their distribution is shown in Figure 
151. The GC-MS spectrum of the individual peak is presented in Figure 152. 
 
Table 43. Fatty acid methyl ester profile of African walnut oil 
Peak No Fatty acid methyl ester Area % Molecular weight 
(g/mol) 
Retention times 
1 Palmitic acid (C16:0) 1.53 270 26.98 
2 Linoleic acid (C18:2) 13.05 294 32.16 
3 Linolenic acid (C18:3) 80.59 292 32.39 
4 Stearic acid (C18:0) 4.41 298 33.07 
5 Eicosenoic acid (C20:0) 0.42 325 18.68 
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Figure 126. Fatty acids methyl esters identified in African walnut oil and proportion through GC-MS 
results.                         
Result shows a higher percentage of polyunsaturated fatty acid linolenic acid with 80.59%. 
8.2.2.1 Chromatograms and spectra results of FAME of African walnut oil 
Figure 127 below shows the GC-MS spectrum of fatty acid methyl esters identified in African 
walnut oil. 
African walnut oil FAME (the peaks labelled was confirmed from the mass fragmentation 
spectra). 
              
Figure 127. GC-MS chromatogram of major fatty acid methyl esters identified in African walnut oil with 
their retention times. 
Figure 127 shows the presence of five (5) major fatty acids between C16:0 and C20:1 which 
includes palmitic, linoleic, linolenic, stearic and eicosenoic acid as listed in Table 43. In the 
chromatogram, the peak with the greatest abundance is shown by the highest peak with 














divided by the charge is called the mass to charge ratio (M/Z). The x-axis represents the M/Z 
ratios. The y-axis represents the signal intensity (abundance) for each of the fragments detected 
during the scan. 
 
          
Figure 128. Mass spectrum of linolenic acid methyl ester (C18:3) identified in African walnut oil with a 
retention time of 32.39 min and an m/z of 292 corresponding to its molecular weight. 
 
 
    
Figure 129. Mass spectrum of palmitic acid methyl esters (C16:0) identified in African walnut oil with 
retention times 26.98 min and an m/z =270 corresponding to its molecular weight. 
 
 
Mass fragmentation of peak 26.98 min, (C16:0) 




                       
Figure 130. Mass spectrum of linoleic acid methyl esters (C18:2) identified in African walnut oil with 
retention time of 32.12 min and m/z = 294 
  
 
                    
Figure 131. Mass spectrum of stearic acid methyl esters (C18:0) identified in African walnut oil with 




Mass fragmentation of peak 32.12 min, (C18:2) 




                 
Figure 132. GC-MS chromatogram and spectrum of eicosenoic acid methyl esters (C20:1) identified in 
African walnut oil with retention time of 37.95 min and m/z = 292.  
 
8.2.3 Chemical and antimicrobial investigation of the active fractions of African walnut 
oil 
8.2.3.1 Separation and purification of African walnut oil 
Fraction distillation was used to separate and purify cold pressed African walnut oil into 
different fractions. The cold pressed extraction method of African walnut oil yielded (69 g). 
100 mL of the oil was distilled, and the vapour yielded 4 (four) fractions as presented in Table 
44. This distillation process was based on the difference in boiling point among all compounds 
in the mixture of fatty acids. Generally, the boiling point of fatty acids such as linoleic acid 
was 230 °C, linolenic acid (230 °C), palmitic acid (351 °C), stearic acid (361 °C) and 
eicosanoic acid (328 °C) (Bono, Pin & Jiun 2010). However, because of their high boiling 
temperature, vacuum distillation helped to reduce temperature and separation into four distinct 
fractions were obtained.  
 
 
Mass fragmentation of peak 37.95 min, (C20:1) 
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Table 44 presents the yield of each fraction, with fraction 2 and 3 having the largest quantity 
indicated by its largest volume among the four fractions. The collected fractions appeared in 
different colours, as a yellow viscous liquid (Figure 133).  Bioassay guided fractionation of 
African walnut oil was used to identify the most active fraction in the oil. 
8.2.3.2 Bioassay-guided fraction and antimicrobial activity of African walnut oil 
fractions. 
The fractional separation of walnut oil was performed in a vacuum distillation column and 
several fractions of oil distillate were collected and their antimicrobial property was analyzed. 
The four fractions were tested for antimicrobial activity against MRSA 252 and S. aureus 
ATCC 6538. The various fractions were tested for antimicrobial activity using Kirby bauer 
well diffusion assay Figure 133. 
 
Fractions Temperature (°C) Volume (mL) 
A. 1 80-115 14.3 
B. 2 115-125 23.0 
C. 3 125-135 17.9 




Figure 133. Scheme of bioassay guided‐fractionation of African walnut oil and antimicrobial activity of the 
four fractions. 
Disc diffusion assay showing zones of each fraction tested on MRSA 252 and ATCC 6538. (A) Fraction A activity 
on MRSA 252 and ATCC 6538. (B) Fraction B activity on MRSA 252 and ATCC 6538. (C) Fraction C activity 





Table 45. Diameter of inhibitory zones produced by the four fractions 
 
Figure 133 shows the zones of diameter obtained from the activity of the different fractions on 
MRSA 252 and S. aureus ATCC 6538. The zones of diameter were obtained from agar wells 
filled with 15 µL of the 100 % pure fraction and incubated for 24-48 h at 37 °C. The 
antimicrobial activity of each fraction was evaluated by measuring the diameter of the clear 
zone of inhibition of growth against the test organisms (MRSA 252 and ATCC 6538) in 
comparison to a control (no fraction added, just 6 mm diameter disc filled with 0.5% DMSO 
(15 µL).  
According to the results, there was variation in the activity of the different fractions against 
MRSA 252 and ATCC 6538. As observed in the diameter of zones, MRSA 252 was resistant 
to fractions A and D (was not active), while fractions B and C was active (clear zones).  For 
ATCC 6538, surprisingly fraction A became active as well as fraction B. However, the strain 
was resistant to C and D as no clear zones were observed on the plate in these areas. 
8.2.4 Molecular structure identification 
8.2.4.1 Fourier transform infra-red spectroscopy of African walnut oil fractions 
FTIR spectra of African walnut oil fractions (Fractions A, B and C) obtained via fractional 
distillation, were collected between numbers of 4000 and 600 cm-1 and results are presented in 
figures 134 to 136. In the FTIR spectra quite intensive bands which may be attributed to 
specific functional groups of fatty acids were obtained. Peaks in the spectra are similar since 
the studied vegetable oil is mainly composed from triglyceride with certain fatty acids. 
However, the spectra of studied oil fractions reveal a bit differences in terms of band intensities 
and the exact frequencies at which the maximum absorbance are generated in each fraction. In 
Fractions Diameter of the zones (mm) 
 
 MRSA 252 ATCC 6538 
A. 1 No growth (no clear zone) 12 mm 
B. 2 13 mm 12 mm 
C. 3 16 mm No growth (no clear zone) 
D. 4 No growth (no clear zone) No growth (no clear zone) 
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the presented absorption spectra of the three fractionated oil samples, they exhibited a broad 
band in the region from 3400 – 2800 cm-1. Bands identified in FTIR spectra of the fractions as 
listed in Tables 46 – 48 confirms the presence of volatile compounds at varying bending and 
stretching such as aldehydes, alkanes, alcohols, esters and derivatives of carboxylic acid.  
Fraction A 
 
Figure 134. FTIR spectrum of fraction A obtained from fractional distillation of African walnut oil. 
 













 Frequency cm-1                                Peak assignment  
3008 = C-H (cis) stretch Fatty acid back bone 
2924 C-H methyl stretch asymmetrical or CH2 
2854 C-H methyl stretch symmetrical Aliphatic group of 
triglycerides or CH2. 
1704 -C=O stretch bends 
1481 C-H methylene scissoring 
1410 C-H methylene scissoring 
1280 -C-O stretch 
1242 -C-O stretch 
1085 -C-O stretch 
970 =CH (trans) 
722 =C–H (cis) bending out of plane conjugated 
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FTIR frequencies in this study were assignment according to Rohman and Man, (2011) and 
Liang et al., (2012). Results presented in table 46 shows the position of absorption bands with 





Figure 135. FTIR spectrum of fraction B obtained from fractional distillation of African walnut oil 
 
 Table 47. Infrared absorption of fraction 2 (B) of African walnut oil 
 
Frequency cm-1 Peak assignment  
2924 C-H methyl stretch asymmetrical or CH2 
2850 C-H methyl stretch symmetrical Aliphatic group of 
triglycerides or CH2 
1707 C=O stretch 
1462 C-H methylene scissoring bends 
1410 C-H methylene scissoring bends 
1186 -C-O stretch; -CH2 weak bending 
1083 -C-O stretch; -CH2 weak bending 
972 =CH (trans) 
723 =C–H (cis) bending out of plane conjugated 
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FTIR frequencies in this study were assignment according to Rohman and Man, (2011) and 
Liang et al., (2012). Results presented in table 47 shows the position of absorption bands with 





Figure 136. FTIR spectrum of fraction C obtained from fractional distillation of African walnut oil. 
 










Frequency cm-1 Peak assignment  
3400 Bending out of plane. 
2924 C-H methyl stretch asymmetrical or CH2 
2855 C-H methyl stretch symmetrical Aliphatic group of 
triglycerides or CH2 
1700 -C=O stretch 
1480 C-H methylene scissoring 
1083 -C-O stretch 
973 -C-H (trans) 
724 =C–H (cis) bending out of plane conjugated 
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FTIR frequencies in this study were assignment according to Rohman and Man, (2011) and 
Liang et al., (2012). Results presented in table 48 shows the position of absorption bands with 
the appropriate vibration in spectral range from 4000 to 600 cm-1 for fraction C of walnut oil. 
 
8.2.4.2 Nuclear magnetic resonance of African walnut oil fractions obtained from 
fractional distillation 
Based on the result obtained from the antimicrobial analysis (diameter of zones) of each 
fraction tested, fractions 2 and 3 were further examined to determine their active component.  
Proton NMR (1H-NMR), Carbon NMR (13C NMR) and 13 C APT results of fractions of 
African walnut oil 
Proton NMR classifies the presence of a hydrogen functional group. 1H NMR spectrum of 
fractions 1(A) - 3 (C) of African walnut oil is shown in tables 49-52. The presence of alkanes, 
carbonyl, and alkene groups with proton shifts are observed and it is detailed in Table 49-52. 
Varying signal characteristics for the shifts were observed in the fractions which includes 
doublets, triplet, quartet and multiplets. In addition, 13 C NMR was performed to allow the 
identification of carbon atoms in each fraction of African walnut oil. Further-more, 13 Carbon 
APT test provides information about the protons attached to carbon atoms in each fraction.  
Fraction 2 (B) 
The 1H NMR spectrum of fraction 2 is shown in Appendix 1. The hydrogen proton of the major 
functional groups present in the fraction were assigned according to literature (Cipriani et al., 
2009) and are shown in Table 49. 1H NMR spectra of fraction 2 show some characteristic 
chemical shifts corresponding to different functional groups in the fraction. Chemical shifts for 
hydrogen protons peaks were recorded between 0.85-5.3 ppm. Chemical shift at 0.85 ppm show 
a CH3 methyl group saturated with CH2 groups but the CH3 appears to be overlapping with 
another CH3. Chemical shift at 0.98 ppm shows linolenic acid. At 1.3 and 1.6 ppm CH2 groups 
are observed. At shift of 2.35 ppm a CH2 attached to a carbonyl is apparent. Chemical shift at 
2.07 ppm and 2.8 ppm, alkane and alkene type hydrogen were observed. The olefinic protons 
was observed at shift 5.3 ppm. However, a strong peak at chemical shift 5.37 ppm ensures the 
presence of esters in major composition (Hariram et al., 2016). In addition, the proton shifts 
obtained in fraction 2 at a chemical shift of 0.85 and 0.98 ppm which indicates the presence of 
CH3s with linoleic and oleic as well as linolenic protons were also identified in 
1H NMR spectra 
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of linolenic acid. This peak corresponds to CH3 group harboured by both linoleic and oleic 
acid, which provides the terminal methyl backbone of fatty acid structure (Cipriani et al., 
2009). However, a comparative assessment of fraction 2 and linolenic 1H NMR spectra showed 
clearly that fraction 2 strongly exhibited very similar shifts (apart from those observed at 0.85 
and 0.98) as linolenic acid (Table 49). Therefore, the spectra of fraction 2 is in a very good 
agreement with the standard chromatogram of linolenic acid, thus it can be certainly concluded 
that these spectra represent linolenic acid which collected as fraction 2 of reduced pressure 
distillation at 115-125°C (See Appendix 1). Furthermore, different signal characteristics were 
observed at the various chemical shifts identified in 1H NMR spectrum of fractions 2 (Table 
49). In the 1H NMR spectrum of fractions 2, the CH3 signal is a triplet, the CH2 signals are 
multiplets, carbonyl (-OCO-CH2-) signals are triplets and quartet. Proton NMR for fraction 2 
and linolenic acid are presented below. The spectra of linolenic acid are provided as evidence 
of great similarity between fraction 2 and linolenic acid (Appendix 4). 
Carbon NMR (13C-NMR) 
13C-NMR technique spectrum for fraction 2 is shown in Appendix 2 and Table 50 shows the 
complete inferences of the spectral data. On analysing the 13C NMR spectrum of fraction 2, 
signal was found between 14.05-14.09 ppm and this indicates the presence of methyl carbon 
region (CH3), signal between 20.53-34.04 ppm indicates the presence of CH2 (alkane), another 
alkene carbon region (127.11 – 131.94 ppm) and carbonyl region (179.86 ppm). Hybridizations 
sp3 for CH3 and CH2, sp
2 for C=C and sp for C=O are observed. CDCl3 deuterated chloroform 
was observed in 76.72-77.36 ppm which is peculiar to all 13C-NMR spectra.  No quaternary 
carbon was observed in the spectra. Furthermore, the linolenic acid 13C NMR spectrum also 
showed similar result (Appendix 5). 
13C Attached-Proton Test (APT)  
Fraction 2 Spectra obtained for APT showed signal of methyl carbon region (CH3) at 9.73-
14.11 ppm, olefinic (127.73-130.20 ppm) (Table 50 and Appendix 3). CH2 signal was present 
between 22.67-43.81 ppm and carbonyl region (179.5 ppm). CH3 signals are pointing upward 
because the carbon has odd number of hydrogen atoms and all the CH2 pointed downwards 
because the carbon has even number of hydrogen atoms. CDCl3 deuterated chloroform was 
observed in 76.73-77.37 ppm. This result was also not too different from signals observed on 
the spectra of linolenic acid (Appendix 6). 
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Proton NMR (1H-NMR), Carbon NMR (13CNMR) and APT results of fractions 3 
1H NMR spectrum classifies the presence of hydrogen functional group at various places of 
carbon chain of fraction 3. 1H NMR spectrum of fractions 3 shows the presence of alkanes, 
carbonyl, alkene and glyceric group. This is detailed and presented in Table 51. Varying signal 
characteristics for the shifts were observed in the fractions which includes doublets, triplet, 
quartet and multiplets. Carbon NMR (13C NMR) and APT are also provided in Table 52. 
1H NMR spectra of fraction 3 show some characteristic chemical shifts corresponding to 
different functional groups in the fraction. Chemical shifts for hydrogen protons peaks were 
recorded between 0.80-5.3 ppm. Chemical shift at 0.80 ppm show a CH3 methyl group next to 
a CH2 group but with another CH3 group next to a CH2. At 1.3 and 1.5 ppm CH2 (alkanes) were 
observed. At shift of 2.0 and 2.3 ppm alkane type hydrogen and most likely an ester type 
hydrogen was observed. Chemical shift at 2.7 ppm shows CH2 an alkane type hydrogen 
observed. At 4.0-4.2 ppm, glycerol hydrogens are observed and lastly at 5.3 ppm an alkane 
type hydrogen which represent the olefinic protons were observed. The chemical shift observed 
between 4.0-4.2 ppm confirms the presence of glyceric group (Cipriani et al., 2009). However, 
a comparative assessment of fraction 2, 3 and linolenic 1H NMR spectra showed clearly that 
fraction 2 strongly exhibited very similar shifts (apart from those observed at 0.8-0.9 and 4.0-
4.2 ppm) as linolenic acid. Therefore, the spectra of fraction 3 is in a very good agreement with 
the standard chromatogram of linolenic acid, thus it can be certainly concluded that these 
spectra represent linolenic acid but contains glycerol group that may be responsible for the 
fraction prominent antimicrobial activity as observed on MRSA 252 (appendix 10 and 
appendix 11). This is the fraction which was collected as fraction 3 of reduced pressure 
distillation at 125-135°C (See Appendix 7).  
Carbon NMR (13C NMR) 
13C NMR spectrum for fraction 3 is shown in Appendix 8 and Table 52. On analysing the 13C 
NMR spectrum of fraction 3, signal was found between 13.70-14.14 ppm and this indicates the 
presence of methyl carbon region (CH3), signal between 20.42-32.76 ppm indicates the 
presence of CH2 (alkane), another carbon region (126.96 – 131.51 ppm) and carbonyl region 
(172.21-172.56 ppm). No quaternary carbon was observed in the spectra. Furthermore, the 




Attached-Proton Test (APT)  
Spectra obtained for APT showed signal of methyl carbon region (CH3) at 14.11 ppm, CH3 
(129.73-130.03 ppm). CH2 signal was present between 21.96-33.95 ppm and carbonyl region 
(179.42-179.70 ppm). CH3 signals are pointing upward because the carbon has odd number of 
hydrogen atoms and all the CH2 pointed downwards because the carbon has even number of 
hydrogen atoms. CDCl3 deuterated chloroform was observed in 76.71-77.34 ppm. This result 
was also not too different from signals observed on the spectra of linolenic acid (Appendix 9). 
From the results, 33 fatty acid methyl esters out of Supelco 37 FAME standards mix were 
identified and a few of them compare favourably well in terms of their retention times with the 
compounds identified in walnut oil FAME. FAME sample of walnut oil showed the presence 
of five (5) compounds and this also compare favourably well with previous results. Through 
fractional distillation, four fractions were obtained in walnut oil and their antimicrobial activity 
against MRSA 252 and ATCC 6538 strains showed that the strains were both susceptible to 
the fractions although they exhibited strong resistance to fractions A. Analysis of FAME 
sample of walnut oil also showed not much of the sample is required to inhibit the growth of 
the strains. In structure elucidation, the FTIR spectra show quite intensive bands which may be 
attributed to specific functional groups of fatty acids and both the Proton NMR (1H NMR), 
Carbon NMR (13C NMR) and APT results of fractions 2 and 3 of walnut oil show clearly that 
the active component in walnut oil is linolenic acid and the presence of a glyceric group 
observed in fraction 3. 
 
 




Table 49. Chemical shifts and assignments of the characteristic resonances in the 1H 
















Fraction 2 of African walnut oil 
δ (ppm) Inferences of 1H NMR Signal characteristics 
0.85 CH3 (Terminal, saturated, oleic and linoleic chain) Triplet 
0.98 CH3 (Terminal linolenic chains) Triplet 
1.3 -(CH2) n- (Methyl group - Alkane) Multiplets 
1.6 -OCO-CH2-CH2- Quartet 
2.07 -HC=CH=CH2 Multiplet 
2.35 -OCO-CH2- Triplet 
2.8 -HC=CH-CH2-CH=CH- (Alkane) Multiplets 
5.3 -CH=CH- (Alkene, Olefinic region all unsaturated fatty 
acids) 
Multiplets 
Linolenic acid standard 
δ (ppm) Inferences of 1H NMR Signal characteristics 
0.98 CH3 (Terminal linolenic chains) Triplet 
1.3 -(CH2) n- (Methyl group - Alkane) Multiplets 
1.6 -OCO-CH2-CH2- (Esters) Quartet 
2.07 -HC=CH=CH2 Multiplets 
2.35 -OCO-CH2- (Ester) Triplet 
2.8 -HC=CH-CH2-CH=CH- (Alkane) Multiplets 





Table 50. Chemical shifts and assignments of the characteristic resonances in fraction 2 
of African walnut oil 
 





Fraction 2 of walnut oil 13C NMR 
Chemical shift (ppm) Carbon type Signal characteristics 
20.53-34.04 C sp3 (likely CH2) bonded to CH3 Multiplets 
76.72, 77.04, 77.36 --- CDCl3 
127.11-131.94 C sp2 (likely CH) bonded to 
carbonyl C sp2 
Singlet and doublet 
179.86 C sp2 (likely C=O) carbonyl C sp2 Singlet 
14.05, 14.09, 14.25 C sp3 (likely CH3)  
APT Shift  
21.94-43.81 
 
C sp3 (likely CH2) bonded. Even 
numbers point downward 
Singlet, doublet, triplet 
179.42, 179.51, 179.70 C sp2 (likely CH) bonded to 
carbonyl C. 
Triplet 
9.73, 14.11 C sp3 CH3 (Odd numbers point up). Singlet 
127.73-130.20 C sp2 CH3. (up) Triplet, quadruplet 
Quaternary carbon -----  
Linolenic acid standard 13C NMR 
Chemical shift (ppm) Carbon type Signal characteristics 
20.55-34.09 C sp3 (likely CH2) bonded to CH3 Singlets, triplets 
76.35, 77.03, 76.72 ---- CDCl3 
127.11-131.95 C sp2 (likely CH) bonded to 
carbonyl C sp2 
Singlet and doublet 
180.39 C sp2 (likely C=O) carbonyl C sp2 Singlet 
14.27 C sp3 (likely CH3)  
APT Shift  
20.55-34.09 C sp3 (likely CH2) bonded. Even 
numbers point downward. 
Doublet, quadruplets 
76.72, 77.03, 77.36   
14.27 CH3 (pointing up) Singlet 
127.11-131.95 CH3 (pointing up)  
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Table 51. Chemical shifts and assignments of the characteristic resonances in the 1H 
NMR spectra of fraction 3 of African walnut oil 
 
Table 52. Chemical shifts and assignments of the characteristic resonances in the 13C 









δ (ppm) Fraction 3 Inferences of 1H-NMR Signal 
characteristics 
0.80 CH3  Doublet 
0.90 CH3  Triplet 
1.3 CH2 (Methyl group - Alkane) Multiplet 
1.5 CH2  Multiplet 
1.9 -CH2-CH=CH (All allylic all unsaturated fatty acids) Multiplet 
2.2 - CH2- C= Multiplet 
2.7 CH2-C=O  Doublet 
4.0 CH2-OCOR (Glyceric region all unsaturated fatty acids) Doublet 
4.2 CH2-OCOR (Glyceric region all unsaturated fatty acids) Quadruplet 
5.3 CH=CH (Alkene, Olefinic region all unsaturated fatty acids). Triplet 
Fraction 3 of walnut oil 13C NMR  
Chemical shift (ppm) Carbon type Signal characteristics 
20.42-33.93 C sp3 (likely CH2) bonded to CH3  Quadruplet and triplet  
126.96-131.55 C sp2 (likely CH) bonded to 
carbonyl C sp2 
Quadruplet and triplet 
172.21, 172.56 C sp2 (likely C=O) carbonyl C sp2 Doublet 
13.70, 13.94, 13.98, 14.14, C sp3 (likely CH3)  Quadruplet 
APT Shift C13APT 
21.96-33.95 C sp3 (likely CH2) bonded. Even 
numbers point downward 
Multiplets 
76.71, 77.03, 77.71 CDCl3. Triplets 
180 C sp2 (likely CH) bonded to 
carbonyl C or C=O. 
Singlet 
14.12 C sp3 CH3 (Odd numbers point up). Singlet 
129.73, 130.03 C sp2 CH. (up) Doublet,  
Quaternary carbon -----  
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8.3 Discussion  
To date, this is the first study to give detailed fatty acid composition of African walnut screw 
press oil fractions from Nigeria. In a previous study on the fatty acids of African walnut oil, it 
was established that palmitic (C16:0), α-linolenic (C18:3), linoleic (C18:3) were the main 
components of the oil (Nkwonta, 2015). Tchiegang, Kapseu & Parmentier (2001) also reported 
same types of saturated and polyunsaturated fatty acids in walnut cultivars grown in Cameroon. 
Although different capillary columns were used by both authors, they still noted that the most 
abundant fatty acid was the conjugated C18:3 - linolenic acid (70 %) followed by C18:2 
(linoleic acid), and C18:0 (palmitic acid) fatty acids. These findings are in good correlation 
with the results obtained in this present study and suggest a strong similarity between the oil 
of African walnuts grown in Nigeria and Cameroon despite different ecological factors that 
possibly influence the growth of the plants. In this present study, polyunsaturated fatty acids 
were observed as major components with strong indication of linolenic acids (C18:3) as the 
major fatty acid component of walnut oil. In previous studies no glyceric group has been 
reported (Ajayi, 2009; Bello, and Anjorin 2012). Whereas, in this study, the presence of 
glyceric groups at chemical shifts between 4.2-4.3 ppm in fraction 3 was observed in addition 
to other groups. According to our finding, African walnut oil may be a good source of glyceric 
acid. 
According to Harwood (1980) the major fatty acids in seed oils are palmitic, linoleic and 
linolenic acids. Linolenic acid is the most usual polyunsaturated fatty acids found in seed fats. 
Linolenic acid is the most usual form of triethenoid C18 acid found in seed oils. It forms 50% 
or more of the mixed fatty acids in linseed oil, and occurs in other seed oils (Harwood, 1980). 
In this study linolenic acid was the predominant fatty acid found in walnut oil and its fractions. 
Ohta et al., (1995) investigated the activity of ten different fatty acids and their methyl esters 
against S. aureus and MRSA. They found that palmitic acid (C16:0), stearic acid (C18:0) and 
oleic acid (C18:1) had no activity, but fatty acids with two or more double bonds (starting with 
C18:2) were more active. Of the polyunsaturated fatty acids tested, the activity of γ-linolenic 
acid (C18:3) and α-linolenic acid (C18:3) was the highest, eicosapentaenoic acid (C20:5), and 
docosahexaenoic acid (C22:6) also had strong activity. The methyl esters were either inactive 
or much less active than the other acidic form. In this study polyunsaturated acid particularly, 
linolenic acid, (C18:3) is a carboxylic acid with 18 carbon chain and three cis double bonds 
was found to be active causing bactericidal activity on MRSA 252 and ATCC 6538. In addition, 
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pure linolenic acid was observed to inhibit biofilm formation in MRSA 252 and ATCC 6538 
at varying concentrations of 7.8 and 15.6 mg/mL respectively which was not different from the 
FAME sample. This value seems lower than the MBIC values obtained for African walnut oil 
and indicate that a lower concentration is needed to inhibit the growth of MRSA 252 and ATCC 
6538. However overall, FAME sample of walnut oil fraction 2 as well as fraction 3 showed 
promising activity against methicillin susceptible and resistant strains. Therefore, in contrast to 
the findings of Ohta et al., (1995) FAME sample of walnut oil was active. Orhan et al., (2011) 
reported that Linolenic acid possesses additional interesting antibacterial activity. Orhan and 
his co-workers (2011) investigated the antibacterial activity of α-linolenic on a pathogenic 
MRSA strain in an hospital in Japan and demonstrated that α-linolenic was able to significantly 
inhibit the growth of MRSA in the growth medium. In this study, disc diffusion assay was able 
to show that fractions 2 and 3 appeared to be bactericidal on the growth of MRSA 252 and 
ATCC 6538 since this was observed by the clear zones obtained on Mueller Hinton agar after 
24-48 h). Surprisingly fraction 4 appeared too acidic by its ability to destroy the petri -
plates. The findings obtained in this study correlates with those of other authors who 
suggested that inhibitory activity of walnut oil on S. aureus is associated with the presence 
of linolenic acid. Yoon et al., (2018) reported that linolenic acid present in walnut oil play 
crucial role in inhibiting the growth of S. aureus. Its inhibitory activity is associated with an 
increase in the permeability of the bacterial membrane. The interaction of linolenic acid in 
plant oils with bacterial cell membranes can destabilize the membrane and increase membrane 
permeability, thereby inducing leakage of cytosolic contents. In extreme cases, the increased 
permeability and corresponding membrane destabilization can eventually lead to cell lysis. 
Similarly, Greenway and Dyke (1979) reported that linolenic acid caused the damage of S. 
aureus cell membranes. Membrane leakage after linolenic acid treatment was detected by 
measuring the release of biomolecules (e.g., glutamic acid) from bacteria.  
African walnut oil, with its very high proportion of linoleic and linolenic acid, contributes to a 
balanced diet and helps prevent cardiovascular diseases (Saxenaa et al., 2009; Ros, 2010; 
Alasalvar and Bolling 2015). In this study, the presence of linolenic acid found as major fatty 
acid of walnut oil show clinical potentials of walnut oil in reducing the risk factors of 
cardiovascular and coronary heard diseases as well as type 2 diabetes. In a study conducted by 
Ohta et al. (1995) α-Linolenic acid is considered to have low toxicity and may be used clinically 
to treat patients infected with MRSA. It is naturally occurring, and hence unfavourable 
reactions would not be anticipated, it should not destroy the commensal flora, resistance to it 
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would not develop, and there would apparently be no risk of resistance to antibiotics developing 



































Chapter 9. General Discussion and Future Research 
9.1 Summary of main findings 
S. aureus is a human pathogenic strain responsible for numerous infections (Gordon and Lowy, 
2008). Its pathogenicity is aided by its ability to form biofilms and the wide range of virulence 
factors produced by it (Morell and Balkin, 2010). Its ability to form biofilms makes the 
infections very difficult to treat thus causing high rates of morbidity and mortality in many 
countries of the world (Hall-Stoodley, Costerton & Stoodley 2004).The biofilm forming ability 
of S. aureus catalysed mainly by the presence of its biofilm formation genes plays a key role 
in protecting the pathogen from antibiotics in the sessile state and contribute immensely to the 
manifestation of antibiotic resistances exhibited by the strain (Silva et al., 2016) which makes 
treatment of S. aureus infections very difficult to treat (Hall-Stoodley, Costerton & Stoodley 
2004). On the other hand, production of other virulence genes such as the adhesion genes and 
antibiotic resistance genes, accompanied by its biofilm forming potential contributes to the 
emergence and prevalence of MRSA infections in various health-care settings world-wide (Gill 
et al., 2005; Davies and Davies, 2010). 
One of the greatest problems of solving an infection is when the pathogenic organism is 
resistant to antibiotics (Davies and Davies, 2010). This is the case of MRSA. MRSA is of 
concern when it comes to treatment because it is resistant to numerous drugs. The pathogen is 
now resistant to antibiotics belonging to different classes such as penicillins, cephalosporins, 
aminoglycosides, tetracyclines, macrolides and floroquinolones (Levy and Marshall, 2004; 
O'neil, 2008). However, some strains of S. aureus still remain susceptible to just two antibiotics 
such as clindamycin and gentamicin (Marston et al., 2016). Most worrisome is the fact that this 
pathogenic strain now resides in many health-care systems including intensive care units across 
the world especially in under-developed countries and everyone visiting the hospital is at risk, 
since majority of MRSA clinical infections occur in patients who have been in the hospital for 
long period, patients who have been admitted during MRSA era, patients with cuts, lesions, or 
wounds, patients with inserted medical device such as catheters and patients placed on 
antibiotics (Bhat and Tenguria, 2014). Despite tremendous efforts by the medical system in 
establishing measures such as the institution of standard treatment guidelines to check 
antibiotic prescriptions and usage, infection control measures such as hand hygiene and good 
professional practice in hospitals, limited achievements have been made in curbing the menace 
of MRSA (Abdullahi and Iregbu, 2018). This is the current situation in Nigeria and other 
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African countries that are under-developed. In Nigeria, drug prescription of antibiotics can be 
given to patients for treatment of mild infections without due procedure, there is lack of 
uniformity in drug prescription despite treatment guidelines, and high cost of healthcare 
facilities which does not allow proper routine infection control (David and Daum, 2010; 
Abdullahi and Iregbu, 2018). All these three factors hinder the successful reduction of MRSA 
in the country.  
Again, a major concern is the increase in the incidence of multidrug-resistant MRSA 
staphylococcal organisms and the development of new clones of MRSA in both developed and 
underdeveloped countries. In Nigeria, recent research studies have found that the prevalence 
of MRSA in Nigeria is between 28% and 30% with an increase in toxic clonal linages which 
include CC80, CC30, CC152 and CC5 in hospitals and environment (Abdulgader et al., 2015). 
Therefore, substantial measures to curb the emergence of sophisticated MRSA in both the 
hospitals and community is necessary especially in ensuring strict application of treatment 
guidelines and provision of infection control facilities (Abdulgader et al., 2015; Abdullahi and 
Iregbu, 2018).  
While many studies have been carried out in search of novel active plant antimicrobials with a 
special focus on the plant extracts from leaves, root and barks of plants due to their active 
secondary metabolites against MRSA recent studies about treating MRSA infections have 
focussed on deriving natural antimicrobials from plants and combination with antibiotics 
(Lewis, 2013; Fair and Tor, 2014; Gupta and Birdi, 2017). Thus, in a continuing search for 
natural products with antibacterial activity against MRSA, the aim of this study was to identify 
novel oils from walnut (Tetracarpidium conophorum), Fluted pumpkin (Telfairia 
occidentalis), Cashew (Anacardium occidentale). Walnut, cashew and pumpkin were first 
identified as nuts and seeds that likely harbour oils with antimicrobial potential, possess 
phytochemical constituents and unobserved potentials in treating S. aureus infections using a 
collection of different methodologies such as mechanical and chemical, phytochemical, 
biochemical and microbiological.   
In this thesis, walnut, cashew and pumpkin oils were extracted using mechanical extraction 
method and their various extracts were obtained using chemical methods. Mechanical 
extraction was done using screw press and a combination of best extraction solvents with good 
polarities described in previous studies (Akpuaka and Nwankwor, 2000; Ajaiyeoba and Fadare, 
2006; Maduabuchi and Onyebuchi, 2016). For the first time, this thesis is producing detailed 
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comparison of both expelled oils and solvent extracted oils. The mechanical method produced 
expelled oils while the chemical method was the solvent extraction method in which three main 
solvents namely, n-hexane, chloroform and petroleum ether were used to obtain extracts. So 
far, results presented in chapter 3 of this thesis showed that a total of three different extracts 
were obtained for walnut, cashew and pumpkin, making a total of 9 extracts examined. Both 
the expelled pressed oils and their respective extracts were of good quality and colour varied 
from brown to shades of yellow. Although the solvent extracted method particularly n-hexane 
gave high yield more than the other extracts.  
In addition, with preliminary phytochemical screening, we identified individual groups of 
phytochemicals in the oils and extracts using ultra violet absorption. The different groups 
obtained are identified in literature has important secondary metabolites that could be active 
components responsible for curative purposes of human infections. In the expelled oils, this 
study identified similar groups of phytochemicals such as flavonoids, alkaloids, saponins, 
tannins and terpenoids present in walnut and pumpkin oil, flavonoids, alkaloids and tannins 
were found in cashew oil. Their respective extracts were mainly found to contain flavonoids, 
saponins and tannins with variations in alkaloids and terpenoids. The different groups were 
concluded to be bioactive agents that could be responsible for the antibacterial activity of the 
oils and extracts against methicillin resistant and susceptible S. aureus strains; MRSA 252 and 
ATCC 6538 tested in this thesis. However, previous reports have showed that walnut oil 
contain the same phytochemicals identified in this study indicating that the medicinal role of 
the oil could be associated with the classes of phytochemicals identified in the oil. In addition, 
the presence of varied combination of phytochemicals in the solvent extracts particularly in n-
hexane extracts is an indication that the solubility of phytocompounds in various solvents 
depends on the polarity of the solvents.  In this study, we established that n-hexane produced 
the highest yield of oil with more classes of phytochemicals a similar observation made by 
(Maduabuchi and Onyebuchi, 2016). This could be related to its effectiveness against MRSA 
252 and ATCC 6538 compared to other extracts. Because numerous studies have reported the 
antifungal, anti-inflammatory, analgesic and antibacterial potentials of alkaloids and 
flavonoids in walnut (Ajaiyeoba and Fadare, 2006; Zakavi et al., 2013), therefore the result of 
this present study may also suggest that walnut oil could also have an anaesthetic potential, 
wound healing potential and possibly anti-inflammatory activity. In all, results presented in 
chapter 3 of this thesis showed that oils could be extracted from walnut, cashew and pumpkin 
using both mechanical and solvent extraction methods producing different yields and that both 
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the oils and extracts possessed different classes of phytochemicals that could be responsible 
for their antibacterial properties. 
Microbiological tests to confirm S. aureus strains were used in this study. These include 
morphological appearances such as colonial appearances on general purpose media were 
assessed. This simple test confirmed their colonial appearances on agar media as golden 
yellow, creamy with trypticase soy agar and Columbia blood base agar as appropriate media 
suitable for their growth. Biochemical tests such as catalase test and lysostaphin tests were used 
in this thesis to further also confirm and characterise MRSA 252 and S. aureus ATCC 6538 
used in this study. Both strains were catalase positive and lysostaphin positive. This 
confirmatory result led to the investigation of their biofilm forming capacity. The aggregation 
phase of biofilm formation of bacteria is linked to the secretion of extracellular polysaccharides 
referred to as slime which play a key role in bacterial adhesion to surfaces (Torlak et al., 2017). 
In this study we established the biofilm forming potentials of MRSA 252 and S. aureus ATCC 
6538 using a simple phenotypic test method such as Congo red to detect their slime production. 
Appearances of black colonies on Congo red agar plates revealed that the S. aureus strains used 
in this study has the ability to form biofilm. Similar approach to determine biofilm forming 
ability of S. aureus strains have been reported in previous studies (Atshan et al., 2012; Atshan 
et al., 2013). Thus, in this thesis, MRSA 252 was identified as a biofilm former and a strong 
one while S. aureus ATCC 6538 was also a biofilm former but weak. Quantification of their 
biofilms were assessed using the microtiter plate method. This made it clearer that biofilm 
formed by both strains was either strong or weak. The results presented in chapter 4 of this 
thesis showed that MRSA 252 and S. aureus ATCC 6538 were S. aureus strains exhibiting 
different colonial morphologies, are biofilm formers and classified into different categories 
based on their degree of biofilm formation.  
Various potentials of each oil sample and extract was determined on MRSA 252 and ATCC 
6538 biofilms. These includes the ability of the oils to kill the strains, inhibit the growth of the 
strains, eradication of the strains and possible synergism with antibiotics. Due to the 
identification and classification of the biofilm forming capacity of MRSA 252 and S. aureus 
ATCC 6538 biofilms, their susceptibility to different concentrations of walnut, cashew and 
pumpkin oils were determined using standard methods such as disk diffusion agar, minimum 
inhibitory concentration, minimum biofilm inhibitory concentration and minimum biofilm 
eradication concentration. In this study, both the agar well diffusion and disk diffusion tests 
used in some previous reports (Magaldi et al., 2004; Ajaiyeoba and Fadare, 2006) were used 
311 
 
to determine whether the oils could kill MRSA 252 and ATCC 6538 in biofilms. This was 
investigated by determining the susceptibility of MRSA 252 and ATCC 6538 biofilms to 
walnut, cashew and pumpkin oils. In the results, walnut oil exhibited the highest activity with 
the strains tested compared to cashew and pumpkin oils. At 1000 mg/mL, it had an activity of 
(23.04 ± 0.21) and (19.00 ± 0.22) mm with MRSA 252 and ATCC 6538 biofilms. Furthermore, 
the antibacterial activity of walnut, cashew and pumpkin extracts displayed poor antibacterial 
activities at 1000 mg/mL. Although the n-hexane extract of walnut oil produced the highest 
activity.  
On the other hand, possible synergism of walnut, cashew and pumpkin oil with varying 
concentration of antibiotics in different classes (already listed in paragraph 2 of this chapter) 
were determined. The concept of combining walnut extract with commercial antibiotics have 
been previously described by Ogbolu and Alli, (2012) although this thesis has elaborated the 
research on biofilms. This test was carried to determine whether the oils could serve as better 
antibacterial agents in the treatment of S. aureus infections. The activities of the oils in 
combination with the antibiotics were tested against MRSA 252 and S. aureus ATCC 6538 
biofilms. Interestingly results obtained which are shown in chapter 5 of this thesis, showed that 
firstly, the oils alone (single treatment with oils only) showed varying susceptibility indicating 
antibacterial activity against the strains, secondly that the oils in combination with some 
antibiotics resulted in varying degrees of drug interactions such synergism, potentiation effect,  
antagonism which are the four groups of drug interactions identified in literature and thirdly 
that drugs that produced small zones in diameter (low activity) that their activity enhanced by 
combination with oils. In the result obtained for this analysis, walnut oil was found to produce 
profound combination effects with drugs such as gentamicin, carbenicillin, streptomycin, 
vancomycin, trimethoprim and oxacillin. This result shows a successful trial of plant oil in 
combination with antibiotics. To this end, this analysis is the first to be carried out on a 
collection of these expelled oil samples and it suggests that the oil samples particularly walnut 
oil could be serve as antibacterial agent with therapeutic purposes in disease treatment against 
methicillin resistant and susceptible S. aureus strains.  
Similarly, all the individual extracts of walnut, cashew and pumpkin except chloroform showed 
activity with the S. aureus strains. Only the n-hexane extract of walnut showed the highest 
activity with MRSA 252 and ATCC 6538. In addition, this study showed that both the expelled 
oils and extracts displayed concentration-dependent antibacterial activities in a concentration 
range of 0.98 mg/mL-500 mg/mL. This activity was determined when MICs, MBICs and 
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MBECs of the oils and extracts were investigated. Using the micro-broth dilution method, our 
result showed for the first time, that walnut, cashew and pumpkin oils showed antibacterial 
activities against MRSA 252 and ATCC 6538 biofilms. Walnut oil exhibited the highest 
inhibitory effect on planktonic and 24 h preformed biofilms of MRSA 252 and ATCC 6538. 
The growth of MRSA 252 and ATCC 6538 biofilms were significantly decreased in planktonic 
cells faster than in biofilms (probably because of the presence of slime covering which is 
responsible for the resistant nature of biofilms). However, this study, showed promising 
antibacterial potential of walnut oil against MRSA 252 and ATCC 6538 biofilms than cashew 
and pumpkin oils. The potential of the oils to eradicate MRSA 252 and ATCC 6538 biofilms 
was determined. This was by using the high throughput screening assay to obtain the 
eradication concentration of each oils sample. Their ability to eradicate the strains was 
determined over a period of 6 h, 12 h, 24 h and 48 h. This study was undertaken to determine 
the effect of walnut, cashew and pumpkin oil on 48 h preformed biofilms of MRSA 252 and 
ATCC 6538. In this study, we present the log-reductions of viable counts of both strains at the 
different time points.  Furthermore, to our knowledge, this is also the first-time log-reductions 
of viable counts of S. aureus strains are determined after treatment with these types of oils. To 
this end, concentration dependent reduction of both strains was observed, and walnut oil had 
the capacity to eradicate the biofilms of MRSA 252 and ATCC 6538 compared to cashew and 
pumpkin. The microbiological analysis presented in chapter 5 of this thesis suggests that walnut 
oil may be useful as natural antimicrobial agent in the treatment of S. aureus infections. Our 
findings in this study showed that walnut oil possess the potential to kill, inhibit and eradicate 
the growth of planktonic cells of MRSA 252 and ATCC 6538 as well as the preformed biofilms 
of the strains. These potentials could no otherwise be related to the presence of phytochemicals 
observed in chapter 3 of this thesis.  
The combinational test results presented for antibiotic synergy with walnut and pumpkin oil in 
chapter 6 indicated that both oils could be used in single treatment against MRSA and ATCC 
6538 as well in combination with antibiotics. Using fractional inhibitory concentration, the 
synergistic activity of walnut and pumpkin oil with selected antibiotics against MRSA and 
ATCC 6538 was determined to ascertain whether the drug reactions observed on the disc plates 
were real. This study found that the best combination of walnut oil was with vancomycin, 
streptomycin and trimethoprim which showed lowest FIC index value (FIC Index ≤0.5). This 
combination was able to work effectively well on both MRSA 252 and ATCC 6538. While for 
pumpkin oil, combination with gentamicin alone produced synergy. Thus, in thesis we show 
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for the first time that walnut oil may effectively be combined with antibiotics for maximum 
results in treatment of S. aureus infections when used in minimally low concentrations. 
Furthermore, biofilm kinetic time assay in Chapter 6 of this thesis showed that walnut, cashew 
and pumpkin oils exhibit the potential of killing MRSA 252 and ATCC 6538 strains with time. 
This was performed by growing the biofilms first on 96-well plates and then treated each well 
of the plate with different concentration of walnut and pumpkin oil. Based on the results, 
findings in this thesis showed that walnut and pumpkin oils can reduce the viable counts of 
MRSA 252 and ATCC 6538 strains in biofilm with time. Viable counts in MRSA 252 and 
ATCC 6538 biofilms were recorded in log reduction forms. However, walnut oil showed the 
highest log reduction in 2 hours after which the count became zero. In this chapter, using G. 
mellonella to mimic the human infection model, the efficacy of using plant oil particularly 
walnut oil in treating S. aureus infections were tested. G. mellonella, is used in this thesis 
because it exhibits similar immunological responses to infection as in human. Recently, this 
has been widely used in many studies in determining the pathogenicity of pathogenic strains 
(Pollitt et al., 2018; Yang et al., 2017).  This study showed that MRSA 252 exhibited stronger 
pathogenicity characterized by the forming of thick pellicles called melanin compared to 
ATCC 6538. This was observed when 100 of MRSA 252 and ATCC 6538 inoculums were 
injected into the worm. However, 10-5 – 10-4 of the same inoculums resulted in reduced number 
of deaths. Treatment of G. mellonella infected with 100 inoculums of MRSA 252 and ATCC 
6538 and treated with 31.25 mg/mL and 15.6 mg/mL concentrations of walnut oil (which was 
the eradication concentrations), showed that waxworms survived for some days even though 
they developed another form of pellicle which appears different to the blackish melanin.  
The investigation of gene regulation of walnut and pumpkin oil against MRSA and ATCC 6538 
strains is described in chapter 7. This was carried out using standard molecular method such as 
reverse transcriptase polymerase chain reaction (RT-PCR) and quantitative real time PCR 
(qRT-PCR).  In this analysis, virulence genes involved in biofilm formation, adhesion, quorum 
sensing, and antibiotic resistance were tested in MRSA 252 and ATCC 6538 biofilms were 
identified. In this study, only genes confirmed to be present in the biofilms of S. aureus strains 
tested had their expression levels determined. This thesis showed the expression of the 
virulence genes in MRSA 252 and ATCC 6538 biofilms before and after treatment with walnut 
and pumpkin oils which makes the findings of the thesis the second and quite different from 
that of Atshan et al., (2013) who was the first to study the expression of adhesion and biofilm 
genes of S. aureus cultures at different growth time points without treatment. Our study showed 
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in chapter 7 of this thesis that without treatment, generally adhesion genes were downregulated 
at 12 h in S. aureus strains, up-regulated at 24 h and down-regulated at 48 h. However, 
treatment with oil further down-regulated the genes. A few biofilm genes like fnbA, fnbB, clfB 
and eno, were up-regulated at 12 h, 24 h and 48 h. Although exceptional cases of up-regulation 
were observed at 24 h for fnbB and icaC. Interestingly in this study we show that walnut and 
pumpkin oils significantly inhibited the expression of all the biofilm and adhesion genes as 
well as the regulatory gene and antibiotic resistance genes such as agrA, blaZ, and mecA genes. 
AgrA, blaZ, and mecA genes tested are responsible for the regulation of gene expressional 
levels at exponential and post exponential phases of growth, penicillin and methicillin 
resistance in S. aureus. 
Lastly, results presented in chapter 8 of this thesis showed the preliminary investigation of fatty 
acid components present in walnut oil. Attempts to identify the fatty acid components of walnut 
oil was carried out because it was found to be the most active oil. This attempt made it possible 
for vital fatty acids in walnut oil to be identified. This study showed that five (5) fatty acid 
compounds were observed in walnut oil with some minor ones. This was obtained using GC-
MS technique. However, linolenic acid was found to be the most predominant fatty acid in the 
oil. This same compound has been reported in previous report of Tchiegang, Kapseu & 
Parmentier (2001) and Nkwonta, (2015).  Other identification procedures such as FTIR showed 
the presence of different functional groups such as aldehydes, alkanes, alcohols, esters and 
derivatives of carboxylic acid. This was found in walnut oil and its fractions. Furthermore, 
NMRs including proton NMR, carbon NMR spectrums confirmed the presence of linolenic 
acid and a combination with linoleic acid a compound found to be peculiar to the oil. From the 
walnut spectra, the presence of glyceric acid as seen in the spectra of walnut fraction makes 
this study the second to be reported.  A simple bioassay guided‐fractionation procedure applied 
in the study helped to confirm the fractions that were active before further analysis were 
performed on them. Similarly, in chapter three of this thesis, FTIR results showed the 
functional groups present in pumpkin and cashew oil although no further study was conducted 
on them.  
In summary, this thesis has made significant and multiple contributions to knowledge: firstly, 
the that oils from walnut, cashew and pumpkin could be extracted by mechanical and chemical 
means, secondly that the expelled press oils contain 3-5 main classes of phytochemicals that 
may be responsible for their activity particularly walnut oil. Thirdly, resistant and susceptible 
strains of S. aureus are biofilm formers that can form varying quantity of biofilm; fourthly that 
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biofilms of MRSA 252 and ATCC 6538 are susceptible to walnut, cashew and pumpkin and 
their extracts; that the expelled oils in combination with antibiotics could be used in the 
treatment of S. aureus infections; that biofim formation in MRSA 252 and ATCC 6538 could 
be inhibited and eradicated by African walnut, cashew and pumpkin oils. That the expression 
levels of most genes associated with virulence of S. aureus can be controlled by plant oils 
particularly walnut oil. Lastly, that significant amount of fatty acids is present in African walnut 
oil and is responsible for is activity. 
9.2 Future Research 
In this study only two S. aureus strains were used throughout the research study. Future work 
should involve the use of more strains which could include reference strains and clinical 
isolates from skin infections and infected wounds. 
Preliminary investigation and identification of fatty acid components of African walnut oil was 
done through fractional distillation, GC-MS, NMR and FTIR. In this study, separation of 
African walnut oil into fractions was really challenging because no favourable result was 
obtained from the column chromatographic technique that was first tried. Although the 
fractional distillation process yielded 4 fractions with some showing slight mixture of 
compounds a better means of separation could be used to obtain maximum separation for 
optimum results. 
Phytochemical analysis was performed to confirm the presence of phytochemicals in African 
walnut, cashew and pumpkin oils. Although standard procedures were used, better 
confirmation process could be coupled with mass spectrometry that will help to quantify them. 
Inorder to quantify trace amounts of phytochemicals present in the oils and extracts, Raman 
and surface enhanced Raman spectroscopy could be used since not all the pigmental ranges 
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Appendix 10 – 11 
1H, NMR of fraction 2 showing the position of the CH3 group of linolenic acid 
1H, NMR of fraction 2 showing the position of the CH3 group of linolenic acid and glyceric 
group 
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